18.11.2014 Views

The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus

The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus

The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />

<strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />

<strong>Malaria</strong> during Pregnancy


<strong>Rapid</strong> <strong>Assessment</strong> Manual<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />

<strong>Malaria</strong> during Pregnancy<br />

Package Contents<br />

Executive Summary<br />

Acknowledgements<br />

Abbreviations<br />

1 <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong><br />

2 Planning a <strong>Rapid</strong> <strong>Assessment</strong><br />

3 Conducting <strong>the</strong> <strong>Assessment</strong><br />

4 Data Management and Analysis<br />

5 Report Preparation and Use<br />

References<br />

Glossary<br />

<strong>Rapid</strong> <strong>Assessment</strong> Modules and Tools<br />

For each survey tool, a module is provided.<br />

1: Antenatal Clinic Survey<br />

2: Delivery Unit Survey<br />

3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease<br />

4: Antenatal Clinic Facility <strong>Assessment</strong><br />

5: Health-Care Worker Observation<br />

6: Focus Group/Individual Interviews with Health-Care Workers<br />

7: Focus Group/Individual Interviews with Traditional Birth Attendants and Midwives<br />

8: Client Exit Interview<br />

9: Focus Group/Individual Interviews with Recently/Currently Pregnant Women<br />

10: Individual Interviews with Key Informants<br />

<strong>Rapid</strong> <strong>Assessment</strong> Resources<br />

Note: <strong>The</strong> CD-ROM enclosed<br />

in <strong>the</strong> inside back pocket <strong>of</strong><br />

this hard copy contains all<br />

<strong>the</strong> package contents.<br />

<strong>The</strong> manual, modules, tools,<br />

and most resources are<br />

also available in Word files;<br />

when pdfs and Word files<br />

differ, use <strong>the</strong> pdfs, as <strong>the</strong>y<br />

are most up-to-date.<br />

Resource 1: Articles and Guidelines<br />

• Relevant Articles: <strong>Malaria</strong> in Pregnancy<br />

• Guidelines: A Strategic Framework for <strong>Malaria</strong> Prevention and Control During Pregnancy in <strong>the</strong> African Region.<br />

WHO, 2004. In English, French, and Portuguese (only on CD-ROM).<br />

Resource 2: Resources for <strong>the</strong> Qualitative <strong>Assessment</strong><br />

• Sample Interviewer Training Manual<br />

• List <strong>of</strong> Resources<br />

Resource 3: PowerPoint Presentations for Training Sessions<br />

(On CD-ROM only)<br />

• Overview <strong>of</strong> rapid assessment: <strong>Rapid</strong> assessment: general issues<br />

• Overview <strong>of</strong> modules: 1 & 2; 3; 4, 5 & 8; 6, 7, 9 & 10<br />

• Epidemiology <strong>of</strong> malaria: Epidemiology and control <strong>of</strong> malaria in pregnancy<br />

• Clinical and laboratory methods: <strong>Assessment</strong> <strong>of</strong> gestational age, Body measurements, Laboratory methods<br />

• O<strong>the</strong>r assessment topics: Data management and sample size calculation<br />

Resource 4: S<strong>of</strong>tware and Planning Tools<br />

• Costing Tool<br />

• Epi Info (for information and to download go to www.cdc.gov/epiinfo/)


For fur<strong>the</strong>r information, please contact:<br />

<strong>Malaria</strong> Branch/DPD<br />

Centers for Disease Control and Prevention<br />

1600 Clifton Rd, Atlanta, GA 30333, U.S.A<br />

nciddpdmalaria@cdc.gov ▪ www.cdc.gov/malaria<br />

Department <strong>of</strong> Making Pregnancy Safer<br />

Global <strong>Malaria</strong> Programme<br />

World Health Organization<br />

20 Avenue Appia-CH-1211 Geneva 27<br />

infogmp@who.int ▪ www.who.int/malaria ▪ www.who.int/making_pregnancy_safer


<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />

<strong>Malaria</strong> during Pregnancy<br />

Contents<br />

1. <strong>The</strong> Manual<br />

Executive Summary.....................................................................................................................................................................ii<br />

Acknowledgements.....................................................................................................................................................................iii<br />

Abbreviations................................................................................................................................................................................iv<br />

1 <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong>.................................................................................. 1<br />

1.1 <strong>The</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy........................................................................................................................ 2<br />

1.1.1 Infection with Plasmodium falciparum.............................................................................................................................. 2<br />

1.1.2 Infection with O<strong>the</strong>r <strong>Malaria</strong> Parasites.............................................................................................................................. 3<br />

1.2 <strong>Malaria</strong> Prevention Interventions for Pregnant Women............................................................................................ 3<br />

1.3 Information for Action.............................................................................................................................................................. 6<br />

1.4 Use <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong> Package............................................................................................................................... 8<br />

2 Planning <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>....................................................................................................................... 9<br />

2.1 Objectives <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>................................................................................................................................... 9<br />

2.2 Potential Information Sources............................................................................................................................................... 9<br />

2.3 Designing <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>.........................................................................................................................................12<br />

3 Conducting <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>..................................................................................................................13<br />

3.1 Selecting a Time Period............................................................................................................................................................13<br />

3.2 Determining a Timetable and Budget................................................................................................................................13<br />

3.3 Building and Organizing <strong>the</strong> <strong>Assessment</strong> Team.............................................................................................................14<br />

3.4 Selecting <strong>Assessment</strong> Areas, Sites, and Sample Sizes..................................................................................................18<br />

3.5 Adapting, Translating, and Preparing <strong>Assessment</strong> Materials..................................................................................21<br />

3.6 Conducting <strong>Assessment</strong> Training.........................................................................................................................................21<br />

3.7 Assuring <strong>Assessment</strong> Quality................................................................................................................................................23<br />

3.8 Providing Information about <strong>the</strong> Survey/Obtaining Informed Consent.............................................................25<br />

3.9 Providing Treatment for <strong>Malaria</strong> and Anemia................................................................................................................25<br />

4 Data Management and Analysis.......................................................................................................................26<br />

4.1 Data Management ......................................................................................................................................................................26<br />

4.2 Data Analysis.................................................................................................................................................................................29<br />

5 Report Preparation and Use <strong>of</strong> Results.........................................................................................................31<br />

References .....................................................................................................................................................................................33<br />

Glossary .....................................................................................................................................................................................34<br />

<strong>The</strong> Manual<br />

i


Executive Summary<br />

Each year, more than 30 million women living in areas where malaria is transmitted<br />

become pregnant, and an estimated 200,000 newborns die as a result <strong>of</strong> <strong>the</strong>ir mo<strong>the</strong>rs’<br />

infection. Nine <strong>of</strong> 10 malaria deaths worldwide occur in Sub-Saharan Africa, <strong>the</strong> part <strong>of</strong> <strong>the</strong><br />

world most affected by malaria, and in that region, as many as 10,000 pregnant women<br />

die each year <strong>of</strong> malaria-related causes, chiefly anemia. Less is known about <strong>the</strong> effects <strong>of</strong><br />

malaria during pregnancy in o<strong>the</strong>r parts <strong>of</strong> <strong>the</strong> world, but large numbers <strong>of</strong> pregnant women<br />

are at risk. Safe and effective interventions for pregnant women—intermittent preventive<br />

treatment, insecticide-treated mosquito nets, and febrile case management—can help<br />

prevent <strong>the</strong> consequences <strong>of</strong> malaria infection. <strong>Malaria</strong>-affected countries vary widely in <strong>the</strong>ir<br />

knowledge <strong>of</strong> <strong>the</strong> burden <strong>of</strong> malaria in pregnancy within <strong>the</strong>ir borders and <strong>of</strong> <strong>the</strong> impact <strong>of</strong><br />

any interventions or programs.<br />

This rapid assessment package is designed to help countries obtain <strong>the</strong> information <strong>the</strong>y<br />

need to assess <strong>the</strong> burden <strong>of</strong> malaria during pregnancy, to develop a policy or program, to<br />

assess program implementation, and to evaluate impact. <strong>The</strong> information can also be used<br />

to advocate for policy change and to provide baseline data. When planning assessments,<br />

countries are encouraged to make use <strong>of</strong> pertinent recent data from reliable sources. However,<br />

because data may be lacking and because worldwide a relatively high number <strong>of</strong> women visit<br />

an antenatal clinic at least once during pregnancy (in sub-Saharan Africa, a high proportion<br />

visit at least once), this package provides sample surveys and interview guides that can be<br />

used to conduct assessments in health facilities that serve pregnant women. By conducting<br />

an assessment, health staff can increase <strong>the</strong>ir knowledge <strong>of</strong> issues regarding malaria during<br />

pregnancy, while improving <strong>the</strong>ir ability to conduct operational research related to malaria<br />

during pregnancy.<br />

<strong>The</strong> package provides most <strong>of</strong> <strong>the</strong> materials needed to conduct a rapid assessment: general<br />

guidance about planning and conducting a rapid assessment (including where to locate<br />

existing data); sample assessment instruments, both quantitative and qualitative, which can<br />

and should be adapted to local circumstances; specific information about how to use each tool;<br />

and guidance about <strong>the</strong> use <strong>of</strong> <strong>the</strong> information obtained. O<strong>the</strong>r resources, including relevant<br />

guidelines, sample PowerPoint presentations for training sessions, training videos, and data<br />

analysis s<strong>of</strong>tware (Epi Info), are also included.<br />

<strong>The</strong> assessment has been piloted in several countries in sub-Saharan Africa and in Asia.<br />

<strong>The</strong>lessons learned from conducting assessments in <strong>the</strong>se regions are reflected in<br />

this package.<br />

ii<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Acknowledgements<br />

We thank malaria control programs in <strong>the</strong> countries that have participated in conducting<br />

rapid assessments — Bangladesh, Benin, Burkina Faso, Ethiopia, India, Indonesia,<br />

Kenya, Madagascar, Mali, Mauritania, Myanmar, Niger, and Senegal — and all <strong>the</strong> women<br />

(and <strong>the</strong>ir babies) in those countries who participated. In particular, we thank our key<br />

collaborators: Dr. Rukhsana Ahmed, Dr. Ralisimalala Andriamampianina, Dr. Eleonore<br />

Antoinette Ba-Nguz, Dr. Kaounde Calixte, Dr. Magda Robalo Correia e Silva, Dr. Amadou<br />

Baïlo Diallo, Dr. Ogobara Doumbo, Dr. M. Abdul Faiz, Dr. Ibrahima Socé Fall, Dr. Afework<br />

Hailemariam, Dr. Mohamed Nezhir Ould Hamed, Dr. Kaythwe Han, Ms. Jenny Hill, Dr. Daddi<br />

Jima, Dr. Ranjalahary Rasol<strong>of</strong>omanana Justin, Dr. Midou Kailou, Dr. Edward Kamau, Dr. Ardi<br />

Kaptiningsih, Dr. Kassoum Kayentao, Dr. Mamadou Kodio, Dr. Amadou Konate, Dr. Ravi Kumar,<br />

Dr. Gita Maya, Mr. Etienne Minkoulou,Dr. Saroj K. Mishra, Ms. Allisyn Moran, Dr. Richard Muga,<br />

Dr. Bernard L. Nahlen, Dr. Jean Louis Ndiaye, Dr. S.K. Sharif, Dr. Neeru Singh, Dr. Sodiomon B.<br />

Sirima, Dr. Madion Silé Nguembayo Souam-Nguelé, Dr. Dianne Terlouw, Dr. Feiko ter Kuile,<br />

Dr. Anniemieke Van Eijk, and Dr. Holly Williams. We thank also health pr<strong>of</strong>essionals in Asia<br />

and Africa who have attended training workshops for rapid assessments and have <strong>of</strong>fered<br />

suggestions for making this package more useful. We thank <strong>the</strong> World Health Organization,<br />

in particular <strong>the</strong> Global <strong>Malaria</strong> Programme and Making Pregnancy Safer Department,<br />

Regional and Country <strong>of</strong>fices, for reviewing and approving this publication and supporting <strong>the</strong><br />

workshops. We are indebted to Dr. Penny Phillips-Howard, who first conceived <strong>of</strong> <strong>the</strong> idea<br />

<strong>of</strong> a rapid assessment manual in order to share this methodology with o<strong>the</strong>rs.<br />

Suggested citation: US Centers for Disease Control and Prevention (CDC) and World Health<br />

Organization. <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy: A Toolkit.<br />

Atlanta: Centers for Disease Control and Prevention, 2009.<br />

<strong>The</strong> contents <strong>of</strong> this toolkit do not necessarily represent <strong>the</strong> <strong>of</strong>ficial position <strong>of</strong> <strong>the</strong><br />

Centers for Disease Control and Prevention.<br />

Cover credit: Virginia Jacobs, Centers for Disease Control and Prevention<br />

<strong>The</strong> Manual<br />

iii


Abbreviations<br />

CDC<br />

DHS<br />

HCW<br />

ID<br />

IPTp<br />

ITN<br />

LBW<br />

MICS<br />

MIPESA<br />

MoH<br />

MIS<br />

RAOPAG<br />

RBM<br />

SP<br />

UNICEF<br />

USAID<br />

WHO<br />

Centers for Disease Control and Prevention<br />

Demographic and Health Survey<br />

health-care worker<br />

identification<br />

intermittent preventive treatment for<br />

pregnant women<br />

insecticide-treated net<br />

low birth weight<br />

Multiple Indicator Cluster Survey<br />

<strong>Malaria</strong> in Pregnancy East and Sou<strong>the</strong>rn Africa:<br />

Coalition for Prevention and Control<br />

Ministry <strong>of</strong> Health<br />

<strong>Malaria</strong> Indicator Survey<br />

Réseau d’Afrique de l’Ouest contre le Paludisme<br />

pendant la grossesse<br />

Roll Back <strong>Malaria</strong><br />

sulfadoxine-pyrimethamine<br />

United Nations Children’s Fund<br />

U.S. Agency for International Development<br />

World Health Organization<br />

iv<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


1. <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong><br />

1.1 <strong>The</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy<br />

Pregnant women and children are particularly vulnerable to infection with any <strong>of</strong> <strong>the</strong><br />

parasites that cause malaria in humans: Plasmodium falciparum, P. vivax, P. malariae, and P.<br />

ovale. Each year, approximately 50 million women in malaria-endemic areas (25 million <strong>of</strong><br />

<strong>the</strong>se live in Africa) become pregnant and are at risk <strong>of</strong> <strong>the</strong> adverse consequences <strong>of</strong> malaria<br />

during pregnancy [1, 2]. <strong>Malaria</strong> is a threat both to <strong>the</strong>mselves and <strong>the</strong>ir babies, leading<br />

to about 200,000 newborn deaths each year as a result <strong>of</strong> malaria in pregnancy [1, 3]. <strong>The</strong><br />

problem <strong>of</strong> malaria in pregnant women has not been extensively studied outside sub-Saharan<br />

Africa, and limited information exists about <strong>the</strong> burden <strong>of</strong> <strong>the</strong> problem in o<strong>the</strong>r areas.<br />

<strong>The</strong> infecting parasite and <strong>the</strong> level <strong>of</strong> transmission (high or low) are key determinants <strong>of</strong> <strong>the</strong><br />

consequences <strong>of</strong> malaria infection during pregnancy. 1<br />

Global <strong>Malaria</strong> Transmission (Endemicity) Levels<br />

Pregnant women<br />

and children<br />

are particularly<br />

vulnerable to<br />

infection with<br />

any <strong>of</strong> <strong>the</strong> parasites<br />

that cause malaria<br />

in humans.<br />

Source: WHO and UNICEF, 2005 World <strong>Malaria</strong> Report.<br />

1 O<strong>the</strong>r determinants can include gravidity, parity, age, HIV infection, and access to prompt and<br />

effective treatment.<br />

<strong>The</strong> Manual<br />

1


1.1.1 Infection with Plasmodium falciparum<br />

Areas <strong>of</strong> High (or Stable) Transmission<br />

Sub-Saharan Africa is <strong>the</strong> region <strong>of</strong> <strong>the</strong> world most affected by malaria, and in high (or<br />

stable) transmission areas in that region, P. falciparum, <strong>the</strong> most lethal <strong>of</strong> <strong>the</strong> four parasites,<br />

predominates.<br />

While most adults in areas <strong>of</strong> high or stable transmission (<strong>the</strong> majority <strong>of</strong> sub-Saharan<br />

Africa) have developed a partial immunity to malaria that largely prevents clinical illness, a<br />

woman’s immune system changes during pregnancy, making her more vulnerable to malaria<br />

infection. Infected red blood cells can sequester in <strong>the</strong> placenta, evading immune detection<br />

and clearance. This infection can endanger <strong>the</strong> pregnant woman’s health, as well as that <strong>of</strong> <strong>the</strong><br />

unborn baby she is carrying, and cause maternal anemia, fetal loss, prematurity, intrauterine<br />

growth retardation, and low birth weight (LBW)(


1.1.2 Infection with O<strong>the</strong>r <strong>Malaria</strong> Parasites<br />

<strong>The</strong> effects <strong>of</strong> <strong>the</strong> o<strong>the</strong>r three malaria parasites are less well-known. Pregnant women in<br />

Africa at risk <strong>of</strong> P. vivax infection live principally in areas <strong>of</strong> low or unstable transmission, and<br />

in <strong>the</strong>se areas, P. vivax infections are likely to result in febrile illness. Most data on P. vivax<br />

infections are from outside Africa, where women have been shown to be at increased risk <strong>of</strong><br />

P. vivax during pregnancy, although <strong>the</strong> risk is less pronounced than it is among women with<br />

P. falciparum[16]. A study among nonimmune pregnant women in Thailand reported that<br />

even single infections with P. vivax in <strong>the</strong> peripheral blood are associated with reductions in<br />

birthweight and maternal hemoglobin but to a lesser extent than are those with P. falciparum<br />

[17, 18]. Robust data on <strong>the</strong> prevalence <strong>of</strong> P. ovale and P. malariae are currently unavailable in<br />

any population.<br />

1.1.3 <strong>Malaria</strong> and HIV<br />

In sub-Saharan Africa, where more than three-fourths (13.5 million) <strong>of</strong> <strong>the</strong> world’s HIVinfected<br />

women reside approximately 25 million pregnant women are at risk <strong>of</strong> P. falciparum<br />

infection every year. A review <strong>of</strong> studies in Africa shows that coinfection with HIV exacerbates<br />

<strong>the</strong> burden <strong>of</strong> malaria in pregnancy. HIV increases <strong>the</strong> degree to which malaria is associated<br />

with severe anemia and low birth weight beyond <strong>the</strong> effect <strong>of</strong> HIV itself on <strong>the</strong>se outcomes.<br />

HIV also puts women <strong>of</strong> all gravidities at risk for placental infection with malaria, not only<br />

women in <strong>the</strong>ir first or second pregnancy [19].<br />

1.2 <strong>Malaria</strong> Prevention Interventions<br />

for Pregnant Women<br />

In areas <strong>of</strong> high (or stable) malaria transmission, prevention <strong>of</strong> <strong>the</strong> ill effects <strong>of</strong> malaria during<br />

pregnancy requires a preventive approach because most women do not become clinically ill.<br />

<strong>The</strong> World Health Organization (WHO) has recommended a three-pronged strategy (IPTp,<br />

ITNs, case management) for controlling malaria during pregnancy in areas <strong>of</strong> high or stable<br />

transmission in Africa [2] (see box). WHO recommends intermittent preventive treatment<br />

(IPTp) as an essential component <strong>of</strong> antenatal care for all pregnant women in areas <strong>of</strong> high or<br />

stable transmission. IPTp involves <strong>the</strong> administration <strong>of</strong> an effective antimalarial at treatment<br />

doses at predefined intervals during pregnancy and at regularly scheduled antenatal visits.<br />

<strong>The</strong> remaining two interventions, insecticide-treated mosquito nets (ITNs) and effective case<br />

management, are recommended for all pregnant women, regardless <strong>of</strong> <strong>the</strong> area’s malaria<br />

transmission level. ITNs are intended to prevent infection, while case management with<br />

an effective antimalarial is a treatment intervention. Each intervention is safe, effective,<br />

affordable, and deliverable.<br />

<strong>The</strong> Manual<br />

3


If <strong>the</strong>se interventions are <strong>of</strong>fered through antenatal clinics, <strong>the</strong>y can reach many to most<br />

pregnant women, since surveys show that a relatively high proportion <strong>of</strong> women worldwide<br />

have at least one antenatal visit with a skilled provider during pregnancy. In many countries in<br />

sub-Saharan Africa, East Asia and <strong>the</strong> Pacific, and Latin America and <strong>the</strong> Caribbean, more than<br />

70% attend an antenatal clinic at least once.<br />

Antenatal Care Coverage by Region<br />

Prevention and control <strong>of</strong> malaria in pregnant women should <strong>the</strong>refore be a critical component<br />

<strong>of</strong> antenatal services, and WHO’s strategic framework for prevention and control <strong>of</strong> malaria<br />

during pregnancy in <strong>the</strong> African region underscores <strong>the</strong> need for close collaboration between<br />

malaria and reproductive health programs [2].<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


WHO’s Recommended Interventions for<br />

<strong>Malaria</strong> Prevention and Control during Pregnancy<br />

in Areas <strong>of</strong> Stable Transmission in Africa<br />

<strong>The</strong> policy for malaria prevention and control during pregnancy in areas <strong>of</strong> stable<br />

transmission in <strong>the</strong> African region should emphasize a preventive package <strong>of</strong> intermittent<br />

preventive treatment (IPTp) and insecticide-treated bed nets (ITNs) and ensure effective case<br />

management <strong>of</strong> malaria illness and anemia.<br />

Intermittent Preventive Treatment<br />

All pregnant women in areas <strong>of</strong> stable malaria transmission should receive at least 2 doses <strong>of</strong><br />

IPTp after quickening. <strong>The</strong> World Health Organization recommends a schedule <strong>of</strong> 4 antenatal<br />

clinic visits, with 3 visits after quickening. <strong>The</strong> delivery <strong>of</strong> IPTp with each scheduled visit after<br />

quickening will likely assure that a high proportion <strong>of</strong> women receive at least 2 doses. IPTp<br />

doses should not be given more frequently than monthly.<br />

Prevention and<br />

control <strong>of</strong> malaria<br />

in pregnant<br />

women is a critical<br />

component <strong>of</strong><br />

antenatal services.<br />

<strong>The</strong> most effective drug for IPTp is sulfadoxine-pyrimethamine (SP) because <strong>of</strong> its safety for use<br />

during pregnancy, effectiveness in reproductive-age women, and feasibility for use in programs,<br />

as it can be delivered as a single-dose treatment under observation by <strong>the</strong> health worker.*<br />

Insecticide-Treated Bed Nets<br />

ITNs should be provided to pregnant women as early in pregnancy as possible, and <strong>the</strong>ir use<br />

should be encouraged for women throughout pregnancy and during <strong>the</strong> postpartum period.<br />

ITNs can be provided ei<strong>the</strong>r through <strong>the</strong> antenatal clinic or through o<strong>the</strong>r systems in <strong>the</strong><br />

private and public sectors that may be available at <strong>the</strong> community level.<br />

Effective Case Management <strong>of</strong> <strong>Malaria</strong> Illness and Anemia<br />

Effective case management <strong>of</strong> malaria illness for all pregnant women in malarious areas must<br />

be assured. Iron/folate supplementation for anemia, an important consequence <strong>of</strong> malaria<br />

infection, should be given to pregnant women as part <strong>of</strong> routine antenatal care package.<br />

Pregnant women should also be screened for anemia, and those with moderate to severe<br />

anemia should be managed according to national reproductive health guidelines.<br />

* Current scientific evidence suggests <strong>the</strong> following: 1) At least 2 IPTp doses are required to achieve optimal<br />

benefit in most women; 2) HIV-infected pregnant women receiving daily cotrimoxazole (CTX) should not<br />

receive IPTp with SP due to concerns with additive sulfa toxicity; 3) In settings where <strong>the</strong> HIV prevalence in<br />

pregnant women is greater than 10%, and where <strong>the</strong> daily CTX recommendation is not implemented among<br />

HIV-infected individuals, it is more cost effective to treat all women with at least a 3-dose IPTp regimen<br />

than to screen for HIV and provide this regimen only to HIV-infected women; 4) In HIV-uninfected pregnant<br />

women, <strong>the</strong>re is no evidence that a third dose <strong>of</strong> IPTp causes any additional risk, that more than 3 IPTp doses<br />

during pregnancy <strong>of</strong>fers additional benefit, or that receiving 3 or more doses <strong>of</strong> IPTp with SP will result in an<br />

increased risk <strong>of</strong> adverse drug reactions. Research to assess <strong>the</strong> safety, efficacy, and program feasibility <strong>of</strong> o<strong>the</strong>r<br />

antimalaria drugs for use in IPTp among both HIV-uninfected pregnant women, and HIV-infected pregnant<br />

women receiving daily CTX, is ongoing.<br />

Source: World Health Organization. A Strategic Framework for <strong>Malaria</strong> Prevention and Control during<br />

Pregnancy in <strong>the</strong> African Region. Brazzaville: WHO Regional Office for Africa, 2004. AFR/MAL/04/01.<br />

However <strong>the</strong> details <strong>of</strong> <strong>the</strong> specific interventions and tools used within this strategy have been updated in<br />

subsequent documents. <strong>The</strong> updated treatment recommendation <strong>of</strong> uncomplicated and severe malaria in<br />

pregnancy is part <strong>of</strong> <strong>the</strong> WHO Guidelines for <strong>the</strong> treatment <strong>of</strong> malaria, (http://www.who.int/malaria/docs/<br />

TreatmentGuidelines2006.pdf), while an updated recommendation on intermittent preventive treatment in<br />

pregnancy (IPTp) is in this report: http://www.who.int/malaria/docs/IPTp/TechnicalExpertMtgIPTpReport.pdf<br />

<strong>The</strong> Manual<br />

5


1.3 Information for Action<br />

<strong>The</strong> following four scenarios describe potential information gaps malaria-endemic countries<br />

may have. Each numbered scenario highlights <strong>the</strong> key unanswered questions and suggests what<br />

implications <strong>the</strong> answers might have for action.<br />

1. <strong>The</strong> magnitude <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria during pregnancy is not well known.<br />

• Does malaria present a problem for pregnant women and <strong>the</strong>ir infants in this area? Does<br />

malaria affect women in <strong>the</strong>ir first trimester? How big is <strong>the</strong> problem? Does malaria<br />

infection during pregnancy affect maternal morbidity and mortality?<br />

Even though it can be assumed that malaria during pregnancy is a significant problem and<br />

requires intervention in areas with high transmission <strong>of</strong> P. falciparum infections, a more<br />

precise documentation <strong>of</strong> <strong>the</strong> problem locally can also be used to advocate for increased<br />

resources and commitment to develop or enhance a program that addresses malaria during<br />

pregnancy. Also, in areas with o<strong>the</strong>r malaria transmission patterns (low-intermediate,<br />

seasonal, unstable), relatively little may be known about <strong>the</strong> burden <strong>of</strong> malaria during<br />

pregnancy. If malaria infection affects women in <strong>the</strong>ir first trimester, women will need to be<br />

encouraged to come in for care early, and <strong>the</strong> National <strong>Malaria</strong> Control Program will need to<br />

look for a strategy to control <strong>the</strong> adverse effects <strong>of</strong> malaria during pregnancy that includes<br />

women in <strong>the</strong>ir first trimester.<br />

2. <strong>The</strong> burden <strong>of</strong> malaria in pregnancy is known, but policy and program strategy have<br />

not yet been developed.<br />

• What proportion <strong>of</strong> pregnant women seek antenatal care in antenatal clinics? What is <strong>the</strong><br />

coverage <strong>of</strong> antenatal clinics? What barriers do pregnant women face when obtaining care<br />

from antenatal clinics?<br />

If antenatal clinics provide services for <strong>the</strong> majority <strong>of</strong> pregnant women in <strong>the</strong> area,<br />

resources should be directed to provide or improve interventions in antenatal clinics.<br />

If antenatal clinic coverage is not high, it is important to learn why and address<br />

<strong>the</strong> causes.<br />

• What should be done if <strong>the</strong> prevalence <strong>of</strong> malaria infection in pregnant women is low? Does<br />

it make a difference if pregnant women are symptomatic or asymptomatic?<br />

If prevalence is low, IPTp should not be <strong>of</strong>fered. If most cases <strong>of</strong> malaria infection are<br />

symptomatic, <strong>the</strong> country may decide to treat cases ra<strong>the</strong>r than <strong>of</strong>fer IPTp; if most<br />

cases are asymptomatic, <strong>the</strong>n preventive treatment is necessary.<br />

3. Policy has been developed, programs have begun, and information is needed on<br />

program implementation.<br />

Coverage <strong>of</strong> interventions<br />

• What percentage <strong>of</strong> pregnant women is <strong>the</strong> program reaching?<br />

If coverage is low, it will be important to determine <strong>the</strong> causes, which can be better<br />

understood by examining issues relating to <strong>the</strong> facility and <strong>the</strong> clients <strong>the</strong>mselves.<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Facility-dependent aspects <strong>of</strong> providing interventions<br />

• Are antenatal clinics equipped to provide <strong>the</strong> recommended interventions? Do <strong>the</strong>y have<br />

trained health workers who can provide <strong>the</strong> needed interventions and care? Are drugs and<br />

supplies available? Are health workers aware <strong>of</strong> what <strong>the</strong> policy says? Are <strong>the</strong> antenatal<br />

clinic health workers providing <strong>the</strong> needed interventions appropriately?<br />

Lack <strong>of</strong> needed supplies point to <strong>the</strong> need for improvement. Any deficiencies<br />

revealed in health-care worker knowledge or provision <strong>of</strong> services can identify<br />

specific training needs.<br />

Client-dependent aspects affecting acceptance and use <strong>of</strong> malaria interventions<br />

• Are pregnant women able to obtain and willing to take antimalarial medications for<br />

IPTp and treatment <strong>of</strong> malaria illness? Do women have access to and do <strong>the</strong>y use ITNs?<br />

What are pregnant women’s knowledge <strong>of</strong> and attitudes about malaria and its effects<br />

during pregnancy? What cultural taboos affect how <strong>the</strong>y seek care if <strong>the</strong>y have malaria<br />

infection during pregnancy? Where do <strong>the</strong>y receive <strong>the</strong>ir information and advice<br />

about malaria prevention? What is <strong>the</strong> best way to provide information about malaria<br />

prevention?<br />

Understanding what facilitators and barriers exist to women’s access and use <strong>of</strong><br />

needed interventions can help in understanding program implementation issues.<br />

Understanding where and how <strong>the</strong>y receive information about malaria can aid in<br />

<strong>the</strong> development <strong>of</strong> health education and communication campaigns, if needed.<br />

4. Intervention coverage is substantial, and <strong>the</strong> country wants to determine <strong>the</strong><br />

impact <strong>of</strong> <strong>the</strong> program.<br />

• Are <strong>the</strong> programs achieving <strong>the</strong>ir goals—improved health for pregnant women and<br />

<strong>the</strong>ir infants?<br />

Measures <strong>of</strong> coverage, placental infection, and LBW, as well as o<strong>the</strong>r indicators can give<br />

a snapshot <strong>of</strong> <strong>the</strong> effectiveness <strong>of</strong> <strong>the</strong> current program. <strong>The</strong>se measures can also serve<br />

as baseline data against which to evaluate <strong>the</strong> impact <strong>of</strong> new interventions.<br />

Information alone is not sufficient to respond to <strong>the</strong> problem <strong>of</strong> malaria during pregnancy.<br />

Commitment and resources are needed to translate this information into action.<br />

►Commitment by malaria programs and reproductive health programs at national<br />

levels and below to use <strong>the</strong> information obtained to develop or refine policy and<br />

guide successful program implementation. <strong>The</strong> conduct <strong>of</strong> <strong>the</strong> assessment may seem<br />

to raise awareness <strong>of</strong> malaria in pregnancy among stakeholders and policymakers—a<br />

crucial step toward mobilizing necessary human and capital resources.<br />

►Adequate human and financial resources to conduct <strong>the</strong> assessment, develop<br />

strategies for local and subregional programs, and provide ongoing monitoring<br />

and evaluation <strong>of</strong> <strong>the</strong>se activities. In <strong>the</strong> process <strong>of</strong> conducting <strong>the</strong> assessment and<br />

obtaining necessary information, <strong>the</strong> country streng<strong>the</strong>ns its capacity to conduct<br />

operational research, which will likely be needed to continue to guide programs<br />

focusing on malaria as well as o<strong>the</strong>r diseases that threaten <strong>the</strong> health <strong>of</strong> its people.<br />

<strong>The</strong> Manual<br />

7


1.4 Use <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong> Package<br />

<strong>The</strong> manual does<br />

not lay out a<br />

"one-size-fits-all"<br />

approach and is<br />

intended to be<br />

adapted for use<br />

by countries in<br />

all regions <strong>of</strong> <strong>the</strong><br />

world affected by<br />

malaria.<br />

This rapid assessment 2 package is intended to assist a country quickly and comprehensively<br />

ga<strong>the</strong>r information it needs about <strong>the</strong> problem <strong>of</strong> malaria during pregnancy and opportunities<br />

for successful intervention.<br />

A country may be able to take advantage <strong>of</strong> a wealth <strong>of</strong> information about <strong>the</strong> problem <strong>of</strong><br />

malaria during pregnancy — current, relevant, available at no cost —within <strong>the</strong> Ministry <strong>of</strong><br />

Health (MoH), for example. Information may also be available from o<strong>the</strong>r reliable sources,<br />

including Demographic Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS),<br />

and <strong>Malaria</strong> Indicator Surveys (MIS). Regional information from networks such as <strong>Malaria</strong><br />

in Pregnancy East and Sou<strong>the</strong>rn Africa: Coalition for Prevention and Control (MIPESA) and<br />

Réseau d’Afrique de l’Ouest contre le Paludisme pendant la grossesse (RAOPAG) can be<br />

ano<strong>the</strong>r important source <strong>of</strong> information.<br />

Available sources may not supply all <strong>the</strong> information needed; thus, this assessment package<br />

was developed. <strong>The</strong> tools in this package are largely designed to obtain information from<br />

antenatal clinics and delivery units, even though not all women seek care from antenatal<br />

clinics or deliver <strong>the</strong>ir babies at a health facility. <strong>The</strong> currently recommended interventions are<br />

facility-based, and most countries that provide interventions for pregnant women concentrate<br />

<strong>the</strong>ir efforts on expanding implementation in facilities. See Chapter 4 for limitations <strong>of</strong> this<br />

approach.<br />

<strong>The</strong> package contains a manual with general guidance:<br />

• Chapter 2 outlines <strong>the</strong> design <strong>of</strong> a rapid assessment.<br />

• Chapter 3 gives general information about preparing for and conducting<br />

a rapid assessment.<br />

• Chapter 4 outlines how to manage, analyze, and interpret <strong>the</strong> data collected.<br />

• Chapter 5 provides information about preparing a report and using <strong>the</strong><br />

assessment information ga<strong>the</strong>red.<br />

<strong>The</strong> rest <strong>of</strong> <strong>the</strong> package has more specific tools and information:<br />

• Modules 1-10 have assessment tools ready to be adapted to <strong>the</strong> needs <strong>of</strong> each<br />

country. Each module contains most <strong>of</strong> <strong>the</strong> information and written materials needed<br />

for that part <strong>of</strong> <strong>the</strong> assessment.<br />

• Resources 1-4 contain a list <strong>of</strong> relevant articles, guidelines, sample PowerPoint<br />

presentations useful for training, and data analysis s<strong>of</strong>tware (Epi Info).<br />

<strong>The</strong> manual does not lay out a “one-size-fits-all” approach and is intended to be adapted for<br />

use by countries in all regions <strong>of</strong> <strong>the</strong> world affected by malaria.<br />

2 <strong>The</strong> term “rapid assessment” can be used in multiple ways. As described in this manual, a rapid assessment<br />

provides a “snapshot” at one point in time <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria and opportunities for intervention.<br />

A rapid assessment does not replace program monitoring and evaluation activities, but can form part <strong>of</strong> a<br />

monitoring and evaluation strategy.<br />

8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


2. Planning <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />

2.1 Objectives <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />

Depending on a country’s information needs, its rapid assessment could have one or<br />

more <strong>of</strong> <strong>the</strong> following objectives:<br />

• Determine <strong>the</strong> burden <strong>of</strong> malaria<br />

• Determine what sort <strong>of</strong> policy and program should be developed<br />

and implemented<br />

• Assess implementation progress<br />

• Assess <strong>the</strong> program’s impact on infant and maternal health.<br />

It is important to note that regardless <strong>of</strong> which malaria-related objectives are selected,<br />

ano<strong>the</strong>r objective—to build national capacity to conduct operational research—will be<br />

achieved through <strong>the</strong> process <strong>of</strong> planning, conducting, and analyzing <strong>the</strong> assessment.<br />

2.2 Potential Information Sources<br />

Information may be readily available that fills some, although perhaps not all, <strong>of</strong> <strong>the</strong><br />

information gaps. Sources 3 <strong>of</strong> ready and recent (e.g., within <strong>the</strong> previous 5 years data are<br />

various and may include<br />

<br />

• Demographic Health Surveys (DHS) (see 2.2.1)<br />

• Multiple Indicator Cluster Surveys (MICS) (see 2.2.2)<br />

• <strong>Malaria</strong> Indicator Surveys (MIS) (see 2.2.3)<br />

• Roll Back <strong>Malaria</strong> (RBM) baseline surveys<br />

• National routine health information systems<br />

• Reports by nongovernmental organizations<br />

• Published scientific articles about malaria in pregnancy in <strong>the</strong> country<br />

or <strong>the</strong> region<br />

Numerous household surveys have been conducted since 2000, including DHS, MICS,<br />

Population Services International surveys, and RBM baseline surveys.<br />

<strong>The</strong> following Web site tracks major household surveys and data collection tools:<br />

http://www.internationalsurveynetwork.org/home/<br />

Pertinent studies include those conducted not only in <strong>the</strong> country or district itself, but<br />

also in <strong>the</strong> subregion (“subregion” denotes an area that is part <strong>of</strong> a WHO-defined “region”).<br />

Subregional data are an <strong>of</strong>ten underutilized source <strong>of</strong> information and may provide adequate<br />

information, especially about <strong>the</strong> magnitude <strong>of</strong> <strong>the</strong> problem (e.g., prevalence <strong>of</strong> malaria<br />

infection in pregnant women’s blood and placenta) from a country with similar geoclimatic<br />

characteristics. In addition, since customs and taboos vary by ethnic group, data from <strong>the</strong><br />

same ethnic group in a neighboring country may provide sufficient information about <strong>the</strong><br />

cultural aspects <strong>of</strong> malaria and its treatment and prevention.<br />

3 It is important to note that some <strong>of</strong> <strong>the</strong> surveys above, for example DHS and MICS, are population-based<br />

ra<strong>the</strong>r than facility-based, and thus cannot be used to validate results <strong>of</strong> this facility-based assessment.<br />

<strong>The</strong> Manual<br />

9


In recognition <strong>of</strong> <strong>the</strong> importance <strong>of</strong> subregional information and approaches to malaria<br />

control and prevention, several subregional networks have been established in <strong>the</strong> African<br />

region that focus on <strong>the</strong> prevention and control <strong>of</strong> malaria during pregnancy. MIPESA was<br />

created in 2002 to bring toge<strong>the</strong>r five countries (Kenya, Malawi, Tanzania, Uganda, Zambia),<br />

all <strong>of</strong> which had adopted policy for control <strong>of</strong> malaria in pregnancy (IPTp, ITNs, and effective<br />

case management), in line with WHO recommendations. In West Africa, RAOPAG was formed<br />

in 2003 and includes malaria-endemic countries <strong>of</strong> West Africa. <strong>The</strong>se organizations routinely<br />

share <strong>the</strong>ir data and experiences at network meetings.<br />

Because using available data can save time and money,<br />

• Determine if a recent 4 study has been done ei<strong>the</strong>r in <strong>the</strong> country or in a country with a<br />

similar malaria pr<strong>of</strong>ile.<br />

• If a recent study has been done, consider when, where, and among whom it was<br />

conducted.<br />

2.2.1 Demographic and Health Surveys<br />

Demographic and Health Surveys (DHS) are nationally representative household surveys that<br />

focus on reproductive and child health. Organized by Macro International, Calverton, MD,<br />

USA, and sponsored by <strong>the</strong> United States Agency for International Development (USAID), a<br />

typical DHS has a large sample size (usually between 5,000 and 30,000 households) and uses<br />

a multiple-stage cluster design. Because questionnaires are standardized and structured and<br />

change little between surveys, DHS outcomes are comparable between countries and over<br />

time. <strong>The</strong> average interval between two DHS is approximately 5 years.<br />

Since 1998, some DHS have used specific questions relevant to malaria prevention and<br />

treatment, including<br />

• antenatal clinic coverage<br />

• delivery unit coverage<br />

• type <strong>of</strong> antimalarial drugs given, timing, and dosage<br />

• possession <strong>of</strong> mosquito nets and <strong>the</strong>ir use for children less than 5 years old and<br />

pregnant women<br />

• use <strong>of</strong> IPTp by pregnant women.<br />

• prevalence <strong>of</strong> anemia by hemoglobin measurement in children less than 5 years old<br />

and pregnant women.<br />

<strong>The</strong> DHS survey package also includes an optional malaria module, which can be used in all<br />

surveys conducted in malarious countries.<br />

Data are available at http://www.measuredhs.com. For more information about DHS, consult<br />

http://www.measuredhs.com/ or contact MEASURE DHS+, Macro International Inc., 11785<br />

Beltsville Drive, Suite 300, Calverton MD 20705 USA; tel: 301-572-0456; fax: 301-572-0999;<br />

e-mail: measure@orcmacro.com.<br />

4 <strong>The</strong> meaning <strong>of</strong> “recent” varies by situation. In some cases, where no new programs have been initiated,<br />

no initiatives to improve services have been instituted, and <strong>the</strong> malaria transmission level is considered to<br />

be about <strong>the</strong> same, a 5-year-old survey may provide adequate information.<br />

10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


2.2.2 Multiple Indicator Cluster Surveys<br />

Multiple Indicator Cluster Surveys (MICS) are also nationally representative household<br />

surveys. <strong>The</strong>y use a two-stage cluster sampling design, with an average sample size <strong>of</strong> around<br />

6,000 households. <strong>The</strong> questionnaire covers living conditions and household assets, allowing<br />

<strong>the</strong> data to be stratified by such factors as place <strong>of</strong> residence, education <strong>of</strong> <strong>the</strong> mo<strong>the</strong>r, and<br />

wealth quintile <strong>of</strong> <strong>the</strong> household. MICS are conducted approximately every 3 years in about 70<br />

countries worldwide.<br />

This survey also has questions about<br />

• prevalence <strong>of</strong> fever in <strong>the</strong> previous 2 weeks<br />

• type <strong>of</strong> treatment received and place <strong>of</strong> treatment<br />

• use <strong>of</strong> any nets and <strong>of</strong> ITNs by children less than 5 years old.<br />

Data are collected on indicators such as all-cause mortality among children less than 5 years<br />

old and coverage <strong>of</strong> antenatal care.<br />

Survey results and questionnaires are available at http://www.childinfo.org/. Like DHS, most<br />

MICS are conducted outside <strong>the</strong> peak malaria season.<br />

2.2.3 <strong>Malaria</strong> Indicator Survey Package<br />

RBM’s Monitoring and Evaluation Reference Group has a package <strong>of</strong> tools for assessing<br />

coverage <strong>of</strong> key RBM interventions at <strong>the</strong> household level: coverage <strong>of</strong> ITNs, antimalarial<br />

treatment among children under 5 with fever, and IPTp. It includes defined indicators;<br />

questionnaire and data tabulation plans for calculation <strong>of</strong> indicators; and guidance on<br />

conducting surveys, designing sampling frames, and calculating sample sizes. <strong>The</strong> sample size<br />

is usually about 3,000 households, smaller than that required for a DHS or MICS. <strong>The</strong> MIS<br />

should be conducted during <strong>the</strong> peak malaria season. <strong>The</strong> MIS package can be accessed at<br />

http://www.rollbackmalaria.org/<br />

<strong>The</strong> following information taken from WHO's World <strong>Malaria</strong> Report 2008 provides an<br />

example <strong>of</strong> data available from recent surveys.<br />

Survey data: Percentage <strong>of</strong> pregnant women who<br />

slept under an insecticide-treated net <strong>the</strong> night before <strong>the</strong> survey<br />

Africa Year Source Percentage<br />

Benin 2006 DHS 2006 20.0<br />

Congo 2005 DHS 2005 4.0<br />

Ethiopia 2007 MIS 2007 35.0<br />

Guinea 2005 DHS 2005 1.0<br />

Kenya 2003 DHS 2003 5.0<br />

Malawi 2004 DHS 2004 15.0<br />

Mali 2006 DHS 2006 29.0<br />

Niger 2006 DHS 2006 7.0<br />

Rwanda 2005 DHS 2005 17.0<br />

Senegal 2006 MIS 2006 17.0<br />

Tanzania 2004 DHS 2004-05 16.0<br />

Uganda 2006 DHS 2006 10.0<br />

Zambia 2006 MIS 2006 24.0<br />

<strong>The</strong> Manual<br />

11


2.3 Designing <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />

<strong>The</strong> table below links potential information needs with <strong>the</strong> appropriate assessment tools in<br />

this package.<br />

Scenarios, Information, <strong>Assessment</strong> Tools<br />

Scenario Information Tool(s)<br />

Size <strong>of</strong> problem<br />

<strong>of</strong> malaria<br />

in pregnancy<br />

Development<br />

<strong>of</strong> policy and<br />

strategy<br />

Program<br />

implementation<br />

Program<br />

impact<br />

Measures <strong>of</strong> impact:<br />

• Prevalence <strong>of</strong> peripheral and placental<br />

malaria and anemia<br />

• Relationship <strong>of</strong> malaria to LBW and<br />

prematurity<br />

• Illness and adverse pregnancy outcomes<br />

due to severe malaria<br />

Sources <strong>of</strong> care:<br />

• Where pregnant women receive care<br />

• Antenatal clinic coverage<br />

Prevalence pr<strong>of</strong>ile:<br />

• Level <strong>of</strong> prevalence, prevalence<br />

by gravidity and locale, symptoms<br />

associated with infection<br />

Coverage <strong>of</strong> interventions:<br />

• Percentage <strong>of</strong> pregnant women<br />

reached by program<br />

Facility-dependent aspects <strong>of</strong><br />

providing interventions:<br />

• Availability <strong>of</strong> equipment, supplies<br />

(including ITNs), medications<br />

• Staffing patterns; schedule; services<br />

• Current practices<br />

• Medications dispensed<br />

• Health education<br />

• Relationship between community<br />

services (traditional birth<br />

attendants 1 ) & facility-level staff<br />

Client-dependent aspects <strong>of</strong> <strong>of</strong>fering<br />

interventions:<br />

• Sources <strong>of</strong> information and advice<br />

about malaria prevention<br />

• Barriers to obtaining antenatal<br />

are and using recommended<br />

interventions<br />

Measures <strong>of</strong> impact:<br />

• Prevalence <strong>of</strong> peripheral parasitemia<br />

and anemia<br />

• Prevalence <strong>of</strong> placental and cord<br />

parasitemia<br />

• Severe malaria outcomes<br />

• Low birth weight<br />

• Incidence <strong>of</strong> prematurity<br />

1: Antenatal clinic surveys<br />

2: Delivery unit surveys<br />

3: Hospital surveillance <strong>of</strong> malaria<br />

disease<br />

Note: No assessment tools will yield<br />

this information. DHS and MIS can<br />

supply information on source <strong>of</strong><br />

care; MICS can supply some <strong>of</strong> this<br />

information.<br />

1: Antenatal clinic surveys<br />

2: Delivery unit surveys<br />

3: Hospital surveillance <strong>of</strong> malaria<br />

Note: No assessment tools will yield<br />

this information. DHS and MIS can<br />

supply information on source <strong>of</strong><br />

care; MICS can supply some <strong>of</strong> this<br />

information.<br />

4: Antenatal clinic facility assessment<br />

5: Health-care worker (HCW)<br />

observation<br />

6: Individual interviews and focus<br />

groups with HCWs<br />

7: Individual interviews and focus<br />

groups with midwives 2 and<br />

traditional birth attendants.<br />

6: Individual interviews and focus<br />

groups with HCWs<br />

7: Individual interviews and focus<br />

groups with midwives and<br />

traditional birth attendants<br />

8: Antenatal clinic client exit<br />

interview<br />

9: Individual interviews and focus<br />

groups with pregnant women<br />

10: Individual interviews with key<br />

informants<br />

1: Antenatal clinic surveys<br />

2: Delivery unit surveys<br />

3: Hospital surveillance <strong>of</strong> malaria<br />

disease<br />

Tools 1, 2, 3, 4, 5, and 8 are quantitative; Tools 6, 7, 9, and 10 are qualitative. Ideally, if<br />

Tool 6, 7, or 9 is selected, both interviews and focus group techniques should be used, as<br />

<strong>the</strong>y may provide different data and can also serve to validate data from o<strong>the</strong>r techniques<br />

(“triangulation”). If both cannot be done, <strong>the</strong> more appropriate technique should be chosen<br />

based on <strong>the</strong> local situation. See Modules 6, 7, and 9 for each technique’s advantages and<br />

disadvantages <strong>of</strong> each technique.<br />

1 Traditional birth attendant refers to a person without formal training who delivers babies.<br />

2 Midwife refers to a person who has pr<strong>of</strong>essional training in <strong>the</strong> delivery <strong>of</strong> babies.<br />

12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3. Conducting <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />

This chapter provides information about specific activities that are relevant to all assessment<br />

instruments: selecting a time period for <strong>the</strong> assessment; determining a general timetable and<br />

budget; building a team; selecting assessment areas and sites and determining sample sizes;<br />

selecting and organizing team members; adapting and translating questionnaires; training <strong>of</strong><br />

<strong>the</strong> assessment team; and conducting <strong>the</strong> assessment (including assuring assessment quality<br />

and providing information to participants about <strong>the</strong> survey/informed consent).<br />

3.1 Selecting a Time Period<br />

<strong>The</strong> following are important considerations for deciding when to conduct <strong>the</strong> assessment:<br />

• Seasonal patterns <strong>of</strong> malaria transmission: It is ideal to maximize <strong>the</strong> number <strong>of</strong> cases<br />

<strong>of</strong> malaria parasitemia by attempting to schedule <strong>the</strong> assessment during periods <strong>of</strong> high<br />

transmission (i.e., during or soon after <strong>the</strong> rainy season). <strong>Assessment</strong>s during this time<br />

capture <strong>the</strong> worst-case scenario and are important for planning and advocacy purposes.<br />

In addition, data can be collected most efficiently during <strong>the</strong>se periods. However, if<br />

prevalence differs markedly by season, it might be preferable to conduct <strong>the</strong> assessment<br />

during both high and low transmission periods. <strong>The</strong> benefit <strong>of</strong> obtaining this information<br />

would need to be balanced against <strong>the</strong> additional use <strong>of</strong> resources required to repeat <strong>the</strong><br />

assessment.<br />

Demographic and<br />

Health Surveys,<br />

Multiple Indicator<br />

Surveys, and<br />

<strong>Malaria</strong> Indicator<br />

Surveys contain<br />

questions related<br />

to malaria<br />

interventions<br />

and outcomes.<br />

• Road conditions and facility/community access: All data collection must take place when<br />

facilities and communities are accessible by road. Travel can be difficult during <strong>the</strong> rainy<br />

season. In addition, one must confirm that <strong>the</strong> health facilities that<br />

will be included in <strong>the</strong> assessment will be open and in use during <strong>the</strong> proposed<br />

assessment dates.<br />

• Availability <strong>of</strong> assessment staff: <strong>Assessment</strong> staff must be available for <strong>the</strong> training and<br />

during <strong>the</strong> entire assessment period.<br />

3.2 Determining a Timetable and Budget<br />

<strong>The</strong> total duration <strong>of</strong> <strong>the</strong> assessment, as well as <strong>the</strong> cost, depends on which, how many, and in<br />

what sequence (simultaneously or sequentially) <strong>the</strong> rapid assessment tools are conducted. It<br />

also depends on <strong>the</strong> number <strong>of</strong> areas where <strong>the</strong> assessment is conducted and <strong>the</strong> number <strong>of</strong><br />

participants selected. See Modules 1 and 2 for sample survey timetables for <strong>the</strong> antenatal clinic<br />

and delivery unit surveys.<br />

If all tools are to be used, it is recommended that <strong>the</strong> qualitative components <strong>of</strong> <strong>the</strong> assessment<br />

(e.g., focus groups, individual interviews) be conducted at <strong>the</strong> same time as <strong>the</strong> quantitative<br />

component. This could be facilitated by, for example, having a local university or o<strong>the</strong>r<br />

institution <strong>of</strong> higher learning conduct <strong>the</strong> individual and focus group interviews while <strong>the</strong> MoH<br />

conducts <strong>the</strong> o<strong>the</strong>r studies.<br />

It is possible that both national and external sources <strong>of</strong> funding may be found to help<br />

finance <strong>the</strong> assessment. A sample costing tool is provided in Resource 4 to assist in<br />

determining a budget.<br />

<strong>The</strong> Manual<br />

13


3.3. Building and Organizing <strong>the</strong> <strong>Assessment</strong> Team<br />

3.3.1 Roles, Responsibilities, and Requirements<br />

<strong>Assessment</strong> Coordinator<br />

An assessment coordinator is essential for planning and supervising all assessment activities.<br />

He or she may do this alone or in conjunction with his or her supervisor. <strong>The</strong> assessment<br />

coordinator is key to building assessment teams that can successfully conduct <strong>the</strong> assessment.<br />

If <strong>the</strong> assessment will include collection <strong>of</strong> qualitative data, ideally <strong>the</strong> assessment coordinator<br />

will have had experience in qualitative data collection. If not, a coordinator for that portion<br />

<strong>of</strong> <strong>the</strong> assessment should be selected and should work closely with <strong>the</strong> overall assessment<br />

coordinator. No activities should occur before an assessment coordinator is selected.<br />

Note: If <strong>the</strong> assessment coordinator will also supervise and conduct qualitative research, he/<br />

she will also have <strong>the</strong> responsibilities listed below for <strong>the</strong> qualitative data coordinator.<br />

Responsibilities<br />

• Discuss <strong>the</strong> assessment with health authorities, local partners, and<br />

community leaders<br />

• Select assessment sites<br />

• Select site supervisors, interviewers, and laboratorians<br />

• Ensure procurement <strong>of</strong> assessment equipment and supplies (See modules for list)<br />

• Organize and manage <strong>the</strong> training <strong>of</strong> site supervisors, interviewers, and<br />

laboratorians<br />

• Collect data from facility assessments and health-care worker observations<br />

• Establish quality control and supervisory mechanisms in each assessment site<br />

• Troubleshoot and make adjustments as needed<br />

• Ensure appropriate analysis and report results from <strong>the</strong> rapid assessment,<br />

in conjunction with assessment coordinator <strong>of</strong> <strong>the</strong> qualitative component,<br />

if different<br />

Requirements<br />

• Have experience working in or have links with <strong>the</strong> health system<br />

• Be familiar with <strong>the</strong> local health system and health divisions<br />

• Have experience conducting facility- and community-based surveys<br />

• Have some technical knowledge in <strong>the</strong> areas <strong>of</strong> reproductive health<br />

and malaria (optimal)<br />

• Be able to troubleshoot and adjust accordingly<br />

• If possible, have experience administering, budgeting, managing public<br />

health programs<br />

14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Qualitative Data Coordinator<br />

Responsibilities<br />

• Discuss <strong>the</strong> assessment with health authorities, local partners, and<br />

community leaders<br />

• Select interviewers, facilitators, recorders<br />

• Organize and manage training <strong>of</strong> interviewers, facilitators, and recorders<br />

• Revise interview guides as necessary<br />

• Supervise interviewers and data management<br />

• Communicate with facilities before <strong>the</strong> site visits to organize interviews so as to not<br />

disrupt patient care, select key informants, select focus group venues<br />

• Ensure procurement <strong>of</strong> assessment equipment and supplies (See modules)<br />

• Establish quality control and supervisory mechanisms<br />

• Ensure appropriate analysis and report results from <strong>the</strong> rapid assessment<br />

Requirements<br />

• Have experience working in/have links with <strong>the</strong> health system<br />

• Be familiar with <strong>the</strong> local health system and health divisions<br />

• Have knowledge <strong>of</strong> qualitative methodology (including differences between<br />

individual and focus group interviews)<br />

• Understand elements <strong>of</strong> qualitative debriefings (See 3.7 and Modules 6, 7, 9, 10)<br />

• Have experience conducting qualitative assessments<br />

• Have skills in qualitative data management (working knowledge <strong>of</strong> computer<br />

programs such as Word, Excel; production <strong>of</strong> field notes; ability to track data<br />

across facilities)<br />

• Have reasonable technical knowledge <strong>of</strong> reproductive health and malaria (optimal)<br />

• Be able to troubleshoot and adjust accordingly<br />

Laboratory Component Supervisor<br />

A laboratory component supervisor is critical for an assessment that conducts antenatal clinic<br />

and/or delivery unit surveys.<br />

Responsibilities<br />

• Ensure control <strong>of</strong> laboratory procedures in all assessment sites<br />

• Oversee all laboratorians working on <strong>the</strong> assessment<br />

Requirements<br />

• Have experience working in/have links with <strong>the</strong> public health system<br />

• Have technical expertise in malaria microscopy (optimally, has several years’<br />

experience reading thick and thin blood films)<br />

• Has been trained to read placental blood smears by <strong>the</strong> time <strong>the</strong> study starts<br />

• Be competent in <strong>the</strong> training and management <strong>of</strong> laboratorians<br />

<strong>The</strong> Manual<br />

15


Site Supervisors, Interviewers, and Laboratorians<br />

Site supervisors, interviewers, and laboratorians should be selected carefully by <strong>the</strong> persons<br />

organizing <strong>the</strong> assessment. <strong>The</strong>se team members are essential to <strong>the</strong> success <strong>of</strong> <strong>the</strong> rapid<br />

assessment. It is important that <strong>the</strong>y be well trained.<br />

Responsibilities<br />

Site supervisors:<br />

Interviewers:<br />

Laboratorians:<br />

• Ensure assessment quality (See 3.7)<br />

• May also assist in administering <strong>the</strong> questionnaires and in conducting<br />

clinical procedures<br />

• Troubleshoot, in consultation with <strong>the</strong> assessment supervisor<br />

• Administer questionnaires and conduct all clinical procedures<br />

• Conduct all laboratory procedures<br />

Data Management Coordinator<br />

Responsibilities<br />

• Ensure that data are kept securely<br />

• Assist in data analysis<br />

3.3.2 Staffing Approaches for <strong>the</strong> <strong>Assessment</strong><br />

Quantitative Component<br />

Depending on which tools are selected for <strong>the</strong> rapid assessment, <strong>the</strong> assessment coordinator<br />

could use ei<strong>the</strong>r or both <strong>of</strong> <strong>the</strong> following approaches to select assessment team members for<br />

<strong>the</strong> quantitative portion <strong>of</strong> <strong>the</strong> assessment (e.g., antenatal clinic survey, delivery unit survey,<br />

severe disease surveillance, client exit interview, health-care worker observation, health<br />

facility assessment):<br />

• Hire new staff<br />

• Use existing antenatal clinic and delivery staff.<br />

New staff hired specifically for <strong>the</strong> quantitative portion <strong>of</strong> <strong>the</strong> assessment should be organized<br />

by teams, with each team composed ei<strong>the</strong>r <strong>of</strong> one laboratorian and three interviewers or one<br />

laboratorian, two interviewers, and one site supervisor. If existing antenatal clinic and delivery<br />

unit staff are used, one <strong>of</strong> <strong>the</strong> staff members at each antenatal clinic or delivery unit should be<br />

designated as <strong>the</strong> site supervisor.<br />

<strong>The</strong> antenatal clinic teams can rotate between antenatal clinics included in <strong>the</strong> assessment<br />

until <strong>the</strong> desired sample size is obtained. Ideally, for <strong>the</strong> delivery unit survey one team member<br />

will be available 24 hours per day in <strong>the</strong> delivery unit to promptly process placental samples.<br />

It may be helpful to include an additional interviewer for this purpose. If this is not possible, a<br />

cooler and icepacks should be available so that placentas can be stored.<br />

16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Advantages and Disadvantages <strong>of</strong> Staffing Approaches<br />

Staffing<br />

Approach<br />

Hire new<br />

staff<br />

Use existing<br />

health staff<br />

Advantages<br />

• <strong>Assessment</strong> is staff’s priority<br />

• Payment is simple<br />

• <strong>Rapid</strong> assessment does not<br />

compromise delivery <strong>of</strong><br />

clinical care<br />

• Builds capacity<br />

• Facilitates enrollment<br />

• Facilitates clinical treatment<br />

when indicated<br />

• Builds morale<br />

• Ownership <strong>of</strong> assessment<br />

• Buy-in for future<br />

interventions<br />

Disadvantages<br />

• No capacity building <strong>of</strong> existing staff<br />

• Existing staff may resent outsiders if<br />

effective linkages to clinic staff not made<br />

• May be more expensive<br />

• May compromise assessment quality if<br />

nonmedical staff do not have sufficient<br />

training<br />

• May be more difficult to ensure treatment<br />

<strong>of</strong> women with anemia or malaria<br />

• MoH may feel less invested in <strong>the</strong><br />

assessment<br />

• May overburden busy staff<br />

• <strong>Assessment</strong> work (if paid) may take<br />

priority over regular work<br />

• Payment issues are delicate<br />

• Staff may think that any work requires<br />

extra payment<br />

• May compromise quality <strong>of</strong> assessment<br />

in busy settings<br />

• May be competing with projects going<br />

on simultaneously<br />

<strong>The</strong> choice <strong>of</strong> whe<strong>the</strong>r or not to hire new staff should be guided by<br />

• Consideration <strong>of</strong> personnel available and able to conduct <strong>the</strong>se activities<br />

• Financial constraints. <strong>The</strong> project budget may make it difficult to hire outside staff,<br />

which is <strong>the</strong> more expensive option.<br />

If existing staff members make up <strong>the</strong> assessment team, <strong>the</strong> following could help show<br />

appreciation for <strong>the</strong>ir assistance in assuming additional responsibilities outside <strong>the</strong>ir normal<br />

workload:<br />

• Improve <strong>the</strong> working environment by supplying equipment, books, and/or teaching<br />

materials or by improving <strong>the</strong> facility (for example, buying teapot and tea supplies,<br />

painting walls)<br />

• Invite staff to dissemination activities/presentation <strong>of</strong> results at <strong>the</strong> end <strong>of</strong><br />

<strong>the</strong> assessment<br />

• Pay a “per diem” for attending assessment training, but not for conducting<br />

<strong>the</strong> assessment<br />

• Provide payment (an “incentive”) for <strong>the</strong> extra work <strong>the</strong> staff does as part<br />

<strong>of</strong> <strong>the</strong> assessment<br />

• Provide certificate <strong>of</strong> participation in study.<br />

See Modules 1-10 for a list <strong>of</strong> specific personnel needed to conduct each tool.<br />

<strong>The</strong> Manual<br />

17


Qualitative Component<br />

If <strong>the</strong> assessment includes a qualitative portion, it is important to consider <strong>the</strong> approach that<br />

will be used for managing data collected from individual and focus group interviews (see<br />

4.2). Each approach has implications for <strong>the</strong> personnel and s<strong>of</strong>tware needed to manage and<br />

analyze <strong>the</strong> data. New staff may need to be hired (current staff is unlikely to be trained in this<br />

type <strong>of</strong> research), or a university or ano<strong>the</strong>r institution with expertise in qualitative research<br />

may be involved. However, if insufficient resources and opportunities exist, current staff can<br />

be provided intensive training. This can be an excellent opportunity to build local/national<br />

capacity to conduct qualitative studies. See Resource 2.<br />

Six to eight people are needed to conduct <strong>the</strong> qualitative portion <strong>of</strong> <strong>the</strong> assessment. For<br />

individual interviews, <strong>the</strong> number <strong>of</strong> staff needed depends on staff experience. An experienced<br />

staff member could both interview and record; if more junior or inexperienced staff members<br />

are used, individual interviews will require one person to interview and ano<strong>the</strong>r to record.<br />

Focus groups require one person to facilitate (i.e., ask questions) and at least two people to<br />

record, if at all possible.<br />

3.4 Selecting <strong>Assessment</strong> Areas, Sites, and Sample Sizes<br />

3.4.1 <strong>Assessment</strong> Areas<br />

<strong>The</strong> objective(s) <strong>of</strong> <strong>the</strong> rapid assessment will guide <strong>the</strong> selection <strong>of</strong> <strong>the</strong> assessment area<br />

or areas. For example, a country may wish to obtain information on <strong>the</strong> problem and<br />

interventions countrywide, or in one or more geographic regions, or in one or more districts,<br />

or in urban versus rural areas.<br />

Whe<strong>the</strong>r <strong>the</strong> assessment focuses on an entire country or only one region <strong>of</strong> a country, <strong>the</strong><br />

most important selection criterion is <strong>the</strong> transmission pattern <strong>of</strong> malaria. If <strong>the</strong> transmission<br />

pattern differs markedly within <strong>the</strong> area <strong>of</strong> interest, an attempt should be made to collect<br />

information from subareas with different transmission patterns. <strong>The</strong> chief concern should be<br />

to obtain representative data from <strong>the</strong> area <strong>of</strong> interest. Although an ideal assessment might involve<br />

sampling a variety <strong>of</strong> sites within <strong>the</strong> country, resources <strong>of</strong>ten dictate choosing one site,<br />

or a number <strong>of</strong> sites in a well-defined geographic area such as a district, which are likely to be<br />

representative <strong>of</strong> <strong>the</strong> general situation <strong>of</strong> malaria during pregnancy.<br />

18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3.4.2 <strong>Assessment</strong> Sites<br />

Quantitative Component<br />

Within <strong>the</strong> country, region, or district <strong>of</strong> interest, <strong>the</strong> following criteria can be used to select<br />

specific sites for facility-based surveys, observations, and interviews:<br />

• A sufficiently high volume <strong>of</strong> antenatal clinic clients (antenatal clinic survey) or facilitybased<br />

deliveries (delivery unit survey) to ensure that numbers are adequate to reach <strong>the</strong><br />

desired sample size most expeditiously and within <strong>the</strong> allotted time for <strong>the</strong> study<br />

• Facilities with both an antenatal clinic and a delivery unit (for <strong>the</strong> sake <strong>of</strong> efficiency in<br />

conducting <strong>the</strong> assessment)<br />

• Ability to gain access to antenatal clinics and delivery units during <strong>the</strong> assessment<br />

• Representativeness <strong>of</strong> <strong>the</strong> facility population (in terms <strong>of</strong> ethnicity, urban/rural<br />

residence, socioeconomic status)<br />

• Geographic area to ensure coverage from different geographic areas. This may be<br />

difficult to achieve in reality, as previously noted.<br />

<strong>The</strong> more facilities involved, <strong>the</strong> more representative <strong>the</strong> data. However, <strong>the</strong> larger <strong>the</strong><br />

number <strong>of</strong> facilities selected, <strong>the</strong> more resources (human, financial, logistic) will be<br />

required to conduct <strong>the</strong> assessment. Thus, those selecting sites should balance <strong>the</strong> need for<br />

representativeness <strong>of</strong> data with <strong>the</strong> availability <strong>of</strong> resources.<br />

Experience with rapid assessments shows that a total <strong>of</strong> two delivery units and four antenatal<br />

clinics from a selected district or region is feasible and reasonably efficient for assessment<br />

<strong>of</strong> burden <strong>of</strong> disease, but <strong>the</strong>se are not “magic” numbers. <strong>The</strong> needed sample size and client<br />

volume in <strong>the</strong> assessment area may affect <strong>the</strong> number <strong>of</strong> sites selected per region or district.<br />

See modules.<br />

Qualitative Component<br />

Participants can be selected from <strong>the</strong> chosen health facility catchment areas or from a larger<br />

number <strong>of</strong> districts or regions, depending on <strong>the</strong> budget. If participants are chosen from a<br />

broader number <strong>of</strong> districts or regions, <strong>the</strong>y should be chosen in much <strong>the</strong> same way that<br />

districts or regions selected for <strong>the</strong> quantitative surveys have been chosen.<br />

Focus groups and individual interviews can be held in health facilities, homes, and community<br />

venues, depending on who is being interviewed.<br />

<strong>The</strong> Manual<br />

19


3.4.3 Sample Sizes<br />

Sample sizes for antenatal clinic and delivery unit surveys depend largely on point estimates<br />

<strong>of</strong> key indicators <strong>of</strong> burden and desired level <strong>of</strong> accuracy. Sample sizes recommended for<br />

o<strong>the</strong>r tools derive from experience conducting assessments. Modules 1 and 2 contain more<br />

information on how to calculate sample sizes for antenatal clinic and delivery unit surveys.<br />

Summary <strong>of</strong> Required Sample Sizes, by Tool<br />

<strong>Assessment</strong> Tool<br />

1. Antenatal clinic<br />

surveys<br />

2. Delivery unit<br />

surveys<br />

3. Hospital surveillance<br />

<strong>of</strong> malaria disease<br />

4. Antenatal clinic<br />

facility assessment<br />

<strong>Assessment</strong> Tool<br />

5. Health-care worker<br />

observation<br />

6. Focus groups<br />

and individual<br />

interviews with<br />

health-care workers<br />

7. Focus groups<br />

and individual<br />

interviews with<br />

midwives and<br />

traditional birth<br />

attendants<br />

8. Antenatal clinic<br />

client exit interview<br />

9. Focus groups<br />

and individual<br />

interviews with<br />

pregnant women<br />

10. Individual<br />

interviews with<br />

key informants<br />

Sample Size/Notes<br />

Sample size will depend on <strong>the</strong> coordinator’s estimate <strong>of</strong><br />

peripheral parasitemia and 3 rd trimester anemia, as well as <strong>the</strong><br />

margin <strong>of</strong> error <strong>the</strong> coordinator thinks acceptable. See Module 1<br />

for more detail.<br />

Sample size will depend on <strong>the</strong> coordinator’s estimate <strong>of</strong><br />

placental parasitemia and LBW, as well as <strong>the</strong> margin <strong>of</strong> error <strong>the</strong><br />

coordinator thinks acceptable. See Module 2 for more detail.<br />

All ill women admitted to <strong>the</strong> hospital during <strong>the</strong> time data are<br />

being collected during <strong>the</strong> antenatal clinic and delivery unit<br />

surveys.<br />

Each <strong>of</strong> <strong>the</strong> antenatal clinics selected for an antenatal clinic survey<br />

(and may be expanded if this sample is believed to be too small).<br />

Sample Size/Notes<br />

Observation <strong>of</strong> approximately 20-25 health-care worker/patient<br />

encounters per each antenatal clinic selected for an antenatal<br />

clinic survey.<br />

Individual interviews are preferable if timing is not an issue.<br />

Could interview as many health-care workers as feasible during<br />

<strong>the</strong> assessment period, probably no more than 5-10 per facility,<br />

but sometimes as few as 1-2 is all that is possible.<br />

At least one focus group with 5 to 15 participants per facility<br />

area. May wish to conduct interviews as well, depending on <strong>the</strong><br />

available pool <strong>of</strong> potential participants.<br />

Approximately 15 per site. Note: Women selected for interviews<br />

should be different from <strong>the</strong> women selected for <strong>the</strong> antenatal<br />

clinic surveys.<br />

At least one focus group with 5 to 15 participants per facility. Four<br />

to five individual interviews per facility.<br />

Individual interviews with 2-4 key informants per facility area.<br />

20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3.5 Adapting, Translating, and Preparing<br />

<strong>Assessment</strong> Materials<br />

Once <strong>the</strong> assessment teams have been formed, assessment instruments (questionnaires,<br />

information sheets/informed consent forms, observation forms, interview guides) and<br />

logbooks will need to be prepared. Each module in this packet contains sample survey<br />

materials, which will likely need to be tailored for use in <strong>the</strong> particular local context. For<br />

example, changes may need to be made to reflect <strong>the</strong> drugs and <strong>the</strong> drug trade names used in<br />

a particular country. Additional questions may need to be added to obtain o<strong>the</strong>r variables <strong>of</strong><br />

interest, for example, such socioeconomic and demographic variables as caste, ethnic group,<br />

or family income. One country may wish to exclude pregnant women younger than 15; o<strong>the</strong>rs<br />

may have no lower age limit.<br />

<strong>The</strong> materials should be reviewed, pretested, and adapted as much as possible prior to<br />

assessment training and <strong>the</strong>n again during <strong>the</strong> training sessions, at which time <strong>the</strong>y may<br />

require additional adjustment.<br />

Focus groups<br />

and individual<br />

interviews can<br />

be held in health<br />

facilities, homes,<br />

and community<br />

venues, depending<br />

on who is being<br />

interviewed.<br />

After <strong>the</strong> survey instruments are adapted, <strong>the</strong>y and <strong>the</strong> information sheet (or informed<br />

consent form if used) should be translated into <strong>the</strong> national language and <strong>the</strong> primary<br />

language spoken by women in <strong>the</strong> assessment area, if different. This initial translation<br />

should be followed by a back-translation (by individuals who did not produce <strong>the</strong> original<br />

translation) into <strong>the</strong> national language to check <strong>the</strong> accuracy <strong>of</strong> <strong>the</strong> translation.<br />

If <strong>the</strong> primary language is not a written language, it will be important to work to achieve<br />

correct, consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet<br />

(or informed consent form). It is important to hold a discussion with all interviewers present<br />

to agree on phrasing and to give <strong>the</strong> interviewers an opportunity to practice. Each participant<br />

should still receive a copy <strong>of</strong> <strong>the</strong> information sheet.<br />

It is critical to maintain participants’ confidentiality according to <strong>the</strong> laws <strong>of</strong> <strong>the</strong> country or<br />

jurisdiction. If appropriate to <strong>the</strong> local situation, questionnaires can be designed with a tear<strong>of</strong>f<br />

identifier page, which can be removed once data entry and validation are complete. <strong>The</strong><br />

removal <strong>of</strong> <strong>the</strong> identifier page ensures that recorded data cannot be linked to <strong>the</strong> participant.<br />

3.6 Conducting <strong>Assessment</strong> Training<br />

Whe<strong>the</strong>r or not <strong>the</strong> qualitative and quantitative components are conducted simultaneously<br />

largely depends on <strong>the</strong> tools selected and <strong>the</strong> availability <strong>of</strong> assessment team members.<br />

In turn, <strong>the</strong> timing <strong>of</strong> <strong>the</strong>se components may help determine how and when training is<br />

conducted, although ideally training should be done within a few days before <strong>the</strong> start <strong>of</strong> <strong>the</strong><br />

assessment. Training <strong>of</strong> <strong>the</strong> teams can occur after <strong>the</strong> preassessment activities described in<br />

<strong>the</strong> previous section and will take approximately 4-5 days.<br />

If training for both will occur during <strong>the</strong> same time period, <strong>the</strong> quantitative and qualitative<br />

teams should meet <strong>the</strong> first day <strong>of</strong> <strong>the</strong> training session to receive an overview <strong>of</strong> <strong>the</strong> entire<br />

assessment. Some topics are relevant to both teams, including providing information/<br />

obtaining informed consent, general information on <strong>the</strong> effect <strong>of</strong> malaria infection during<br />

pregnancy, politics <strong>of</strong> and sensitivities to conducting an assessment in health-care facilities<br />

(if assessment staff is hired from outside <strong>the</strong> system), and approaching potential participants.<br />

<strong>The</strong> teams can <strong>the</strong>n separate to learn <strong>the</strong>ir specific tasks. <strong>The</strong> training period can also be used<br />

<strong>The</strong> Manual<br />

21


to ensure that <strong>the</strong> assessment tools are linguistically and culturally consistent. After this,<br />

ideally, <strong>the</strong> entire team should be brought back toge<strong>the</strong>r to review assessment timing, learn<br />

who will work at each facility, and review who will assume supervisory roles. Regardless <strong>of</strong><br />

when training is conducted, each team should understand what <strong>the</strong> o<strong>the</strong>r teams are doing, <strong>the</strong><br />

types <strong>of</strong> data that <strong>the</strong>y are ga<strong>the</strong>ring, and <strong>the</strong> methods <strong>the</strong>y are using. <strong>The</strong> entire team should<br />

be prepared to answer questions about <strong>the</strong> assessment as a whole.<br />

Quantitative Component<br />

During training, each question on <strong>the</strong> questionnaire should be reviewed, and team members<br />

should be given a chance to practice conducting <strong>the</strong> questionnaire with o<strong>the</strong>r team members<br />

and <strong>the</strong>n with clients in local antenatal clinics. Team members should become familiar<br />

with how to fill out logbooks. <strong>The</strong> coordinator should explain why an information sheet (or<br />

informed consent) is necessary (see 3.8).<br />

Training will also focus on ensuring that team members can perform <strong>the</strong> needed clinical<br />

procedures including collecting blood using fingersticks, preparing slides, and weighing a<br />

newborn. <strong>The</strong>y should practice <strong>the</strong>se skills in a working facility. Because women in <strong>the</strong> surveys<br />

should receive treatment according to national policy, if <strong>the</strong>y are found to be anemic or are<br />

suspected or confirmed to have malaria infection, interviewers should be prepared to ensure<br />

that women and neonates receive proper treatment. Laboratorians should be trained in how<br />

to read peripheral, placental, and umbilical cord blood films. See each module for additional<br />

information about training.<br />

Note: Because many countries may choose to conduct both an antenatal clinic and<br />

delivery unit survey and because it is more efficient to conduct training for <strong>the</strong>se two<br />

simultaneously, this manual describes combined training in Modules 1 and 2, which<br />

can be modified, if necessary.<br />

Qualitative Component<br />

During training, qualitative teams should focus on learning and practicing how to interview,<br />

as well as how to record notes during an interview. Ideally, several days should be allowed for<br />

training. <strong>The</strong> coordinator or facilitator should review <strong>the</strong> essential elements <strong>of</strong> interviewing,<br />

particularly recording (i.e., taking notes on) interviews. Recording individual interviews or<br />

focus groups, while not difficult, must be done well, as it determines <strong>the</strong> quality <strong>of</strong> <strong>the</strong> data.<br />

Team members should be observed role playing and giving mock interviews with people who<br />

are not members <strong>of</strong> <strong>the</strong> assessment teams. Teams can <strong>of</strong>ten practice in local clinics where<br />

<strong>the</strong> assessment will not be conducted to assess <strong>the</strong> individual team members’ strengths and<br />

weaknesses. Practice might show that one person is a better focus group facilitator than an<br />

interviewer, for example. Team members’ positions should closely match <strong>the</strong>ir strengths.<br />

Consult <strong>the</strong> Sample Interviewer Training Manual in Resource 2 for additional information<br />

about training.<br />

22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3.7 Assuring <strong>Assessment</strong> Quality<br />

A quality assurance mechanism for data collection, transport, and storage should be<br />

established to ensure that data are <strong>of</strong> high quality. To oversee quality control, a supervisory<br />

system should be in place that ensures that questions, concerns, and technical issues are<br />

addressed in a timely manner.<br />

Quantitative Component<br />

<strong>The</strong> site supervisor (one per team) is responsible for <strong>the</strong> following:<br />

• Reviewing all questionnaires, enrollment, laboratory, and treatment logbooks<br />

(and written consent forms, if used) each day for accuracy and completeness<br />

• Maintaining a daily logbook that shows <strong>the</strong> identification (ID) numbers <strong>of</strong> <strong>the</strong><br />

interviews that were completed during that day, in which facility <strong>the</strong>y were<br />

completed, date <strong>of</strong> interview, and name <strong>of</strong> interviewer<br />

• Ensuring that each consecutive page <strong>of</strong> <strong>the</strong> interview has an ID number in case<br />

<strong>the</strong> pages become separated<br />

• Giving feedback to interviewers regarding accuracy and completeness <strong>of</strong><br />

questionnaires and logbooks<br />

• Discussing issues and concerns and developing solutions (e.g., completeness<br />

<strong>of</strong> logbooks, inconsistent completion <strong>of</strong> questionnaires, patient flow, lack <strong>of</strong> supplies,<br />

equipment failures)<br />

To oversee<br />

quality control, a<br />

supervisory system<br />

should be in place<br />

that ensures<br />

that questions,<br />

concerns, and<br />

technical issues<br />

are addressed in a<br />

timely manner.<br />

<strong>The</strong> laboratory component supervisor is responsible for:<br />

<br />

<br />

• Ensuring that adequate reagents and o<strong>the</strong>r needed materials are available<br />

• Reviewing laboratory logbooks and ensuring that <strong>the</strong>y are accurate and complete<br />

• Reread a sample (for example, 10%) <strong>of</strong> all assessment blood films weekly for<br />

accurate diagnosis<br />

• Evaluating quality <strong>of</strong> slides (both blood film preparation and staining), and<br />

providing technical support when needed for slide reading<br />

<strong>The</strong> assessment coordinator also plays an important role in ensuring <strong>the</strong> quality <strong>of</strong> <strong>the</strong> entire<br />

rapid assessment by:<br />

<br />

<br />

<br />

• Making at least weekly visits to review all logbooks and questionnaires from all<br />

assessment teams and giving feedback to site supervisors and <strong>the</strong> microscopy<br />

supervisor as appropriate. <strong>The</strong> coordinator should transport completed forms and<br />

blood films to a secure central location on a weekly basis.<br />

• Establishing a mechanism to distribute and re-stock assessment supplies. During<br />

<strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for assuring<br />

that each assessment site has adequate equipment and supplies for at least 2 weeks<br />

<strong>of</strong> data collection. During <strong>the</strong> assessment, site supervisors are responsible for<br />

inventory <strong>of</strong> all supplies and equipment throughout <strong>the</strong> assessment period at each<br />

assessment site to assure that data collection is not interrupted.<br />

• Ensuring that adequate copies <strong>of</strong> antenatal clinic and delivery unit questionnaires<br />

are available at each assessment site. During <strong>the</strong> assessment start-up, <strong>the</strong><br />

assessment coordinator is responsible for assuring that each assessment site has<br />

adequate copies <strong>of</strong> antenatal clinic and delivery unit questionnaires and informed<br />

consent forms (or information sheets) for at least 2 weeks <strong>of</strong> data collection. During<br />

<strong>the</strong> assessment, site supervisors are responsible for inventory <strong>of</strong> questionnaires<br />

throughout <strong>the</strong> assessment period and at each assessment site to assure that data<br />

collection is not interrupted.<br />

• Ensuring adequate numbers <strong>of</strong> focus group and interview guides are available.<br />

• Ensuring participant confidentiality.<br />

<strong>The</strong> Manual<br />

23


Qualitative Component<br />

<strong>The</strong> coordinator for <strong>the</strong> qualitative part <strong>of</strong> <strong>the</strong> assessment (individual and focus group<br />

interviews), if different from <strong>the</strong> overall assessment coordinator, has primary responsibility<br />

for that portion <strong>of</strong> <strong>the</strong> assessment but should work closely with <strong>the</strong> overall assessment<br />

coordinator.<br />

<strong>The</strong> qualitative assessment coordinator is responsible for<br />

<br />

<br />

<br />

• Observing groups and interviews periodically to ensure that <strong>the</strong> facilitators and<br />

interviewers are using proper technique, e.g., that <strong>the</strong>y are using questions in <strong>the</strong><br />

guide but adapting <strong>the</strong>m as necessary in order to elicit <strong>the</strong> intended responses<br />

• Reviewing all recorded interviews for completeness and accuracy <strong>of</strong> recording<br />

• Ensuring accurate and consistent use <strong>of</strong> traditional terms for illnesses, symptoms,<br />

and prevention and treatment strategies, including usage and spelling.<br />

• Ensuring that <strong>the</strong> needed information is being obtained by reviewing recorded<br />

interviews and focus group notes and adjusting (e.g., adding new questions, making<br />

questions more specific) <strong>the</strong> interview/focus group guides accordingly.<br />

At <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview before <strong>the</strong> respondent leaves, qualitative interviewers who also<br />

serve as recorders should examine <strong>the</strong>ir data to make sure <strong>the</strong> information is understandable.<br />

During training, <strong>the</strong>y can learn to use standard abbreviations to help <strong>the</strong>m record quickly. In<br />

addition, <strong>the</strong>y can use symbols (such as an asterisk in <strong>the</strong> column) to alert <strong>the</strong>m to a question<br />

that <strong>the</strong>y might have for <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview. <strong>The</strong> interviewers should be trained to look<br />

for such symbols and to ask <strong>the</strong> respondent for clarification. Once <strong>the</strong> respondent leaves, <strong>the</strong><br />

interviewer should again review <strong>the</strong> interview, spelling out abbreviations and making sure <strong>the</strong><br />

handwriting is legible. If both an interviewer and recorder are involved in <strong>the</strong> interview, both<br />

need to review <strong>the</strong> data toge<strong>the</strong>r.<br />

Supervisors should also check interviews at <strong>the</strong> end <strong>of</strong> <strong>the</strong> day, as well as hold a “debriefing.”<br />

A debriefing helps determine: 1) whe<strong>the</strong>r <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />

data (qualitative methods are iterative; thus, questions can be changed as needed during<br />

<strong>the</strong> assessment), 2) whe<strong>the</strong>r people have understood <strong>the</strong> question (for example: is <strong>the</strong><br />

misunderstanding a sentence structure, content, or a translation problem?), 3) whe<strong>the</strong>r data<br />

are similar across facilities or show wide variability, which might require adding questions<br />

to understand <strong>the</strong> variability, and 4) whe<strong>the</strong>r expressions in <strong>the</strong> local language are being<br />

translated appropriately. <strong>The</strong> debriefing should be led by <strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />

<strong>The</strong> team listens to what each interviewer has learned, identifies what is common or different,<br />

and mutually agrees on what local expressions mean (particularly important when <strong>the</strong> team<br />

is trying to understand local beliefs about malaria and/or drugs during pregnancy). During<br />

<strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong> each<br />

debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms, as well as <strong>the</strong><br />

agreed-upon translations.<br />

<strong>The</strong> supervisor should ensure that each consecutive page <strong>of</strong> <strong>the</strong> interview has an ID number in<br />

case <strong>the</strong> pages become separated. <strong>The</strong> supervisor should also have a logbook for each day that<br />

shows <strong>the</strong> ID numbers <strong>of</strong> <strong>the</strong> interviews that were completed during that day, in which facility<br />

<strong>the</strong>y were completed, date <strong>of</strong> interview, and name <strong>of</strong> interviewer.<br />

24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3.8 Providing Information about <strong>the</strong> Survey<br />

and Obtaining Informed Consent<br />

Each country’s human subjects requirements should be followed in <strong>the</strong> conduct <strong>of</strong> <strong>the</strong> rapid<br />

assessment. Some countries may require that a participant give informed consent and sign a<br />

form; o<strong>the</strong>rs may require that each prospective participant simply be given information. <strong>The</strong><br />

assessment described here is usually classified as program evaluation ra<strong>the</strong>r than research<br />

and as such, may not require formal institutional review board (IRB) or ethics committee<br />

review. However, depending on <strong>the</strong> modifications to <strong>the</strong> assessment tools and local rules<br />

and regulations, <strong>the</strong> assessment may require such formal IRB or ethics committee review<br />

and approval. Generally, if blood will be collected and stored or kept longer than <strong>the</strong> local<br />

guidelines suggest, documentation <strong>of</strong> informed consent will probably be required.<br />

Each country’s<br />

human subjects<br />

requirements<br />

should be followed<br />

in <strong>the</strong> conduct<br />

<strong>of</strong> <strong>the</strong> rapid<br />

assessment.<br />

If it is decided that participants should be given an information sheet, it should be written in<br />

<strong>the</strong>ir primary language and include <strong>the</strong> following information, if applicable:<br />

• Purpose<br />

• Procedures<br />

• Alternatives to participation<br />

• Risks and discomforts<br />

• Potential benefits<br />

• Provisions <strong>of</strong> confidentiality<br />

• Voluntary participation and right to discontinue without penalty<br />

• Contacts for questions/additional information<br />

• Any o<strong>the</strong>r relevant information (e.g., who is conducting <strong>the</strong> survey, how many people<br />

will participate)<br />

If <strong>the</strong> participants cannot read or <strong>the</strong>y have low literacy skills, <strong>the</strong> information on <strong>the</strong> sheet<br />

can be read to <strong>the</strong>m. <strong>The</strong> sheet would <strong>the</strong>n serve as a script for <strong>the</strong> interviewer. In ei<strong>the</strong>r<br />

case, <strong>the</strong> participants should be given a copy. If true informed consent is being obtained, <strong>the</strong>n<br />

<strong>the</strong>re should be a witness present for those persons who cannot sign and whose consent to<br />

participate will be documented with a thumb print. Both <strong>the</strong> copy retained and <strong>the</strong> copy given<br />

to <strong>the</strong> participant should be signed. <strong>The</strong> supervisors should keep a record <strong>of</strong> <strong>the</strong> number <strong>of</strong><br />

refusals and <strong>the</strong> reasons for refusal. For example, <strong>of</strong>ten <strong>the</strong> women in antenatal clinic do not<br />

want to participate in an interview because it would extend <strong>the</strong> length <strong>of</strong> <strong>the</strong>ir visit.<br />

3.9 Providing Treatment for <strong>Malaria</strong> and Anemia<br />

In addition to ga<strong>the</strong>ring information about a pregnant woman’s experience and practices with<br />

regard to malaria, <strong>the</strong> antenatal clinic survey will also ga<strong>the</strong>r information on <strong>the</strong> proportion<br />

<strong>of</strong> women with anemia and malaria. Blood slides for women who are currently or recently<br />

(as defined by country guidelines, e.g., within <strong>the</strong> previous 7 days) febrile should be read<br />

promptly. Ideally, such slides would be read <strong>the</strong> same day. <strong>The</strong>se women should wait to receive<br />

<strong>the</strong>ir blood results before leaving clinic that day. If <strong>the</strong> slides are positive, <strong>the</strong>y should receive<br />

treatment with <strong>the</strong> appropriate antimalarial drug, according to national policy. If women are<br />

found to be anemic, <strong>the</strong>y should also receive appropriate treatment, according to national<br />

policy. If it is determined that a neonate has malaria infection, that neonate should also be<br />

treated as outlined in national policy.<br />

<strong>The</strong> Manual<br />

25


4. Data Management and Analysis<br />

This chapter is devoted to <strong>the</strong> management and analysis <strong>of</strong> data ga<strong>the</strong>red from <strong>the</strong><br />

assessment; individual modules contain fur<strong>the</strong>r guidance.<br />

4.1 Data Management<br />

Quantitative Component<br />

A statistical computer package should be used to enter and analyze <strong>the</strong> quantitative data from<br />

<strong>the</strong> assessment. Epi Info is available free <strong>of</strong> charge and has been included in this package<br />

(Resource 4). It is also available from <strong>the</strong> U.S. Centers for Disease Control and Prevention<br />

(CDC) Web site (www.cdc.gov/epiinfo). O<strong>the</strong>r packages such as SAS or SPSS may also be used,<br />

although <strong>the</strong>y are not available free; thus, <strong>the</strong>ir cost should be included in <strong>the</strong> budget for <strong>the</strong><br />

assessment.<br />

Ideally two computers should be available for data entry. Since all data should be entered<br />

twice to ensure accuracy, two computers could speed <strong>the</strong> process by allowing simultaneous<br />

entry.<br />

Before <strong>the</strong> rapid assessment begins, <strong>the</strong> assessment coordinator should identify a data<br />

management coordinator with experience in using statistical computer s<strong>of</strong>tware and<br />

managing data entry and analysis activities (see 3.3). Possible candidates for this position<br />

include<br />

• <strong>Assessment</strong> coordinator<br />

• Local program data manager or o<strong>the</strong>r local program staff<br />

• National-level program staff<br />

• Outside consultant, if necessary (one <strong>of</strong> <strong>the</strong> intended outcomes <strong>of</strong> <strong>the</strong> assessment is to<br />

develop national capacity; <strong>the</strong>refore, use <strong>of</strong> an outside consultant is not ideal).<br />

Step 1: Modify (or create) data entry programs<br />

Epi Info can be used to create data entry files for <strong>the</strong> assessment instruments. Epi Info’s<br />

data entry files consist <strong>of</strong> questionnaire (.QES), checking (.CHK), and record (.REC) files. <strong>The</strong><br />

checking file (.CHK) should specify valid (allowed) variables for each question as well as skip<br />

patterns, which could be defined as sequences <strong>of</strong> questions asked and omitted in a survey<br />

instrument.<br />

Note: Data entry files for Tools 1, 2, and 3 are included in this package in Resource 4. <strong>The</strong>y<br />

should be modified to reflect any changes made to <strong>the</strong> surveys that reflect <strong>the</strong> local situation<br />

or concerns. <strong>The</strong>se Micros<strong>of</strong>t Access–based .MDB files contain essentially all information that<br />

would be contained in <strong>the</strong> .QES, CHK, and .REC files mentioned in <strong>the</strong> next paragraph and can<br />

be opened by Epi Info 2000 and higher.<br />

26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Step 2: Test programs<br />

<strong>The</strong> assessment coordinator should test <strong>the</strong> data entry files for each questionnaire by entering<br />

data from pilot or initial questionnaires. Each file should be tested several times and reviewed<br />

to ensure that <strong>the</strong> data entry files are working correctly.<br />

Step 3: Identify and train data management staff<br />

It is recommended that two people be identified to enter data and trained by <strong>the</strong> assessment<br />

coordinator or data manager; <strong>the</strong> training should not take more than a few hours.<br />

Step 4: Enter and store data<br />

It is critical<br />

to maintain<br />

participants’<br />

confidentiality<br />

according to <strong>the</strong><br />

laws <strong>of</strong> <strong>the</strong><br />

country/<br />

jurisdiction.<br />

Data can be entered throughout <strong>the</strong> data collection period or all at once at <strong>the</strong> end <strong>of</strong> data<br />

collection. It is strongly recommended that data be entered throughout <strong>the</strong> time data are being<br />

collected. During <strong>the</strong> process <strong>of</strong> data entry, problems in questionnaire design or completion can<br />

be revealed and corrected. <strong>The</strong> assessment coordinator is responsible for determining which<br />

method is best suited to <strong>the</strong> setting.<br />

<strong>The</strong> following suggestions may help improve <strong>the</strong> process <strong>of</strong> data entry:<br />

• Find an appropriate pace for data entry. If data entry is attempted too quickly, errors<br />

are more likely to occur.<br />

• Enter data from all questionnaires <strong>of</strong> one type sequentially (e.g., all antenatal clinic<br />

questionnaires).<br />

• If Epi Info6 is used, <strong>the</strong> program will assign a record number. Write that number on<br />

<strong>the</strong> questionnaire.<br />

• Mark each questionnaire with a check or cross after data entry <strong>of</strong> questionnaire<br />

information to indicate that data entry has been completed. Make sure that after <strong>the</strong><br />

data are double entered, <strong>the</strong> questionnaires have two checks or crosses.<br />

• Encourage data entry clerks to mark items that appear erroneous with a<br />

“post-it” note. Data entry clerks <strong>of</strong>ten uncover logical errors in questionnaire design<br />

which can be corrected early on. However, data clerks should be encouraged to note<br />

errors or problems <strong>the</strong>y encounter throughout data entry<br />

and notify <strong>the</strong> assessment coordinator.<br />

• Back up all data files regularly on a diskette or o<strong>the</strong>r storage device such as a zip<br />

disk or flash card, both during data entry and at <strong>the</strong> end <strong>of</strong> <strong>the</strong> day.<br />

• File questionnaires by type <strong>of</strong> questionnaire and enrollee’s number.<br />

To ensure that all data have been entered accurately, <strong>the</strong> data management coordinator<br />

(or assessment coordinator) should<br />

• Run <strong>the</strong> data validation program in Epi Info to uncover possible data entry<br />

errors. This needs to be done at <strong>the</strong> end <strong>of</strong> data entry. Note that questionnaires will<br />

need to be available for review during <strong>the</strong> validation process in order to reconcile<br />

discrepancies.<br />

• If .REC files are used, review <strong>the</strong> file for each questionnaire by running frequencies<br />

for each variable, identifying inconsistencies, and investigating possible errors (and<br />

<strong>the</strong>n correcting <strong>the</strong> data file based on <strong>the</strong> hard copies <strong>of</strong> <strong>the</strong> questionnaires). This is<br />

best done at <strong>the</strong> end <strong>of</strong> data entry.<br />

• Supervise data entry and periodically check quality <strong>of</strong> data entry by randomly<br />

selecting questionnaires for review.<br />

<strong>The</strong> Manual<br />

27


To store data safely<br />

• Store questionnaires (and backed-up data files) in a locked cabinet available only<br />

to <strong>the</strong> assessment coordinator and data management team to ensure participants’<br />

confidentiality.<br />

• If <strong>the</strong> questionnaire was designed with a tear-<strong>of</strong>f identifier page, <strong>the</strong> page with<br />

information identifying <strong>the</strong> participant should be removed once data entry and<br />

validation are complete.<br />

It is critical to maintain participants’ confidentiality according to <strong>the</strong> laws <strong>of</strong> <strong>the</strong><br />

country/jurisdiction.<br />

Qualitative Component<br />

Some decisions about <strong>the</strong> management <strong>of</strong> qualitative data will need to be made.<br />

• Will <strong>the</strong> interviews be tape recorded?<br />

• Will <strong>the</strong> recorders’ field notes be expanded to a full transcript <strong>of</strong> <strong>the</strong> interviews?<br />

• Will <strong>the</strong> qualitative data be entered into a computer for analysis?<br />

• What types <strong>of</strong> s<strong>of</strong>tware are likely to be useful?<br />

<strong>The</strong> assessment team may consider at least three approaches for managing data collected<br />

from individual and focus group interviews. All have implications for <strong>the</strong> personnel and<br />

s<strong>of</strong>tware needed to manage and analyze <strong>the</strong> data. Choosing between <strong>the</strong> options will<br />

involve a trade-<strong>of</strong>f for <strong>the</strong> level <strong>of</strong> detail.<br />

• <strong>The</strong> simplest approach is to record short open-ended responses directly on <strong>the</strong><br />

interview forms. <strong>The</strong> responses can later be grouped by hand or coded using<br />

relatively limited qualitative analysis s<strong>of</strong>tware such as CDC EZ - Text (http://www.<br />

cdc.gov/hiv/s<strong>of</strong>tware/ez-text.htm). This approach gleans <strong>the</strong> least detail but may<br />

be appropriate when experienced qualitative researchers and data collectors are not<br />

available.<br />

• A second approach would be to have <strong>the</strong> data recorders expand <strong>the</strong> notes taken<br />

during <strong>the</strong> interview into a structured report <strong>of</strong> <strong>the</strong> responses.<br />

• A third would be to tape record 5 <strong>the</strong> interview and <strong>the</strong>n have it transcribed word<br />

for word.<br />

Expanded field notes and interview transcripts can be managed by a more experienced<br />

qualitative researcher and will contain far more detail. However, data in <strong>the</strong>se formats will<br />

require much more time for coding and analysis. <strong>The</strong> analysis can be completed by hand, but<br />

when a large number <strong>of</strong> data are generated, s<strong>of</strong>tware products like NUDIST, <strong>the</strong> Ethnograph, or<br />

ATLAS.ti can be helpful.<br />

Choosing among <strong>the</strong>se approaches, or choosing ano<strong>the</strong>r alternative, should be left to <strong>the</strong><br />

individual responsible for coordinating and analyzing <strong>the</strong> qualitative data and needs to be<br />

decided prior to recruiting and training data collectors.<br />

5 Although tape recorders can capture everything that is said, <strong>the</strong> tape recorder may malfunction without its<br />

being realized, and all data will be lost. Transcribing a 1-hour tape takes 2-3 hours. In addition, if <strong>the</strong> interviews<br />

are held outdoors (which occurs in many facility and home interviews), <strong>the</strong> tape <strong>of</strong>ten picks up ambient<br />

noises, which obscure what is said. Focus groups interviews are difficult to listen to, as <strong>of</strong>ten, more than one<br />

person is speaking at a time. <strong>The</strong> cost <strong>of</strong> <strong>the</strong> tape recorders, tapes, and transcription also need to be considered.<br />

For <strong>the</strong>se reasons, it is <strong>of</strong>ten preferable to record <strong>the</strong> interviews and focus groups by hand.<br />

28 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


4.2 Data Analysis<br />

Quantitative Component<br />

<strong>The</strong> assessment coordinator should work with <strong>the</strong> assessment and data management teams<br />

to develop an analysis plan before <strong>the</strong> survey begins. This plan should include key indicators<br />

that will affect policy and program.<br />

For each quantitative tool included in <strong>the</strong> package, its respective module specifies outcome<br />

variables and samples <strong>of</strong> tables that are critical for analysis. Additional indicators could<br />

be selected and fur<strong>the</strong>r analyses could be done, but this may not be essential for action.<br />

Whatever indicators are selected, <strong>the</strong>re must be a plan for how that information can be used<br />

to affect <strong>the</strong> policy and program.<br />

Two months should be sufficient to enter and analyze data, write <strong>the</strong> report, and disseminate<br />

<strong>the</strong> results.<br />

A s<strong>of</strong>tware program can be used to run <strong>the</strong> analysis on quantitative data to determine<br />

• Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women who have peripheral parasitemia, anemia,<br />

placental parasitemia, and LBW (as well as <strong>the</strong>ir 95% confidence intervals)<br />

• Estimated gravidity-specific parasitemia, anemia, and LBW rates<br />

• Frequencies <strong>of</strong> key variables collected from <strong>the</strong> facility assessment and<br />

antenatal clinic health-care worker observation.<br />

It is useful to generate a table summarizing basic sociodemographic variables. If <strong>the</strong><br />

assessment involves more than one site, it may be useful to present data by site, with one site<br />

per column. Alternatively, if sites are similar, data may be aggregated. Data from antenatal<br />

clinics and delivery units should be presented separately.<br />

It is also generally useful to analyze parasitemia, anemia, and LBW by gravidity, using <strong>the</strong>se<br />

categories: primigravidae, secundigravidae, and multigravidae.<br />

If <strong>the</strong>re is a functioning malaria prevention program, it may be useful to analyze <strong>the</strong> data<br />

by degree <strong>of</strong> self-reported adherence to <strong>the</strong> intervention (e.g., chemoprophylaxis or IPTp).<br />

Categories <strong>of</strong> adherence might be complete, incomplete, or none.<br />

Limitations<br />

<strong>The</strong> limitations <strong>of</strong> <strong>the</strong> antenatal clinic and delivery unit data will affect interpretation <strong>of</strong><br />

results. Both antenatal clinic and delivery unit surveys use a convenience sample, not a<br />

randomly selected sample. <strong>The</strong>refore, women attending antenatal clinics and delivering<br />

in delivery units are not completely representative <strong>of</strong> all pregnant women. In countries<br />

with high antenatal clinic coverage, <strong>the</strong> pregnant women surveyed are likely to be more<br />

representative <strong>of</strong> <strong>the</strong> general population <strong>of</strong> pregnant women. As is <strong>of</strong>ten <strong>the</strong> case, more<br />

women visit antenatal clinics during <strong>the</strong>ir pregnancies than deliver in facilities, and so women<br />

in <strong>the</strong> delivery units are usually less representative <strong>of</strong> all pregnant women. In countries with<br />

low coverage, a facility-based rapid assessment will not give a very accurate picture <strong>of</strong> <strong>the</strong><br />

burden <strong>of</strong> malaria in pregnancy nationwide.<br />

<strong>The</strong> Manual<br />

29


Qualitative Component<br />

Regardless <strong>of</strong> <strong>the</strong> approach used to record and manage data, analysis <strong>of</strong> qualitative data ideally<br />

begins at <strong>the</strong> start <strong>of</strong> data collection, and <strong>the</strong> supervisor should begin reviewing data as <strong>the</strong>y<br />

are collected in order to identify <strong>the</strong> need to expand or revise <strong>the</strong> interview/focus group<br />

guides to capture detail that might not have been anticipated. Daily debriefing sessions can<br />

be used to identify and track <strong>the</strong>mes as <strong>the</strong>y emerge. See 3.7 and Modules 6, 7, 9, and 10 for<br />

fur<strong>the</strong>r discussion <strong>of</strong> debriefing.<br />

Content analysis <strong>of</strong> completed qualitative data can be performed by hand or using one <strong>of</strong><br />

several s<strong>of</strong>tware tools (see 4.1). Usually one person or several will review all <strong>of</strong> <strong>the</strong> data and<br />

assign codes to <strong>the</strong> passages <strong>of</strong> text that contain each <strong>the</strong>me.<br />

Content analysis can be performed on qualitative data, with data aggregated into general<br />

<strong>the</strong>mes to reflect <strong>the</strong> consensus <strong>of</strong> <strong>the</strong> participants. For example, a question might focus on<br />

barriers to care. Responses might include “distance,” “need to farm,” “lack <strong>of</strong> money during<br />

planting season,” “bad relationships with health-care facility staff,” “no drugs available at<br />

<strong>the</strong> health-care facility,” “being mocked at <strong>the</strong> facility for being poor or not dressing well,”<br />

and “need to obtain permission from family.” <strong>The</strong>se responses could <strong>the</strong>n be grouped into<br />

higher level codes, for example those reflecting facility issues (lack <strong>of</strong> equipment/drugs, poor<br />

provider-patient relationships), financial concerns (need to maintain income, seasonal income<br />

sources), and statements about <strong>the</strong> locus <strong>of</strong> power within households (need permission). It is<br />

<strong>of</strong>ten <strong>the</strong> case that ideas for new codes will occur to researchers while <strong>the</strong> analysis is under<br />

way. <strong>The</strong> process <strong>of</strong> qualitative analysis can accommodate this by incorporating new ideas<br />

and codes as <strong>the</strong>y emerge. If more than one person is involved in coding text-based data, it is<br />

important that <strong>the</strong> coders apply a common approach and work toge<strong>the</strong>r closely to ensure that<br />

<strong>the</strong> codes are applied consistently and newly identified <strong>the</strong>mes are incorporated as <strong>the</strong>y are<br />

identified.<br />

Generally, qualitative findings are presented in terms <strong>of</strong> <strong>the</strong> most typical responses.<br />

Occasionally <strong>the</strong> statements <strong>of</strong> participants with exceptional views are useful as well. Direct<br />

quotes from participants can be a powerful way to illustrate <strong>the</strong> key <strong>the</strong>mes identified in<br />

qualitative studies. It is frequently helpful to quantify some qualitative data to indicate which<br />

<strong>the</strong>mes or opinions were stated most frequently. For example, responses to <strong>the</strong> question “If<br />

you are sick during pregnancy, from whom would you seek advice?” might include husband,<br />

traditional?? birth attendants, mo<strong>the</strong>rs-in-law, elders. Frequency counts can illustrate which<br />

categories were mentioned most <strong>of</strong>ten. Frequencies derived from qualitative data are purely<br />

illustrative and cannot be subjected to statistical tests. If a population-based frequency is<br />

desired (e.g., to compare care-seeking preferences across study sites or sub-populations),<br />

quantitative surveys are usually a more appropriate approach.<br />

30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


5. Report Preparation and Use <strong>of</strong> Results<br />

Once data analysis is complete, a report should be promptly drafted, finalized, and<br />

disseminated to key stakeholders. It is important that <strong>the</strong> report reach <strong>the</strong> appropriate<br />

<strong>of</strong>ficials and decision makers in <strong>the</strong> areas <strong>of</strong> malaria and reproductive health so that <strong>the</strong><br />

findings <strong>of</strong> <strong>the</strong> rapid assessment can promptly be used for action. <strong>The</strong> presentation and use <strong>of</strong><br />

results greatly depend on <strong>the</strong> focus <strong>of</strong> <strong>the</strong> assessment. Communications about an assessment<br />

designed to determine <strong>the</strong> burden <strong>of</strong> malaria during pregnancy would probably be quite<br />

different from an assessment designed to determine program impact.<br />

Results <strong>of</strong> <strong>the</strong> assessment can be used to provide:<br />

► Information to guide decisions about whe<strong>the</strong>r to recommend IPTp<br />

Although <strong>the</strong>re is agreement that in areas <strong>of</strong> stable (or high) transmission, <strong>the</strong> control<br />

package for malaria in pregnancy should include IPTp, <strong>the</strong>re is less agreement about whe<strong>the</strong>r<br />

IPTp belongs in <strong>the</strong> control package in areas <strong>of</strong> unstable (or low) transmission or areas that<br />

are epidemic-prone.<br />

One commonly asked question is at (or above) what level <strong>of</strong> transmission IPTp should be<br />

recommended and at (or below) what level IPTp should not be recommended. To date, <strong>the</strong>re<br />

has not been a formal cost-effectiveness or cost-benefit analysis to guide policy in this regard,<br />

but several factors could be taken into account in decision-making:<br />

It is important<br />

that <strong>the</strong> report<br />

reach <strong>the</strong><br />

appropriate<br />

<strong>of</strong>ficials and<br />

decision makers<br />

in <strong>the</strong> areas <strong>of</strong><br />

malaria and<br />

reproductive<br />

health so that <strong>the</strong><br />

findings <strong>of</strong> <strong>the</strong><br />

rapid assessment<br />

can promptly be<br />

used for action.<br />

Prevalence <strong>of</strong> P. falciparum malaria parasitemia. Studies show that if malaria prevalence<br />

is high, IPTp will help prevent malaria’s ill effects on <strong>the</strong> health <strong>of</strong> pregnant women<br />

and babies, and a policy <strong>of</strong> IPTp should be recommended. However, <strong>the</strong>re have been no<br />

studies that have examined <strong>the</strong> effects <strong>of</strong> IPTp in areas <strong>of</strong> low or unstable transmission. If<br />

malaria prevalence is low and IPTp were recommended for all pregnant women, it would<br />

be given to many women who, because <strong>the</strong>y were not infected, would not benefit. As <strong>the</strong><br />

prevalence <strong>of</strong> parasitemia decreases, it becomes less compelling to recommend IPTp.<br />

For example, consistent use <strong>of</strong> IPTp has been shown to bring prevalence rates down<br />

to about 5% – 10% in <strong>the</strong> high and moderate transmission areas where studies have<br />

been conducted. One might <strong>the</strong>n argue that a cut-<strong>of</strong>f prevalence <strong>of</strong> 10% could be used.<br />

However, if <strong>the</strong> prevalence rate was 10% and all women were given IPTp, 90% would<br />

receive a drug <strong>the</strong>y did not need. <strong>The</strong> malaria community needs to address what cut-<strong>of</strong>f<br />

to recommend in areas <strong>of</strong> low prevalence.<br />

<strong>The</strong> Manual<br />

31


Effect <strong>of</strong> malaria parasitemia: A rapid assessment conducted in Ethiopia found that<br />

women in low or unstable or epidemic-prone areas had relatively low rates <strong>of</strong> peripheral<br />

parasitemia (1.8%) and low rates <strong>of</strong> placental parasitemia (2.5%), but that placental<br />

parasitemia was associated with prematurity and a 7-fold increased risk <strong>of</strong> stillbirths.<br />

<strong>The</strong>se findings suggested that routine use <strong>of</strong> IPTp may be inappropriate given <strong>the</strong> low<br />

prevalence <strong>of</strong> peripheral and placental parasitemia, but given <strong>the</strong> strong association<br />

with adverse outcomes, malaria had <strong>the</strong> potential to contribute substantially to <strong>the</strong><br />

population-attributable risk <strong>of</strong> <strong>the</strong>se adverse outcomes if disease prevalence increased,<br />

for example, during an epidemic. In this situation, <strong>the</strong> researchers concluded that <strong>the</strong><br />

situation should be evaluated during an epidemic to examine prevention and intervention<br />

opportunities [20].<br />

Presence <strong>of</strong> symptomatic malaria: In areas <strong>of</strong> high transmission, pregnant women<br />

who become infected are generally assumed not to have symptoms because <strong>the</strong>y have<br />

developed some level <strong>of</strong> immunity, even though this immunity is somewhat compromised<br />

by pregnancy. Despite being asymptomatic, <strong>the</strong>se women and <strong>the</strong>ir babies can still<br />

be adversely affected by <strong>the</strong> infection. <strong>The</strong>refore, IPTp was developed as a preventive<br />

intervention to be given to all women. In areas <strong>of</strong> low transmission or epidemic-prone<br />

areas, pregnant women have little or no immunity and may experience symptoms <strong>of</strong><br />

malaria infection and become ill. In <strong>the</strong>se areas, IPTp would not necessarily keep a<br />

woman parasite-free throughout gestation and thus women could still become very ill,<br />

causing harm to <strong>the</strong>mselves and <strong>the</strong>ir infants. <strong>The</strong>refore, in areas <strong>of</strong> lower transmission<br />

where women may develop severe malaria during pregnancy, IPTp will not prevent<br />

severe disease, and prompt and effective case management is still critical. In <strong>the</strong>se<br />

settings, <strong>the</strong> role <strong>of</strong> case management based on proactive screening for malaria infection<br />

<strong>of</strong> women attending ANC, compared to preventive approaches with IPTp or ITNs remains<br />

to be established.<br />

► Advocacy for policy development and change. <strong>The</strong> information ga<strong>the</strong>red can<br />

also be used to advocate for resources to change or implement a new policy<br />

► Suggestions for improving ANC attendance. <strong>The</strong> assessment may discover multiple barriers<br />

to women’s decisions to attend an antenatal clinic during pregnancy. To address this, more<br />

effective information, education, and communication (IEC) campaigns need to be planned<br />

and conducted, or structural factors, such as price <strong>of</strong> care, may need to be addressed.<br />

► Suggestions for improving service delivery. Results may indicate, for example, that more<br />

focused health-care worker training needs to be provided or that adequate supplies <strong>of</strong><br />

medications and ITNs need to be made accessible and affordable.<br />

► A snapshot <strong>of</strong> <strong>the</strong> impact <strong>of</strong> current interventions. <strong>The</strong> country may never have evaluated<br />

its policy and program, or an evaluation may not have been done recently. <strong>The</strong>refore, a<br />

rapid assessment may point to <strong>the</strong> need for routinely <strong>of</strong>fering a different intervention. For<br />

example, a rapid assessment in Burkina Faso showed that high coverage with chloroquine<br />

chemoprophylaxis (as opposed to IPTp) did not decrease <strong>the</strong> adverse effects <strong>of</strong> malaria<br />

during pregnancy and that IPTp was needed.<br />

► Directions for fur<strong>the</strong>r study. A rapid assessment may have equivocal findings. For example,<br />

a rapid assessment conducted in Ethiopia found that women in low or unstable or<br />

epidemic-prone areas had relatively low rates <strong>of</strong> peripheral parasitemia (1.8%) and low<br />

rates <strong>of</strong> placental parasitemia (2.5%), but that placental parasitemia was associated with<br />

prematurity and a 7-fold increased risk <strong>of</strong> stillbirths. <strong>The</strong>se findings suggested that routine<br />

use <strong>of</strong> IPTp may be inappropriate given <strong>the</strong> low prevalence <strong>of</strong> peripheral and placental<br />

parasitemia, but given <strong>the</strong> association with adverse outcomes, <strong>the</strong> magnitude <strong>of</strong> <strong>the</strong><br />

burden <strong>of</strong> malaria during pregnancy should be evaluated during an epidemic to examine<br />

prevention and intervention opportunities.<br />

32 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


References<br />

1. Desai, M., et al., Epidemiology and burden <strong>of</strong> malaria in pregnancy. Lancet Infect Dis,<br />

2007. 7(2): p. 93-104.<br />

2. WHO, A Strategic Framework for <strong>Malaria</strong> Prevention and Control During Pregnancy in<br />

<strong>the</strong> African Region. 2004, Brazzaville: WHO Regional Office for Africa.<br />

3. Steketee, R.W., et al., <strong>The</strong> burden <strong>of</strong> malaria in pregnancy in malaria-endemic areas.<br />

American Journal <strong>of</strong> Tropical Medicine & Hygiene, 2001. 64(1-2 Suppl): p. 28-35.<br />

4. Brabin, B., An assessment <strong>of</strong> low birthweight risk in primiparae as an indicator <strong>of</strong><br />

malaria control in pregnancy. International Journal <strong>of</strong> Epidemiology, 1991. 20(1):<br />

p. 276-83.<br />

5. Jelliffe, E.F., Low birth-weight and malarial infection <strong>of</strong> <strong>the</strong> placenta. Bulletin <strong>of</strong> <strong>the</strong><br />

World Health Organization, 1968. 38(1): p. 69-78.<br />

6. McGregor, I.A., M.E. Wilson, and W.Z. Billewicz, <strong>Malaria</strong> infection <strong>of</strong> <strong>the</strong> placenta in<br />

<strong>The</strong> Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and<br />

placental weight. Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene,<br />

1983. 77(2): p. 232-44.<br />

7. Menendez, C., <strong>Malaria</strong> during pregnancy: a priority area <strong>of</strong> malaria research and<br />

control. Parasitology Today, 1995. 11(5): p. 178-183.<br />

8. Steketee, R.W., et al., <strong>The</strong> problem <strong>of</strong> malaria and malaria control in pregnancy in<br />

sub-Saharan Africa. American Journal <strong>of</strong> Tropical Medicine & Hygiene, 1996. 55<br />

(1 Suppl): p. 2-7.<br />

9. Guyatt, H.L. and R.W. Snow, <strong>The</strong> epidemiology and burden <strong>of</strong> Plasmodium falciparumrelated<br />

anemia among pregnant women in sub-Saharan Africa. American Journal <strong>of</strong><br />

Tropical Medicine & Hygiene, 2001. 64(1-2 Suppl): p. 36-44.<br />

10. Bloland, P., et al., Rates and risk factors for mortality during <strong>the</strong> first two years <strong>of</strong> life in<br />

rural Malawi. American Journal <strong>of</strong> Tropical Medicine & Hygiene, 1996. 55<br />

(1 Suppl): p. 82-6.<br />

11. McCormick, M.C., <strong>The</strong> contribution <strong>of</strong> low birth weight to infant mortality and<br />

childhood morbidity. New England Journal <strong>of</strong> Medicine, 1985. 312(2): p. 82-90.<br />

12. Kramer, M.S., Determinants <strong>of</strong> low birth weight: methodological assessment and metaanalysis.<br />

Bulletin <strong>of</strong> <strong>the</strong> World Health Organization, 1987. 65(5): p. 663-737.<br />

13. Steketee, R.W., J.J. Wirima, and C.C. Campbell, Developing effective strategies for<br />

malaria prevention programs for pregnant African women. American Journal <strong>of</strong><br />

Tropical Medicine & Hygiene, 1996. 55(1): p. 95-100.<br />

14. Guyatt, H. and R.W. Snow, Impact <strong>of</strong> malaria during pregnancy on low birth weight in<br />

sub-Saharan Africa. Clin Microbiol Rev, 2004(17): p. 760-9.<br />

15. Brabin, B.J., M. Hakimi, and D. Pelletier, An analysis <strong>of</strong> anemia and pregnancy-related<br />

maternal mortality. Journal <strong>of</strong> Nutrition, 2001. 131(2S-2): p. 604S-614S; discussion<br />

614S-615S.<br />

16. Memórias do Instituto Oswaldo Cruz. Volume 99, Issue 1: p. 19-21<br />

17. Nosten, F., et al., Effects <strong>of</strong> Plasmodium vivax malaria in pregnancy. Lancet, 1999.<br />

354(9178): p. 546-9.<br />

18. McGready, R., et al., <strong>The</strong> effects <strong>of</strong> Plasmodium falciparum and P. vivax infections on<br />

placental histopathology in an area <strong>of</strong> low malaria transmission. Am J Trop Med Hyg,<br />

2004. 70(4): p. 398-407.<br />

19. ter Kuile, F.O., et al., <strong>The</strong> burden <strong>of</strong> co-infection with human immunodeficiency virus<br />

type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg,<br />

2004. 71(2 Suppl): p. 41-54.<br />

20. Newman, R.D., et al., <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy in Areas <strong>of</strong> Stable and<br />

Unstable Transmission in Ethiopia during a Nonepidemic Year. J Infect Dis, 2003.<br />

187(11): p. 1765-72.<br />

<strong>The</strong> Manual<br />

33


Glossary<br />

Anemia and severe anemia: Conditions in which hemoglobin is less than 11 and 7 grams/<br />

deciliter, respectively.<br />

Case management refers to treatment <strong>of</strong> malaria illness. Case management requires<br />

proper diagnosis and prompt access to antimalarial drugs to treat <strong>the</strong> illness.<br />

Chemoprophylaxis: <strong>The</strong> prevention <strong>of</strong> an infectious disease by <strong>the</strong> use <strong>of</strong> chemical agents at<br />

sub<strong>the</strong>rapeutic doses. Weekly chemoprophylaxis is no longer recommended as <strong>the</strong> preferred<br />

malaria prevention strategy for pregnant women in areas <strong>of</strong> stable (high) P. falciparum<br />

transmission.<br />

Fetal loss: Expulsion or delivery <strong>of</strong> a fetus without evidence <strong>of</strong> cardiac or respiratory effort,<br />

regardless <strong>of</strong> number <strong>of</strong> weeks’ gestation.<br />

Fever: An axillary temperature >37.5 o C.<br />

Insecticide-treated mosquito net (ITN): Mosquito nets treated with an effective insecticide<br />

to repel or kill mosquitoes.<br />

Intermittent preventive treatment (IPT): <strong>The</strong> administration <strong>of</strong> full, curative treatment<br />

doses <strong>of</strong> an effective antimalarial drug during pregnancy in order to reduce placental malaria<br />

infection, low birth weight babies, and maternal anemia. WHO no longer recommends weekly<br />

chemoprophylaxis (administration <strong>of</strong> an antimalarial drug in sub<strong>the</strong>rapeutic doses) for several<br />

reasons, including poor adherence with a weekly or daily regimen and increasing resistance to<br />

<strong>the</strong> most popular antimalarial drug used in chemoprophylaxis, chloroquine.<br />

Low birth weight: Infants weighing less than 2,500 grams at birth.<br />

<strong>Malaria</strong> infection: A woman or baby is considered to have a malaria infection if any asexual<br />

blood stage parasites are seen on a thick blood smear.<br />

Neonatal death: Death <strong>of</strong> a live-born infant during <strong>the</strong> first 28 days <strong>of</strong> life.<br />

Parasitemia (in peripheral, placental, or umbilical cord blood): A condition in which <strong>the</strong><br />

blood contains asexual stage malaria parasites.<br />

Premature: Assessed as less than 37 weeks gestation at birth by <strong>the</strong><br />

Ballard examination.<br />

Small-for-gestational-age (SGA) newborn: Weight for gestational age at birth can be<br />

used to categorize infants as having normal or subnormal growth in utero. A newborn can<br />

be considered small for gestational age if <strong>the</strong> birth weight is less than <strong>the</strong> 10 th percentile <strong>of</strong><br />

weight for gestational age. However, for most rapid assessments, it is not necessary to make<br />

this determination. Note: Existing data on weight for gestational age are from industrialized<br />

countries.<br />

34 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 1: Conducting an Antenatal Clinic Survey<br />

An Antenatal Clinic (ANC) Survey is designed to determine <strong>the</strong><br />

magnitude <strong>of</strong> <strong>the</strong> burden <strong>of</strong> malaria during pregnancy, specifically:<br />

• What is <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia in<br />

pregnant women?<br />

• What is <strong>the</strong> prevalence <strong>of</strong> maternal anemia?<br />

• Does <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia vary by<br />

gravidity or locale?<br />

This module contains sample materials for an Antenatal Clinic Survey (and in some<br />

cases for <strong>the</strong> Delivery Unit Survey also). <strong>The</strong>se materials can and should be adapted<br />

to suit local needs. General guidance for conducting an Antenatal Clinic Survey<br />

and managing data can be found in Chapters 3-4 <strong>of</strong> <strong>the</strong> manual. See Resource 3 for<br />

presentations that address some <strong>of</strong> <strong>the</strong> topics below.<br />

A. Antenatal Clinic Survey Timetable<br />

B. Selecting Sample Sizes<br />

C. Eligibility Criteria<br />

D. List <strong>of</strong> Supplies and Equipment<br />

E. <strong>Assessment</strong> Teams<br />

F. <strong>Assessment</strong> Team Training<br />

Contents<br />

G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />

H. <br />

I. <br />

Supervisor’s Guide to Conducting Antenatal Clinic and Delivery<br />

Unit Surveys<br />

Supervisor’s Guide to Data Management for Antenatal Clinic and Delivery<br />

Unit Surveys<br />

J. Sample Logbooks: Enrollment and Laboratory<br />

K. Handbook for <strong>Assessment</strong> Teams<br />

L. <br />

Blood Test Procedures: HemoCue for Determination <strong>of</strong> Hemoglobin Level<br />

M. Blood Test Procedures: Thick and Thin Films for Microscopic Diagnosis <strong>of</strong><br />

<strong>Malaria</strong> Infection/Finger-Stick Blood Collection<br />

N. Antenatal Clinic Survey Information Sheet<br />

O. Analysis <strong>of</strong> Antenatal Clinic Data<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

1


A. Antenatal Clinic Survey Timetable<br />

This timetable outlines key steps in planning for and conducting Antenatal Clinic and<br />

Delivery Unit Surveys and <strong>the</strong> approximate length <strong>of</strong> time to allow. Many key steps will<br />

require advance planning.<br />

Planning <strong>the</strong><br />

assessment<br />

Period Time Activities<br />

2-4<br />

weeks<br />

Preassessment 2-3<br />

weeks<br />

• Determine what assessment components, if any, need to<br />

be conducted<br />

• Determine what approvals (ethical, scientific, o<strong>the</strong>r<br />

ministerial) are needed and initiate approval process<br />

• Secure funding<br />

• Select site(s)<br />

• Explain <strong>the</strong> assessment to <strong>the</strong> community<br />

• Procure assessment equipment and supplies<br />

• Hire assessment team and/or identify<br />

existing staff<br />

• Adapt and translate questionnaires<br />

• Pretest questionnaires<br />

• Identify site for training<br />

• Identify responsible persons for all presentations that<br />

will be given during training (See Resource 3 for sample<br />

presentations)<br />

• Manage logistics <strong>of</strong> training, including per diem,<br />

transportation, meals, and lodging<br />

• Arrange for on-site training in delivery units and<br />

antenatal clinics<br />

<strong>Assessment</strong> training 1 week • Conduct training course (4-5 days)<br />

• Finalize questionnaires based on pretest and make adequate<br />

copies for final day <strong>of</strong> training<br />

• Meet with supervisors to coordinate assessment start-up in<br />

clinical facilities<br />

Start-up <strong>of</strong> assessment 2 weeks • Make adequate copies <strong>of</strong> antenatal clinic and delivery<br />

unit questionnaires, enrollment logbooks, and laboratory<br />

logbooks, and ensure questionnaires are at assessment sites<br />

• Distribute supplies to each assessment site<br />

and ensure a system <strong>of</strong> re-stocking supplies is in place<br />

• Establish quality control mechanism for data collection,<br />

including clinical and laboratory procedures, transport,<br />

and storage<br />

• Establish a supervisory system that addresses logistics<br />

(staffing, supplies), quality <strong>of</strong> interviewing, quality <strong>of</strong> data<br />

collected on questionnaires, quality <strong>of</strong> obtaining specimens,<br />

laboratory quality (slide and staining, HemoCue calibration),<br />

logbook maintenance<br />

<strong>Assessment</strong> 8-9<br />

weeks<br />

• Enroll women and collect data<br />

• Ensure supervisory system and quality control mechanisms<br />

are functioning<br />

• Ensure adequate supplies and equipment<br />

are available and functioning at each assessment site<br />

Postassessment 8 weeks Conduct data entry, cleaning, and analysis<br />

Write final report<br />

Disseminate results<br />

Initiate policy discussions<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


B. Selecting Sample Sizes<br />

<strong>The</strong> sample size needed for <strong>the</strong> Antenatal Clinic Survey depends on<br />

1. <strong>the</strong> estimated prevalence <strong>of</strong> women with parasitemia and with anemia,<br />

2. <strong>the</strong> acceptable margin <strong>of</strong> error, AND<br />

3. <strong>the</strong> design effect<br />

<strong>The</strong> sample size required to measure each <strong>of</strong> <strong>the</strong> survey’s main indicators (peripheral<br />

parasitemia and anemia) can be calculated by using Statcalc in EPI-INFO. <strong>The</strong> EPI-INFO<br />

calculation should include an adjustment (i.e., design effect [see note at end <strong>of</strong> this section,<br />

Selecting Sample Sizes]) for <strong>the</strong> fact that <strong>the</strong> survey uses cluster sampling, ra<strong>the</strong>r than<br />

random sampling.<br />

If <strong>the</strong> sample size required to measure one indicator is larger than <strong>the</strong> sample size<br />

required for <strong>the</strong> o<strong>the</strong>r indicator, <strong>the</strong> larger <strong>of</strong> <strong>the</strong> two sample sizes should be selected. <strong>The</strong><br />

sample size may need to be modified to account for o<strong>the</strong>r factors (see example below).<br />

<strong>The</strong> sample size for <strong>the</strong> Antenatal Clinic Survey can be determined using<br />

1. Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women with peripheral parasitemia and <strong>the</strong><br />

proportion with anemia. Because hemoglobin levels change throughout pregnancy,<br />

<strong>the</strong> prevalence <strong>of</strong> anemia should be estimated for women in <strong>the</strong> same trimester<br />

(e.g., third). If no estimates are available from <strong>the</strong> district or region where <strong>the</strong><br />

survey is being conducted, data from a neighboring area or national data could be<br />

used.<br />

2. Level <strong>of</strong> accuracy desired, for example + 10%.<br />

3. <strong>The</strong> design effect.<br />

Antenatal Clinic Survey Sample Size Calculation: An Example<br />

Point estimates: In this example, <strong>the</strong> assessment coordinator estimates <strong>the</strong> prevalence<br />

<strong>of</strong> peripheral parasitemia in <strong>the</strong> area to be 35%, on <strong>the</strong> basis <strong>of</strong> a previous study done in<br />

<strong>the</strong> area. <strong>The</strong> prevalence <strong>of</strong> anemia (Hgb


Peripheral<br />

parasitemia<br />

Third<br />

trimester<br />

anemia<br />

Total<br />

sample<br />

size<br />

Estimated<br />

prevalence*<br />

Margin<br />

<strong>of</strong> error<br />

Needed sample<br />

size (from<br />

Statcalc)<br />

O<strong>the</strong>r<br />

factors<br />

35% 10% 174 --- 174<br />

50% 10% 192<br />

% women<br />

attending<br />

antenatal<br />

clinic<br />

during third<br />

trimester:<br />

50%<br />

Sample<br />

size (after<br />

adjusting<br />

for o<strong>the</strong>r<br />

factors)<br />

384<br />

384<br />

* If <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia during <strong>the</strong> high transmission season is unknown,<br />

assume a level <strong>of</strong> 50% for calculating sample size. This level is <strong>the</strong> most conservative estimate,<br />

as it yields <strong>the</strong> largest required sample size.<br />

If <strong>the</strong> assessment is being used as a baseline that will be repeated after an intervention<br />

in order to demonstrate impact, <strong>the</strong> sample required will be larger and <strong>the</strong> sample size<br />

calculations more complex. It is advisable to consult a statistician for fur<strong>the</strong>r guidance.<br />

Note on design effect:<br />

Large surveys are <strong>of</strong>ten conducted using cluster surveys, meaning that <strong>the</strong> population is<br />

divided into clusters and sampled accordingly. Clusters are selected by random sampling and<br />

<strong>the</strong>n random samples are taken within <strong>the</strong> selected clusters. <strong>The</strong> benefits <strong>of</strong> cluster sampling<br />

are that it is <strong>of</strong>ten easier and less expensive to conduct than simple random sampling as <strong>the</strong><br />

needed sample size is smaller. However, its disadvantage is that <strong>the</strong>re is a loss <strong>of</strong> precision<br />

because <strong>the</strong> elements within <strong>the</strong> cluster are generally more correlated (similar) than those<br />

between <strong>the</strong> clusters. Selecting an additional member from <strong>the</strong> same cluster adds less<br />

new information than would a completely independent selection. As <strong>the</strong> cluster size and<br />

intracluster correlation increase, cluster variances increase more than one would find in a<br />

simple random sample. <strong>The</strong> benefits <strong>of</strong> cluster sampling <strong>of</strong>ten outweigh <strong>the</strong> disadvantage <strong>of</strong><br />

<strong>the</strong> loss in precision.<br />

Because cluster sampling results in a loss <strong>of</strong> precision and a smaller sample size, an<br />

adjustment called <strong>the</strong> design effect should be used to determine survey sample size when<br />

clustering is involved. <strong>The</strong> design effect is basically <strong>the</strong> ratio <strong>of</strong> <strong>the</strong> actual variance 1 , under <strong>the</strong><br />

sampling method actually used, to <strong>the</strong> variance computed under <strong>the</strong> assumption <strong>of</strong> simple<br />

random sampling. <strong>The</strong> main components <strong>of</strong> <strong>the</strong> design effect are <strong>the</strong> intraclass correlation and<br />

<strong>the</strong> cluster sample sizes. <strong>The</strong> design effect is calculated as follows:<br />

DEFF = 1 + ρ (n – 1),<br />

where Deff is <strong>the</strong> design effect, ρ is <strong>the</strong> intraclass correlation for <strong>the</strong> statistic in question, and<br />

n is <strong>the</strong> average size <strong>of</strong> <strong>the</strong> cluster. <strong>The</strong> interpretation <strong>of</strong> a value <strong>of</strong> DEFF <strong>of</strong>, say, 3.0 is that <strong>the</strong><br />

sample variance is 3 times bigger than it would be if <strong>the</strong> survey were based on <strong>the</strong> same<br />

1 Variation measured in a set <strong>of</strong> data for one variable, defined as <strong>the</strong> sum <strong>of</strong> squares <strong>of</strong> <strong>the</strong> deviation <strong>of</strong> each<br />

data point from <strong>the</strong> mean for <strong>the</strong> data, divided by <strong>the</strong> degrees <strong>of</strong> freedom (sample observation – 1).<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


sample size but selected randomly. It can be seen that <strong>the</strong> design effect increases as <strong>the</strong> cluster<br />

sizes increase, and as <strong>the</strong> intraclass correlation increases. <strong>The</strong> square root <strong>of</strong> <strong>the</strong> design effect<br />

shows how much <strong>the</strong> sample standard error, and consequently <strong>the</strong> confidence intervals,<br />

will increase because <strong>of</strong> <strong>the</strong> clustering. <strong>The</strong> intraclass correlation represents <strong>the</strong> likelihood<br />

that two elements in <strong>the</strong> same cluster have <strong>the</strong> same value, for a given statistic, relative to<br />

two elements chosen completely at random in <strong>the</strong> population. A value <strong>of</strong> 0.10 is interpreted,<br />

<strong>the</strong>refore, to mean that <strong>the</strong> elements in <strong>the</strong> cluster are about 10% more likely to have <strong>the</strong> same<br />

value than if <strong>the</strong> two elements were chosen at random in <strong>the</strong> survey.<br />

Design effects vary from survey to survey and even within <strong>the</strong> same survey will vary from<br />

question to question. In summary, using a cluster sample generally requires ei<strong>the</strong>r a larger<br />

sample size than a simple random sample or a wider confidence interval. <strong>The</strong> design effect<br />

is used to determine how much larger <strong>the</strong> sample size or confidence interval needs to be.<br />

In general, for a well-designed study, <strong>the</strong> design effect usually ranges from 1 to 3. It is not<br />

uncommon, however, for <strong>the</strong> design effect to be much larger.<br />

<strong>The</strong> survey methodology recommended for both <strong>the</strong> Antenatal Clinic Surveys and <strong>the</strong> Delivery<br />

Unit surveys use cluster sample methodology and thus require that a design effect be used.<br />

C. Eligibility Criteria<br />

• Women who participate in <strong>the</strong> assessment should be as representative as possible<br />

<strong>of</strong> all women attending <strong>the</strong> antenatal clinic.<br />

Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements:<br />

Stage <strong>of</strong> Gestation: Women who have experienced “quickening” (i.e., <strong>the</strong> recognition <strong>of</strong> fetal<br />

movement).<br />

Gravidity: All gravidities. Although primigravidae and secundigravidae are typically most<br />

affected in high transmission areas, women <strong>of</strong> all gravidities should be eligible so that <strong>the</strong> local<br />

situation can be confirmed.<br />

Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />

most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />

and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> age <strong>of</strong><br />

<strong>the</strong> youngest participants may well be less than <strong>the</strong> age <strong>of</strong> majority and should be consistent<br />

with any country policy or norm regarding this type <strong>of</strong> survey. Many countries consider a<br />

woman with a child and her own household to be an emancipated minor regardless <strong>of</strong> age.<br />

However, 15 years is <strong>of</strong>ten chosen as a minimum age.<br />

Note: Women who have not yet experienced quickening should not be included in <strong>the</strong> survey.<br />

This exclusion criterion helps avoid use <strong>of</strong> drugs in <strong>the</strong> first trimester o<strong>the</strong>r than what would<br />

be recommended in <strong>the</strong> national policy. For example, in this survey, women may be treated for<br />

asymptomatic parasitemia, but would not o<strong>the</strong>rwise, according to national policy.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

5


D. List <strong>of</strong> Supplies and Equipment<br />

Make sure that each antenatal clinic has <strong>the</strong> necessary supplies and equipment<br />

before <strong>the</strong> start <strong>of</strong> <strong>the</strong> survey.<br />

Item<br />

Quantity per<br />

ANC<br />

Comments/Use<br />

# in<br />

stock/<br />

Balance<br />

needed<br />

Date<br />

Ordered<br />

Screening &<br />

Clinical Evaluation<br />

Electronic<br />

<strong>the</strong>rmometers<br />

Laboratory<br />

2<br />

Temperature<br />

measurement;<br />

if electronic<br />

<strong>the</strong>rmometers are<br />

unavailable, mercury<br />

glass <strong>the</strong>rmometers<br />

are an acceptable<br />

alternative.<br />

Count-down timer 1 For laboratory use.<br />

Slides 1/participant Allow extras for waste.<br />

Lancets 1/participant Allow extras for waste.<br />

Isopropyl alcohol<br />

Enough to<br />

clean 1 finger/<br />

participant<br />

Premoistened alcohol<br />

wipes are an acceptable<br />

alternative.<br />

Cotton wool or<br />

gauze<br />

Giemsa stain<br />

Toilet paper (or<br />

slide boxes)<br />

Container for used<br />

lancets<br />

Staining jars<br />

Slide drying rack<br />

Enough to<br />

clean 1 finger/<br />

participant<br />

Sufficient<br />

to wrap (or<br />

store) all<br />

slides from<br />

assessment<br />

2/site<br />

2/lab<br />

1/lab<br />

Based upon sample size.<br />

In addition to Giemsa<br />

powder, need all o<strong>the</strong>r<br />

materials to mix stain,<br />

including distilled<br />

water, buffer, glycerol,<br />

and glassware to mix<br />

and store.<br />

Sharps container;<br />

should only be used<br />

for lancets (or o<strong>the</strong>r<br />

sharps), microcuvettes,<br />

and microhematocrit<br />

tubes.<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Item<br />

Quantity per<br />

ANC<br />

Comments/Use<br />

# in<br />

stock/<br />

Balance<br />

needed<br />

Date<br />

Ordered<br />

Basin/bleach<br />

1 basin<br />

Bleach for disinfecting<br />

and cleaning spreader<br />

slides if using thin films.<br />

Hair dryer<br />

1/lab<br />

May be needed,<br />

depending on climate.<br />

Optional.<br />

Microhematocrit<br />

tubes<br />

1/participant<br />

Centrifuge for<br />

microhematocrit<br />

tubes<br />

1<br />

HemoCue machine and<br />

microcuvettes may<br />

be substituted when<br />

available.<br />

Microscope<br />

1/lab<br />

Spare light bulbs<br />

for microscope<br />

3/lab<br />

Immersion oil<br />

3 tubes/lab<br />

Lens cleaner<br />

1 bottle/lab<br />

Lens cleaning<br />

tissue<br />

2 sheets/day<br />

<strong>of</strong> survey<br />

Sharpie markers<br />

(ultra fine)<br />

3/team/site<br />

Examination gloves<br />

1 pair/<br />

participant<br />

Extra for breakage,<br />

extra for lab personnel.<br />

Trash can/trash<br />

bags<br />

1 can and bags<br />

as needed<br />

For non-sharp waste<br />

(gloves, cotton, etc.).<br />

Tally counters<br />

2/laboratory<br />

If using 2-channel<br />

counter, 1 is sufficient.<br />

Computer 1-2<br />

2 is ideal, 1 is adequate;<br />

with at least Windows<br />

2000.<br />

Epi-Info or ano<strong>the</strong>r<br />

statistical s<strong>of</strong>tware<br />

package (Epi Info is<br />

preferred)<br />

Office Supplies<br />

1-2<br />

Installed on each<br />

computer.<br />

AA batteries<br />

If using HemoCue.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

7


Item<br />

Quantity per<br />

ANC<br />

Comments/Use<br />

# in<br />

stock/<br />

Balance<br />

needed<br />

Date<br />

Ordered<br />

Clipboards<br />

1/interviewer<br />

Pencils<br />

1/interviewer<br />

Only if preparing thin<br />

films.<br />

Pencil sharpener<br />

1/interviewer<br />

Only if preparing thin<br />

films.<br />

Pens<br />

2/interviewer<br />

Stapler 1<br />

Staples<br />

2 boxes<br />

Ink pad/Ink<br />

1/site<br />

For fingerprinting<br />

women if signature<br />

needed and woman<br />

cannot sign.<br />

Logbooks<br />

Drug Supplies<br />

Antimalarials for<br />

IPTp (if IPTp is <strong>the</strong><br />

policy); should be<br />

available as part<br />

<strong>of</strong> routine ANC<br />

supplies<br />

2/clinical site<br />

and 1/lab<br />

Should be bound books,<br />

not spiral-bound or<br />

perforated. 2 in clinical<br />

site: 1 for register, 1 for<br />

hemoglobin. 1 in lab for<br />

slide results.<br />

Antimalarial for<br />

treatment<br />

Iron and folate<br />

8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


E. <strong>Assessment</strong> Teams<br />

<strong>The</strong> number <strong>of</strong> assessment teams depends on <strong>the</strong> number<br />

<strong>of</strong> antenatal clinics used.<br />

<strong>The</strong> following example assumes that 4 antenatal clinics will be surveyed.<br />

Title<br />

Number needed<br />

<strong>Assessment</strong> coordinator 1<br />

Laboratorian supervisor 1<br />

Site supervisors<br />

4 (1 per site)<br />

Interviewers<br />

8 (2 per site)<br />

Laboratorians<br />

4 (1 per site)<br />

Data management coordinator 1<br />

Data entry clerks 2<br />

<strong>The</strong>re is no magic formula for how to staff <strong>the</strong> assessment. If <strong>the</strong> antenatal clinic sites<br />

see patients every day, it may be advantageous to staff <strong>the</strong>m continuously, and <strong>the</strong>refore have a<br />

complete team at each site. If <strong>the</strong>re are antenatal clinic sites that are not open daily, <strong>the</strong>n it may<br />

be more efficient to have a team <strong>of</strong> newly hired staff who rotate among two or more sites.<br />

F. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training for site supervisors, interviewers, and laboratorians should be held after<br />

preassessment activities. Training will take approximately 4-5 days.<br />

<strong>The</strong> text below explains how to conduct <strong>the</strong> training. A sample schedule follows <strong>the</strong><br />

explanation.<br />

Note: If both Antenatal Clinic and Delivery Unit Surveys will be conducted, it is more<br />

efficient to conduct training for both surveys simultaneously. <strong>The</strong>refore, this module<br />

describes simultaneous training. If only one <strong>of</strong> <strong>the</strong> surveys is conducted,<br />

this module will need to be modified accordingly.<br />

Note: If qualitative studies will be conducted about <strong>the</strong> same time as <strong>the</strong> quantitative<br />

studies, it would be beneficial to conduct <strong>the</strong> training simultaneously. Consult <strong>the</strong><br />

qualitative training manual (or <strong>the</strong> modules that accompany <strong>the</strong> qualitative surveys)<br />

for guidance on how to combine <strong>the</strong> two.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

9


Day 1:<br />

Morning: <strong>The</strong> assessment coordinator should present background information on malaria<br />

during pregnancy and assessment objectives. (See Resource 3 for sample presentations)<br />

Afternoon: <strong>The</strong> assessment coordinator reviews antenatal clinic and delivery unit policies and<br />

procedures located in <strong>the</strong> assessment team member’s handbook (see K in this Module). This<br />

provides a general overview <strong>of</strong> <strong>the</strong> assessment. Once <strong>the</strong> overview is complete, <strong>the</strong> assessment<br />

coordinator should split <strong>the</strong> interviewers into teams. Each team will rotate through antenatal<br />

clinic and delivery unit clinical procedures. Depending on <strong>the</strong> size <strong>of</strong> <strong>the</strong> assessment team,<br />

<strong>the</strong> logistics can be varied. In a small team, everyone might work toge<strong>the</strong>r to go through all<br />

procedures. In a large team with a sufficient number <strong>of</strong> facilitators, it may be worthwhile to<br />

divide teams into groups that rotate around a series <strong>of</strong> workstations. <strong>The</strong> important thing is<br />

that each staff member has <strong>the</strong> opportunity to learn and practice each procedure that he/she<br />

will be conducting.<br />

Antenatal clinic procedures include: 2<br />

<br />

<br />

• Exercise universal precaution for handling blood (prior to this exercise,<br />

presentation on lab safety [see Resources] could be shown)<br />

• Take and read axillary temperature<br />

• Collect blood samples (fingersticks) from each o<strong>the</strong>r<br />

• Prepare slide (recording date and ID number on slide) (see M)<br />

• Prepare thick films (and thin films in an area with substantial P. vivax<br />

transmission) (see M)<br />

• Collect blood on cuvette and use HemoCue machine to perform <strong>the</strong> Hb<br />

reading (see L)<br />

Delivery unit procedures include: 2<br />

<br />

• Take woman’s temperature<br />

• Measure woman’s mid-upper arm circumference<br />

• Measure woman’s height<br />

• Prepare slides—peripheral, placental, and cord blood<br />

• Weigh newborn using scale<br />

• Conduct <strong>the</strong> Ballard examination and apply <strong>the</strong> scoring system (See Resource<br />

3 for Ballard video; see also Module 2 for Ballard check list)<br />

Day 2:<br />

Morning: <strong>The</strong> assessment coordinator arranges for interviewers to visit a delivery unit site<br />

for practice <strong>of</strong> delivery unit procedures. At <strong>the</strong> same time, <strong>the</strong> laboratorian supervisor trains<br />

assessment laboratorians on how to read peripheral, placental and cord films.<br />

Afternoon: In a group setting, <strong>the</strong> assessment coordinator reviews each question on antenatal<br />

clinic and delivery unit questionnaires and <strong>the</strong> information sheet (or consent form), depending<br />

on which is being used. <strong>The</strong> coordinator also describes why <strong>the</strong>re is a consent form if a consent<br />

form has been determined necessary. Interviewers should be encouraged to ask questions and<br />

<strong>of</strong>fer suggestions. After reviewing each questionnaire, <strong>the</strong> interviewers should break into small<br />

groups and practice each questionnaire one-on-one using copies <strong>of</strong> actual antenatal clinic<br />

2 In some circumstances it may be possible to conduct polymerase chain reaction (PCR) on filter paper samples<br />

or to examine tissue specimens preserved in formalin. However, in many settings <strong>the</strong>se are nei<strong>the</strong>r possible<br />

nor necessary.<br />

10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


cards from <strong>the</strong> clinic. It is important that <strong>the</strong> antenatal clinic cards have had all identifiers<br />

removed. Any discrepancies regarding data extraction from antenatal clinic cards should be<br />

addressed with <strong>the</strong> assessment coordinator, and questionnaires revised as necessary.<br />

Day 3:<br />

Morning: After <strong>the</strong> survey instruments are adapted, <strong>the</strong> survey instruments, as well as <strong>the</strong><br />

information sheet (or informed consent form if used), should be translated into <strong>the</strong> national<br />

language and <strong>the</strong> primary language spoken by women in <strong>the</strong> assessment area, if different.<br />

This initial translation should be followed by a back-translation (by individuals who did not<br />

produce <strong>the</strong> original translation) into <strong>the</strong> national language to check <strong>the</strong> adequacy <strong>of</strong> <strong>the</strong><br />

translation. Once <strong>the</strong> translation is complete, pretesting can begin. While <strong>the</strong> surveys are being<br />

pretested, laboratorians could practice film reading.<br />

Note: If <strong>the</strong> primary language is not a written language, it will be important to use correct,<br />

consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet (or<br />

informed consent form) so that questions are asked in a standardized manner. All interviewers<br />

should work toge<strong>the</strong>r to achieve correct, consistent phrasing <strong>of</strong> <strong>the</strong> questions and have <strong>the</strong><br />

opportunity to practice.<br />

Afternoon: <strong>The</strong> assessment coordinator arranges for interviewers to visit two antenatal clinic<br />

sites to practice <strong>the</strong> antenatal clinic questionnaire with clients.<br />

NOTE: <strong>The</strong> delivery unit questionnaire is very similar to <strong>the</strong> antenatal clinic<br />

questionnaire, which will have been pretested. Because <strong>of</strong> this, it is not necessary to<br />

pretest <strong>the</strong> delivery unit questionnaire. This avoids <strong>the</strong> need to ask women who may be<br />

in physical discomfort to practice interviews.<br />

Divide <strong>the</strong> interviewers into two teams. Each team should visit one <strong>of</strong> <strong>the</strong> selected sites to<br />

pretest <strong>the</strong> antenatal clinic questionnaires with at least 15 clients (total, not per interviewer)<br />

in each facility.<br />

Day 4:<br />

Morning: <strong>The</strong> assessment coordinator will explain <strong>the</strong> purpose <strong>of</strong> antenatal clinic and delivery<br />

unit enrollment and laboratory logbooks. <strong>The</strong>n, <strong>the</strong> coordinator should demonstrate and<br />

review <strong>the</strong>se log books. It is important that all assessment team members understand that<br />

<strong>the</strong> enrollment logbooks are used to record everyone who is enrolled in <strong>the</strong> assessment as<br />

well as those who are excluded for any reason. <strong>The</strong> interviewers should be divided into pairs<br />

to continue practicing <strong>the</strong> revised questionnaires. <strong>The</strong> rest <strong>of</strong> <strong>the</strong> morning should be used to<br />

resolve outstanding issues, and conclude <strong>the</strong> training.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

11


Day 5:<br />

If <strong>the</strong> training is scheduled for 5 days, Day 5 can be reserved for work on any remaining issues.<br />

Sample Training Schedule<br />

Day 1 Day 2 Day 3 Day 4<br />

Introduction/<br />

Overview<br />

Delivery<br />

Unit Clinical<br />

Procedures<br />

Pretest<br />

questionnaires<br />

Wrap-up<br />

Morning<br />

-Welcome<br />

-Training objectives<br />

-<strong>Malaria</strong> situation in<br />

country<br />

-Epidemiology <strong>of</strong><br />

malaria during<br />

pregnancy<br />

-<strong>Rapid</strong> assessment<br />

objectives<br />

See Resource 3 for<br />

sample presentations<br />

Microscopy training<br />

for laboratorians<br />

On site delivery<br />

unit clinical<br />

procedures training<br />

and practice for<br />

interviewers<br />

Practice<br />

questionnaires<br />

and consent form<br />

administration in<br />

local language(s)<br />

with translator<br />

Practice<br />

questionnaires<br />

and consent form<br />

administration in<br />

local language(s) in<br />

small groups<br />

Introduce enrollment<br />

and laboratory registers<br />

Practice questionnaires<br />

in pairs (using<br />

antenatal clinic cards<br />

and antenatal clinic and<br />

delivery unit registers).<br />

Conclusion <strong>of</strong> training<br />

Afternoon<br />

Policy and procedures<br />

in antenatal clinic and<br />

delivery unit (worker’s<br />

handbook)<br />

Practice clinical<br />

procedures for<br />

antenatal clinic and<br />

delivery unit (show<br />

video <strong>of</strong> Ballard)<br />

if available. Live<br />

demonstrations<br />

using an adult model<br />

before practicing on<br />

live newborns can be<br />

useful.<br />

Review antenatal<br />

clinic and delivery<br />

unit questionnaires<br />

and consent forms<br />

Practice<br />

questionnaires<br />

in pairs (using<br />

antenatal clinic<br />

cards). Resolve<br />

discrepancies<br />

regarding data<br />

extraction from<br />

antenatal clinic<br />

cards.<br />

Pretest<br />

questionnaires on<br />

site in antenatal<br />

clinic facilities<br />

Meet with supervisors<br />

to discuss assessment<br />

start-up:<br />

-Make copies <strong>of</strong><br />

antenatal clinic<br />

and delivery unit<br />

questionnaires<br />

-Ensure antenatal clinic<br />

and delivery unit log<br />

books are at each<br />

assessment site<br />

-Distribute supplies to<br />

each assessment site<br />

-Establish quality<br />

control mechanism<br />

-Establish a supervisory<br />

system<br />

Evening<br />

Team members to read<br />

questionnaires and<br />

consent forms<br />

<strong>Assessment</strong><br />

coordinator finalizes<br />

both questionnaires<br />

based on pretests.<br />

12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />

<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor during <strong>the</strong><br />

start-up phase <strong>of</strong> <strong>the</strong> assessment.<br />

Note: This list pertains to both Antenatal Clinic and Delivery Unit Surveys, as most likely<br />

both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> list will need to be<br />

modified accordingly.<br />

Explain <strong>the</strong> purpose <strong>of</strong> <strong>the</strong> assessment to <strong>the</strong> “community,” through direct communication<br />

where possible, and also through <strong>the</strong> display <strong>of</strong> malaria posters in <strong>the</strong> clinic, and any o<strong>the</strong>r<br />

communication means.<br />

Set up <strong>the</strong> supply management system:<br />

• Verify that all supplies on <strong>the</strong> list are available.<br />

• Provide <strong>the</strong> delivery unit, antenatal clinic unit, and <strong>the</strong> lab each with a set <strong>of</strong> supplies<br />

(papers, laboratory materials, examination materials, antimalarial drugs and<br />

hematinics) to last at least one week.<br />

• If supply shortages (batteries, slides, etc.) are noticed, find a solution to continue <strong>the</strong><br />

assessment uninterrupted.<br />

• Keep spare supplies in a safe place, preferably a locked cupboard or box.<br />

• Keep a record <strong>of</strong> available stocks.<br />

Have planning meeting with <strong>the</strong> assessment team:<br />

• Make sure every person understands what is expected <strong>of</strong> him/her.<br />

• Draw up a time and duty schedule for each team member, aiming for 8 hrs/day<br />

antenatal clinic presence, and 24 hrs/day delivery room presence.<br />

• Rehearse every team member’s interviewer number, and go over <strong>the</strong> patient number<br />

system once more.<br />

Also:<br />

• Instruct <strong>the</strong> night staff <strong>of</strong> <strong>the</strong> delivery room to routinely store ALL placentas for <strong>the</strong><br />

assessment in individually marked plastic bags in <strong>the</strong> ice box if no assessment team<br />

member happens to be present<br />

• Assign responsibility for <strong>the</strong> ice box and for replacing <strong>the</strong> ice packs to an assessment<br />

team member<br />

• Arrange additional laboratory support, if needed<br />

• Identify possible translators for local languages among <strong>the</strong> hospital staff. Where<br />

possible, make <strong>the</strong>m familiar with <strong>the</strong> questionnaire beforehand.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

13


Set up instruments:<br />

• Set up measuring tape, scales and Ballard chart in <strong>the</strong> delivery room<br />

• Set up HemoCue instructions in <strong>the</strong> antenatal clinic room, if using HemoCue. Set up<br />

<strong>the</strong> HemoCue and calibrate. Recalibrate daily.<br />

• Find a safe and stable place for <strong>the</strong> infant weighing scale. Make sure that it is never<br />

lifted by <strong>the</strong> cradle, as this will damage it.<br />

• Keep instrument instructions in a safe place for future reference.<br />

Set up data management system:<br />

• Provide staff with enough information sheets (or consent forms, if used) and<br />

questionnaires for at least one week.<br />

• Make <strong>the</strong> arrangements for daily review <strong>of</strong> assessment results by <strong>the</strong> supervisor<br />

toge<strong>the</strong>r with <strong>the</strong> antenatal clinic and delivery unit staff.<br />

• Make arrangements for daily storing <strong>of</strong> papers and slides (and filter papers and test<br />

tubes, if being used).<br />

• Make arrangements for weekly storing <strong>of</strong> papers and slides (and filter papers and<br />

test tubes, if being used).<br />

• Go through <strong>the</strong> data management system with <strong>the</strong> team members.<br />

Set up assessment logs:<br />

• Antenatal clinic logbook, delivery unit logbook, laboratory logbooks<br />

(one for malaria, one for hemoglobin results)<br />

14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


H. Supervisor’s Guide for Conducting Antenatal Clinic<br />

and Delivery Unit Surveys<br />

<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in noting <strong>the</strong> progress<br />

<strong>of</strong> <strong>the</strong> survey, reminding <strong>the</strong> supervisor <strong>of</strong> important tasks (e.g., calibrating <strong>the</strong> HemoCue<br />

machine daily), and guiding <strong>the</strong> supervisor in reviewing questionnaires.<br />

<strong>The</strong>se worksheets should be filled out on a regular basis, as determined by <strong>the</strong> supervisor.<br />

Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />

likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms will need to<br />

be modified accordingly.<br />

Site: _______________________________________________________________________________________________________<br />

Date: __ __ /__ __ /__ __<br />

1. Enrollment and rates <strong>of</strong> positivity<br />

Antenatal clinic enrolled to date (No): ________________________________________________________________<br />

Number positive: ________________________________________________________________________________________<br />

Last antenatal clinic ID number used: _________________________________________________________________<br />

Delivery enrolled to date (No): _________________________________________________________________________<br />

Number positive (Mo<strong>the</strong>r): _____________________________________________________________________________<br />

Number positive (Placenta): ___________________________________________________________________________<br />

Number positive (Cord): ________________________________________________________________________________<br />

Last delivery ID number used:__ __ /__ __ /__ __<br />

2. Staff, supplies and samples<br />

Have any staff left <strong>the</strong> assessment?_____________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Are all nights on <strong>the</strong> delivery unit being covered by <strong>the</strong> assessment team? ________________________<br />

If this is not possible, are sufficient coolers (with icepacks) available for placental storage? ____<br />

Using <strong>the</strong> supply list above, note if supplies are adequate.<br />

YES =1 NO = 2<br />

Any o<strong>the</strong>r missing supplies: ____________________________________________________________________________<br />

If any supplies are needed, what is <strong>the</strong> plan for restocking?_ ________________________________________<br />

Are questionnaires and samples well organized and in a safe place?_______________________________<br />

____________________________________________________________________________________________________________<br />

If not, plan to improve situation:_______________________________________________________________________<br />

Samples and questionnaires taken to central location<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

15


ANC:<br />

Questionnaire numbers __ __ - __ __ __ to __ __ - __ __ __<br />

Slide numbers: to Delivery __ __ - __ __ __ to __ __ - __ __ __<br />

Questionnaire numbers __ __ - __ __ __ to __ __ - __ __ __<br />

Slide numbers (M,P,C):__ __ - __ __ __ to __ __ - __ __ __<br />

Tissue sample numbers, if collected: __ __ - __ __ __ to __ __ - __ __ __<br />

Filter paper numbers (M,P), if collected: __ __ - __ __ __ to __ __ - __ __ __<br />

3. Antenatal Care Survey<br />

Is <strong>the</strong> HemoCue machine being calibrated daily?_____________________________________________________<br />

Check calibration today: ________________________________________________________________________________<br />

Examine <strong>the</strong> logbooks. Are <strong>the</strong>y being filled out correctly? __________________________________________<br />

(Note: Enrollment logbook should contain all patients, whe<strong>the</strong>r or not enrolled in<br />

assessment.]<br />

Note any problems with logbooks: ____________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> plan to correct any problems with logbooks? ___________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />

If it is too high or too low, examine reasons, and make a plan for correction: ______________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />

discuss with that person. Pay particular attention to whe<strong>the</strong>r hemoglobin, temperature, and<br />

blood smear results are completed.<br />

Note any important problems and what measures were taken to fix <strong>the</strong>m: ________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Are women with anemia receiving iron? ______________________________________________________________<br />

If not, why not? __________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Are women with positive blood smears receiving treatment for malaria?_________<br />

If not, why not? __________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />

country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed? _ ________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


4. Delivery Unit Survey<br />

Examine logbooks. Are <strong>the</strong>y being filled out correctly?_______________________________________________<br />

(Note: Enrollment logbook should contain all women who deliver, whe<strong>the</strong>r or not enrolled<br />

in assessment)<br />

Note any problems with logbook: ______________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> plan to correct any problems with <strong>the</strong> logbook: ________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />

____________________________________________________________________________________________________________<br />

If it seems very low, examine reasons, and make a plan for correction: _ ___________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Are enrollments evenly spaced throughout <strong>the</strong> day (i.e., not all in <strong>the</strong> a.m. or p.m.)?______________<br />

____________________________________________________________________________________________________________<br />

Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />

discuss with that person. Pay particular attention to ensure that <strong>the</strong> following are completed:<br />

height, arm circumference, baby weight, Ballard gestational age, blood smear results and<br />

treatment.<br />

Note any specific problems and what measures were taken to fix <strong>the</strong>m: ___________________________<br />

____________________________________________________________________________________________________________<br />

Is <strong>the</strong> baby’s sex being documented on <strong>the</strong> Delivery Unit questionnaire?__________________________<br />

Are women with positive blood smears receiving treatment for malaria? _ ________________________<br />

If not, why not? __________________________________________________________________________________________<br />

If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />

country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in<br />

as instructed? ____________________________________________________________________________________________<br />

Are sample sets complete for each delivery patient (that is, do <strong>the</strong>y contain a questionnaire, 3<br />

slides (M, P, C), and, if collected, 2 filter papers (M, P), and a tissue sample? ______________________<br />

If not, why not? __________________________________________________________________________________________<br />

5. Laboratory (Supervisor may need assistance from Laboratory Supervisor on first few<br />

items below.)<br />

Examine <strong>the</strong> results books. Are <strong>the</strong> books being completed correctly? _____________________________<br />

If problems are found, document here, and make a plan for correction: ___________________________<br />

____________________________________________________________________________________________________________<br />

Are <strong>the</strong> results for mo<strong>the</strong>rs from antenatal clinic with fever, and mo<strong>the</strong>rs and babies from<br />

delivery, being given promptly to assessment team? _________________________________________________<br />

If not, what steps can be taken to improve <strong>the</strong> speed <strong>of</strong> obtaining results? ________________________<br />

____________________________________________________________________________________________________________<br />

Reread 10% <strong>of</strong> <strong>the</strong> slides <strong>of</strong> each type (ANC, Delivery M, Delivery P, Delivery C).<br />

Rate <strong>the</strong> accuracy <strong>of</strong> slides:<br />

Thick: (1 to 5, 5 is highly accurate): ___________________________________________________________________<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

17


Thin: (1 to 5, 5 is highly accurate): _____________________________________________________________________<br />

If quality is poor, examine reasons (e.g., smears badly done, thick specimen is fixed, or stain<br />

coloration is bad), and try to find a solution to <strong>the</strong> problem: ________________________________________<br />

____________________________________________________________________________________________________________<br />

Are slides being stored in a good manner (in slide boxes or, if slide boxes cannot be obtained,<br />

rolled in tissue paper)?: ________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

If not, plan for correction: ______________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Does <strong>the</strong> laboratory have adequate supplies? ________________________________________________________<br />

If not, plan to correct <strong>the</strong> problem: ____________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

6. Data Entry<br />

Review at least 5 questionnaires that have been entered in <strong>the</strong> computer.<br />

Number <strong>of</strong> errors found in 5 ANC: _____________________________________________________________________<br />

Number <strong>of</strong> errors found in 5 Delivery: ________________________________________________________________<br />

Is <strong>the</strong> record number being written at <strong>the</strong> top <strong>of</strong> each questionnaire on each page?______________<br />

____________________________________________________________________________________________________________<br />

O<strong>the</strong>r comments, observations or problems not mentioned above____________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


I. Supervisor’s Guide to Data Management for Antenatal Clinic<br />

and Delivery Unit Surveys<br />

<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in managing and collecting<br />

data. Worksheets outline tasks for assessment team members, as well as <strong>the</strong> supervisor.<br />

Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys,<br />

as most likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms can<br />

be modified accordingly.<br />

1. Enrollment targets:<br />

List for each site:<br />

Desired # <strong>of</strong> antenatal clinic visits: _____ at least x/day<br />

Desired # <strong>of</strong> deliveries: _____ at least x/day<br />

2. Target data collection period:<br />

ANC<br />

Deliveries<br />

List months during which to collect <strong>the</strong>se data<br />

List months during which to collect <strong>the</strong>se data<br />

3. Assigning an ID number<br />

1 st digit: assessment site<br />

Site #1 1<br />

Site #2 2<br />

Site #3 3<br />

Site #4 4<br />

2 nd digit: type <strong>of</strong> health service<br />

ANC A<br />

Delivery D<br />

3 rd – 5 th digit: consecutive number identifying each patient<br />

Example: 35 th antenatal clinic woman in Site#3 = 3A – 035<br />

46 th delivery in Site#1 = 1D – 046<br />

Note: If <strong>the</strong> woman has been assigned an ID number but enrollment has to be abandoned for<br />

whatever reason, file all related papers and test results, and assign <strong>the</strong> next woman <strong>the</strong> next<br />

number. ID numbers should only be used once. All ID numbers should be accounted for at <strong>the</strong><br />

final data analysis.<br />

• All data must be entered in computer<br />

• All data items must be returned to designated location for re-entering into computer<br />

(for double data entry) and quality control <strong>of</strong> slide readings<br />

Mark ID NUMBERS on each item and each page!!<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

19


4. Assigning an interviewer number<br />

<strong>The</strong> supervisor should assign each interviewer a unique number to be used throughout<br />

assessment.<br />

For example:<br />

Site #1 01 – 20<br />

Site #2 21 – 40<br />

Site #3 41 – 60<br />

Site #4 61 – 80<br />

5. Hints to provide interviewers for filling out questionnaires<br />

<br />

<br />

<br />

• Keep all pages <strong>of</strong> <strong>the</strong> consent forms (if used) and <strong>of</strong> <strong>the</strong> questionnaires stapled toge<strong>the</strong>r<br />

• Number all pages immediately with <strong>the</strong> ID number<br />

• Write clearly<br />

• ………….. is a connecting line<br />

• ________ is a line to write on<br />

<br />

• Feel free to make notes in <strong>the</strong> margin <strong>of</strong> <strong>the</strong> questionnaire form if <strong>the</strong> answer<br />

you received was not very clear or if you have doubts. <strong>The</strong> more information<br />

<strong>the</strong> better.<br />

• If it states “check all that apply,” please do not enter dashes for negative. Just leave those<br />

spaces blank. O<strong>the</strong>rwise it may confuse <strong>the</strong> data entry.<br />

<br />

• Make sure to write <strong>the</strong> right information in <strong>the</strong> right places: Some information comes from<br />

asking <strong>the</strong> woman, some from <strong>the</strong> antenatal clinic card, and some from <strong>the</strong> examination<br />

done for <strong>the</strong> assessment.<br />

• Completed consent forms (if used), questionnaires, slides, filter papers (if used), placenta<br />

tubes (if used), and logbooks should be guarded very carefully: Any missing or mislabeled<br />

items will compromise <strong>the</strong> final interpretation <strong>of</strong> <strong>the</strong> assessment.<br />

20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Antenatal Clinic Survey<br />

Each antenatal clinic enrollment will have at least 2 loose pieces <strong>of</strong> information<br />

• Signed consent form, if used<br />

• Completed questionnaire (…pages)<br />

• 1 blood slide (thick and thin)<br />

Data management tasks <strong>of</strong> antenatal clinic staff:<br />

Each enrollment:<br />

• Mark ID number clearly on each item and each page<br />

• Mark ID number clearly on blood slide result from <strong>the</strong> lab<br />

Before woman leaves:<br />

During <strong>the</strong> day:<br />

• Verify that questionnaire is completed, and iron/folate given as indicated<br />

•If woman is febrile or had a fever recently: Ensure that lab results are returned<br />

as soon as possible. If <strong>the</strong> slide was positive, treat <strong>the</strong> woman with appropriate<br />

antimalarial drug as per national policy before she leaves that clinic that day (or<br />

when you visit <strong>the</strong> woman at home with results.)<br />

• Obtain lab results from all o<strong>the</strong>r women and if any were positive, prepare for treatment<br />

when <strong>the</strong> woman returns that afternoon or <strong>the</strong> next day<br />

Data management tasks <strong>of</strong> supervisor:<br />

At <strong>the</strong> end <strong>of</strong> each day:<br />

Each week:<br />

• Keep antenatal clinic log <strong>of</strong> enrollment and refusals up to date<br />

• Collect and review for completeness all data items<br />

• File all forms toge<strong>the</strong>r each day<br />

• Store all papers chronologically by assessment number<br />

• Store all slides chronologically by assessment number<br />

• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />

• Put all items aside in a safe place<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

21


Delivery Unit Survey<br />

Each delivery will have at least 4 and as many as 8 loose pieces <strong>of</strong> information<br />

• Signed consent form, if used<br />

• Completed questionnaire (…pages)<br />

• 3 blood slides:<br />

Mo<strong>the</strong>r (thick and thin)<br />

Placenta (thick and thin)<br />

Cord (thick and thin)<br />

• 2 filter papers:, if used:<br />

Mo<strong>the</strong>r<br />

Placenta<br />

• Placenta tissue in tube, if used:<br />

Data management tasks <strong>of</strong> delivery unit staff:<br />

Each enrollment:<br />

• Mark patient number clearly on each item and each page<br />

• Mark M or P or C clearly on blood slides and filter papers, if used<br />

• Mark patient number + M or P or C in <strong>the</strong> laboratory logbook<br />

Before woman leaves:<br />

• Verify that questionnaire is completed<br />

• Verify that M and C slide results are back from laboratory, and treat her if positive<br />

Data management tasks <strong>of</strong> supervisor:<br />

At <strong>the</strong> end <strong>of</strong> each day:<br />

Each week:<br />

• Keep delivery log <strong>of</strong> enrollment and refusals up to date<br />

• Collect and review all data items for completeness<br />

• File all forms toge<strong>the</strong>r each day<br />

• Store all papers chronologically by assessment number<br />

• Store all slides chronologically by assessment number<br />

• Mark patient number range on each set <strong>of</strong> items, e.g.: 42.001 – 42.035<br />

• Put all items aside in a safe place<br />

22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


J. Sample Logbooks: Enrollment and Laboratory<br />

• Enrollment logbook: Records a list, by facility, <strong>of</strong> <strong>the</strong> pregnant women visiting <strong>the</strong> site<br />

each day <strong>of</strong> <strong>the</strong> survey, her antenatal clinic number, and whe<strong>the</strong>r or not she was enrolled<br />

(and if not, why not).<br />

• Laboratory logbooks (two): One records information about <strong>the</strong> malaria blood films <strong>of</strong><br />

enrolled women and <strong>the</strong> o<strong>the</strong>r records information about enrolled women’s hemoglobin<br />

or hematocrit, by facility.<br />

During <strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for ensuring that<br />

each site has prepared enrollment and laboratory logbooks.<br />

During <strong>the</strong> assessment, site supervisors are responsible for monitoring <strong>the</strong> use <strong>of</strong> <strong>the</strong> logbooks<br />

and preparing additional books as necessary.<br />

<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> - Enrollment Antenatal Clinic Logbook<br />

Facility: __________________________________________________________________________________________________<br />

District/Region: ________________________________________________________________________________________<br />

Date<br />

Woman’s<br />

antenatal<br />

clinic<br />

number<br />

Name <strong>of</strong><br />

Woman<br />

Age<br />

G/P*<br />

Mo<strong>the</strong>r<br />

tongue<br />

Enrolled?<br />

Yes/No<br />

Woman’s<br />

ID<br />

number<br />

Comments**<br />

*Gravidity/parity<br />

**It may be helpful to make a list <strong>of</strong> reasons for nonenrollment, along with a code number for each<br />

reason, and place it on <strong>the</strong> face page <strong>of</strong> <strong>the</strong> logbook. For example, if <strong>the</strong> first reason on <strong>the</strong> list was<br />

“woman refused to participate” and <strong>the</strong> code for that reason was “1,” “1” could be written in <strong>the</strong><br />

comments column above.<br />

<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> – Laboratory Antenatal Clinic Logbook for<br />

<strong>Malaria</strong> Facility: ________________________________________________________________________________________<br />

District/Region:________________________________________________________________________________________<br />

Date<br />

Woman’s<br />

ID<br />

number<br />

Blood<br />

smear<br />

+/-<br />

Species* Density Comments<br />

*In some settings may need a column for malaria species.<br />

<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> – Laboratory Antenatal Clinic Logbook for<br />

Hemoglobin Facility: _ _________________________________________________________________________________<br />

District/Region: ________________________________________________________________________________________<br />

Date<br />

Woman’s ID<br />

number<br />

Hb<br />

Comments<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

23


K. Handbook for <strong>Assessment</strong> Teams<br />

Each member <strong>of</strong> <strong>the</strong> assessment team should receive a handbook during<br />

assessment training.<br />

<strong>The</strong> handbook briefly describes <strong>the</strong> enrollment procedure and postenrollment activities,<br />

including <strong>the</strong> questionnaire, measurements and laboratory specimens, medications, and<br />

follow-up activities.<br />

Note: <strong>The</strong> team member’s handbook has space for including <strong>the</strong> number <strong>of</strong> women to be<br />

enrolled each day.<br />

HANDBOOK FOR ASSESSMENT TEAMS<br />

Antenatal Clinic Survey<br />

Contents<br />

I. Enrollment<br />

Identification <strong>of</strong> eligible women<br />

Inclusion criteria<br />

Exclusion criteria<br />

Provision <strong>of</strong> information or consent (if necessary)<br />

II. Postenrollment<br />

Questionnaire<br />

Measurements and laboratory specimens<br />

Medications<br />

Follow-up<br />

(Throughout woman’s stay at antenatal clinic unit: follow normal procedures to ensure safety <strong>of</strong><br />

mo<strong>the</strong>r and baby. Ensure proper medical care.)<br />

Goal: Enroll ____ women/day<br />

24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Procedures<br />

Comments<br />

Enrollment<br />

1. Identify eligible women.<br />

Check antenatal clinic card<br />

Confirm information with woman<br />

Note regarding gravidity: All pregnancies count, not just live<br />

births. Inquire if <strong>the</strong> woman has had any pregnancies end in<br />

death <strong>of</strong> <strong>the</strong> fetus for completeness <strong>of</strong> gravidity history.<br />

Not previously enrolled in this assessment<br />

All pregnancies; have experienced quickening.<br />

Note: Record for all women attending antenatal<br />

clinic in <strong>the</strong> enrollment logbook:<br />

Date<br />

Woman’s antenatal clinic number<br />

Name<br />

Age<br />

Gravidity/parity<br />

Mo<strong>the</strong>r tongue<br />

Whe<strong>the</strong>r or not enrolled<br />

Woman’s ID number<br />

Reasons for nonenrollment:<br />

• refused to participate, already enrolled, not<br />

selected, etc.<br />

2. Ask every eligible woman to participate. Note: If antenatal clinic volume is high, it may be<br />

necessary to select every o<strong>the</strong>r eligible woman to<br />

avoid selection bias. It is not a good idea to select<br />

<strong>the</strong> first 10 women for example, as those who come<br />

early for antenatal clinic may be different from<br />

women who come later in <strong>the</strong> day.<br />

3. Verify criteria. Exclusion criteria:<br />

Gestational age before quickening<br />

Age


L. Blood Test Procedures: HemoCue for Determination <strong>of</strong><br />

Hemoglobin Level<br />

<strong>The</strong> following describes how to take a blood sample for use in a HemoCue machine.<br />

Note: Not all countries and sites routinely use <strong>the</strong> HemoCue method and so should use <strong>the</strong><br />

method currently used. However, if a choice exists, use <strong>of</strong> <strong>the</strong> HemoCue system is preferable<br />

as it allows a quick assessment <strong>of</strong> hemoglobin level that can be easily compared across<br />

countries and sites.<br />

• Organize <strong>the</strong> supplies you need:<br />

gloves<br />

cotton<br />

disinfectant swab<br />

lancet<br />

HemoCue<br />

HemoCue cuvette<br />

sharps disposal container<br />

hospital waste basket<br />

slide marker<br />

• Take one HemoCue cuvette from <strong>the</strong> container and close <strong>the</strong> lid again.<br />

• Switch HemoCue ON and open cuvette holder to loading position.<br />

• Put on gloves.<br />

• Use <strong>the</strong> third or fourth finger for sampling. Clean puncture site with disinfectant and<br />

allow to dry.<br />

• Use your thumb to lightly press <strong>the</strong> finger from top <strong>of</strong> <strong>the</strong> knuckle to <strong>the</strong> tip (to increase<br />

blood flow).<br />

• Using disposable lancet, prick <strong>the</strong> side <strong>of</strong> <strong>the</strong> fingertip. (See steps 1-3 in Figure A-1 in <strong>the</strong><br />

next section.) Immediately dispose <strong>of</strong> <strong>the</strong> lancet in a sharps container.<br />

• Wipe away <strong>the</strong> first 2-3 drops <strong>of</strong> blood. If necessary, apply light pressure again, until<br />

ano<strong>the</strong>r drop <strong>of</strong> blood appears. Avoid “milking.”<br />

• Fill HemoCue cuvette in one continuous process. Wipe <strong>of</strong>f excess blood on outside <strong>of</strong><br />

cuvette tip. Place in cuvette holder. Push HemoCue cuvette holder into <strong>the</strong> measuring<br />

position.<br />

• Wipe and clean puncture site.<br />

• Note Hb value (within 10 minutes <strong>of</strong> reading).<br />

• Take cuvette out <strong>of</strong> holder and throw away.<br />

• Clean up and be careful with sharps.<br />

• Switch HemoCue OFF.<br />

26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


M. Blood Test Procedures: Thick and Thin Films for <strong>the</strong> Microscopic<br />

Diagnosis <strong>of</strong> <strong>Malaria</strong> Infection 3<br />

<strong>The</strong> following describes how to make thick and thin films for <strong>the</strong> determination <strong>of</strong> malaria<br />

infection. If <strong>the</strong>re are a substantial number <strong>of</strong> non–Plasmodium falciparum infections in <strong>the</strong><br />

area, both thick and thin films should be made. O<strong>the</strong>rwise, thick films are generally adequate.<br />

Note: <strong>Rapid</strong> tests are available that can detect <strong>the</strong> presence <strong>of</strong> malaria parasites in peripheral<br />

blood. <strong>The</strong>se tests, although expensive, perform well when conducted by trained personnel.<br />

<strong>The</strong>y show decreased sensitivity in persons/settings with low parasite load. <strong>The</strong>re are<br />

currently not enough data to recommend <strong>the</strong> use <strong>of</strong> rapid Organize <strong>the</strong> supplies you need:<br />

lab coat<br />

gloves<br />

cotton<br />

disinfectant swab<br />

2 slides (labeled slide & swipe slide)<br />

lancet<br />

sharps disposal container<br />

hospital waste basket<br />

slide marker<br />

Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />

concentrated, allowing a greater volume <strong>of</strong> blood to be examined. However, thick films are<br />

difficult to read. Thick films are stained unfixed after drying.<br />

Thin films should be used if <strong>the</strong>re are a substantial number <strong>of</strong> non—P. falciparum infections in<br />

<strong>the</strong> area, as thin films make it easier to identify species. <strong>The</strong> thin film should be air-dried, fixed<br />

with methanol, and allowed to dry before staining.<br />

For best results, both thick and thin films should be stained with a 3% Giemsa solution (pH <strong>of</strong><br />

7.2) for 30--45 minutes. A Wright-Giemsa stain can also indicate malaria parasites but does<br />

not demonstrate Schüffner’s dots as reliably as Giemsa.<br />

Plasmodium parasites are always intracellular, and <strong>the</strong>y demonstrate, if stained correctly, blue<br />

cytoplasm with a red chromatin dot. Common errors in reading malaria films are caused by<br />

platelets overlying a red blood cell and <strong>the</strong> misreading <strong>of</strong> artifacts as parasites.<br />

Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />

concentrated, allowing a greater volume <strong>of</strong> blood to be examined. WHO recommends that<br />

at least 100 fields, each containing approximately 20 white blood cells (WBCs), be screened<br />

before calling a thick smear negative.<br />

To quantify malaria parasites against WBCs (i.e., determine parasite density) on <strong>the</strong> thick<br />

smear: Tally <strong>the</strong> parasites against <strong>the</strong> WBCs, until you have counted 500 parasites or 1,000<br />

WBC, whichever comes first. Express <strong>the</strong> results as parasites per microliter <strong>of</strong> blood, using <strong>the</strong><br />

WBC count if known, or o<strong>the</strong>rwise assuming 8,000 WBCs per microliter blood.<br />

3 We have slightly adapted <strong>the</strong> following article for this section: Shah S, Filler S, Causer L et al. MMWR.<br />

Surveillance Summary. <strong>Malaria</strong> surveillance --- United States, 2002. April 30, 2004. 53 (SS01); 21-34.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

27


Parasites/microliter blood = (parasites/WBCs) x WBC count per microliter (or 8,000).<br />

Thin smears are useful for species identification <strong>of</strong> parasites already detected on thick smears.<br />

<strong>The</strong>y are also useful for screening for parasites if adequate thick smear are not available and as<br />

a rapid screen while <strong>the</strong> thick smear is still drying.<br />

To quantify parasites (i.e., determine parasite density) against red blood cells (RBCs) on thin<br />

smear: Count <strong>the</strong> parasitized RBCs among 500-2,000 RBCs on <strong>the</strong> thin smear and express <strong>the</strong><br />

results as % parasitemia.<br />

% parasitemia = (parasitized RBCs/total RBCs) x 100. If <strong>the</strong> parasitemia is high (>10%)<br />

examine 500 BBCs; if it is low (


Figure A-1<br />

Figure A-2<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

29


N. Antenatal Clinic Survey Information Sheet 4<br />

<strong>The</strong> following information sheet should be given to each potential survey participant.<br />

If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong><br />

information should be read aloud to her. All potential participants should receive a<br />

copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />

Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or if she has<br />

low literacy skills, read this information aloud to her. Give each potential survey<br />

participant a copy <strong>of</strong> this information sheet to take home.<br />

Introduction<br />

<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />

[assessment area] have malaria. This will help us find <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong><br />

malaria on pregnant women and <strong>the</strong>ir babies. As you know, sometimes you may get malaria<br />

and feel sick. What you may not know is that sometimes you may have malaria without<br />

feeling sick. <strong>The</strong> only way for us to know how many women may have this problem is to check<br />

women’s blood. We plan to assess this problem in about _____ women in antenatal clinics in <strong>the</strong><br />

[assessment area].<br />

Purpose <strong>of</strong> <strong>the</strong> Survey<br />

We plan to check women’s blood for malaria to know how many women in <strong>the</strong> [assessment<br />

area] are infected. This will help us plan and measure <strong>the</strong> effects <strong>of</strong> programs to decrease<br />

malaria in pregnant women.<br />

Procedures<br />

If you agree to participate in this survey, we will ask you some questions about yourself and<br />

your health since you have been pregnant. We will not be telling anyone about your individual<br />

answers to <strong>the</strong> questions, and we will keep all assessment information about you safe and<br />

secure. You also do not need to answer any questions on <strong>the</strong> survey forms that you do not<br />

want to. We will review your clinic card and take your temperature. We will take a few drops <strong>of</strong><br />

blood from a finger stick to check your blood for anemia and malaria. You will still go through<br />

<strong>the</strong> usual clinic exam by <strong>the</strong> clinic staff. If we find that you have malaria, we will treat you<br />

with a drug called ___________ (enter appropriate drug name). If we find you need treatment for<br />

anemia, we will inform <strong>the</strong> clinic staff so <strong>the</strong>y will be sure to give you treatment for it. If you<br />

participate in <strong>the</strong> survey, it will take about x number <strong>of</strong> minutes more than if you did not.<br />

If you do not wish to participate in this survey, it will not affect <strong>the</strong> care given to you by <strong>the</strong><br />

clinic. If you have questions later, please feel free to ask. You can ask me today or if you have<br />

questions later, you can ask _________________ (responsible assessment team member).<br />

4 It is very important that <strong>the</strong> country’s human subjects or ethics requirements be followed with regard to<br />

whe<strong>the</strong>r provision <strong>of</strong> information only is sufficient or documentation <strong>of</strong> participant’s informed consent is<br />

necessary. It may also be required to obtain consent <strong>of</strong> <strong>the</strong> baby’s fa<strong>the</strong>r.<br />

30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Risks or discomforts<br />

You will feel a “pinch” that lasts for a few seconds when <strong>the</strong> finger stick is done to take blood<br />

from your finger.<br />

Benefits<br />

One <strong>of</strong> <strong>the</strong> benefits to you <strong>of</strong> participating in this survey is that if we find that you have malaria,<br />

we will give you___________ (enter appropriate drug name) to cure it. If you have anemia, you’ll<br />

receive treatment for it.<br />

Treatment<br />

__________ (enter appropriate drug name) works very well to treat malaria. Studies have shown<br />

that this drug is very safe for you to take while you are pregnant and that it will not harm your<br />

baby. We believe that treating you for <strong>the</strong> malaria and recent fever outweighs any risk from <strong>the</strong><br />

drug.<br />

We are always concerned that abnormal events may occur when you are pregnant that might<br />

affect <strong>the</strong> baby inside <strong>of</strong> you. You may have seen babies that were born with some defects.<br />

Most <strong>of</strong> <strong>the</strong>se we cannot do anything about and it was no fault <strong>of</strong> <strong>the</strong> woman or clinic workers.<br />

If we treat you with any drug, we would only use one that we think is very safe and would not<br />

cause any <strong>of</strong> <strong>the</strong>se problems. If you have any questions about this, please ask now, or you can<br />

ask _______ (assessment team member) at <strong>the</strong> clinic at any time during <strong>the</strong> assessment. (Be sure<br />

to give enough information so that <strong>the</strong> woman can find <strong>the</strong>m.) If you have any questions about<br />

your rights as a survey participant, you may contact _________ (name and address to be filled in).<br />

Thank you very much for your time. Would you like to participate?<br />

Please keep this information sheet in case you have questions later on.<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

31


O. Analysis <strong>of</strong> Antenatal Clinic Data: Key Indicators<br />

and Summary Tables<br />

Below are key indicators for <strong>the</strong> Antenatal Clinic Survey and summary tables <strong>of</strong> survey<br />

results. Fur<strong>the</strong>r data analysis may be helpful, but it is generally not necessary for decision<br />

making.<br />

Tables can be useful for showing relationships between outcome variables.<br />

• Table 1 shows how representative <strong>the</strong> women in <strong>the</strong> survey are <strong>of</strong> <strong>the</strong> women in <strong>the</strong><br />

country.<br />

• Table 2 shows women’s reported use <strong>of</strong> prevention and control measures, such as IPTp,<br />

ITNs, and antimalarial drugs for treatment <strong>of</strong> illness.<br />

• Table 3 focuses on parasitemia, fever, and anemia by use <strong>of</strong> antenatal clinics and malaria<br />

prevention interventions.<br />

• Table 4 looks at <strong>the</strong> relationship between peripheral parasitemia, fever, and anemia.<br />

Note: <strong>The</strong> tables can also break down <strong>the</strong> numbers and percentages by locale (e.g., region,<br />

site, urban vs. rural).<br />

32 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Outcome Variables<br />

No. Outcome Variable (%) Numerator/Denominator<br />

1 Pregnant women with peripheral<br />

parasitemia<br />

Number <strong>of</strong> pregnant women with positive<br />

peripheral parasitemia blood films/<br />

Number <strong>of</strong> women with valid blood films<br />

2 Pregnant women with anemia<br />

(Hb


Table 1. Characteristics <strong>of</strong> Women in <strong>the</strong> Antenatal Clinic Survey and Women<br />

Country-Wide<br />

Characteristic<br />

Median age in years [range]<br />

Median gravidity [range]<br />

Antenatal clinic visits, median no. [range]<br />

Able to read<br />

Attended school (any)<br />

Married<br />

Owns own home<br />

Owns moped<br />

Owns bike<br />

Owns radio<br />

Works for cash<br />

Grows cash crops<br />

TOTAL<br />

Women in Antenatal<br />

Clinic Survey* (n= # )<br />

Women in national<br />

DHS**<br />

*Data are % <strong>of</strong> participants unless o<strong>the</strong>rwise indicated.<br />

**If available, national data (e.g., from Demographic and Health Surveys) can be used to<br />

compare how similar women in <strong>the</strong> assessment are to women nationally.<br />

34 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Table 2. Use <strong>of</strong> Prevention and Control Measures by Women in <strong>the</strong> Antenatal<br />

Clinic Survey<br />

Treatment and Prevention Measures<br />

(#sites) (#women)<br />

Gestational age at 1 st antenatal clinic visit<br />

Owns insecticide-treated bed net (ITN)<br />

Uses ITN<br />

Slept under ITN previous night<br />

Used antimalarial drug during pregnancy for prevention (IPTp)<br />

Used antimalarial drug during pregnancy for treatment <strong>of</strong> malaria<br />

illness<br />

Module 1: Conducting an Antenatal Clinic Survey<br />

35


Table 3. Status <strong>of</strong> Peripheral Parasitemia, Fever, and Anemia among<br />

Women in <strong>the</strong> Antenatal Clinic Survey<br />

All<br />

women<br />

(n=#)<br />

Women<br />

with no<br />

prior<br />

ANC<br />

(n=#)<br />

Women<br />

with at<br />

least 1<br />

prior<br />

antenatal<br />

clinic visit<br />

(n=#)<br />

Slept<br />

under<br />

bednet<br />

previous<br />

night<br />

(n=#)<br />

Use <strong>of</strong> antimalarial drug for IPTp<br />

during pregnancy among women<br />

with at least 1 prior antenatal<br />

clinic visit (n=#)<br />

Complete Incomplete None<br />

Parasitemia<br />

Overall<br />

Primigravidae<br />

Secundigravidae<br />

Multigravidae<br />

(>3 pregnancies)<br />

Fever<br />

Reported<br />

fever or<br />

malaria during<br />

pregnancy and<br />

took antimalarial<br />

drug<br />

Reported fever<br />

within 7 days <strong>of</strong><br />

enrollment<br />

Fever (>37.5ºC)<br />

at visit<br />

Anemia<br />

(Hb3 pregnancies)<br />

Moderate to<br />

severe anemia<br />

(Hb


Table 4. Relationship between Peripheral Parasitemia, Fever, and Anemia<br />

among Women in <strong>the</strong> Antenatal Clinic Survey<br />

Characteristic<br />

Reported fever<br />

within week before<br />

enrollment<br />

Parasitemic<br />

(n=#)<br />

Aparasitemic<br />

(n=#)<br />

Risk<br />

ratio<br />

95%<br />

Confidence<br />

interval<br />

P<br />

Anemia (Hb


38 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Woman’s full name:____________________________________________________________________________________<br />

ID #_____A________<br />

Tool 1: Antenatal Clinic Questionnaire<br />

Today’s date: ______/_______/______<br />

Day/Month/Year<br />

ID number: ___ _1__ -- ___ ___ ___<br />

Digit 1 = facility number Digit 2 = A (for antenatal clinic)<br />

Digits 3, 4 & 5 = woman’s consecutive number<br />

SCREENING QUESTION<br />

Interviewer number _______<br />

1. Age (years):: [ ]<br />

(If <strong>the</strong> mo<strong>the</strong>r does not know her age, <strong>the</strong>n estimate her age using <strong>the</strong> categories below)<br />

less than 15 years [ ] 30-34 years [ ]<br />

15-19 years [ ] 35-39 years [ ]<br />

20-24 years [ ] 40-44 years [ ]<br />

25-29 years [ ] more than 44 years [ ]<br />

If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time and<br />

DO NOT enroll her in this survey.<br />

2. Have you felt <strong>the</strong> baby move inside you? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If <strong>the</strong> woman has not experienced quickening, thank her for her time, and<br />

DO NOT enroll her in this survey.<br />

DEMOGRAPHIC INFORMATION<br />

3. Village/town: ____________________________________________<br />

Interviewer: Skip <strong>the</strong> next question; it will be coded later so that it is done uniformly.<br />

4. Is this a rural or urban area? [ ]<br />

Urban = 1<br />

Rural = 2<br />

Periurban = 3<br />

Unknown = 9<br />

5. What language do you usually speak with family members at home? [ ]<br />

Language a = 1<br />

Language b = 2<br />

Language c = 3<br />

O<strong>the</strong>r = 8 (specify) ______________________________________<br />

6. Are you married? [ ]<br />

yes, married and living with husband = 1<br />

yes, married but do not live with husband = 2<br />

not married but living with a man = 3<br />

separated or divorced = 4<br />

widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 5<br />

never married or lived with a man = 6<br />

<br />

Tool 1: Antenatal Clinical Questionnaire<br />

1


EDUCATION<br />

7. What is <strong>the</strong> highest level <strong>of</strong> school you attended? [ ]<br />

Primary = 1<br />

Secondary = 2<br />

Higher = 3<br />

Never attended = 4<br />

Unknown = 9<br />

8. Can you read? [ ]<br />

YES = 1<br />

NO = 2<br />

SOCIOECONOMIC INDICATORS<br />

9. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />

corrugated iron = 1<br />

cement or concrete = 2<br />

wood and mud = 3<br />

thatch or grass = 4<br />

reed or bamboo = 5<br />

plastic sheet = 6<br />

mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />

o<strong>the</strong>r = 8 (specify) ________________________________<br />

10. What kind <strong>of</strong> floor does your house have? [ ]<br />

earth or sand = 1<br />

dung = 2<br />

wood planks = 3<br />

reed or bamboo = 4<br />

vinyl tiles or carpet = 5<br />

cement = 6<br />

cement tiles or brick = 7<br />

o<strong>the</strong>r = 8 (specify) ________________________________<br />

11. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />

job a = 1<br />

job b = 2<br />

job c = 3<br />

job d = 4<br />

12. What is <strong>the</strong> monthly household income for your family? [ ]<br />

income bracket a = 1<br />

income bracket b= 2<br />

income bracket c=3<br />

FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE<br />

13. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound own:<br />

YES = 1<br />

NO = 2<br />

A bicycle/scooter/moped? [ ]<br />

A radio? [ ]<br />

A TV? [ ]<br />

Own <strong>the</strong> house you are living in? [ ]<br />

Own crop land? [ ]<br />

Grow cash crops? [ ]<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


REPRODUCTIVE AND CLINICAL HISTORY<br />

14. How many times have you become pregnant? [ ]<br />

(including this one and all o<strong>the</strong>r pregnancies, including abortions and miscarriages)<br />

14a. How many pregnancies with a live-born child? [ ]<br />

14b. How many pregnancies with loss <strong>of</strong> <strong>the</strong> fetus? [ ]<br />

MALARIA PREVENTION<br />

15. Did you take malaria medicine during this pregnancy to prevent/protect from malaria to keep illness from coming into<br />

<strong>the</strong> body when you did not have symptoms?<br />

(NOTE: This question does NOT concern treatment for malaria illness.) [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If NO OR UNKNOWN, skip to question 16<br />

If YES:<br />

15a. What type <strong>of</strong> medicine did you take?<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (SP, Fansidar) [ ]<br />

Proguanil [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify): ______________________________<br />

Unknown [ ]<br />

15b. When you started taking <strong>the</strong> medicine, how many months pregnant were you? [ ]<br />

15c. For <strong>the</strong> first time you took <strong>the</strong> medicine, how many total tablets did you take? [ ]<br />

15d. How many times in a week did you take <strong>the</strong> medicine? [ ]<br />

15e. How many tablets did you take each time? [ ]<br />

15f. After <strong>the</strong> first dose, how <strong>of</strong>ten did you take this medicine? [ ]<br />

Every week = 1<br />

Almost every week = 2<br />

Some weeks = 3<br />

Monthly = 4<br />

Rarely = 5<br />

Do not know = 6<br />

16. Did you sleep under a bed net during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If no, skip to question 17<br />

16a. If yes, how frequently? [ ]<br />

all <strong>the</strong> time = 1<br />

most <strong>of</strong> <strong>the</strong> time = 2<br />

sometimes = 3<br />

rarely = 4<br />

16b. Did you sleep under <strong>the</strong> net last night? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

Tool 1: Antenatal Clinical Questionnaire<br />

3


16c. Has this net ever been treated with insecticide? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16d. If yes, has <strong>the</strong> net been treated with insecticide in <strong>the</strong> past one year? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16e. Is <strong>the</strong> net a long-lasting insecticide-treated net (LLN)? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

HISTORY OF FEVER OR MALARIA<br />

17. Have you had a fever that you thought was malaria during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If NO, skip to question 18<br />

17a. Did you get a convulsion with fever/malaria? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

17b. Did you stay in hospital overnight for treatment <strong>of</strong> fever/malaria? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

17c. Did you get a blood transfusion? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

17d. Did you take iron and folic acid tablets? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

17e. Have you taken a medication to treat malaria or fever during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


17f. Type <strong>of</strong> medication taken (check all that apply)<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (SP) [ ]<br />

Quinine [ ]<br />

Antipyretics [ ]<br />

Coartem [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify):_________________________________<br />

Unknown [ ]<br />

18. Have you had a fever that you thought was malaria during <strong>the</strong> past week? [ ]<br />

(IF yes, perform a rapid diagnostic test and treat accordingly.)<br />

ANTENATAL RECORD INFORMATION<br />

(Copy <strong>the</strong> following information from <strong>the</strong> antenatal record)<br />

19. ANTENATAL CLINIC VISITS<br />

19a. Total number <strong>of</strong> visits (including this one) [ ]<br />

19b. Timing <strong>of</strong> visits:<br />

Date <strong>of</strong> visit______________Gestational age______________Fundal______________ (weeks)______________height______________<br />

first visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />

this visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />

19c. Last menstrual period (LMP)(if recorded)… ___ __/_____/____<br />

TODAY’S EXAMINATION BY ASSESSMENT TEAM<br />

20. Hemoglobin (g/dl): _____ _____ . _____<br />

If Hgb < 11, ensure that treatment for anemia is given<br />

If Hgb < 7, ensure that treatment for severe anemia given and refer to ANC staff<br />

21. Temperature ____ ____.____ (Celsius)<br />

(If temperature >37.5, do a rapid diagnostic test.)<br />

22. <strong>Rapid</strong> diagnostic test result [ ]<br />

Positive = 1<br />

Negative = 2<br />

Result available and examined, but undetermined = 9<br />

23. Blood film result [ ]<br />

Positive = 1<br />

Negative = 2<br />

Result available and examined, but undetermined = 9<br />

(If febrile, or history <strong>of</strong> fever in past 7 days with negative RDT, <strong>the</strong>n read <strong>the</strong> slide in <strong>the</strong> clinic immediately.)<br />

24. <strong>Malaria</strong> species. Check all that apply.<br />

Plasmodium falciparum = 1 [ ]<br />

P. vivax = 2 [ ]<br />

P. malariae = 3 [ ]<br />

P. ovale = 4 [ ]<br />

Undetermined = 9 [ ]<br />

25. Parasite density [ ]<br />

Tool 1: Antenatal Clinical Questionnaire<br />

5


26. Antimalarial drug given? [ ]<br />

YES = 1<br />

NO = 2<br />

If NO, skip to Q27<br />

26a. If YES, what type [ ]<br />

Chloroquine = 1<br />

Sulfadoxine-pyrimethamine (SP) = 2<br />

Chloroquine and SP = 3<br />

Quinine = 4<br />

Coartem = 5<br />

O<strong>the</strong>r = 8 (specify and explain): ____________________________________________________________<br />

26b. Date administered: ___ ___ / ___ ___ / ___ ___<br />

26c. Name <strong>of</strong> person administering antimalarial drugs _________________________________________<br />

27. Treatment given for anemia, according to national policy? [ ]<br />

YES = 1<br />

NO = 2 (If no, go to end <strong>of</strong> questionnaire)<br />

27a. What was <strong>the</strong> dose? _________<br />

27b. Was she given <strong>the</strong> appropriate amount to take home and complete her<br />

anemia treatment?<br />

Note to Interviewer: If a woman is currently febrile or reports having had a fever in <strong>the</strong> last 7 days, she should<br />

wait to receive her blood smear results prior to leaving clinic that day, and her blood slides should be promptly<br />

read. If <strong>the</strong> slide is positive, she should receive treatment with <strong>the</strong> appropriate antimalarial drug. If a woman<br />

is currently afebrile, with no history <strong>of</strong> fever in <strong>the</strong> past week, she need not wait for smear results but can<br />

return for <strong>the</strong>m <strong>the</strong> following day. If a woman is anemic or severely anemic, she should receive appropriate<br />

treatment.<br />

OR<br />

If above differs from <strong>the</strong> country’s national policy, follow national policy.<br />

PLEASE CHECK OVER THE QUESTIONNAIRE NOW TO MAKE SURE THAT ALL QUESTIONS HAVE BEEN ANSWERED, THEN<br />

CHECK THIS BOX [ ]<br />

Thank <strong>the</strong> woman for her time.<br />

28. QUALITY CONTROL<br />

Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end <strong>of</strong> all interviews.<br />

Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />

Person Name/Signature Date<br />

28a Site Supervisor<br />

28b Data Entry Clerk 1<br />

28c Data Entry Clerk 2<br />

28d <strong>Assessment</strong> Coordinator<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 2: Conducting a Delivery Unit Survey<br />

A Delivery Unit Survey is designed to determine <strong>the</strong> magnitude<br />

<strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria, specifically:<br />

• What is <strong>the</strong> prevalence <strong>of</strong> peripheral, placental, and umbilical cord<br />

parasitemia in pregnant women?<br />

• What is <strong>the</strong> prevalence <strong>of</strong> low birth weight and premature delivery?<br />

• Is <strong>the</strong>re a relationship between parasitemia and low birth weight or<br />

premature delivery?<br />

• Does <strong>the</strong> prevalence <strong>of</strong> placental parasitemia vary by gravidity or locale?<br />

This module contains sample materials for a Delivery Unit Survey. <strong>The</strong>se<br />

materials can and should be adapted to suit local needs. General guidance for<br />

conducting a Delivery Unit Survey and managing data can be found in Chapters<br />

3 and 4 <strong>of</strong> <strong>the</strong> manual.<br />

Contents<br />

Consult Resource 3 for presentations that address some <strong>of</strong> <strong>the</strong><br />

topics below.<br />

A. Delivery Unit Survey Timetable<br />

B. Selecting Sample Sizes<br />

C. Eligibility Criteria<br />

D. List <strong>of</strong> Supplies and Equipment<br />

E. <strong>Assessment</strong> Teams<br />

F. <strong>Assessment</strong> Team Training (Resource 3)<br />

G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />

H. Supervisor’s Guide to Conducting Antenatal Clinic<br />

and Delivery Unit Surveys<br />

I. Supervisor’s Guide to Data Management for Antenatal Clinic and<br />

Delivery Unit Surveys<br />

J. Sample Logbooks: Enrollment and Laboratory<br />

K. Handbook for <strong>Assessment</strong> Teams<br />

L. Guide for Night-time Admissions to <strong>the</strong> Delivery Unit<br />

M. Ballard Score Sheet for Determining Gestational Age<br />

(see also Resource 3)<br />

N. Blood Test Procedures: Making Thick and Thin Films for <strong>the</strong> Microscopic<br />

Detection <strong>of</strong> <strong>Malaria</strong> Infection<br />

O. Taking Blood Samples from a Finger, Placenta,<br />

and Umbilical Cord<br />

P. Making a Placental Impression Smear<br />

Q. Information Sheet<br />

R. Analysis <strong>of</strong> Delivery Unit Survey Data<br />

Module 2: Delivery Unit Survey<br />

1


A. Delivery Unit Survey Timetable<br />

<strong>The</strong> timetable below outlines key steps in planning for and conducting Delivery Unit (and<br />

antenatal clinic) survey activities and <strong>the</strong> approximate length <strong>of</strong> time to allow for <strong>the</strong>se steps.<br />

Note that this timetable is <strong>the</strong> same as that for <strong>the</strong> ANC survey and that <strong>the</strong>se preparations and<br />

activities should be undertaken simultaneously.<br />

Period Time Activities<br />

Planning <strong>the</strong><br />

assessment<br />

2-4 weeks •Determine what assessment components, if any, need<br />

to be conducted<br />

• Determine what approvals (ethical, scientific, o<strong>the</strong>r<br />

ministerial) are needed and initiate approval process<br />

Preassessment 2-3 weeks • Select Site(s)<br />

• Explain <strong>the</strong> assessment to <strong>the</strong> community<br />

• Procure assessment equipment and supplies<br />

• Hire assessment team and/or identify existing staff<br />

• Adapt and translate questionnaires<br />

• Pretest questionnaires<br />

• Identify site for training<br />

• Identify responsible persons for all presentations<br />

(See Resource 3 for sample presentations)<br />

• Manage logistics <strong>of</strong> training, including per diem,<br />

transportation, meals, and lodging<br />

• Arrange for on-site training in DUs and in ANCs<br />

<strong>Assessment</strong><br />

training<br />

Start-up <strong>of</strong><br />

assessment<br />

1 week • Conduct training course<br />

• Finalize questionnaires based on pretest and make<br />

adequate copies for final day <strong>of</strong> training<br />

• Meet with supervisors to coordinate assessment<br />

start-up in clinical facilities<br />

2 weeks • Make adequate copies <strong>of</strong> ANC and Delivery Unit<br />

questionnaires, enrollment logbooks, and laboratory<br />

logbooks, and ensure questionnaires are at assessment<br />

sites<br />

• Distribute supplies to each assessment site and ensure<br />

a system <strong>of</strong> re-stocking supplies is in place<br />

• Establish quality control mechanism for data collection,<br />

including clinical and laboratory procedures,<br />

transport, and storage<br />

• Establish a supervisory system that addresses logistics<br />

(staffing, supplies), quality <strong>of</strong> interviewing, quality<br />

<strong>of</strong> questionnaires, quality <strong>of</strong> obtaining specimens,<br />

laboratory quality (slide and staining, Hemocue<br />

calibration), logbook maintenance<br />

<strong>Assessment</strong> 8-9 weeks • Enroll women and collect data<br />

• Ensure supervisory system and quality control<br />

mechanisms are functioning<br />

• Ensure adequate supplies and equipment are available<br />

and functioning at each assessment site<br />

Postassessment 8 weeks • Conduct data entry, cleaning, and analysis<br />

• Write final report<br />

• Disseminate results<br />

• Initiate policy discussions<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


B. Selecting Sample Sizes<br />

<strong>The</strong> sample size needed for <strong>the</strong> Delivery Unit Survey depends on<br />

1) <strong>the</strong> estimated prevalence <strong>of</strong> women with placental parasitemia and <strong>of</strong> LBW babies,<br />

2) <strong>the</strong> acceptable margin <strong>of</strong> error, and<br />

3) <strong>the</strong> design effect<br />

<strong>The</strong> sample size required to measure each <strong>of</strong> <strong>the</strong> survey’s main indicators (placental<br />

parasitemia and low-birth-weight babies) can be calculated by using Statcalc in EPI-INFO. <strong>The</strong><br />

EPI-INFO calculation should include an adjustment (i.e., design effect [see note at end <strong>of</strong> this<br />

section, Selecting Sample Sizes]) for <strong>the</strong> fact that <strong>the</strong> survey uses cluster sampling, ra<strong>the</strong>r than<br />

random sampling.<br />

If <strong>the</strong> sample size required to measure one indicator is larger than <strong>the</strong> sample size required for<br />

<strong>the</strong> o<strong>the</strong>r indicator, <strong>the</strong> larger <strong>of</strong> <strong>the</strong> two sample sizes should be selected. <strong>The</strong> sample size may<br />

need to be modified to account for o<strong>the</strong>r factors (see example below).<br />

Determination <strong>of</strong> <strong>the</strong> sample size for <strong>the</strong> Delivery Unit Survey begins with<br />

1. Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women with placental parasitemia and<br />

<strong>the</strong> proportion <strong>of</strong> babies with LBW<br />

2. <strong>The</strong> level <strong>of</strong> accuracy desired, for example + 10%, and<br />

3. <strong>The</strong> design effect<br />

Delivery Unit Survey Sample Size Calculation: An Example<br />

Point estimates: <strong>The</strong> prevalence <strong>of</strong> placental parasitemia during high transmission season<br />

among women <strong>of</strong> all gravidities is estimated at 35%, and <strong>the</strong> prevalence <strong>of</strong> LBW is estimated to<br />

be 14%.<br />

Level <strong>of</strong> accuracy: <strong>The</strong> assessment coordinator determines that it is acceptable if <strong>the</strong> survey<br />

can estimate <strong>the</strong> prevalence <strong>of</strong> placental parasitemia within 10% (that is, <strong>the</strong> prevalence <strong>of</strong><br />

parasitemia could be between 25% and 45%) and <strong>the</strong> prevalence <strong>of</strong> low birth weight within<br />

5% [that is, low birth weight could be between 9% and 19%].<br />

<strong>The</strong>se numbers are <strong>the</strong>n entered in Statcalc, with a design effect=2 (to correct for <strong>the</strong> fact that<br />

this is not a random community sample) for each indicator. <strong>The</strong> design effect <strong>of</strong> 2 is chosen on<br />

<strong>the</strong> basis <strong>of</strong> previous similar studies. EPI-INFO <strong>the</strong>n calculates sample sizes: 174 for placental<br />

parasitemia and 370 for LBW. <strong>The</strong> larger <strong>of</strong> <strong>the</strong>se two is 370, and thus this is <strong>the</strong> sample size<br />

for <strong>the</strong> Delivery Unit Survey.<br />

Estimated<br />

prevalence<br />

Margin <strong>of</strong><br />

error<br />

Needed<br />

sample size<br />

(from Statcalc)<br />

O<strong>the</strong>r<br />

factors<br />

Placental 35% 10% 174 --- 174<br />

parasitemia<br />

during high<br />

transmission<br />

season<br />

LBW 14% 5% 370 --- 370<br />

Total<br />

delivery unit<br />

Sample size<br />

(after adjusting<br />

for o<strong>the</strong>r factors)<br />

Note: If <strong>the</strong> prevalence <strong>of</strong> placental parasitemia during high transmission season is unknown,<br />

assume a level <strong>of</strong> 50% for calculating sample size. This level is <strong>the</strong> most conservative estimate,<br />

as it yields <strong>the</strong> largest required sample size. If <strong>the</strong> prevalence <strong>of</strong> LBW is unknown, countries<br />

could use <strong>the</strong> following estimates from UNICEF and WHO to calculate sample sizes:<br />

East Africa, 13.5%; Middle Africa, 12.3%; Sou<strong>the</strong>rn Africa, 14.6%; and Western Africa, 15.4%.<br />

370<br />

Module 2: Delivery Unit Survey<br />

3


Note: If <strong>the</strong> assessment is being used as a baseline that will be repeated after an intervention<br />

in order to demonstrate impact, <strong>the</strong> sample required will be larger and <strong>the</strong> sample size calculations<br />

more complex. It is advisable to consult a statistician for fur<strong>the</strong>r guidance.<br />

Note on design effect:<br />

Large surveys are <strong>of</strong>ten conducted using cluster surveys, meaning that <strong>the</strong> population is<br />

divided into clusters and sampled accordingly. Clusters are selected by random sampling and<br />

<strong>the</strong>n random samples are taken within <strong>the</strong> selected clusters. <strong>The</strong> benefits <strong>of</strong> cluster sampling<br />

are that it is <strong>of</strong>ten easier and less expensive to conduct than simple random sampling as <strong>the</strong><br />

needed sample size is smaller. However, its disadvantage is that <strong>the</strong>re is a loss <strong>of</strong> precision<br />

because <strong>the</strong> elements within <strong>the</strong> cluster are generally more correlated (similar) than those<br />

between <strong>the</strong> clusters. Selecting an additional member from <strong>the</strong> same cluster adds less<br />

new information than would a completely independent selection. As <strong>the</strong> cluster size and<br />

intracluster correlation increase, cluster variances increase more than one would find in a<br />

simple random sample. <strong>The</strong> benefits <strong>of</strong> cluster sampling <strong>of</strong>ten outweigh <strong>the</strong> disadvantage <strong>of</strong><br />

<strong>the</strong> loss in precision.<br />

Because cluster sampling results in a loss <strong>of</strong> precision and a smaller sample size, an<br />

adjustment called <strong>the</strong> design effect should be used to determine survey sample size when<br />

clustering is involved. <strong>The</strong> design effect is basically <strong>the</strong> ratio <strong>of</strong> <strong>the</strong> actual variance , under <strong>the</strong><br />

sampling method actually used, to <strong>the</strong> variance computed under <strong>the</strong> assumption <strong>of</strong> simple<br />

random sampling. <strong>The</strong> main components <strong>of</strong> <strong>the</strong> design effect are <strong>the</strong> intraclass correlation and<br />

<strong>the</strong> cluster sample sizes. <strong>The</strong> design effect is calculated as follows:<br />

DEFF = 1 + þ (n – 1),<br />

where Deff is <strong>the</strong> design effect, þ is <strong>the</strong> intraclass correlation for <strong>the</strong> statistic in question, and<br />

n is <strong>the</strong> average size <strong>of</strong> <strong>the</strong> cluster. <strong>The</strong> interpretation <strong>of</strong> a value <strong>of</strong> DEFF <strong>of</strong>, say, 3.0 is that<br />

<strong>the</strong> sample variance is 3 times bigger than it would be if <strong>the</strong> survey were based on <strong>the</strong> same<br />

sample size but selected randomly. It can be seen that <strong>the</strong> design effect increases as <strong>the</strong> cluster<br />

sizes increase, and as <strong>the</strong> intraclass correlation increases. <strong>The</strong> square root <strong>of</strong> <strong>the</strong> design effect<br />

shows how much <strong>the</strong> sample standard error, and consequently <strong>the</strong> confidence intervals,<br />

will increase because <strong>of</strong> <strong>the</strong> clustering. <strong>The</strong> intraclass correlation represents <strong>the</strong> likelihood<br />

that two elements in <strong>the</strong> same cluster have <strong>the</strong> same value, for a given statistic, relative to<br />

two elements chosen completely at random in <strong>the</strong> population. A value <strong>of</strong> 0.10 is interpreted,<br />

<strong>the</strong>refore, to mean that <strong>the</strong> elements in <strong>the</strong> cluster are about 10% more likely to have <strong>the</strong> same<br />

value than if <strong>the</strong> two elements were chosen at random in <strong>the</strong> survey.<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Design effects vary from survey to survey and even within <strong>the</strong> same survey will vary from<br />

question to question. In summary, using a cluster sample generally requires ei<strong>the</strong>r a larger<br />

sample size than a simple random sample or a wider confidence interval. <strong>The</strong> design effect<br />

is used to determine how much larger <strong>the</strong> sample size or confidence interval needs to be.<br />

In general, for a well-designed study, <strong>the</strong> design effect usually ranges from 1 to 3. It is not<br />

uncommon, however, for <strong>the</strong> design effect to be much larger.<br />

<strong>The</strong> survey methodology recommended for both <strong>the</strong> antenatal clinic surveys and <strong>the</strong> Delivery<br />

Unit Surveys use cluster sample methodology and thus require that a design effect be used.<br />

C. Eligibility Criteria<br />

All women who are delivering babies should be asked to participate in <strong>the</strong> survey.<br />

Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements:<br />

Gravidity: All gravidities. Although primigravidae and secundigravidae are <strong>the</strong> groups<br />

typically most affected in high transmission areas, women <strong>of</strong> all gravidities should be eligible<br />

so that <strong>the</strong> burden <strong>of</strong> malaria during pregnancy can be estimated for all pregnant women.<br />

Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />

most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />

and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> usual<br />

minimum age is 15 years. <strong>The</strong> age <strong>of</strong> <strong>the</strong> youngest participants may well be less than <strong>the</strong> age<br />

<strong>of</strong> majority and should be consistent with any country policy or norm regarding this type <strong>of</strong><br />

survey.<br />

Notes: Women who participated in <strong>the</strong> ANC survey are eligible to also participate in <strong>the</strong><br />

Delivery Unit Survey, but should not be selected for <strong>the</strong> Client Exit Interview.<br />

Module 2: Delivery Unit Survey<br />

5


D. List <strong>of</strong> Supplies and Equipment<br />

Make sure that each delivery unit has <strong>the</strong> necessary supplies and equipment before <strong>the</strong><br />

start <strong>of</strong> <strong>the</strong> survey.<br />

Item Quantity Comments/Use # in<br />

stock/<br />

Balance<br />

needed<br />

Screening<br />

& Clinical<br />

Evaluation<br />

Electronic<br />

<strong>the</strong>rmometers<br />

2 Temperature collection; if electronic<br />

<strong>the</strong>rmometers are unavailable,<br />

mercury glass <strong>the</strong>rmometers are an<br />

acceptable alternative.<br />

Baby scale 1 Ideally, an electronic digital scale.<br />

A well-calibrated balance scale is<br />

also acceptable.<br />

Tape measure 1 Mo<strong>the</strong>r’s mid-upper arm<br />

circumference.<br />

Height stick 1 Can make height measuring area on<br />

wall <strong>of</strong> DU.<br />

Laboratory<br />

Count-down 1 For laboratory use.<br />

timer<br />

Slides 3/participant Allow extras for waste<br />

Lancets 2/participant Allow extras for waste;<br />

1 for peripheral blood film and 1 to<br />

pierce <strong>the</strong> umbilical cord.<br />

Isopropyl<br />

alcohol<br />

Cotton wool<br />

or gauze<br />

Giemsa stain<br />

Toilet paper<br />

(or slide boxes)<br />

Container for<br />

used lancets<br />

Staining jars<br />

Slide drying rack<br />

Enough<br />

to clean<br />

1 finger/<br />

participant<br />

Enough<br />

to clean<br />

1 finger/<br />

participant<br />

Premoistened alcohol wipes are an<br />

acceptable alternative.<br />

Gauze is preferable to wool as it<br />

leaves fewer fibers on <strong>the</strong> placenta<br />

and <strong>the</strong>refore on <strong>the</strong> slide.<br />

Based upon sample size. In addition<br />

to Giemsa powder, need all<br />

o<strong>the</strong>r materials to mix stain, including<br />

distilled water, buffer, glycerol,<br />

and glassware to mix and store.<br />

Sufficient to wrap (or store) all<br />

slides from assessment<br />

1 Sharps container<br />

2/lab<br />

1/lab<br />

Hair dryer 1/lab May be needed, depending on<br />

climate. Optional.<br />

Microscope 1/lab<br />

Surgical scissors 6 pairs/site<br />

Forceps<br />

6/site<br />

Date<br />

Ordered<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Item Quantity Comments/Use # in<br />

stock/<br />

Balance<br />

needed<br />

Date<br />

Ordered<br />

Wooden<br />

applicator sticks<br />

or plastic<br />

transfer pipettes<br />

1/participant<br />

To transfer placental blood to slide<br />

Spare light bulbs<br />

for microscope<br />

Immersion oil<br />

Lens cleaner<br />

Lens cleaning<br />

tissue<br />

Sharpie markers<br />

(ultra fine)<br />

Examination<br />

gloves<br />

1/lab<br />

3 tubes/lab<br />

3 pairs/<br />

participant<br />

Need 1 pair for peripheral film<br />

and 2 pairs for placental sampling.<br />

Need extra for laboratory and extra<br />

for breakage<br />

Tally counters 2/laboratory<br />

Computer 1-2 2 is ideal, 1 is adequate<br />

(with at least<br />

Windows 2000)<br />

Epi-Info or ano<strong>the</strong>r<br />

1-2 Installed on each computer<br />

statistical<br />

s<strong>of</strong>tware package<br />

(Epi Info is<br />

preferred)<br />

Goggles 2 pairs/site For use when handling placenta to<br />

prevent splashes to eyes.<br />

Tray<br />

1/site<br />

Tissue paper<br />

Filter paper<br />

Bleach<br />

Beaker and 1/site<br />

basin<br />

Office Supplies<br />

AA batteries<br />

If using digital baby scale.<br />

Clipboards 1/interviewer<br />

Pencils<br />

1/interviewer<br />

Only if preparing thin films.<br />

Pencil sharpener 1/interviewer<br />

Only if preparing thin films.<br />

Pens<br />

2/interviewer<br />

Stapler 1<br />

Staples<br />

2 boxes<br />

Ink pad/Ink 1/site For fingerprinting women if signature<br />

needed and woman cannot<br />

sign. Should be bound books, not<br />

spiral-bound or perforated.<br />

Logbooks 1/site and 1/<br />

lab<br />

Module 2: Delivery Unit Survey<br />

7


E. <strong>Assessment</strong> Teams<br />

<strong>The</strong> number <strong>of</strong> assessment teams depends on <strong>the</strong> number <strong>of</strong> delivery units used.<br />

<strong>The</strong> following example assumes that 4 delivery units will be used.<br />

Title<br />

Number needed<br />

<strong>Assessment</strong> coordinator 1<br />

Laboratorian supervisor 1<br />

Site supervisors<br />

Interviewers<br />

Laboratorians<br />

Data management coordinator 1<br />

Data entry clerks 2<br />

4 (1 per site)<br />

8 (2 per site)<br />

4 (1 per site)<br />

Note: At least one assessment team member should be available 24 hours per day to enroll all<br />

women who are delivering and promptly process placentas. If this is not possible, a cooler and<br />

icepacks should be available in order to store placentas.<br />

F. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training for site supervisors, interviewers, and laboratorians should be held after<br />

preassessment activities. Training will take approximately 4-5 days.<br />

Below is a detailed explanation <strong>of</strong> how to conduct <strong>the</strong> training. A sample schedule follows <strong>the</strong><br />

explanation.<br />

Note: If both antenatal clinic (ANC) and Delivery Unit (DU) surveys will be conducted, it is<br />

more efficient to conduct training for both surveys simultaneously. <strong>The</strong>refore, this module<br />

describes simultaneous training. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, this module will need<br />

to be modified accordingly.<br />

Note: If qualitative studies will be conducted about <strong>the</strong> same time as <strong>the</strong> quantitative studies,<br />

it would be beneficial to conduct <strong>the</strong> training simultaneously. Consult <strong>the</strong> qualitative training<br />

manual (or <strong>the</strong> modules that accompany <strong>the</strong> qualitative surveys) for guidance on how to<br />

combine <strong>the</strong> two.<br />

Day 1:<br />

Morning: <strong>The</strong> assessment coordinator should present background information on malaria<br />

during pregnancy and assessment objectives. (See Resource 3 for sample presentations)<br />

Afternoon: <strong>The</strong> assessment coordinator reviews ANC policies and procedures located in<br />

<strong>the</strong> assessment team member’s handbook (see K in this Module). This provides a general<br />

overview <strong>of</strong> <strong>the</strong> assessment. Once <strong>the</strong> overview is complete, <strong>the</strong> assessment coordinator<br />

should split <strong>the</strong> interviewers into teams. Each team will rotate through ANC and delivery unit<br />

clinical procedures. Depending on <strong>the</strong> size <strong>of</strong> <strong>the</strong> assessment team, <strong>the</strong> logistics can be varied.<br />

In a small team, everyone might work toge<strong>the</strong>r to go through all procedures. In a large team<br />

with a sufficient number <strong>of</strong> facilitators, it may be worthwhile to divide teams into groups that<br />

rotate around a series <strong>of</strong> workstations. <strong>The</strong> important thing is that each staff member have <strong>the</strong><br />

opportunity to learn and practice each procedure that he/she will be conducting.<br />

8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


ANC procedures include 1 :<br />

• Exercise universal precaution for handling blood<br />

Take and read axillary temperature<br />

• Collect blood samples (fingersticks) from each o<strong>the</strong>r<br />

Prepare slide (recording date and ID number on slide)<br />

• Prepare thick films (and thin films in an area with substantial P. vivax transmission)<br />

• Prepare Hemocue cuvette for hemoglobin reading; or Measure Hb or Hct by methods<br />

used in that clinic<br />

Delivery unit procedures include:<br />

• Measure women’s mid-upper arm circumference<br />

• Measure woman’s height<br />

• Prepare slides—peripheral, placental, and cord blood<br />

• Weigh newborn using scale<br />

• Conduct <strong>the</strong> Ballard examination and apply <strong>the</strong> scoring system<br />

(See Resource 3 for Ballard video)<br />

Day 2:<br />

Morning: <strong>The</strong> assessment coordinator arranges for interviewers to visit a delivery unit site<br />

for practice <strong>of</strong> delivery unit procedures. At <strong>the</strong> same time, <strong>the</strong> laboratorian supervisor trains<br />

assessment laboratorians on how to read peripheral, placental and cord films. (See N and O in<br />

this module)<br />

Afternoon: In a group setting, <strong>the</strong> assessment coordinator reviews each question on ANC and<br />

delivery unit questionnaires and <strong>the</strong> information sheet (or consent form), depending on which<br />

is being used. <strong>The</strong> coordinator also describes why <strong>the</strong>re is a consent form if a consent form<br />

has been determined necessary. Interviewers should be encouraged to ask questions and <strong>of</strong>fer<br />

suggestions. After reviewing each questionnaire, <strong>the</strong> interviewers should break into small<br />

groups and practice each questionnaire one-on-one using copies <strong>of</strong> actual ANC cards from <strong>the</strong><br />

clinic. Any discrepancies regarding data extraction from ANC cards should be addressed with<br />

<strong>the</strong> assessment coordinator, and questionnaires revised as necessary.<br />

Day 3:<br />

Morning: After <strong>the</strong> survey instruments are adapted, <strong>the</strong> survey instruments, as well as <strong>the</strong><br />

information sheet (or informed consent form if used), should be translated into <strong>the</strong> national<br />

language and <strong>the</strong> primary language spoken by women in <strong>the</strong> assessment area, if different.<br />

This initial translation should be followed by a back-translation (by individuals who did not<br />

produce <strong>the</strong> original translation) into <strong>the</strong> national language to check <strong>the</strong> adequacy <strong>of</strong> <strong>the</strong><br />

translation. Once <strong>the</strong> translation is complete, pretesting can begin. While <strong>the</strong> surveys are<br />

being pretested, laboratorians could practice film reading.<br />

Note: If <strong>the</strong> primary language is not a written language, it will be important to use correct,<br />

consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet (or<br />

informed consent form) so that questions are asked in a standardized manner. All<br />

interviewers should work toge<strong>the</strong>r to achieve correct, consistent phrasing <strong>of</strong> <strong>the</strong> questions<br />

and have <strong>the</strong> opportunity to practice.<br />

Afternoon: <strong>The</strong> assessment coordinator arranges for interviewers to visit two ANC sites to<br />

practice <strong>the</strong> ANC questionnaire with clients. NOTE: Since <strong>the</strong> delivery unit questionnaire<br />

is very similar to <strong>the</strong> ANC questionnaire, it is not necessary to pretest <strong>the</strong> delivery unit<br />

questionnaire due to ethical considerations related to practicing interviewing women in labor<br />

without <strong>the</strong>ir being enrolled in <strong>the</strong> assessment.<br />

Divide <strong>the</strong> interviewers into two teams. Each team should visit one <strong>of</strong> <strong>the</strong> selected sites to pretest<br />

<strong>the</strong> ANC questionnaires with at least 15 clients (total, not per interviewer) in each facility.<br />

1 In some circumstances it may be possible to conduct polymerase chain reaction (PCR) on filter paper<br />

samples or to examine tissue specimens preserved in formalin. However, in many settings <strong>the</strong>se are nei<strong>the</strong>r<br />

possible nor necessary.<br />

Module 2: Delivery Unit Survey<br />

9


Day 4:<br />

Morning: <strong>The</strong> assessment coordinator will explain <strong>the</strong> purpose <strong>of</strong> ANC and delivery unit<br />

enrollment and laboratory logbooks. <strong>The</strong>n, <strong>the</strong> coordinator should demonstrate and review<br />

<strong>the</strong>se logbooks. Many people may not understand that <strong>the</strong> logbooks are used to record<br />

everyone who is enrolled in <strong>the</strong> assessment as well as those who are excluded for any reason.<br />

<strong>The</strong> interviewers should be divided into pairs to practice <strong>the</strong> revised questionnaires. <strong>The</strong> rest<br />

<strong>of</strong> <strong>the</strong> morning should be used to resolve outstanding issues, and conclude <strong>the</strong> training.<br />

Day 5:<br />

If training is scheduled for 5 days, Day 5 can be reserved for work on any remaining issues.<br />

Sample Training Schedule<br />

Day 1 Day 2 Day 3 Day 4<br />

Introduction/ Overview<br />

Delivery Unit Clinical<br />

Procedures<br />

Pretest<br />

questionnaires<br />

Wrap-up<br />

Morning<br />

• Welcome<br />

• Training objectives<br />

• <strong>Malaria</strong> situation in<br />

country<br />

• Epidemiology <strong>of</strong><br />

malaria during<br />

pregnancy<br />

• <strong>Rapid</strong> assessment<br />

objectives<br />

See Resource 3 for<br />

sample presentations.<br />

Microscopy training<br />

for laboratorians<br />

On site delivery unit<br />

clinical procedures<br />

training and practice<br />

for interviewers<br />

Practice<br />

questionnaires<br />

and consent form<br />

administration in<br />

local language(s)<br />

with translator<br />

Practice<br />

questionnaires<br />

and consent form<br />

administration in<br />

local language(s) in<br />

small groups<br />

Introduce enrollment and<br />

laboratory registers<br />

Practice questionnaires<br />

in pairs (using ANC cards<br />

and ANC and delivery unit<br />

registers).<br />

Conclusion <strong>of</strong> training<br />

Afternoon<br />

Policy and procedures<br />

in ANC and delivery unit<br />

(worker’s handbook)<br />

Practice clinical<br />

procedures for ANC and<br />

delivery unit (video <strong>of</strong><br />

Ballard) if available.<br />

Use live demonstrations<br />

using an adult model<br />

before practicing on live<br />

newborns.<br />

Review ANC and<br />

delivery unit<br />

questionnaires and<br />

consent forms<br />

Practice<br />

questionnaires in<br />

pairs (using ANC<br />

cards). Resolve<br />

discrepancies<br />

regarding data<br />

extraction from ANC<br />

cards.<br />

Pretest<br />

questionnaires on<br />

site in ANC facilities<br />

• Meet with supervisors<br />

to discuss assessment<br />

start-up:<br />

• Make copies <strong>of</strong> ANC<br />

and delivery unit<br />

questionnaires<br />

• Ensure ANC and<br />

delivery unit log books<br />

are at each assessment<br />

site<br />

• Distribute supplies to<br />

each assessment site<br />

• Establish quality control<br />

mechanism<br />

• Establish a supervisory<br />

system<br />

Evening<br />

Read questionnaires<br />

and consent forms<br />

<strong>Assessment</strong><br />

coordinator<br />

finalizes ANC<br />

and delivery unit<br />

questionnaires<br />

based on pretests.<br />

10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />

<strong>The</strong> following contains worksheets to assist <strong>the</strong> supervisor during <strong>the</strong> start-up phase <strong>of</strong> <strong>the</strong><br />

assessment. <strong>The</strong>se sheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />

likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> list will need to be<br />

modified accordingly.<br />

Explain <strong>the</strong> purpose <strong>of</strong> <strong>the</strong> assessment to <strong>the</strong> “community,” through direct communication<br />

where possible, and also through <strong>the</strong> display <strong>of</strong> malaria posters in <strong>the</strong> clinic, and any o<strong>the</strong>r<br />

communication means.<br />

Set up <strong>the</strong> supply management system:<br />

• Verify that all supplies on <strong>the</strong> list are available.<br />

• Provide <strong>the</strong> delivery unit, antenatal clinic unit, and <strong>the</strong> lab each with a set <strong>of</strong> supplies<br />

(papers, laboratory materials, examination materials, antimalarial drugs and hematinics)<br />

to last at least one week.<br />

• If supply shortages (batteries, slides, etc.) are noticed, find a solution to continue <strong>the</strong><br />

assessment uninterrupted.<br />

• Keep spare supplies in a safe place, preferably a locked cupboard or box.<br />

• Keep <strong>the</strong> record <strong>of</strong> available stocks.<br />

Have planning meeting with <strong>the</strong> assessment team:<br />

• Make sure every person understands what is expected <strong>of</strong> him/her.<br />

• Draw up a time and duty schedule for each team member, aiming for 8 hrs/day antenatal<br />

clinic presence, and 24 hrs/day delivery room presence.<br />

• Rehearse every team member’s interviewer number, and go over <strong>the</strong> patient number<br />

system once more.<br />

Also:<br />

• Instruct <strong>the</strong> night staff <strong>of</strong> <strong>the</strong> delivery room to routinely store ALL placentas for <strong>the</strong><br />

assessment in individually marked plastic bags in <strong>the</strong> ice box if no assessment team<br />

member happens to be present<br />

• Assign responsibility for <strong>the</strong> ice box and for replacing <strong>the</strong> ice packs to an assessment<br />

team member<br />

• Arrange additional laboratory support, if needed<br />

• Identify possible translators for local languages among <strong>the</strong> hospital staff. Where<br />

possible, make <strong>the</strong>m familiar with <strong>the</strong> questionnaire beforehand.<br />

Module 2: Delivery Unit Survey<br />

11


Set up instruments:<br />

• Set up measuring tape, scales and Ballard chart in <strong>the</strong> delivery room<br />

• Set up Hemocue instructions in <strong>the</strong> antenatal clinic room, if using Hemocue. Set up <strong>the</strong><br />

Hemocue and calibrate. Recalibrate daily.<br />

• Find a safe and stable place for <strong>the</strong> infant weighing scale. Make sure that it is never lifted<br />

by <strong>the</strong> cradle, as this will damage it.<br />

• Keep instrument instructions in a safe place for future reference.<br />

Set up data management system:<br />

• Provide staff with enough information sheets (or consent forms, if used) and<br />

questionnaires for at least one week.<br />

• Make <strong>the</strong> arrangements for daily review <strong>of</strong> assessment results by <strong>the</strong> supervisor toge<strong>the</strong>r<br />

with <strong>the</strong> antenatal clinic and delivery unit staff.<br />

• Make arrangements for daily storing <strong>of</strong> papers and slides (and filter papers and test<br />

tubes, if being used).<br />

• Make arrangements for weekly storing <strong>of</strong> papers and slides (and filter papers and test<br />

tubes, if being used).<br />

• Go through <strong>the</strong> data management system with <strong>the</strong> team members.<br />

Set up assessment logs:<br />

• Antenatal clinic logbook, delivery unit logbook, laboratory logbooks<br />

(one for malaria, one for anemia)<br />

12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


H. Supervisor’s Guide to Conducting Antenatal Clinic<br />

and Delivery Unit Surveys<br />

<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in noting <strong>the</strong> progress <strong>of</strong> <strong>the</strong><br />

survey, reminding <strong>the</strong> supervisor <strong>of</strong> important tasks (e.g., calibrating <strong>the</strong> Hemocue machine<br />

daily), and guiding <strong>the</strong> supervisor in reviewing questionnaires.<br />

<strong>The</strong>se worksheets should be filled out on a regular basis, as determined by <strong>the</strong> supervisor.<br />

Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most likely<br />

both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms can be modified<br />

accordingly.<br />

Site: ______________________________<br />

Date: ___ ___ / ___ ___ / ___ ___<br />

1. Enrollment and rates <strong>of</strong> positivity<br />

Antenatal clinic enrolled to date (No): ___________ Number positive: __________<br />

Last antenatal clinic ID number used: ___ ___ - ___ ___ ___<br />

Delivery enrolled to date (No):___________<br />

Number positive (Placental): __________<br />

Number positive (Maternal): __________<br />

Number positive (Cord): __________<br />

Last delivery ID number used: ___ ___ - ___ ___ ___<br />

2. Staff, supplies and samples<br />

Have any staff left <strong>the</strong> assessment?<br />

Are all nights on <strong>the</strong> delivery unit being covered by <strong>the</strong> assessment team? ______<br />

If this is not possible, are sufficient coolers (with icepacks) available for placental storage? ____<br />

____________________________________________________________________________________________________________<br />

Using <strong>the</strong> supply list above, note if supplies are adequate.<br />

YES =1 NO = 2<br />

Any o<strong>the</strong>r missing supplies: ______________________________________<br />

If any supplies are needed, what is <strong>the</strong> plan for restocking? _________________________________________<br />

____________________________________________________________________________________________________________<br />

Are questionnaires and samples well organized and in a safe place?_______________________________<br />

____________________________________________________________________________________________________________<br />

If not, plan to improve situation:_______________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Samples and questionnaires taken to central location:<br />

Module 2: Delivery Unit Survey<br />

13


ANC:<br />

Questionnaire numbers<br />

Slide numbers:<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

Delivery<br />

Questionnaire numbers<br />

Slide numbers (M,P,C):<br />

Tissue sample numbers, if collected:<br />

Filter paper numbers (M,P), if collected:<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />

3. Antenatal Care<br />

Is <strong>the</strong> Hemocue machine being calibrated daily?______________________________________________________<br />

____________________________________________________________________________________________________________<br />

Check calibration today: ________________________________________________________________________________<br />

Examine <strong>the</strong> logbooks. Are <strong>the</strong>y being filled out correctly? __________________________________________<br />

(Note: Enrollment logbooks should contain all patients, whe<strong>the</strong>r or not enrolled in<br />

assessment]<br />

Note any problems with logbooks:_____________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> plan to correct any problems with logbooks? ___________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />

If it is too high or too low, examine reasons, and make a plan for correction:______________________<br />

____________________________________________________________________________________________________________<br />

Are enrollments evenly spaced throughout <strong>the</strong> day (i.e., not all in <strong>the</strong> a.m. or p.m.)? _____________<br />

Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />

discuss with that person. Pay particular attention to whe<strong>the</strong>r hemoglobin, temperature, and<br />

blood smear results are completed.<br />

Note any important problems and what measures were taken to fix <strong>the</strong>m:<br />

Are women with anemia receiving iron or iron/folate? ________<br />

If not, why not? ______________________________________________________________________<br />

Are women with positive blood smears receiving treatment for malaria?__________________________<br />

If not, why not?__________________________________________________________________________________________<br />

If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />

country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed?__________<br />

____________________________________________________________________________________________________________<br />

14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


4. Delivery Unit<br />

Examine logbooks. Are <strong>the</strong>y being filled out correctly? ______________________________________________<br />

(Note: Enrollment logbook should contain all deliveries, whe<strong>the</strong>r or not enrolled in<br />

assessment)<br />

Note any problems with logbook: ______________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

What is <strong>the</strong> plan to correct any problems with <strong>the</strong> logbook: ________________________________________<br />

___________________________________________________________________________<br />

What is <strong>the</strong> average enrollment per day? (look at last 10 days): __________<br />

If it seems very low, examine reasons, and make a plan for correction:<br />

___________________________________________________________________________<br />

___________________________________________________________________________<br />

Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />

discuss with that person. Pay particular attention to ensure that <strong>the</strong> following are completed:<br />

height, arm circumference, baby weight, Ballard gestational age, blood smear results and<br />

treatment.<br />

Note any specific problems and what measures were taken to fix <strong>the</strong>m:___________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Is <strong>the</strong> baby’s sex being documented on <strong>the</strong> Delivery Unit questionnaire ?__________________________<br />

Are women with positive blood smears receiving treatment for malaria?__________________________<br />

If not, why not?__________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />

country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed?__________<br />

____________________________________________________________________________________________________________<br />

Are sample sets complete for each delivery patient (that is, do <strong>the</strong>y contain a questionnaire, 3<br />

slides (M, P, C), and, if collected, 2 filter papers (M, P), and a tissue sample? ______________________<br />

____________________________________________________________________________________________________________<br />

If not, why not? __________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

Module 2: Delivery Unit Survey<br />

15


5. Laboratory<br />

Examine <strong>the</strong> results books. Are <strong>the</strong> books being completed correctly?_____________________________<br />

If problems are found, document here, and make a plan for correction: ___________________________<br />

____________________________________________________________________________________________________________<br />

Are <strong>the</strong> results for mo<strong>the</strong>rs from antenatal clinic with fever, and mo<strong>the</strong>rs and babies from<br />

delivery, being given promptly to assessment team? _________________________________________________<br />

____________________________________________________________________________________________________________<br />

If not, what steps can be taken to improve <strong>the</strong> speed <strong>of</strong> obtaining results? ________________________<br />

____________________________________________________________________________________________________________<br />

Reread 10% <strong>of</strong> <strong>the</strong> slides <strong>of</strong> each type (ANC, Delivery M, Delivery P, Delivery C).<br />

Rate <strong>the</strong> accuracy <strong>of</strong> slides:<br />

Thick: (1 to 5, 5 is highly accurate):_______________<br />

Thin: (1 to 5, 5 is highly accurate): _______________<br />

If quality is poor, examine reasons (e.g., smears badly done, thick specimen is fixed, or stain<br />

coloration is bad), and try to find a solution to <strong>the</strong> problem: ________________________________________<br />

____________________________________________________________________________________________________________<br />

Are slides being stored in a good manner (in slide boxes or, if slide boxes cannot be obtained,<br />

rolled in tissue paper)?: ________________________________________________________________________________<br />

If not, plan for correction: ______________________________________________________________________________<br />

Does <strong>the</strong> laboratory have adequate supplies?_________________________________________________________<br />

If not, plan to correct <strong>the</strong> problem: ____________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

7. Data Entry<br />

Review at least 5 questionnaires that have been entered in <strong>the</strong> computer.<br />

Number <strong>of</strong> errors found in 5 ANC: _____________________________________________________________________<br />

Number <strong>of</strong> errors found in 5 Delivery:_________________________________________________________________<br />

Is <strong>the</strong> record number being written at <strong>the</strong> top <strong>of</strong> each questionnaire on each page? ______________<br />

O<strong>the</strong>r comments, observations or problems not mentioned above_________________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

____________________________________________________________________________________________________________<br />

16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


I. Supervisor’s Guide to Data Management for Antenatal Clinic<br />

and Delivery Unit Surveys<br />

<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in managing and collecting<br />

data. Worksheets outline tasks for assessment team members, as well as <strong>the</strong> supervisor.<br />

Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />

likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms will need to be<br />

modified accordingly.<br />

Enrollment targets:<br />

• List for each site:<br />

Desired # <strong>of</strong> antenatal clinic visits: at least x/day<br />

Desired # <strong>of</strong> deliveries:<br />

at least x/day<br />

Target data collection period:<br />

• ANC<br />

• Deliveries<br />

Assigning an ID number:<br />

List months during which to collect <strong>the</strong>se data<br />

List months during which to collect <strong>the</strong>se data<br />

1st digit: assessment site<br />

Site #1 1<br />

Site #2 2<br />

Site #3 3<br />

Site #4 4<br />

2nd digit: type <strong>of</strong> health service<br />

ANC<br />

Delivery<br />

A<br />

D<br />

3rd – 5th digit: consecutive number identifying each patient<br />

Example: 35th antenatal clinic woman in Site#3 = 3A – 035<br />

46th delivery in Site#1 = 1D – 046<br />

Note: If <strong>the</strong> woman has been assigned an ID number but enrollment has to be abandoned for<br />

whatever reason, file all related papers and test results, and assign <strong>the</strong> next woman <strong>the</strong> next<br />

number. ID numbers should only be used once. All ID numbers should be accounted for at <strong>the</strong><br />

final data analysis.<br />

• All data must be entered in computer<br />

• All data items must be returned to designated location for re-entering into computer (for<br />

double data entry) and quality control <strong>of</strong> slide readings<br />

Mark ID NUMBERS on each item and each page!!<br />

Module 2: Delivery Unit Survey<br />

17


Assigning an interviewer number:<br />

<strong>The</strong> supervisor should assign each interviewer a unique number to be used throughout<br />

assessment.<br />

For example:<br />

Site #1 01 – 20<br />

Site #2 21 – 40<br />

Site #3 41 – 60<br />

Site #4 61 – 80<br />

Hints to provide interviewers for filling out questionnaires:<br />

• Keep all pages <strong>of</strong> <strong>the</strong> consent forms (if used) and <strong>of</strong> <strong>the</strong> questionnaires stapled toge<strong>the</strong>r<br />

• Number all pages immediately with <strong>the</strong> ID number<br />

• Write clearly<br />

•………….. is a connecting line<br />

•________ is a line to write on<br />

• Feel free to make notes in <strong>the</strong> margin <strong>of</strong> <strong>the</strong> questionnaire form if <strong>the</strong> answer you<br />

got was not very clear or if you have doubts. <strong>The</strong> more information <strong>the</strong> better.<br />

• If it states “check all that apply,” please do not enter dashes for negative. Just leave<br />

those spaces blank. O<strong>the</strong>rwise it may confuse <strong>the</strong> data entry.<br />

• Make sure to get <strong>the</strong> right information in <strong>the</strong> right places: Some information comes<br />

from asking <strong>the</strong> woman, some from <strong>the</strong> antenatal clinic card, and some from <strong>the</strong><br />

examination done for <strong>the</strong> assessment.<br />

Completed consent forms (if used), questionnaires, slides, filter papers (if used), placenta<br />

tubes (if used), and logbooks should be guarded very carefully: Any missing or<br />

mislabeled items will compromise <strong>the</strong> final interpretation <strong>of</strong> <strong>the</strong> assessment.<br />

Antenatal Clinic Survey<br />

Each antenatal clinic enrollment will have at least 2 loose pieces <strong>of</strong> information<br />

• Signed consent form, if used<br />

• Completed questionnaire (…pages)<br />

• 1 blood slide (thick and thin)<br />

Data management tasks <strong>of</strong> antenatal clinic staff:<br />

Each enrollment:<br />

• Mark patient number clearly on each item and each page<br />

• Mark patient number clearly on blood slide result from <strong>the</strong> lab<br />

Before woman leaves:<br />

• Verify that questionnaire is completed, and iron/folate given as indicated<br />

• If woman is febrile or had a fever recently: Ensure that lab results are returned as soon as<br />

possible and treat <strong>the</strong> woman with appropriate antimalarial drug as per national policy<br />

before she leaves <strong>the</strong> clinic that day (Monica has a question here) if <strong>the</strong> slide was positive<br />

During <strong>the</strong> day:<br />

• Obtain lab results from all o<strong>the</strong>r women and if any were positive, prepare for treatment<br />

when <strong>the</strong> woman returns that afternoon or <strong>the</strong> next day<br />

18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Data management tasks <strong>of</strong> supervisor:<br />

At <strong>the</strong> end <strong>of</strong> each day:<br />

• Keep antenatal clinic log <strong>of</strong> enrollment and refusals up to date<br />

• Collect and review for completeness all data items<br />

• File all forms toge<strong>the</strong>r each day<br />

Each week:<br />

• Store all papers chronologically by assessment number<br />

• Store all slides chronologically by assessment number<br />

• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />

• Put all items aside in a safe place<br />

Delivery Unit Survey<br />

Each delivery will have at least 4 and as many as 8 loose pieces <strong>of</strong> information<br />

• Signed consent form, if used<br />

• completed questionnaire (…pages)<br />

• 3 blood slides:<br />

• Mo<strong>the</strong>r (thick and thin)<br />

• Placenta (thick and thin)<br />

• Cord (thick and thin)<br />

• 2 filter papers:, if used:<br />

• Mo<strong>the</strong>r<br />

• Placenta<br />

• Placenta tissue in tube, if used:<br />

Data management tasks <strong>of</strong> delivery unit staff:<br />

Each enrollment:<br />

• Mark patient number clearly on each item and each page<br />

• Mark M or P or C clearly on blood slides and filter papers, if used<br />

• Mark patient number + M or P or C in <strong>the</strong> laboratory logbook<br />

Before woman leaves:<br />

• Verify that questionnaire is completed<br />

• Verify that M and C slide results are back from laboratory, and treat her if positive<br />

Data management tasks <strong>of</strong> supervisor:<br />

At <strong>the</strong> end <strong>of</strong> each day:<br />

• Keep delivery log <strong>of</strong> enrollment and refusals up to date<br />

• Collect and review all data items for completeness<br />

• File all forms toge<strong>the</strong>r each day<br />

Each week:<br />

• Store all papers chronologically by assessment number<br />

• Store all slides chronologically by assessment number<br />

• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />

• Put all items aside in a safe place<br />

Module 2: Delivery Unit Survey<br />

19


J. Sample Logbooks: Enrollment and Laboratory<br />

• Enrollment logbook: Records a list, by facility, <strong>of</strong> <strong>the</strong> pregnant women visiting <strong>the</strong> site<br />

each day <strong>of</strong> <strong>the</strong> survey, her survey number, and whe<strong>the</strong>r or not she was enrolled (and if<br />

not, why not).<br />

• Laboratory logbooks: One records information about enrolled women’s malaria blood<br />

films, and <strong>the</strong> o<strong>the</strong>r records information about enrolled women’s hemoglobin or<br />

hematocrit, by facility.<br />

During <strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for ensuring that<br />

each site has prepared enrollment and laboratory logbooks. During <strong>the</strong> assessment, site<br />

supervisors are responsible for monitoring <strong>the</strong> use <strong>of</strong> <strong>the</strong> logbooks and preparing additional<br />

books as necessary.<br />

<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> - Enrollment Delivery Unit Logbook<br />

Facility: __________________________________________________________________________________________________<br />

District/Region:________________________________________________________________________________________<br />

Date<br />

Woman’s<br />

DU<br />

number<br />

Name <strong>of</strong><br />

Woman<br />

Age G/P* Mo<strong>the</strong>r<br />

tongue<br />

Enrolled?<br />

Yes/No<br />

Woman’s<br />

ID number<br />

Comments**<br />

*Gravidity/parity<br />

**It may be helpful to make a list <strong>of</strong> reasons for nonenrollment, along with a code number for<br />

each reason, and place it on <strong>the</strong> face page <strong>of</strong> <strong>the</strong> logbook. For example, if <strong>the</strong> first reason on<br />

<strong>the</strong> list was “woman refused to participate” and <strong>the</strong> code for that reason was “1,” “1” could be<br />

written in <strong>the</strong> comments column above.<br />

<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> –<br />

Laboratory Delivery Unit Logbook for <strong>Malaria</strong><br />

Facility: __________________________________________________________________________________________________<br />

District/Region:________________________________________________________________________________________<br />

Date<br />

Woman’s<br />

ID number<br />

Blood<br />

smear<br />

+/-<br />

Maternal:<br />

Placenta:<br />

Cord:<br />

M:<br />

P:<br />

C:<br />

Species*<br />

Density (only<br />

for maternal<br />

sample)<br />

*Some settings may need a column for malaria species.<br />

Pigment<br />

Comments<br />

20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


K. Handbook for <strong>Assessment</strong> Teams<br />

Each member <strong>of</strong> <strong>the</strong> assessment team should receive a handbook during assessment training.<br />

<strong>The</strong> handbook briefly describes <strong>the</strong> enrollment procedure and postenrollment activities,<br />

including <strong>the</strong> questionnaire, measurements and laboratory specimens, medications, and<br />

follow-up activities.<br />

Note: <strong>The</strong> team member’s handbook has space for including <strong>the</strong> number <strong>of</strong> women to be<br />

enrolled each day.<br />

Throughout woman’s stay at delivery unit: Follow normal procedures to ensure safety<br />

<strong>of</strong> mo<strong>the</strong>r and baby. Ensure proper medical care.<br />

Ensure that ei<strong>the</strong>r an interviewer is available 24 hours/day in <strong>the</strong> delivery unit to enroll<br />

all women and process placentas OR that an ice pack and cooler is available for storage<br />

and <strong>the</strong> interviewer arriving in <strong>the</strong> morning can retrospectively enroll women who<br />

arrived during <strong>the</strong> night.<br />

Procedures<br />

Enrollment<br />

1. Identify eligible women.<br />

• Confirm information with woman<br />

Note: Enroll all women at delivery, even<br />

those who may have participated in <strong>the</strong><br />

ANC survey.<br />

Comments<br />

All deliveries<br />

Mo<strong>the</strong>rs at least 15 years old<br />

(or minimum age limit)<br />

Note: Record for all women attending delivery<br />

unit in <strong>the</strong> enrollment logbook:<br />

Date<br />

Woman’s delivery unit number<br />

Name<br />

Age<br />

Gravidity/parity<br />

Mo<strong>the</strong>r tongue<br />

Whe<strong>the</strong>r or not enrolled<br />

Woman’s ID number<br />

Reasons for no enrollment:<br />

• Refused to participate, placenta not available,<br />

left delivery unit without being enrolled, less<br />

than minimum age.<br />

2. Verify criteria. Exclusion criteria:<br />

• Allergic to antimalarial drugs being used or<br />

related drugs<br />

• Age


Postenrollment<br />

Mo<strong>the</strong>r<br />

4. Complete <strong>the</strong> questionnaire, collecting<br />

information on <strong>the</strong> current pregnancy.<br />

Note: Peripheral blood samples are taken<br />

before and after delivery. Parasitemia<br />

<strong>of</strong>ten clears quickly after delivery.<br />

Baby<br />

5. Examine <strong>the</strong> baby within 24 hours <strong>of</strong><br />

delivery.<br />

Note: Nonlive births should be enrolled, if<br />

feasible and culturally appropriate.<br />

• Administer questionnaire.<br />

• Mark <strong>the</strong> thick film slide with <strong>the</strong> date, woman’s<br />

enrollment number, and <strong>the</strong> letter “M” to<br />

indicate that slide is mo<strong>the</strong>r’s peripheral blood<br />

film.<br />

• Take mo<strong>the</strong>r’s height and midupper arm circumference<br />

If live birth:<br />

• Determine sex<br />

• Weigh (in grams)<br />

• Assign a Ballard score (see directions later in<br />

this module)<br />

• Determine gestation age in weeks<br />

• Note any physical abnormalities<br />

If nonlive birth:<br />

• Take placental and umbilical cord samples<br />

• Weigh<br />

• Record probable cause <strong>of</strong> death<br />

Placenta<br />

6. Take placenta samples<br />

(see directions later in this module)<br />

7. Give treatment to <strong>the</strong> mo<strong>the</strong>r if she has<br />

a positive peripheral blood film and<br />

to <strong>the</strong> baby if <strong>the</strong> baby has a positive<br />

umbilical cord film.<br />

Note re: night-time deliveries: Ideally, interviewers<br />

will be available 24 hours/day to enroll<br />

women who deliver at night and to promptly<br />

process placentas. If not, ensure that ice packs<br />

and coolers are available for placenta storage.<br />

Mark two separate slides with <strong>the</strong> following<br />

information:<br />

• Mark <strong>the</strong> placental thick film slide with <strong>the</strong><br />

date, woman’s enrollment number, and <strong>the</strong> letter<br />

“P” to indicate that this slide is <strong>the</strong> mo<strong>the</strong>r’s<br />

placental film.<br />

• Mark <strong>the</strong> umbilical cord thick film slide with<br />

<strong>the</strong> date, woman’s enrollment number, and <strong>the</strong><br />

letter “C” to indicate slide as cord film.<br />

• Provide treatment according to <strong>the</strong><br />

country policy<br />

• A thin blood film may be required in areas with high prevalence <strong>of</strong> mixed or pure non—P.<br />

falciparum species.<br />

22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


L. Guide for Night-Time Admissions to <strong>the</strong> Delivery Unit<br />

Ideally, interviewers will be available 24 hours per day to enroll women who deliver at<br />

night and to promptly process placentas, but this is not always possible. Coolers (with<br />

ice packs) should be available for storing placentas.<br />

<strong>The</strong> following describes how to handle enrollment and placenta samples for women<br />

who are admitted during <strong>the</strong> night if no interviewer is present.<br />

At night if no team member is present:<br />

•Store all placentas in individual bags in <strong>the</strong> cooler (outfitted with ice packs). Mark patient<br />

name and hospital registration number on <strong>the</strong> bag.<br />

• Enter patient data in <strong>the</strong> hospital’s delivery ward admissions book.<br />

• Encourage women to stay in <strong>the</strong> hospital until <strong>the</strong> assessment team arrives in <strong>the</strong> morning.<br />

In <strong>the</strong> morning on arrival <strong>of</strong> <strong>the</strong> assessment team member:<br />

• Check hospital’s delivery ward admissions book for deliveries, copy into assessment log.<br />

• Check placenta box to see if all are <strong>the</strong>re.<br />

• See if mo<strong>the</strong>rs and newborns are still on <strong>the</strong> ward.<br />

• Enroll patients for whom placentas are available. Do questionnaire, obtain Mo<strong>the</strong>r’s thick<br />

and thin blood smear and examine mo<strong>the</strong>r and child. Encourage mo<strong>the</strong>r to wait for slide<br />

results from <strong>the</strong> laboratory. Submit M slide with priority to <strong>the</strong> laboratory.<br />

• Once all questionnaires and clinical examinations are done, take <strong>the</strong> placenta samples.<br />

Batch placenta testing toge<strong>the</strong>r, submit C slide with priority to <strong>the</strong> laboratory.<br />

• Get lab results back and treat mo<strong>the</strong>r and newborn if slides were positive.<br />

Note: Leave <strong>the</strong> placenta tests for after you have finished with <strong>the</strong> mo<strong>the</strong>r and baby.<br />

<strong>The</strong> placentas will stay in <strong>the</strong> ice box, but <strong>the</strong> mo<strong>the</strong>r might o<strong>the</strong>rwise leave <strong>the</strong> hospital.<br />

Module 2: Delivery Unit Survey<br />

23


M. Ballard Score Sheet for Determining Gestational Age<br />

<strong>The</strong> Ballard score sheet can be used to determine gestational age. A video that<br />

describes <strong>the</strong> Ballard method is included on <strong>the</strong> accompanying CD-ROM, with <strong>the</strong> kind<br />

permission <strong>of</strong> Dr. Jeanne Ballard.<br />

Some researchers have proposed a modification <strong>of</strong> <strong>the</strong> Ballard examination in<br />

which only <strong>the</strong> external criteria are evaluated and <strong>the</strong> neurologic examination is not<br />

performed [Verhoeff FH, Milligan P, Brabin BJ, Mlanga S, Nakoma N. 1997. Gestational<br />

age assessment by nurses in a developing country using <strong>the</strong> Ballard method, external<br />

criteria only. Annals <strong>of</strong> Tropical Paediatrics, 1997. 17: 333-342]. <strong>The</strong> resulting score is<br />

<strong>the</strong>n doubled to arrive at a total Ballard score with which an estimated gestational age<br />

may be correlated. This modification can be useful for stillbirths. While <strong>the</strong> results<br />

from <strong>the</strong>se researchers suggest that <strong>the</strong> approach compares favorably with o<strong>the</strong>r<br />

approaches for estimating gestational age, <strong>the</strong>re is less experience with <strong>the</strong> Ballard<br />

external-only method than <strong>the</strong>re is with <strong>the</strong> standard Ballard examination.<br />

Note: If several or many interviewers are working on <strong>the</strong> rapid assessment in one<br />

site, <strong>the</strong> Ballard score results should be assessed by a smaller subset <strong>of</strong> interviewers.<br />

This would help improve consistency <strong>of</strong> <strong>the</strong> results by reducing <strong>the</strong> possibility <strong>of</strong><br />

interpersonal differences. In addition, those who are assigned <strong>the</strong> responsibility <strong>of</strong><br />

determining gestational age will gain substantial experience. <strong>The</strong> supervisor should<br />

check to make sure that age is being assessed consistently.<br />

24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Physical Maturity<br />

Skin<br />

Sticky, friable,<br />

transparent<br />

Gelatinous,<br />

red,<br />

translucent<br />

Smooth,<br />

pink;<br />

visible<br />

veins<br />

Superficial<br />

peeling and/<br />

or rash; few<br />

veins<br />

Cracking,<br />

pale<br />

areas; rare<br />

veins<br />

Parchment,<br />

deep<br />

cracking; no<br />

vessels<br />

Lanugo None Sparse Abundant Thinning Bald areas Mostly bald<br />

Plantar<br />

surface<br />

Heel-toe<br />

40-50 mm:-1<br />

50 mm;<br />

no crease<br />

Breast Imperceptible Barely<br />

perceptible<br />

Eye/Ear<br />

Genitals<br />

(male)<br />

Genitals<br />

(female)<br />

Lids fused<br />

loosely: -1<br />

Tightly: -2<br />

Scrotum flat,<br />

smooth<br />

Clitoris<br />

prominent,<br />

labia flat<br />

Lids open;<br />

pinna<br />

flat: stays<br />

folded<br />

Scrotum<br />

empty, faint<br />

rugae<br />

Clitoris<br />

prominent,<br />

small labia<br />

minora<br />

Faint red<br />

marks<br />

Flat areola,<br />

no bud<br />

Slightly<br />

curved<br />

pinna: s<strong>of</strong>t;<br />

slow recoil<br />

Testes<br />

in upper<br />

canal, rare<br />

rugae<br />

Clitoris<br />

prominent,<br />

enlarging<br />

minora<br />

Anterior<br />

transverse<br />

crease only<br />

Stippled<br />

areola, 1-2<br />

mm bud<br />

Well-curved<br />

pinna: s<strong>of</strong>t but<br />

ready recoil<br />

Testes<br />

descending,<br />

few rugae<br />

Majora and<br />

minora equally<br />

prominent<br />

Creases<br />

anterior<br />

2/3<br />

Raised<br />

areola, 3-4<br />

mm bud<br />

Formed<br />

and firm,<br />

instant<br />

recoil<br />

Testes<br />

down,<br />

good<br />

rugae<br />

Majora<br />

large,<br />

minora<br />

small<br />

Creases<br />

over entire<br />

sole<br />

Full areola,<br />

5-10 mm<br />

bud<br />

Thick<br />

cartilage, ear<br />

stiff<br />

Testes<br />

pendulous,<br />

deep rugae<br />

Majora cover<br />

clitoris and<br />

minora<br />

Lea<strong>the</strong>ry,<br />

cracked,<br />

wrinkled<br />

Score<br />

Maturity<br />

Rating<br />

-10 20<br />

-5 22<br />

0 24<br />

5 26<br />

10 28<br />

15 30<br />

20 32<br />

25 34<br />

30 36<br />

35 38<br />

40 40<br />

45 42<br />

50 44<br />

Weeks<br />

Module 2: Delivery Unit Survey<br />

25


N. Blood Test Procedures: Making Thick and Thin Films for <strong>the</strong><br />

Microscopic Diagnosis <strong>of</strong> <strong>Malaria</strong> Infection<br />

<strong>The</strong> following describes how to make thick and thin films for <strong>the</strong> determination <strong>of</strong><br />

malaria infection. If <strong>the</strong>re are a substantial number <strong>of</strong> non–Plasmodium falciparum<br />

infections in <strong>the</strong> area, both thick and thin films should be made. O<strong>the</strong>rwise, thick films<br />

are generally adequate.<br />

Note: <strong>Rapid</strong> tests are available that can detect <strong>the</strong> presence <strong>of</strong> malaria parasites in<br />

peripheral blood. <strong>The</strong>se tests, although expensive, perform well when conducted by<br />

trained personnel. <strong>The</strong>y show decreased sensitivity in persons/settings with low<br />

parasite load. <strong>The</strong>re are currently not enough data to recommend <strong>the</strong> use <strong>of</strong> rapid tests<br />

to detect malaria infection in placental blood.<br />

Organize <strong>the</strong> supplies you need:<br />

lab coat<br />

gloves<br />

cotton<br />

disinfectant swab<br />

2 slides (labeled slide & swipe slide)<br />

lancet<br />

sharps disposal container<br />

hospital waste basket<br />

slide marker<br />

Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />

concentrated, allowing a greater volume <strong>of</strong> blood to be examined. However, thick films are<br />

difficult to read. Thick films are stained unfixed after drying.<br />

Thin films should be used if <strong>the</strong>re are a substantial number <strong>of</strong> non—P. falciparum infections in<br />

<strong>the</strong> area, as thin films make it easier to identify species. <strong>The</strong> thin film should be air-dried, fixed<br />

with methanol, and allowed to dry before staining.<br />

For best results, both thick and thin films should be stained with a 3% Giemsa solution (pH <strong>of</strong><br />

7.2) for 30--45 minutes. A Wright-Giemsa stain can also indicate malaria parasites but does<br />

not demonstrate Schüffner’s dots as reliably as Giemsa.<br />

Plasmodium parasites are always intracellular, and <strong>the</strong>y demonstrate, if stained correctly, blue<br />

cytoplasm with a red chromatin dot. Common errors in reading malaria films are caused by<br />

platelets overlying a red blood cell and <strong>the</strong> misreading <strong>of</strong> artifacts as parasites.<br />

Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />

concentrated, allowing a greater volume <strong>of</strong> blood to be examined. WHO recommends that<br />

at least 100 fields, each containing approximately 20 white blood cells (WBCs), be screened<br />

before calling a thick smear negative.<br />

To quantify malaria parasites against WBCs (i.e., determine parasite density) on <strong>the</strong> thick<br />

smear: Tally <strong>the</strong> parasites against <strong>the</strong> WBCs, until you have counted 500 parasites or 1,000<br />

WBC, whichever comes first. Express <strong>the</strong> results as parasites per microliter <strong>of</strong> blood, using <strong>the</strong><br />

WBC count if known, or o<strong>the</strong>rwise assuming 8,000 WBCs per microliter blood.<br />

26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Parasites/microliter blood = (parasites/WBCs) x WBC count per microliter (or 8,000).<br />

Thin smears are useful for species identification <strong>of</strong> parasites already detected on thick smears.<br />

<strong>The</strong>y are also useful for screening for parasites if adequate thick smear are not available and<br />

as a rapid screen while <strong>the</strong> thick smear is still drying.<br />

To quantify parasites (i.e., determine parasite density) against red blood cells (RBCs) on thin<br />

smear: Count <strong>the</strong> parasitized RBCs among 500-2,000 RBCs on <strong>the</strong> thin smear and express <strong>the</strong><br />

results as % parasitemia.<br />

% parasitemia = (parasitized RBCs/total RBCs) x 100. If <strong>the</strong> parasitemia is high (>10%)<br />

examine 500 RBCs; if it is low (


O. How to Take Blood Samples from a Finger, Placenta,<br />

and Umbilical Cord<br />

Finger Prick:<br />

Organize <strong>the</strong> supplies you will need:<br />

gloves<br />

cotton gauze<br />

2 slides per finger-stick (1 labeled M for maternal peripheral blood and 1 swipe slide)<br />

lancet<br />

sharps disposal container<br />

<strong>The</strong> figure below shows how blood may be obtained by pricking <strong>the</strong> patient’s finger.<br />

* In Figure A-1, <strong>the</strong> hands are illustrated ungloved to better indicate <strong>the</strong>ir placement during <strong>the</strong> procedures. However,<br />

wearing gloves while processing blood specimens is recommended to prevent transmission <strong>of</strong> bloodborne pathogens<br />

(MMWR 1988;37:377--82, 387--8 and MMWR 1987;36[No. S2]).<br />

Placenta and Umbilical Cord:<br />

Organize <strong>the</strong> supplies you need:<br />

gloves<br />

cotton gauze<br />

3 slides per placenta (1 labeled P for placenta, 1 labeled C for cord, and 1 swipe slide)<br />

tweezers<br />

scissors<br />

lancet<br />

sharps disposal container<br />

basin with disinfectant for tweezers, scissors<br />

1. Label all slides with ID number, date, and site obtained (i.e., P or C)<br />

2. Put on gloves<br />

3. Keep placentas in plastic bags whenever possible<br />

4. Wipe cord<br />

5. Use lancet to puncture cord<br />

6. Obtain cord slide by touching from above, make thick and thin film<br />

7. Turn placenta over and find maternal side<br />

8. Wipe <strong>of</strong>f placenta<br />

9. Make placenta thick and thin film<br />

10. Clean up and be careful with sharps<br />

If more than one placenta is done at once: Be careful not to cross-contaminate. Change<br />

gloves and instruments after sampling each placenta.<br />

28 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


P. Making a Placental Impression Smear<br />

Although both impression smears and thick smears require taking blood samples,<br />

impression smears require more manipulation <strong>of</strong> <strong>the</strong> placenta than do thick smears.<br />

Thus, <strong>the</strong> benefit <strong>of</strong> <strong>the</strong> additional information gained from an impression smear needs<br />

to be balanced against <strong>the</strong> potential risk incurred.<br />

Materials and equipment needed to collect <strong>the</strong> sample:<br />

Tray<br />

Blunt-ended scissors<br />

Forceps with blunt tips<br />

Scissors/scalpel knife<br />

Gloves<br />

Marking pen<br />

Absorbent material such as paper towel<br />

Safety cover or transparent disposable plastic face shield to cover <strong>the</strong> face to protect against<br />

any blood splash<br />

Beaker containing 10% bleach<br />

How to make a smear:<br />

1. Label <strong>the</strong> slide with a marking pen, include <strong>the</strong> sample/placenta number and date.<br />

2. Place <strong>the</strong> whole placenta in <strong>the</strong> tray.<br />

3. Open up <strong>the</strong> membranes covering <strong>the</strong> maternal side <strong>of</strong> <strong>the</strong> placenta and move <strong>the</strong>m aside.<br />

4. Holding <strong>the</strong> piece <strong>of</strong> placenta with forceps, cut a small (about 5mm3) piece with scissors<br />

or a scalpel knife.<br />

5. Absorb <strong>the</strong> excess blood with absorbent material.<br />

6. Blot several times on a piece <strong>of</strong> absorbent material.<br />

7. Make 3 to 6 impressions <strong>of</strong> <strong>the</strong> tissue along one long edge <strong>of</strong> <strong>the</strong> slide by gently dabbing<br />

<strong>the</strong> tissue. <strong>The</strong> blood impression should be no thicker than a thin smear.<br />

8. For increased surface area for smear reading, make smears along <strong>the</strong> o<strong>the</strong>r long edge <strong>of</strong><br />

<strong>the</strong> slide using short, diagonal strokes.<br />

9. Place <strong>the</strong> forceps and scissors/scalpel knife in <strong>the</strong> beaker containing 10% bleach.<br />

10. Allow <strong>the</strong> slide to dry.<br />

11. Process as for thin blood smears.<br />

For an impression smear, <strong>the</strong> level <strong>of</strong> infection should be reported as percent parasitemia<br />

ra<strong>the</strong>r than number <strong>of</strong> parasites/ul <strong>of</strong> blood.<br />

Module 2: Delivery Unit Survey<br />

29


Q. Delivery Unit Survey Information Sheet 2<br />

<strong>The</strong> following information sheet should be given to each potential survey participant.<br />

If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong> information<br />

should be read aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong><br />

information sheet to take home.<br />

Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or has low literacy<br />

skills, read this information aloud to her. Give all potential participants a copy <strong>of</strong> this<br />

information sheet to take home.<br />

Introduction<br />

<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />

[assessment area] have malaria. This will help us find <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong><br />

malaria on pregnant women and <strong>the</strong>ir babies. As you know, sometimes you may get malaria<br />

and feel sick. What you may not know is that sometimes you may have malaria without feeling<br />

sick. When you are pregnant and you have malaria, <strong>the</strong> baby can be born small and weak, even<br />

if you have not felt sick. <strong>The</strong> only way for us to know how many women may have this problem<br />

is to check blood from <strong>the</strong> placenta (afterbirth) after <strong>the</strong> woman gives birth. We plan to assess<br />

this problem in about ________ women in <strong>the</strong> [assessment area].<br />

Purpose <strong>of</strong> <strong>the</strong> Survey<br />

We plan to check blood from <strong>the</strong> placenta for malaria to know how many women in <strong>the</strong><br />

[assessment area] are infected. This will help us plan and measure <strong>the</strong> effects <strong>of</strong> programs<br />

to decrease malaria in pregnant women.<br />

Procedures<br />

If you agree to be in this assessment, we will ask you some questions about yourself and<br />

your health since you have been pregnant. We will not be telling anyone about your individual<br />

answers to <strong>the</strong> questions, and we will keep all assessment information about you safe and<br />

secure. You also do not need to answer any questions on <strong>the</strong> survey forms that you do not<br />

want to. We will review your clinic card. You will be measured for height and have a<br />

measurement done <strong>of</strong> <strong>the</strong> width <strong>of</strong> your arm. Before you have <strong>the</strong> baby, we will take a few<br />

drops <strong>of</strong> blood from a finger stick to check your blood for malaria. After you give birth, we<br />

will weigh and examine your baby. We will also take ano<strong>the</strong>r finger stick to look for malaria,<br />

and we’ll also be looking for malaria in <strong>the</strong> placenta and in <strong>the</strong> cord that goes to <strong>the</strong> baby after<br />

you have <strong>the</strong> baby.<br />

2 It is very important that <strong>the</strong> country’s human subjects or ethics requirements be followed with regard to<br />

provision <strong>of</strong> information and documentation <strong>of</strong> participant’s consent.<br />

30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


[Note: <strong>The</strong> two paragraphs that follow have been used in assessments in areas <strong>of</strong> high<br />

transmission; <strong>the</strong>y should be adapted to reflect policy and practice in <strong>the</strong> country where <strong>the</strong><br />

assessment is being conducted. ] If we find malaria in your blood before you give birth, we will<br />

treat you with _____________ (enter appropriate drug name).<br />

We rarely find malaria in <strong>the</strong> cord that goes to <strong>the</strong> baby but, if we do, we will treat <strong>the</strong> baby<br />

with____________ (enter appropriate drug name).<br />

If you join <strong>the</strong> assessment, it will probably take about x number <strong>of</strong> minutes more than if you<br />

didn’t join <strong>the</strong> assessment. How much extra time will depend on if we find malaria in your<br />

blood or <strong>the</strong> cord that goes to your baby.<br />

If you do not wish to join in <strong>the</strong> assessment, you and your baby will still get <strong>the</strong> best possible<br />

care from <strong>the</strong> hospital. If you join <strong>the</strong> assessment, but <strong>the</strong>n decide you don't want to be in <strong>the</strong><br />

assessment, you can withdraw yourself from <strong>the</strong> assessment at any time. This will not affect<br />

<strong>the</strong> health care you get here.<br />

Risks or discomforts<br />

You will feel a “pinch” that lasts for a few seconds when <strong>the</strong> finger stick is done to take blood.<br />

Benefits<br />

You and/or your baby will be treated if you or <strong>the</strong> baby has malaria after birth. <strong>The</strong><br />

information we get from <strong>the</strong> assessment will help us know how best to prevent malaria in<br />

pregnant women in this [assessment area].<br />

Treatment<br />

_________ (enter appropriate drug name) works well to treat malaria and has been used safely to<br />

treat malaria in adults and in children. If you or <strong>the</strong> baby has any side effect which you think<br />

might be due to _________ (enter appropriate drug name), please come back to <strong>the</strong> hospital right<br />

away to be checked and treated by one <strong>of</strong> <strong>the</strong> doctors.<br />

If you join <strong>the</strong> assessment and have questions later, please feel free to ask. You can ask me<br />

today or if you have questions later, you can ask _________________ (responsible assessment team<br />

member).<br />

Thank you very much for your time. Would you like to join in <strong>the</strong> assessment?<br />

Please keep this information sheet in case you have questions later.<br />

Module 2: Delivery Unit Survey<br />

31


R. Analysis <strong>of</strong> Delivery Unit Survey Data<br />

Below are outcome variables for <strong>the</strong> Delivery Unit Survey and summary tables <strong>of</strong> survey<br />

results. Fur<strong>the</strong>r data analysis may be helpful, but is not necessary for decision making.<br />

Tables can be useful for showing relationships between outcome variables.<br />

• Table 1 shows how representative <strong>the</strong> women in <strong>the</strong> survey are <strong>of</strong> <strong>the</strong> women in <strong>the</strong><br />

country.<br />

• Table 2 shows women’s reported use <strong>of</strong> prevention and control measures, such as<br />

IPTpp, ITNs, and antimalarial drugs for treatment <strong>of</strong> illness.<br />

• Table 3 focuses on prevalence <strong>of</strong> parasitemia and fever among pregnant women and<br />

low birth weight, and prematurity among <strong>the</strong>ir babies.<br />

• Table 4 looks at <strong>the</strong> relationship between placental and peripheral malaria<br />

parasitemia, low birth weight, and premature delivery.<br />

No. Outcome Variable Numerator/Denominator<br />

1. Women with peripheral<br />

parasitemia<br />

2. Women with placental<br />

parasitemia<br />

Number <strong>of</strong> pregnant women with a positive result <strong>of</strong><br />

peripheral blood film/ Total number <strong>of</strong> pregnant women<br />

with peripheral blood films<br />

Number <strong>of</strong> pregnant women with a positive result <strong>of</strong><br />

placental blood film/ Total number <strong>of</strong> pregnant women<br />

with placental blood film<br />

3. Infants with umbilical cord parasitemia Number <strong>of</strong> infants with positive result <strong>of</strong> umbilical cord<br />

blood film/ Total number <strong>of</strong> infants with umbilical cord<br />

blood film<br />

4. Infants with low birth weight (


Table 1. Characteristics <strong>of</strong> Women in <strong>the</strong> Delivery Unit Survey and Women Country-Wide<br />

Characteristic<br />

Median age in years [range]<br />

Median gravidity [range]<br />

ANC visits, median no. [range]<br />

Able to read<br />

Attended school (any)<br />

Married<br />

Owns own home<br />

Owns moped<br />

Owns bike<br />

Owns radio<br />

Works for cash<br />

Grows cash crops<br />

TOTAL<br />

Women in Delivery<br />

Unit Survey* (n= # )<br />

Women in national<br />

DHS**<br />

*Data are % <strong>of</strong> participants unless o<strong>the</strong>rwise indicated.<br />

**If available, national data (e.g., Demographic and Health Surveys) can be used to compare<br />

how similar women in <strong>the</strong> assessment are to women nationally.<br />

Table 2. Use <strong>of</strong> Prevention and Control Measures by Women in <strong>the</strong> Delivery Unit Survey<br />

Treatment and Prevention Measures<br />

Gestational age at 1st ANC visit<br />

Owns insecticide-treated bed net (ITN)<br />

Uses ITN<br />

Slept under ITN previous night<br />

Used antimalarial drug during pregnancy for prevention (IPTpp)<br />

Used antimalarial drug during pregnancy for treatment <strong>of</strong> malaria<br />

illness<br />

Used <strong>the</strong> correct dose <strong>of</strong> antimalarial drug for treatment<br />

(#sites) (#women)<br />

Module 2: Delivery Unit Survey<br />

33


Table 3. Rates <strong>of</strong> Peripheral and Placental Parasitemia, Reported Fever, Low Birth<br />

Weight, and Prematurity among Delivering Women<br />

Characteristic All women (n= ) Use <strong>of</strong> IPTp or Chemoprophylaxis P<br />

Peripheral parasitemia<br />

Overall<br />

Primigravidae<br />

Secundigravidae<br />

Multigravidae<br />

Placental parasitemia<br />

Overall<br />

Primigravidae<br />

Secundigravidae<br />

Multigravidae<br />

Umbilical cord parasitemia<br />

Fever during pregnancy<br />

Self-reported use <strong>of</strong> an<br />

antimalarial for treatment<br />

during pregnancy<br />

Fever within week before<br />

enrollment<br />

Singleton live-born birth<br />

weight (g) ± SD<br />

Low birth weight (liveborn<br />

singletons


Table 4. Relationship between Placental <strong>Malaria</strong> Parasitemia and Peripheral <strong>Malaria</strong><br />

Parasitemia, Low Birth Weight, and Premature Delivery among Delivering Women<br />

Characteristic<br />

Positive result <strong>of</strong><br />

peripheral blood film<br />

Low birth weight<br />

(


36 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Woman’s full name:<br />

ID #_____A________<br />

Tool 2: Delivery Unit Questionnaire<br />

Today’s date: ______/_______/______<br />

Day/Month/Year<br />

ID number: ___ _1__ -- ___ ___ ___<br />

Digit 1 = facility number Digit 2 = D (for Delivery Unit)<br />

Digits 3, 4 & 5 = woman’s consecutive number<br />

SCREENING QUESTION<br />

Interviewer number _______<br />

1. Age (years): [ ]<br />

If <strong>the</strong> mo<strong>the</strong>r does not know her age, estimate her age using <strong>the</strong> categories below.<br />

less than 15 years [ ] 30-34 years [ ]<br />

15-19 years [ ] 35-39 years [ ]<br />

20-24 years [ ] 40-44 years [ ]<br />

25-29 years [ ] more than 44 years [ ]<br />

If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time and<br />

DO NOT enroll her in this survey.<br />

DEMOGRAPHIC INFORMATION<br />

<br />

2. Village/town: ____________________________________________<br />

Interviewer: Skip <strong>the</strong> next question; it will be coded later so that it is done uniformly.<br />

3. Is this a rural or urban area? [ ]<br />

Urban = 1<br />

Rural = 2<br />

Periurban = 3<br />

Unknown = 9<br />

4. What language do you usually speak with family members at home? [ ]<br />

Language a = 1<br />

Language b = 2<br />

Language c = 3<br />

O<strong>the</strong>r = 8 (specify) ______________________________________<br />

5. Are you married? [ ]<br />

yes, married and living with husband = 1<br />

yes, married but do not live with husband = 2<br />

not married but living with a man = 3<br />

separated or divorced = 4<br />

widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 5<br />

never married or lived with a man = 6<br />

Tool 2: Delivery Unit Questionnaire<br />

1


EDUCATION<br />

6. What is <strong>the</strong> highest level <strong>of</strong> school that you attended?..[ ]<br />

Primary = 1<br />

Secondary = 2<br />

Higher = 3<br />

Never attended = 4<br />

Unknown = 9<br />

7. Can you read [ ]<br />

YES = 1 NO = 2<br />

SOCIOECONOMIC INDICATORS<br />

8. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />

corrugated iron = 1<br />

cement or concrete = 2<br />

wood and mud = 3<br />

thatch or grass = 4<br />

reed or bamboo = 5<br />

plastic sheet = 6<br />

mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />

o<strong>the</strong>r = 8 (specify) __________________________________<br />

9. What kind <strong>of</strong> floor does your house have? [ ]<br />

earth or sand = 1<br />

dung = 2<br />

wood planks = 3<br />

reed or bamboo = 4<br />

vinyl tiles or carpet = 5<br />

cement = 6<br />

cement tiles or brick = 7<br />

o<strong>the</strong>r = 8 (specify) ___________________________________<br />

10. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />

job a = 1<br />

job b = 2<br />

job c = 3<br />

job d = 4<br />

11. What is <strong>the</strong> monthly household income for your family? [ ]<br />

income bracket a = 1<br />

income bracket b= 2<br />

income bracket c=3<br />

(FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE)<br />

12. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound:<br />

YES = 1 NO = 2<br />

Own a bicycle/scooter/moped? [ ]<br />

Own a radio? [ ]<br />

Own a TV? [ ]<br />

Own <strong>the</strong> house you are living in? [ ]<br />

Own crop land? [ ]<br />

Grow cash crops? [ ]<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


REPRODUCTIVE AND CLINICAL HISTORY<br />

13. How many times have you become pregnant? [ ]<br />

(including this one and all o<strong>the</strong>r pregnancies, including abortions and miscarriages)<br />

13a. How many pregnancies with a live-born child?<br />

13b. How many pregnancies with loss <strong>of</strong> <strong>the</strong> fetus?<br />

MALARIA PREVENTION<br />

14. Did you take medicine during pregnancy to protect you from malaria and keep illness from coming into <strong>the</strong> body when<br />

you did not have symptoms? [ ]<br />

(NOTE, NOT treatment for malaria illness)<br />

YES = 1<br />

NO = 2 If NO, skip to question 16<br />

UNKNOWN = 9<br />

If YES:<br />

14a. What type <strong>of</strong> medicine did you take?<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (SP, Fansidar) [ ]<br />

Proguanil [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify): ______________________________<br />

Unknown [ ]<br />

14b. When you started taking <strong>the</strong> medicine, how many months pregnant were you? [ ]<br />

14c. For <strong>the</strong> first time you took <strong>the</strong> medicine, howmany total tablets did you take? [ ]<br />

14d. How many times in a week did you take <strong>the</strong> medicine? [ ]<br />

14e. How many tablets did you take each time? [ ]<br />

14f. After <strong>the</strong> first dose, how <strong>of</strong>ten did you take this medicine? [ ]<br />

Every week=1<br />

Almost every week=2<br />

Some weeks=3<br />

Monthly=4<br />

Rarely=5<br />

Do not know=6<br />

15. Did you sleep under a bed net during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If no, skip to question 17<br />

15a. If yes, how frequently? [ ]<br />

all <strong>the</strong> time = 1<br />

most <strong>of</strong> <strong>the</strong> time = 2<br />

sometimes = 3<br />

rarely = 4<br />

15b. Did you sleep under <strong>the</strong> net last night? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

Tool 2: Delivery Unit Questionnaire<br />

3


15c. Has this net ever been treated with insecticide? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

15d. If yes, has <strong>the</strong> net been treated with insecticide in <strong>the</strong> past one year? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

15e. Is <strong>the</strong> net a long-lasting insecticide-treated net (LLN)? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

HISTORY OF FEVER OR MALARIA (DURING THE PRESENT PREGNANCY)<br />

16. Have you had a fever or malaria during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If NO, skip to question 17<br />

16a. Did you get a convulsion with fever/malaria? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16b. Did you stay in hospital overnight for treatment <strong>of</strong> fever/malaria? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16c. Did you get a blood transfusion: [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16d. Did you take iron and folic acid tablets? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16e. Have you taken a medication to treat malaria or fever during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

16f. Type <strong>of</strong> medication taken (check all that apply)<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (SP) [ ]<br />

Quinine [ ]<br />

Antipyretics [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify):______________________________________<br />

Unknown [ ]<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


ANTENATAL CARE CLINIC VISITS AND ANC CARD DETAILS<br />

17. Have you previously attended antenatal clinic for this pregnancy? [ ]<br />

YES = 1 NO = 2<br />

18. Did you bring your ANC card today? [ ]<br />

YES = 1 NO = 2<br />

If yes, RECORD THE INFORMATION BELOW FROM THE ANC CLINIC CARD.<br />

19. Total number <strong>of</strong> ANC visits [ ]<br />

20. Timing <strong>of</strong> visits:<br />

Date <strong>of</strong> visit Gestational age Fundal<br />

(weeks) height<br />

first visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />

most recent visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />

21. Last menstrual period (LMP) if recorded: ________/___/____<br />

22. Estimated date <strong>of</strong> delivery ___ ___ / ___ ___ / ___ ___<br />

23. Risk factors during <strong>the</strong> current pregnancy:<br />

(Check if any <strong>of</strong> <strong>the</strong> following are written in <strong>the</strong> antenatal record –<br />

Please put a 1 or 2 for each risk factor)<br />

YES = 1 NO = 2<br />

Anemia (Hb < 7 g/dl) [ ]<br />

BP > 140/90 [ ]<br />

Pre-eclampsia [ ]<br />

Gestational diabetes [ ]<br />

APH (antepartum hemorrhage) [ ]<br />

Malpresentation [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify) ____________________________<br />

RECENT MALARIA MORBIDITY HISTORY<br />

24. Have you had a fever or malaria during <strong>the</strong> past week? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If NO, skip to question 25<br />

24a. If YES, Have you received any treatment for this illness? [ ]<br />

YES = 1<br />

NO = 2<br />

24b. If YES, check treatments received (check all that apply)<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (Fansidar) [ ]<br />

Quinine [ ]<br />

Artemisinin-combination <strong>the</strong>rapy (ACT) [ ]<br />

If an ACT, specify : ___________________________<br />

O<strong>the</strong>r [ ]<br />

(Specify): _____________________________________<br />

Not known [ ]<br />

Tool 2: Delivery Unit Questionnaire<br />

5


DELIVERY DATA (from hospital records and observation <strong>of</strong> present delivery)<br />

25. Date <strong>of</strong> Delivery ____ / ____ / ____<br />

26. Type <strong>of</strong> Delivery: [ ]<br />

Spontaneous vaginal delivery = 1<br />

Caesarian section = 2<br />

Forceps/vacuum = 3<br />

O<strong>the</strong>r = 8 Specify: _____________________________________<br />

27. Number <strong>of</strong> babies delivered [ ]<br />

1 = singleton (1 baby)<br />

2 = twins<br />

3 = more than two<br />

27a. If singleton (1 baby), please describe if <strong>the</strong> baby was<br />

1 = born alive, left hospital alive (Skip to Q. 30)<br />

2 = born alive, died before leaving hospital (Skip to Q. 27c)<br />

3 = born dead/stillbirth (Skip to Q. 27b)<br />

9 = unknown (Skip to Q. 30)<br />

27b. (For all singletons), did <strong>the</strong> baby move arms and legs after birth? [ ]<br />

YES = 1 NO = 2 (If NO, skip to Q. 27d)<br />

27c. (For singletons) If <strong>the</strong> baby was born alive but died before leaving hospital, what was <strong>the</strong> cause <strong>of</strong> death?<br />

(Answer this question and <strong>the</strong>n skip to Q. 30)<br />

____________________________________________________________________________________________<br />

27d. (For singletons born dead) If <strong>the</strong> baby was born dead, what was <strong>the</strong> estimated gestational age?<br />

________________weeks<br />

28. If <strong>the</strong> singleton child was born dead, check all possible causes<br />

[ ] <strong>Malaria</strong><br />

[ ] Fever<br />

[ ] Spontaneous without explanation<br />

[ ] Infection (septic)<br />

[ ] Trauma<br />

[ ] Intentional<br />

[ ] Cephalopelvic disproportion (head too big, baby got stuck)<br />

[ ] Weak expulsion<br />

[ ] Prolonged labor<br />

[ ] Fetal distress<br />

[ ] Asphyxia<br />

[ ] Nuchal cord<br />

[ ] Placental abruption<br />

[ ] Chorioamnionitis<br />

[ ] Hydrops fetalis<br />

[ ] Not known<br />

[ ] O<strong>the</strong>r (specify): _____________________________________<br />

29. If <strong>the</strong> singleton was born dead, was <strong>the</strong> fetus:<br />

Fresh? = 1<br />

Macerated? = 2<br />

Not known = 9<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


EXAMINATION: BEFORE DELIVERY<br />

30. Mo<strong>the</strong>r’s axillary temperature _____._____ degrees C<br />

31. Mo<strong>the</strong>r's height (centimeters): ____ ____ ____<br />

32. Mo<strong>the</strong>r’s mid-upper arm circumference (centimeters) ____ ____<br />

34. Was a rapid diagnostic test (RDT) for malaria done? [ ]<br />

YES = 1<br />

NO = 2 (If “no” or “unknown” skip to Q36.<br />

UNKNOWN = 9<br />

35. RDT result [ ]<br />

Positive = 1<br />

Negative = 2<br />

Result available, examined, but undetermined = 9<br />

36. Was a blood sample taken from a prick <strong>of</strong> <strong>the</strong> mo<strong>the</strong>r’s finger? [ ]<br />

YES = 1<br />

NO = 2 (If “no” or “unknown” skip to Q39.<br />

UNKNOWN = 9<br />

37. Blood smear result [ ]<br />

Positive = 1<br />

Negative = 2<br />

Result available, examined, but undetermined = 9<br />

38. <strong>Malaria</strong> species. Check all that apply .[ ]<br />

Plasmodium falciparum = 1 [ ]<br />

P. vivax = 2 [ ]<br />

P. malariae = 3 [ ]<br />

P. ovale = 4 [ ]<br />

Undetermined = 9<br />

39. If ei<strong>the</strong>r <strong>of</strong> <strong>the</strong> tests above was positive, was an antimalarial given? [ ]<br />

YES = 1 NO = 2<br />

39a. If YES, what type [ ]<br />

Chloroquine = 1<br />

Sulfadoxine-pyrimethamine (SP) = 2<br />

Chloroquine and SP = 4<br />

Quinine = 3<br />

Coartem = 4<br />

O<strong>the</strong>r = 8 (specify and explain): ______________________<br />

39b. Date administered: ___ ___ / ___ ___ / ___ ___<br />

39c. Name <strong>of</strong> person administering antimalarials:______________________________________<br />

Note: All women who are currently febrile or report having had a fever in <strong>the</strong> last 7 days should wait to receive <strong>the</strong>ir<br />

blood smear results prior to leaving clinic that day. <strong>The</strong>ir blood slides should be promptly read. If positive, <strong>the</strong>y will<br />

receive treatment with appropriate antimalarial drug. Women who are presently afebrile with no history <strong>of</strong> fever in<br />

<strong>the</strong> past week need not wait for smear results but can return for <strong>the</strong> results <strong>the</strong> following day.<br />

OR<br />

If above differs from <strong>the</strong> country’s national policy, follow national policy.<br />

Tool 2: Delivery Unit Questionnaire<br />

7


EXAMINATION OF LIVE-BORN SINGLETON BABY<br />

40. Weight <strong>of</strong> baby (g) ____ . ____ ____<br />

FROM SCALE, NOT FROM DELIVERY RECORD<br />

41. Sex <strong>of</strong> baby [ ]<br />

Male = 1<br />

Female = 2<br />

42. Ballard score ____ ____<br />

43. Gestational age (weeks) by Ballard score………………..[ ]<br />

44. Physical abnormalities? [ ]<br />

YES = 1 NO = 2<br />

If yes, list any abnormalities__________________________________<br />

MATERNAL OUTCOMES<br />

45. Maternal death [ ]<br />

YES = 1<br />

NO = 2<br />

If maternal death, list cause: ______________________________<br />

If not known, please state: “Unknown”<br />

46. Were <strong>the</strong>re any o<strong>the</strong>r complications <strong>of</strong> labor? [ ]<br />

0 = No o<strong>the</strong>r complications<br />

1 = Puerperal sepsis<br />

2 = Pre-eclampsia<br />

3 = Eclampsia<br />

4 = Obstructed labor<br />

5 = Breech delivery<br />

6 = Antepartum hemorrhage<br />

7 = Postpartum hemorrhage<br />

8 = Uterine rupture<br />

9 = O<strong>the</strong>r (specify) _______________________________________<br />

PLEASE CHECK OVER THE QUESTIONNAIRE NOW TO MAKE SURE THAT ALL QUESTIONS HAVE BEEN ANSWERED, THEN<br />

CHECK THIS BOX [ ]<br />

Thank <strong>the</strong> woman for her time.<br />

47. QUALITY CONTROL<br />

Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end <strong>of</strong> all interviews.<br />

Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />

Person Name/Signature Date<br />

47a Site Supervisor<br />

47b Data Entry Clerk 1<br />

47c Data Entry Clerk 2<br />

47d <strong>Assessment</strong><br />

Coordinator<br />

8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong><br />

Disease: Data Abstraction Form<br />

Ga<strong>the</strong>ring information about malaria disease among all hospitalized women can<br />

provide descriptive information about whe<strong>the</strong>r or not pregnant women have<br />

more malaria illness, which in turn can be used to determine if intermittent<br />

preventive treatment (IPTp) should be recommended or if <strong>the</strong> focus should be on<br />

case management and use <strong>of</strong> insecticide-treated bed nets (ITNs).<br />

A data abstraction form is used to collect <strong>the</strong> following information about all<br />

hospitalized women: history <strong>of</strong> illness and treatment, admission and discharge<br />

diagnoses, laboratory results <strong>of</strong> tests for malaria, and indicators related to severe<br />

malaria, treatment, and clinical outcome for <strong>the</strong> mo<strong>the</strong>r and fetus.<br />

This module contains sample materials for hospital surveillance <strong>of</strong> malaria<br />

disease. <strong>The</strong>se materials can and should be adapted to suit local needs. General<br />

guidance for conducting assessment surveys and managing data can be found in<br />

Chapters 3 and 4.<br />

A. Eligibility Criteria<br />

Contents<br />

B. Surveillance Team<br />

C. Notes for <strong>Assessment</strong> Team<br />

D. Sample Logbook<br />

E. Severe Plasmodium falciparum <strong>Malaria</strong> in Adults: WHO’s List <strong>of</strong> Clinical<br />

Manifestations and Laboratory Findings<br />

F. Analysis <strong>of</strong> Data<br />

1<br />

Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form 1


A. Eligibility Criteria<br />

Women and units/wards: All women (both pregnant and nonpregnant) admitted to <strong>the</strong>se<br />

hospital units/wards: women’s internal medicine unit, gynecology, or delivery. <strong>The</strong> choice<br />

<strong>of</strong> units/wards should be individualized to <strong>the</strong> local situation so as to capture as many<br />

admissions by women---both pregnant and nonpregnant---as possible. <strong>The</strong> hospital may be<br />

operated by <strong>the</strong> government or by private concerns.<br />

Note: If <strong>the</strong> surveillance is conducted only in maternity units, it will not provide data on <strong>the</strong><br />

difference between how many pregnant and nonpregnant women become ill with malaria.<br />

B. Surveillance Team<br />

<strong>The</strong> abstraction form involves interpretation <strong>of</strong> medical records as well as making clinical<br />

judgments; <strong>the</strong>refore, <strong>the</strong> surveillance team should be made up <strong>of</strong> persons with clinical<br />

training, e.g., physicians, nurses, midwives.<br />

C. Notes for <strong>Assessment</strong> Team<br />

A record will need to be kept <strong>of</strong> all women who are admitted, pregnant or nonpregnant, with<br />

or without malaria or anemia. Data abstraction forms need to be filled out only for those with<br />

malaria.<br />

It is important to ask about last menstrual period in order not to omit women early in <strong>the</strong>ir<br />

pregnancy.<br />

Questions 7 and 19 should be adapted to reflect <strong>the</strong> medications that are available and used in<br />

<strong>the</strong> country. It might be helpful to list both generic and trade names.<br />

Questions 10-18 (Laboratory Results) should also be adapted to reflect laboratory tests used<br />

in <strong>the</strong> country.<br />

Note that <strong>the</strong> laboratory results recorded in Q. 10-18 may serve to validate symptoms and<br />

conditions noted in Q.9.<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


D. Sample Logbook<br />

Date Ward Newly<br />

admitted<br />

women<br />

(total #)<br />

<strong>Malaria</strong> and anemia admissions—<br />

women only<br />

Number<br />

<strong>of</strong> forms<br />

completed<br />

Comments<br />

Day/mo/yr<br />

Day/mo/yr<br />

Int<br />

Gyn<br />

Delivery<br />

Int<br />

Gyn<br />

Delivery<br />

Total Preg Nonpreg<br />

E. Severe Plasmodium falciparum <strong>Malaria</strong> in Adults: WHO’s List <strong>of</strong><br />

Clinical Manifestations and Laboratory Findings<br />

Clinical manifestations and laboratory findings <strong>of</strong> severe P. falciparum in adults<br />

include:*<br />

Prostration<br />

Impaired consciousness<br />

Respiratory distress (acidotic breathing)<br />

Multiple convulsions<br />

Circulatory collapse<br />

Pulmonary edema (radiological)<br />

Abnormal bleeding<br />

Jaundice<br />

Hemoglobinuria<br />

Severe anemia<br />

*Adapted from: World Health Organization. Severe falciparum malaria. Royal Society <strong>of</strong><br />

Tropical Medicine and Hygiene, 2000. 94 (1 Suppl): p. 2.<br />

F. Analysis <strong>of</strong> Data<br />

Important outcome variables include:<br />

• Percentage <strong>of</strong> women admitted to <strong>the</strong> hospital with malaria, anemia, or severe malaria<br />

who were pregnant,<br />

by level <strong>of</strong> transmission (if surveillance is conducted in areas <strong>of</strong> both stable and unstable<br />

malaria)<br />

• Percentage <strong>of</strong> pregnancies with a fatal outcome for <strong>the</strong> fetus or for <strong>the</strong> mo<strong>the</strong>r<br />

Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form<br />

3


4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Woman’s full name:________________________________________________________________ ID #_____A________<br />

Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease<br />

Data Abstraction Form<br />

NOTE: Abstract data only from forms <strong>of</strong> women who are <strong>of</strong> reproductive age.<br />

Abstracter name ____________________<br />

Today’s date ____/____/_____<br />

Day Month Year<br />

Interviewer number _______<br />

Patient record ID# (or patient hospital file #): ______________________<br />

Type <strong>of</strong> facility_____________________________________<br />

PATIENT DETAILS<br />

1. Age <strong>of</strong> patient (years): [ ]<br />

<br />

2. Last menstrual period<br />

Not applicable [ ]<br />

Date <strong>of</strong> last menstrual period ____ ___ / ___ ___ / ___ ___<br />

if UNKNOWN, mark this box [ ]<br />

3. Pregnant [ ]<br />

YES = 1, NO = 2, UNKNOWN = 3<br />

3a. If YES, what is <strong>the</strong> gestational age (weeks) [ ]<br />

3b. If NO, has she ever been pregnant? [ ]<br />

YES = 1, NO = 2, UNKNOWN = 3<br />

3c. If YES, what is <strong>the</strong> date <strong>of</strong> <strong>the</strong> last delivery ____ ___ / ___ ___ / ___<br />

If UNKNOWN, mark this box [ ]<br />

4. Patient’s village/town/district_________________________<br />

Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form<br />

1


HISTORY OF CURRENT ILLNESS AND TREATMENT<br />

5. How long has <strong>the</strong> patient been ill?[days]<br />

6. Prior to admission, did <strong>the</strong> patient have<br />

YES = 1, NO = 2, UNKNOWN = 3<br />

a. Convulsions [ ]<br />

b. Decreased consciousness [ ]<br />

c. Coma [ ]<br />

7. Did patient receive any antimalarial treatment in <strong>the</strong> 7 days before admission [ ]<br />

YES = 1, NO = 2, UNKNOWN = 3<br />

If YES, mark all that apply<br />

Chloroquine [ ]<br />

Sulfadoxine-Pyrimethamine (SP) [ ]<br />

Quinine [ ]<br />

Artesunate [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify and explain): ________________________<br />

ADMISSION DATA<br />

8. Admitting diagnosis: (mark all that apply)<br />

malaria = 1 [ ]<br />

severe malaria = 2 [ ]<br />

cerebral malaria = 3 [ ]<br />

anemia = 4 [ ]<br />

o<strong>the</strong>r = 5 (specify): ____________________________________________<br />

9. Any manifestations <strong>of</strong> severe or cerebral malaria (mark all that apply)<br />

Prostration [ ]<br />

Respiratory distress (acidotic breathing) [ ]<br />

Multiple convulsions [ ]<br />

Circulatory collapse (shock) [ ]<br />

Pulmonary oedema (radiological) [ ]<br />

Abnormal bleeding [ ]<br />

Jaundice [ ]<br />

Haemoglobinuria [ ]<br />

Severe anemia [ ]<br />

Impaired consciousness [ ]<br />

Hypoglycemia [ ]<br />

Decreased consciousness [ ]<br />

Coma [ ]<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


LABORATORY RESULTS (provide if available)<br />

10. <strong>Malaria</strong> blood film done [ ]<br />

YES = 1, NO = 2<br />

10a. If YES, result [ ]<br />

Positive = 1<br />

Negative = 2<br />

Result available, examined, but undetermined = 9<br />

10b. If positive, parasite count: __________<br />

10c. If positive, species (mark all that apply) [ ]<br />

Plasmodium falciparum = 1 [ ]<br />

P. vivax = 2 [ ]<br />

P. malariae = 3 [ ]<br />

P. ovale = 4 [ ]<br />

Not determined = 5 [ ]<br />

11. Hemoglobin/Hematocrit (lowest) ____ ____<br />

12. Glucose (lowest) _______________<br />

13. Creatinine (highest) _______________<br />

14. Bilirubin (highest) _______________<br />

15. Plasma bicarbonate ________________<br />

16. Mean cell volume ________________<br />

17. Lumbar puncture<br />

Glucose_________<br />

Protein__________<br />

Cell Count<br />

RBC: _______ WBC: _______ WBC differential: _______<br />

18. O<strong>the</strong>r [ ]<br />

(specify): ___________________________________<br />

Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease Data Abstraction Form<br />

3


TREATMENT<br />

19. Antimalarial medications given (mark all that apply)<br />

Chloroquine [ ]<br />

Sulfadoxine-pyrimethamine (SP) [ ]<br />

Quinine [ ]<br />

Artesunate [ ]<br />

Primaquine [ ]<br />

Proguanil [ ]<br />

Artemisinin-containing combination <strong>the</strong>rapy (ACT) [ ]<br />

If ACT, specify __________________________________<br />

O<strong>the</strong>r [ ]<br />

(specify and explain): _________________________<br />

20. O<strong>the</strong>r <strong>the</strong>rapy given (mark all that apply)<br />

Anticonvulsant [ ]<br />

Transfusion <strong>of</strong> whole blood / packed RBC [ ]<br />

Glucose [ ]<br />

Furosemide (or o<strong>the</strong>r diuretic) [ ]<br />

Oxygen [ ]<br />

Vitamin K [ ]<br />

O<strong>the</strong>r [ ]<br />

(specify): ___________________________________<br />

DISCHARGE INFORMATION<br />

21. Woman’s outcome [ ]<br />

Full recovery = 1<br />

Recovered with some residual disability = 2<br />

Died = 3<br />

Unknown = 9<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


22. Pregnancy outcome (for pregnant women only):<br />

Did woman deliver [ ]<br />

YES = 1, NO = 2, UNKNOWN = 3<br />

22a. If YES, outcome [ ]<br />

alive = 1<br />

fetal loss = 2<br />

22b. If NO, outcome [ ]<br />

no labor = 1<br />

false labor = 2<br />

23. Discharge diagnosis: (mark all that apply)<br />

uncomplicated malaria = 1 [ ]<br />

severe malaria = 2 [ ]<br />

anemia = 3 [ ]<br />

o<strong>the</strong>r = 4 [ ]<br />

(specify):_________________________________<br />

24. Additional comments:<br />

_______________________________________________________________________________________________________<br />

_______________________________________________________________________________________________________<br />

25. QUALITY CONTROL<br />

Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end<br />

<strong>of</strong> all interviews.<br />

Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />

Person Name/Signature Date<br />

25a Site Supervisor<br />

25b Data Entry Clerk 1<br />

25c Data Entry Clerk 2<br />

25d <strong>Assessment</strong> Coordinator<br />

Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease Data Abstraction Form<br />

5


6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 4: Conducting an Antenatal Clinic<br />

Facility <strong>Assessment</strong><br />

<strong>The</strong> antenatal clinic facility assessment is designed to determine<br />

• Antental clinic services provided<br />

• Stockouts <strong>of</strong> medicine/vaccine/laboratory supplies<br />

• Facility staffing and equipment<br />

• Cost <strong>of</strong> services<br />

This module contains sample materials for an antenatal clinic facility assessment.<br />

<strong>The</strong>se materials can and should be adapted to suit local needs. General guidance for<br />

conducting assessment tools survey and managing data can be found in Chapters 3-4.<br />

Contents<br />

A. Antenatal Clinic Facility <strong>Assessment</strong> Timetable<br />

B. Sample Size<br />

C. <strong>Assessment</strong> Team<br />

D. Data Analysis<br />

Module 4: Conducting an Antenatal Clinic Facility <strong>Assessment</strong><br />

1


A. Antenatal Clinic Facility <strong>Assessment</strong> Timetable<br />

<strong>The</strong> Antenatal Clinic Facility <strong>Assessment</strong> can be conducted before, during, or after <strong>the</strong><br />

Antenatal Clinic Surveys take place.<br />

B. Sample Size<br />

An Antenatal Clinic Facility <strong>Assessment</strong> should be conducted with <strong>the</strong> manager, or his/<br />

her designee, <strong>of</strong> each antenatal clinic in which an Antenatal Clinic Survey is conducted.<br />

C. <strong>Assessment</strong> Team<br />

<strong>The</strong> site supervisor or his or her designee should serve as <strong>the</strong> interviewer.<br />

D. Data Analysis<br />

Outcome Variables<br />

No. Outcome Variable<br />

1 Proportion <strong>of</strong> facilities with a written protocol on malaria during pregnancy<br />

2 Proportion <strong>of</strong> facilities reporting stock-out <strong>of</strong> antimalarial drugs in<br />

antenatal clinic within <strong>the</strong> last calendar month<br />

3 Proportion <strong>of</strong> facilities that distribute/sell insecticide treated nets (ITNs)<br />

Summary Tables<br />

Table 1. Services provided to women in antenatal clinics by site or region,<br />

by percentage <strong>of</strong> clinics.<br />

Service Region X (%) Region Y (%)<br />

IPTp<br />

Counseling on use<br />

<strong>of</strong> ITNs<br />

Hemoglobin test<br />

Iron<br />

Folate<br />

Iron and folate<br />

combined<br />

Blood films<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Table 2. Availability <strong>of</strong> medication and supplies by site or region,<br />

by percentage <strong>of</strong> clinics<br />

Item Region X (%) Region Y (%)<br />

Iron<br />

Folate<br />

Iron and folate combined<br />

Chloroquine<br />

Proguanil<br />

Quinine<br />

SP<br />

Hemoglobin tests<br />

Materials for blood films<br />

<strong>The</strong>rmometer<br />

Alcohol<br />

Gloves<br />

Glass slides<br />

Lancets<br />

Microscope<br />

Giemsa and staining equipment<br />

Hemoglobin measuring supplies<br />

Clean water<br />

Cups to drink from<br />

Module 4: Conducting an Antenatal Clinic Facility <strong>Assessment</strong><br />

3


4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Name <strong>of</strong> person interviewed: ________________________<br />

Facility number:_______________<br />

TOOL 4: ANTENATAL CLINIC FACILITY ASSESSMENT<br />

Interviewer name ___________________________________________<br />

Interviewer number __________<br />

Facility number: ____________________________<br />

Facility name:________________________________<br />

Today’s Date: ____/_____/_______<br />

Day Month Year<br />

Instructions for <strong>the</strong> interviewer: Please administer this assessment to <strong>the</strong> manager <strong>of</strong> <strong>the</strong> health facility. Respond<br />

to each question as completely as possible and add all comments in <strong>the</strong> space provided at <strong>the</strong> end <strong>of</strong> <strong>the</strong> assessment.<br />

Please read <strong>the</strong> following paragraph to <strong>the</strong> respondent before beginning <strong>the</strong> interview:<br />

I am here today to conduct an assessment <strong>of</strong> antenatal care facilities to learn more information regarding malaria<br />

during pregnancy. We would like to ask you several questions about <strong>the</strong> prevention <strong>of</strong> malaria during pregnancy in<br />

your facility. <strong>The</strong> information ga<strong>the</strong>red will be used to ______________________. Your participation in this process is very<br />

important. Your responses will be kept confidential. No institution or individual will be identified by name in <strong>the</strong> final<br />

report. This assessment will not last more than 30 minutes.<br />

We ask you to respond to each question to <strong>the</strong> best <strong>of</strong> your ability. If you have questions at any moment during <strong>the</strong><br />

interview, do not hesitate to ask. Do you agree to participate in this assessment?<br />

Instructions to <strong>the</strong> interviewer: If <strong>the</strong> respondent agrees to participate in <strong>the</strong> assessment, place an « X » in <strong>the</strong><br />

following box.<br />

<strong>The</strong> respondent agreed to participate in <strong>the</strong> assessment.<br />

<br />

Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />

1


BACKGROUND<br />

1. Name <strong>of</strong> <strong>the</strong> facility:______________________________________________<br />

2. Type <strong>of</strong> facility: [ ]<br />

Regional hospital = 1<br />

District hospital = 2<br />

Health center = 3<br />

Health dispensary = 4<br />

O<strong>the</strong>r = 9 (specify) _____________________________________________<br />

3. District: _______________________________________________________<br />

4. Region: ________________________________________________________<br />

5. Title <strong>of</strong> <strong>the</strong> respondent: __________________________________________<br />

6. Number <strong>of</strong> years <strong>of</strong> service in <strong>the</strong> facility: [ ] Years<br />

7. Training <strong>of</strong> <strong>the</strong> respondent: [ ]<br />

Doctor = 1<br />

Nurse = 2<br />

Midwife = 3<br />

O<strong>the</strong>r = 9 (specify) ______________________________________<br />

ASSESSMENT OF ANC SERVICES<br />

8. Are ANC cards used in this facility? [ ]<br />

Yes = 1<br />

No = 2 (SKIP TO Q11)<br />

Don’t know = 98 (SKIP TO Q11)<br />

If yes, are ANC cards provided free by <strong>the</strong> facility or are women required to purchase <strong>the</strong>m? [ ]<br />

Provided by <strong>the</strong> clinic for free = 1<br />

Provided by <strong>the</strong> clinic for a fee = 2<br />

Used at <strong>the</strong> clinic, but woman must provide = 3<br />

Don’t know = 98<br />

9. Do <strong>the</strong>se cards have a place to record antimalarial drug use?<br />

Yes = 1<br />

No = 2<br />

Don’t know = 98<br />

If yes, do <strong>the</strong> cards have a place to record (check all that apply)<br />

Treatment <strong>of</strong> malaria illness ________<br />

Intermittent preventive treatment (IPTp)_________<br />

Chemoprophylaxis__________<br />

10. If yes, Interviewer should examine at least 20 ANC cards <strong>of</strong> women making second or greater ANC visit and<br />

note how many cards have any information recorded on antimalarial drug use 1 [ ]<br />

All have antimalarial drug use information recorded = 1<br />

Half have antimalarial drug use information recorded = 2<br />

Fewer than half have antimalarial drug use information = 3<br />

O<strong>the</strong>r = 9 (specify): ____________________________________________<br />

Don’t know = 98<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


11. How many ANC visits are recommended in your clinic?<br />

11a. Number <strong>of</strong> recommended visits: [ ]<br />

11b. Average gestational age at first ANC visit (weeks) [ ] weeks<br />

11c. Number <strong>of</strong> visits per trimester<br />

First [ ]<br />

Second [ ]<br />

Third [ ]<br />

12. Actual practices in ANC services:<br />

Interviewer: Read each practice to respondent and record appropriate response.<br />

PRACTICE<br />

12a. Intermittent preventive<br />

treatment<br />

12b. Counseling on<br />

use <strong>of</strong> ITNs<br />

12c. Hemoglobin test<br />

12d. Iron<br />

12e. Folate<br />

12f. Iron and folate<br />

(combined tablet)<br />

12g. Blood films<br />

NEVER<br />

PROVIDED<br />

PROVIDED TO<br />

ALL WOMEN<br />

PROVIDED TO<br />

CERTAIN WOMEN<br />

If provided to certain<br />

women, reason why<br />

13. Are health education sessions held during ANC visits? [ ]<br />

Yes = 1<br />

No = 2 (SKIP TO Q15)<br />

Don’t know = 98 (SKIP TO Q15)<br />

If Yes,<br />

13a. Number <strong>of</strong> days with health education sessions/week: [ ]<br />

13b. Is <strong>the</strong> location for <strong>the</strong>se sessions adequate? [ ]<br />

Women can sit down = 1<br />

Certain women remain standing = 2<br />

All women are standing, but can fit in <strong>the</strong> room = 3<br />

<strong>The</strong> room is too full and women cannot enter into <strong>the</strong> room = 4<br />

O<strong>the</strong>r = 9 (specify): ___________________________________<br />

13c. <strong>The</strong>mes covered that are relevant to malaria: ______________________________________________<br />

__________________________________<br />

14. Are visual aids used during <strong>the</strong>se sessions? [ ]<br />

Yes = 1<br />

No = 2<br />

Don’t know = 98<br />

14a. If Yes,<br />

Are <strong>the</strong>re materials that women can take home with <strong>the</strong>m? [ ]<br />

Yes = 1 No = 2 Don’t know = 98<br />

Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />

3


15. Are <strong>the</strong>re any job aids related to malaria during pregnancy<br />

available for <strong>the</strong> health-care workers (for example, wall posters, laminated sheets)? [ ]<br />

Yes = 1<br />

If yes, specify:___________________________________________________<br />

No = 2<br />

Don’t know = 98<br />

16. How do <strong>the</strong> women usually obtain <strong>the</strong>ir antimalarial drugs? [ ]<br />

Directly from <strong>the</strong> ANC (by <strong>the</strong> health provider) = 1<br />

From <strong>the</strong> pharmacy on site at <strong>the</strong> ANC after getting<br />

a prescription from <strong>the</strong> provider = 2<br />

Having a prescription filled elsewhere = 3<br />

O<strong>the</strong>r = 9 (SPECIFY)________________<br />

Don’t know = 98<br />

17. Quantities <strong>of</strong> medicines available at facility:<br />

Note <strong>the</strong> estimated number <strong>of</strong> boxes <strong>of</strong> pills or containers present. (If pregnant women’s medicines are<br />

stored toge<strong>the</strong>r with medicines for all o<strong>the</strong>r patients, note <strong>the</strong> total number. If pregnant women’s medicines are<br />

stored separately, note <strong>the</strong> number set aside for pregnant women.)<br />

Number <strong>of</strong> boxes <strong>of</strong> pills, containers<br />

17a. Chloroquine [ ]<br />

17b. Paracetamol [ ]<br />

17c. Sulfadoxine-Pyrimethamine [ ]<br />

17d. Quinine [ ]<br />

17e. Iron sulfate [ ]<br />

17f. Folate [ ]<br />

17g. Iron/folate [ ]<br />

18. Number <strong>of</strong> stock-outs: (Collect <strong>the</strong> following information from facility records)<br />

Medicine/vaccines/laboratory<br />

18a. Iron<br />

18b. Folate<br />

18c. Iron/folate<br />

18d. Chloroquine<br />

18e. Proguanil<br />

18f. Quinine<br />

18g. Sulfadoxine-pyrimethamine (SP)<br />

18h. Hemoglobin tests<br />

18i. Materials for blood films<br />

18j. O<strong>the</strong>r (specify): ___________________<br />

___________________________<br />

Number Total number Not available<br />

<strong>of</strong> stock- outs in <strong>the</strong><br />

last 6 months*<br />

*If 6 months is not feasible, could specify 3 months.<br />

<strong>of</strong> days with stockouts<br />

in <strong>the</strong> last 6<br />

months*<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


19. Facility Equipment:<br />

Present and working =1<br />

Present but not working = 2<br />

Not present = 3<br />

19a. <strong>The</strong>rmometer [ ]<br />

19b. Alcohol [ ]<br />

19c. Gloves [ ]<br />

19d. Cotton [ ]<br />

19e. Glass slides [ ]<br />

19f. Lancets [ ]<br />

19g. Microscope [ ]<br />

19h. Giemsa and staining equipment [ ]<br />

19i. Hemoglobin measuring supplies [ ]<br />

19j. Clean water [ ]<br />

19k. Cups to drink from [ ]<br />

MALARIA DURING PREGNANCY<br />

20. If malaria prophylaxis is recommended, does <strong>the</strong> clinic have a written copy <strong>of</strong> <strong>the</strong> national protocol? [ ]<br />

Yes = 1<br />

No = 2 (SKIP TO Q21)<br />

Don’t know = 98 (SKIP TO Q21)<br />

If yes,<br />

20a. Can <strong>the</strong> respondent show you <strong>the</strong> written protocol? [ ]<br />

Yes = 1 No = 2 Don’t know = 98<br />

20b. Treatment recommended in <strong>the</strong> protocol: [ ]<br />

Chloroquine treatment dose <strong>the</strong>n once per week = 1<br />

Two doses <strong>of</strong> SP = 2<br />

None = 3<br />

O<strong>the</strong>r = 9 (specify): _______________________________________<br />

21. Are insecticide-treated mosquito nets (ITNs) available for distribution or sale in your facility? [ ]<br />

Yes = 1<br />

No = 2 (SKIP TO Q22)<br />

Don’t know = 98 (SKIP TO Q22)<br />

If Yes:<br />

21a. Approximate cost to <strong>the</strong> ANC client <strong>of</strong> one ITN ___________________<br />

21b. Average number <strong>of</strong> ITNs distributed/sold per month: [ ]<br />

22. Are re-impregnation kits available for distribution or sale in your facility? [ ]<br />

Yes =1<br />

No = 2 (SKIP TO Q23)<br />

Don’t know = 98 (SKIP TO Q23)<br />

If yes<br />

22a. Approximate cost <strong>of</strong> one re-impregnation kit (to <strong>the</strong> ANC client)?: ___________________<br />

22b. Average number <strong>of</strong> kits distributed/sold per month [ ]<br />

Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />

5


23. If ITNs are not available directly for sale, are vouchers/coupons distributed to women?<br />

Yes=1 No=2 Don’t know=98<br />

If Yes:<br />

23a. How much is <strong>the</strong> voucher/coupon worth? ____________<br />

COSTS OF ANC SERVICES<br />

24. Do women pay for ANC services? [ ]<br />

Yes = 1<br />

No = 2 (SKIP TO Q26)<br />

Don’t know = 98 (SKIP TO Q26)<br />

24a. If women pay for ANC services, what is <strong>the</strong> schedule <strong>of</strong> payments? [ ]<br />

Pay each visit = 1<br />

One payment for all ANC services = 2<br />

One payment for ANC and childbirth services = 3<br />

O<strong>the</strong>r = 9 (specify): ______________________________________________<br />

24b. How much do <strong>the</strong>y pay? ___________ per _____________<br />

25. Please indicate in <strong>the</strong> table below what women pay for each <strong>of</strong> <strong>the</strong> following medications:<br />

Medicines/Vaccinations/ Laboratory<br />

25a. Iron<br />

25b. Folate<br />

25c. Iron/Folate<br />

25c. Chloroquine (treatment)<br />

25d. Chloroquine (chemoprophylaxis)<br />

25e. SP (treatment)<br />

25f. SP (IPTp)<br />

25g. O<strong>the</strong>r antimalarial drug for<br />

treatment (specify): ___________________<br />

25h. O<strong>the</strong>r antimalarial drug for<br />

prevention (specify):__________________<br />

Cost to <strong>the</strong> woman<br />

Free = 0<br />

Included in cost <strong>of</strong> ANC services = 1<br />

Purchase at pharmacy part <strong>of</strong> <strong>the</strong><br />

facility = 2<br />

Purchase elsewhere = 3<br />

Not available = 4<br />

If purchased at <strong>the</strong> facility, cost<br />

(per quantity) (For example, 10<br />

packets for US$1)<br />

26. Which <strong>of</strong> <strong>the</strong> following information is routinely collected each month and forwarded on to <strong>the</strong> district health<br />

management team? (Check all that apply)<br />

26a. Number <strong>of</strong> first antenatal clinic consultations _______<br />

26b. Number <strong>of</strong> repeat antenatal clinic consultations _______<br />

26c. Number <strong>of</strong> tetanus toxoid vaccinations delivered _______<br />

26d. Number <strong>of</strong> 1st dose <strong>of</strong> IPTp delivered _______<br />

26e. Number <strong>of</strong> 2nd dose <strong>of</strong> IPTp delivered _______<br />

26f. Number <strong>of</strong> chemoprophylaxis doses delivered _______<br />

26g. Number <strong>of</strong> ITNs sold and distributed _______<br />

Thank <strong>the</strong> respondent for his or her time!<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


INTERVIEWER COMMENTS:<br />

(Please note any additional observations in <strong>the</strong> following space):<br />

Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />

7


8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 5: Conducting a Health-Care Worker<br />

Observation<br />

<strong>The</strong> health-care worker observation is designed to<br />

• Determine whe<strong>the</strong>r health-care workers are providing <strong>the</strong> needed healthcare<br />

services, specifically whe<strong>the</strong>r health-care workers are providing IPTp ,<br />

antimalarial drugs for a febrile illness, and tetanus toxoid<br />

This module contains sample materials for a health-care worker observation.<br />

<strong>The</strong>se materials can and should be adapted to suit local needs. General guidance for<br />

conducting assessment tools survey and managing data can be found in Chapters 3<br />

and 4 <strong>of</strong> <strong>the</strong> manual.<br />

A. Sample Size<br />

B. <strong>Assessment</strong> Team Members<br />

C. Data Analysis<br />

Contents<br />

A. Sample Size<br />

Approximately 20-25 health-care worker/patient encounters per each ANC clinic<br />

selected for an ANC survey should be observed and recorded.<br />

B. <strong>Assessment</strong> Team Members<br />

<strong>The</strong> health-care worker observations can be done by <strong>the</strong> assistant coordinator or his or<br />

her designee.<br />

C. Data Analysis<br />

No.<br />

Outcome variables<br />

1 Proportion <strong>of</strong> health providers who universally prescribed/distributed<br />

iron/folate during <strong>the</strong> ANC visit<br />

2 Proportion <strong>of</strong> health providers who universally prescribed/distributed<br />

antimalarial drug during <strong>the</strong> ANC visit<br />

3 Proportion <strong>of</strong> health providers who performed at least 90% <strong>of</strong> ANC<br />

services correctly<br />

Module 5: Conducting a Health-Care Worker Observation<br />

1


2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Provider’s name: ________________<br />

Observation ID #____________________________<br />

TOOL 5: HEALTH-CARE WORKER OBSERVATION<br />

Observer name _____________________________________________________ Today’s date: ____/____/____<br />

Observer number _______<br />

Day Month Year<br />

Observation ID number: ___ -- ___ ___ ___<br />

Digit 1 = facility number<br />

Digits 2, 3 & 4 = provider’s consecutive number<br />

1. Woman’s arrival time: ___:___ AM/PM<br />

<br />

2. Training <strong>of</strong> health care worker [ ]<br />

Physician = 1<br />

Health Officer = 2<br />

Midwife = 3<br />

Nurse = 4<br />

Health assistant = 5<br />

Sanitarian = 6<br />

O<strong>the</strong>r = 9 (specify) ___________________________<br />

3. Number <strong>of</strong> ANC visits during this pregnancy (including this one) [ ]<br />

Obtain information from ANC card. If no ANC card is available, skip this question.<br />

3a. Check this box if woman’s first ANC visit<br />

4. Observation <strong>of</strong> health care worker with woman (check if behavior was performed<br />

by any <strong>of</strong> <strong>the</strong> clinic staff):<br />

YES NO<br />

___ ___ Checks if has ANC card<br />

___ ___ Takes history (during 1st ANC visit):<br />

___ ___ Age<br />

___ ___ Gravidity<br />

___<br />

___ Last menstrual period<br />

YES NO<br />

___ ___ Pregnancy symptoms<br />

___ ___ Contraceptive history<br />

___ ___ Reproductive history - prior deliveries/outcomes; complications<br />

___ ___ Medical history<br />

___ ___ Asks woman about HIV status<br />

___ ___ Counsels women about HIV/AIDS during pregnancy, childbirth, postpartum<br />

Tool 5: Health-Care Worker Observation<br />

1


Physical examination (during each ANC visit):<br />

___ ___ Measures blood pressure<br />

___ ___ Measures fundal height (abdominal exam)<br />

___ ___ Listens to fetal heart<br />

___ ___ Screens for anemia (physical signs)<br />

___ ___ Prescribes or dispenses iron/folate<br />

___ ___ Prescribes or dispenses antimalarial prophylaxis<br />

___ ___ Administers tetanus toxoid if needed<br />

Laboratory examination:<br />

___ ___ Orders urine test<br />

___ ___ Orders hemoglobin<br />

___ ___ Orders syphilis test<br />

___ ___ Treats for syphilis, if positive ____<br />

___ ___ Arranges partner follow up, if syphilis (+) ____<br />

Procedure related to problems:<br />

___ ___ Checks temperature, if reports fever ____<br />

___ ___ Refer for blood smear, if reports fever and malaria is suspected ____<br />

___ ___ Prescribes/dispenses antimalarial, if reports fever___<br />

General care during each ANC visit:<br />

___ ___ Social history & support<br />

___ ___ Assesses for woman’s complaints<br />

___ ___ Asks woman if has questions<br />

___ ___ Answers questions, if woman has questions<br />

___ ___ Discusses individualized birth plan<br />

(including clean and safe delivery)<br />

___ ___ Gives individual health education (specify) ________________<br />

___ ___ Washes hands before touching patient<br />

___ ___ Uses gloves if genital examination performed, disposes <strong>of</strong><br />

gloves properly<br />

___ ___ Fills out ANC card<br />

___ ___ Marks next visit<br />

___ ___ Reminds woman <strong>of</strong> next visit<br />

___ ___ O<strong>the</strong>r (specify) ______________________________________<br />

5. Time spent with woman for exam (minutes) _____<br />

6. Time seen by health-care worker (minutes) _____<br />

7. Time woman leaves clinic ___:___AM/PM<br />

8. Total time (minutes) _____<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 6: Conducting Individual Interviews and<br />

Focus Groups with Health-Care Workers<br />

Individual interviews and focus groups with health-care workers are designed<br />

to determine<br />

• <strong>The</strong> health-care workers’ knowledge <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria<br />

• Role <strong>of</strong> health-care workers in influencing pregnant women’s behavior in<br />

seeking antenatal care at health facilities<br />

• What types <strong>of</strong> preventive and treatment measures <strong>the</strong>y currently<br />

recommend and provide<br />

• Factors that motivate or inhibit women from using antenatal care<br />

• Best methods for promoting health education messages to pregnant women<br />

This module contains sample materials relevant to conducting a focus group or an<br />

individual interview. <strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong><br />

<strong>the</strong> local situation.<br />

Contents<br />

A. Interview/Focus Group Timetable<br />

B. Focus Group or Individual Interview or Both?<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

D. Eligibility Criteria<br />

E. Venues and Equipment<br />

F. <strong>Assessment</strong> Team Members<br />

G. <strong>Assessment</strong> Team Training<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

I. Information Sheet<br />

J. Debriefing<br />

K. Focus Group/Interview Analysis<br />

In addition, please see Resource 2, which includes a Sample Interviewer Training<br />

Manual and a Resource List.<br />

Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />

1


A. Focus Group/Interview Timetable<br />

To prepare for focus groups or individual interviews, it is important to alert health facilities<br />

and community leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong><br />

facilities so that potential participants know that this activity will be occurring and that <strong>the</strong>y<br />

will be asked to participate. In addition, advance notice is needed so that community and/<br />

or facility focus groups can be established and that arrangements can be made for interview<br />

venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />

After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />

<strong>the</strong> focus groups/interviews can begin.<br />

B. Focus Group or Individual Interview or Both?<br />

It may not always be possible to conduct both focus groups and individual interviews and<br />

thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />

chosen based on <strong>the</strong> local situation.<br />

• Individual interviews are a better choice when individual variability within communities<br />

is <strong>of</strong> interest.<br />

• Focus group interviews elicit community norms.<br />

• Focus group interviews might help stimulate thinking and expose conflicting feelings–<br />

<strong>the</strong>y can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />

Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which<br />

<strong>the</strong>y might individually be unaware or not <strong>of</strong>ten think about.<br />

• Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />

individual opinions or emotions.<br />

• Focus group interviews are better for a small number <strong>of</strong> issues.<br />

• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />

• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />

vehicles), and money—are limited.<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

Individual interviews are preferable if timing is not an issue. Could interview as many healthcare<br />

workers as feasible during <strong>the</strong> assessment period, probably no more than 5-10 per<br />

facility, but sometimes only 1 or 2 is all that is possible.<br />

D. Eligibility Criteria<br />

HCWs who routinely provide antenatal care or care for sick pregnant women who<br />

have malaria.<br />

E. Venues and Equipment<br />

<strong>The</strong> focus group will ideally be held in a quiet space in a health facility or within a village.<br />

Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a tape<br />

recorder if <strong>the</strong> decision to use one has been made.<br />

Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator and<br />

<strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong> interested<br />

people, ask that a member <strong>of</strong> <strong>the</strong> health-care facility or a community member politely dismiss<br />

<strong>the</strong> crowd, with a brief explanation <strong>of</strong> what is occurring.<br />

Individual interviews can also be conducted at health facilities.<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />

have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />

that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session, even<br />

if a tape recorder is used.<br />

F. <strong>Assessment</strong> Team Members<br />

For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders are<br />

used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong> summary<br />

<strong>of</strong> findings.<br />

An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />

interviews.<br />

G. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal Clinic<br />

and Delivery Unit Surveys.<br />

Training can include <strong>the</strong> following subjects:<br />

• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />

• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and<br />

treatment, epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and<br />

local beliefs related to malaria)<br />

• differences between qualitative and quantitative studies<br />

• interviewing techniques<br />

• data recording techniques<br />

• differences between individual and focus group interviews<br />

For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />

can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />

to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />

sessions.<br />

To assist in building capacity in qualitative research methodologies, all team members can be<br />

given information on qualitative assessments and methodology, as well as written handouts on<br />

interviewing techniques.<br />

<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />

consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />

should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />

minor modifications in <strong>the</strong> interview guides can be made.<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide. <strong>The</strong> guide<br />

will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder with <strong>the</strong> questions<br />

that will be discussed.<br />

<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />

It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />

<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See J below, Debriefing.<br />

Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r it<br />

is used for a focus group or an individual interview.<br />

Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />

3


I. Information Sheet<br />

<strong>The</strong> following information sheet should be given to each potential interview participant. If <strong>the</strong><br />

person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to her. All<br />

potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />

Notes to interviewer:<br />

• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use<br />

words that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong><br />

<strong>the</strong> participant.<br />

• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in<br />

several different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks<br />

confused or scared, try to clarify <strong>the</strong>ir concerns.<br />

• If participant refuses to participate, please remember that this was an INVITATION to<br />

participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />

• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that<br />

refuse, keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />

Introduction<br />

<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />

pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />

malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women<br />

seek health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria<br />

when <strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and<br />

o<strong>the</strong>rs will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />

Purpose<br />

What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />

are pregnant will help us plan programs to decrease malaria in pregnant women.<br />

Procedures<br />

Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />

be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />

and do about malaria, and about where you get help and information about malaria. You also<br />

do not need to answer any questions that we ask that you do not want to. If you agree to<br />

participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />

can withdraw at any time. We will not be asking for any blood or urine samples.<br />

Benefits<br />

Although what we learn might not help you directly, it will help us know how best to prevent<br />

malaria in pregnant women in this district.<br />

Risks or discomforts<br />

We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />

Would you like to participate?<br />

Thank you very much for your time.<br />

Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


J. Debriefing<br />

Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />

focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />

hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />

<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />

Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />

data (qualitative methods are iterative, thus, you can change questions as needed as you<br />

conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />

sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />

show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />

if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />

<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />

collected that day), identifies what is common, what is different, and mutually agrees on what<br />

local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />

local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />

tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />

clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />

During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />

each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />

local language), as well as <strong>the</strong> agreed-upon translations.<br />

During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />

<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />

and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />

understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />

<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />

during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />

order to obtain <strong>the</strong> needed information.<br />

K. Focus Group/Interview Analysis<br />

Recording and analyzing information for a focus group is somewhat different from recording<br />

and analyzing information for an individual interview.<br />

For focus groups:<br />

• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />

details afterwards.<br />

• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />

participants felt <strong>the</strong> same way is.<br />

• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />

different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />

• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by<br />

<strong>the</strong>ir job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />

When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />

local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />

primary language used in <strong>the</strong> rapid assessment, if different.<br />

Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />

5


6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


TOOL 6: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />

HEALTH-CARE WORKERS<br />

This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />

Region_______________________________<br />

Name <strong>of</strong> facility/facility area_______________<br />

Date: ____/____/____<br />

Month Day Year<br />

Time_________________________<br />

Interviewer_____________________<br />

Recorder_______________________<br />

INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />

participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />

A. Demographics:<br />

Age:<br />

Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />

Job description at health facility:<br />

<br />

B. Topical area: Prevailing health problems and malaria in pregnancy<br />

1. What are <strong>the</strong> 3 most serious health problems among pregnant women in this area?<br />

List <strong>the</strong>m in order <strong>of</strong> how serious <strong>the</strong>y are.<br />

2. (Ask if malaria is not mentioned in Question 1) Is malaria a serious or common health problem among<br />

pregnant women in this community?<br />

C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />

1. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria among pregnant women?<br />

D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />

1. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />

2. Are pregnant women more susceptible to malaria? Do pregnant women with malaria get more severely<br />

ill than o<strong>the</strong>r people?<br />

Tool 6: Individual Interview/ Focus Group Guide for Health-Care Workers<br />

1


E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />

1. From whom do women seek advice regarding malaria or pregnancy issues in general?<br />

2. Who influences women <strong>the</strong> most when <strong>the</strong>y need information about pregnancy or malaria? For example, someone<br />

at <strong>the</strong> health facility, a traditional birth attendant, a midwife, someone else in <strong>the</strong> community (example village elder),<br />

or someone in <strong>the</strong>ir family?<br />

What is <strong>the</strong> order <strong>of</strong> seeking advice? First, second, third?<br />

3. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />

IF YES: please describe <strong>the</strong>ir role.<br />

4. What is <strong>the</strong> best (most effective) way to reach women in this community in order to provide <strong>the</strong>m malaria<br />

prevention and treatment information?<br />

F. Topical area: Preventive strategies<br />

1. In general, how do people protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probe for<br />

traditional remedies, use <strong>of</strong> insecticides, insecticide-treated nets or curtains, mosquito coils, dress, etc.)<br />

Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman or her baby? Yes___No___ IF YES: Which ones?<br />

IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />

2. What preventive methods are provided at <strong>the</strong> clinic?<br />

3. For intermittent preventive treatment (IPTp), what drugs are given?<br />

• When are <strong>the</strong>se given? How many doses do <strong>the</strong> women get?<br />

• Do you use directly observed treatments? Yes___ No___<br />

• Are <strong>the</strong>re any times when you can not do this? (Probes: for example, no drinkable water or drug shortages, woman<br />

complains that she has not eaten?)<br />

• If you do not see <strong>the</strong> woman taking <strong>the</strong> pill, do you think most women are compliant?<br />

• How are you recording <strong>the</strong> doses? For example, do you have a written record <strong>of</strong> women receiving doses or do you<br />

only ask <strong>the</strong> women if <strong>the</strong>y have received a dose? Is it written in <strong>the</strong>ir clinic cards?<br />

• When did this facility start implementing IPT?<br />

• What has been <strong>the</strong> response <strong>of</strong> <strong>the</strong> women to <strong>the</strong> IPTp? (Probe: Do <strong>the</strong>y see it as a welcome addition to antenatal<br />

care, are <strong>the</strong>y concerned about toxic effects to <strong>the</strong> baby?)<br />

4. What has been <strong>the</strong>ir response to insecticide-treated nets/nets?<br />

• Are <strong>the</strong>se provided to pregnant women? Yes___No___<br />

• Do you think most women sleep under <strong>the</strong>se nets? Yes___No___ IF NO: who sleeps under <strong>the</strong> net in most <strong>of</strong> <strong>the</strong>se<br />

families?<br />

• What comments have you heard from <strong>the</strong> women about <strong>the</strong> nets?<br />

• How are <strong>the</strong>y provided:<br />

o given free<br />

o given as a cost-sharing mechanism (If so, how much do you charge for <strong>the</strong> net?)<br />

o If using a cost-sharing mechanism, can most women afford <strong>the</strong>m? Yes___No___<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


G. Topic area: Treatment strategies<br />

1. What treatment do you use for a pregnant woman with uncomplicated malaria? Does this vary with gestational age?<br />

2. Are <strong>the</strong>re any antimalarials you will not use in pregnant women? Why? Does this vary with gestational age?<br />

3. What concerns do most women express regarding malaria treatments during pregnancy? (Probes: Are women<br />

concerned that <strong>the</strong> medicines are too harsh for <strong>the</strong> baby? Is <strong>the</strong> medicine worse for <strong>the</strong> baby or is <strong>the</strong> malaria worse?<br />

Will taking treatments during pregnancy put a curse on <strong>the</strong> baby?)<br />

H. Topical area: Acceptance <strong>of</strong> antenatal care (from health facilities and<br />

traditional birth attendants)<br />

1. How can health-care workers work better with traditional birth attendants? With o<strong>the</strong>r community-based workers?<br />

2. In your opinion, what could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />

3. How could services for pregnant women regarding <strong>the</strong> prevention and treatment <strong>of</strong> malaria be improved?<br />

4. Do you feel that you have had adequate training regarding malaria during pregnancy?<br />

BE SURE TO THANK THE HEALTH CARE WORKER FOR HIS OR HER TIME, AND ASK IF HE OR SHE HAS ANY<br />

QUESTIONS FOR YOU.<br />

Tool 6: Individual Interview/ Focus Group Guide for Health-Care Workers<br />

3


4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 7: Conducting Individual Interviews and<br />

Focus Groups with Traditional Birth<br />

Attendants (TBAs)<br />

Individual interviews and focus groups with traditional birth attendants<br />

(TBAs) are designed to determine<br />

• Role <strong>of</strong> TBAs in influencing pregnant women’s behavior in seeking antenatal<br />

care at health facilities<br />

• What types <strong>of</strong> preventive and treatment measures are currently being<br />

recommended and used<br />

• Factors that motivate or inhibit women from using antenatal care<br />

• Best methods for promoting health education messages to pregnant women<br />

This module contains sample materials relevant to conducting a focus group or an<br />

individual interview. <strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong><br />

<strong>the</strong> local situation.<br />

Contents<br />

A. Interview/Focus Group Timetable<br />

B. Focus Group or Individual Interview or Both?<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

D. Eligibility Criteria<br />

E. Venues and Equipment<br />

F. <strong>Assessment</strong> Team Members<br />

G. <strong>Assessment</strong> Team Training<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

I. Information Sheet<br />

J. Debriefing<br />

K. Focus Group/Interview Analysis<br />

In addition, please see Resource 2, which includes a Sample Interviewer Training<br />

Manual and a Resource List.<br />

Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />

1


A. Focus Group/Interview Timetable<br />

To prepare for focus groups or individual interviews, it is important to alert community<br />

leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits so that potential<br />

participants know that this activity will be occurring and that <strong>the</strong>y will be asked to participate.<br />

In addition, advance notice is needed so that community and/or facility focus groups can be<br />

established and that arrangements can be made for interview venues. It is helpful to follow up<br />

a week before <strong>the</strong> assigned meeting times.<br />

After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />

<strong>the</strong> focus groups/interviews can begin.<br />

B. Focus Group or Individual Interview or Both?<br />

It may not always be possible to conduct both focus groups and individual interviews and<br />

thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />

chosen based on <strong>the</strong> local situation.<br />

• Individual interviews are a better choice when individual variability within communities is<br />

<strong>of</strong> interest.<br />

• Focus group interviews elicit community norms.<br />

• Focus group interviews might help stimulate thinking and expose conflicting feelings–<strong>the</strong>y<br />

can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />

• Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which <strong>the</strong>y<br />

might individually be unaware or not <strong>of</strong>ten think about.<br />

•Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />

individual opinions or emotions.<br />

• Focus group interviews are better for a small number <strong>of</strong> issues.<br />

• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />

• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />

vehicles), and money—are limited.<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

At least one focus group with 5 to 15 participants per facility area. May wish to conduct<br />

interviews as well, depending on <strong>the</strong> available pool <strong>of</strong> potential participants.<br />

Note: Community health workers, church leaders, and primary school teachers can help<br />

identify TBAs who attend home births.<br />

D. Eligibility Criteria<br />

TBAs who attend home births and advise pregnant women are eligible.<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


E. Venues and Equipment<br />

<strong>The</strong> focus group will ideally be held in a quiet space within a village.<br />

Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a<br />

tape recorder if <strong>the</strong> decision to use one has been made.<br />

Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator<br />

and <strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong><br />

interested people, ask that a community member politely dismiss <strong>the</strong> crowd, with a brief<br />

explanation <strong>of</strong> what is occurring.<br />

Homes in villages near <strong>the</strong> health facilities can also serve as interview sites.<br />

<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />

have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />

that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session, even<br />

if a tape recorder is used.<br />

F. <strong>Assessment</strong> Team Members<br />

For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders<br />

are used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong><br />

summary <strong>of</strong> findings.<br />

An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />

interviews.<br />

G. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal<br />

Clinic and Delivery Unit Surveys.<br />

Training can include <strong>the</strong> following subjects:<br />

• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />

• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />

epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />

related to malaria)<br />

• differences between qualitative and quantitative studies<br />

• interviewing techniques<br />

• data recording techniques<br />

• differences between individual and focus group interviews<br />

For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />

can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />

to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />

sessions.<br />

To assist in building capacity in qualitative research methodologies, all team members can be<br />

given information on qualitative assessments and methodology, as well as written handouts on<br />

interviewing techniques.<br />

Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />

3


<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />

consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />

should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />

minor modifications in <strong>the</strong> interview guides can be made.<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide. <strong>The</strong><br />

guide will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder with<br />

<strong>the</strong> questions that will be discussed.<br />

<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />

It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />

<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See H below, Debriefing.<br />

Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r it<br />

is used for a focus group or an individual interview.<br />

I. Information Sheet<br />

<strong>The</strong> following information sheet should be given to each potential interview participant.<br />

If <strong>the</strong> person cannot read or has low literacy skills, <strong>the</strong> information should be read<br />

aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet<br />

to take home.<br />

Notes to interviewer:<br />

• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />

that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />

participant.<br />

• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />

different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />

scared, try to clarify <strong>the</strong>ir concerns.<br />

• If participant refuses to participate, please remember that this was an INVITATION to<br />

participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go on to <strong>the</strong> next person.<br />

• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />

keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />

4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Introduction<br />

<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />

pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />

malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women<br />

seek health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria<br />

when <strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and<br />

o<strong>the</strong>rs will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />

Purpose<br />

What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />

are pregnant will help us plan programs to decrease malaria in pregnant women.<br />

Procedures<br />

Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />

be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />

and do about malaria, and about where you get help and information about malaria. You also<br />

do not need to answer any questions that we ask that you do not want to. If you agree to<br />

participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue,<br />

you can withdraw at any time. We will not be asking for any blood or urine samples.<br />

Benefits<br />

Although what we learn might not help you directly, it will help us know how best to prevent<br />

malaria in pregnant women in this district.<br />

Risks or discomforts<br />

We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />

Would you like to participate?<br />

Thank you very much for your time.<br />

Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />

Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />

5


J. Debriefing<br />

Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />

focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />

hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />

<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />

Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />

data (qualitative methods are iterative, thus, you can change questions as needed as you<br />

conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />

sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />

show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />

if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />

<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />

collected that day), identifies what is common, what is different, and mutually agrees on what<br />

local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />

local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />

tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />

clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />

During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />

each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />

local language), as well as <strong>the</strong> agreed-upon translations.<br />

During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />

<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />

and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />

understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />

<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />

during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />

order to obtain <strong>the</strong> needed information.<br />

K. Focus Group/Interview Analysis<br />

Recording and analyzing information for a focus group is somewhat different from recording<br />

and analyzing information for an individual interview.<br />

For focus groups:<br />

• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />

details afterwards.<br />

• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />

participants felt <strong>the</strong> same way is.<br />

• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />

different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />

• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by <strong>the</strong>ir<br />

job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />

When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />

local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />

primary language used in <strong>the</strong> rapid assessment, if different.<br />

6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


TOOL 7: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />

TRADITIONAL BIRTH ATTENDANTS<br />

This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />

Region_______________________________<br />

Name <strong>of</strong> facility/facility area_______________<br />

Date: ____/____/____<br />

Month Day Year<br />

Time_________________________<br />

Interviewer_____________________<br />

Recorder____________________________<br />

INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />

participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />

A. Demographics: For each <strong>of</strong> <strong>the</strong> participants, record <strong>the</strong> following information:<br />

Age:<br />

Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />

For traditional birth attendants, number <strong>of</strong> years <strong>of</strong> experience as a traditional birth attendant:<br />

Ethnic group (If group is diverse):<br />

<br />

B. Topical area: Prevailing health problems and malaria in pregnancy<br />

1. What are <strong>the</strong> 3 most important health problems among pregnant women in this area?<br />

List <strong>the</strong>m in order <strong>of</strong> importance.<br />

2. (If malaria is not already mentioned in Question 1) Is malaria a serious or common health problem among pregnant<br />

women in this community?<br />

C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />

1. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria among pregnant women?<br />

D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />

1. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />

2. Are pregnant women more susceptible to malaria? Do pregnant women with malaria get more severely ill than<br />

o<strong>the</strong>r people?<br />

E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />

1. From whom do women seek advice regarding malaria or pregnancy issues in general?<br />

2. Who influences women <strong>the</strong> most when <strong>the</strong>y need information about pregnancy or malaria? For example, someone<br />

at <strong>the</strong> health facility, a traditional birth attendant, someone else in <strong>the</strong> community (example village elder), or<br />

someone in <strong>the</strong>ir family?<br />

What is <strong>the</strong> order <strong>of</strong> seeking advice? First, second, third?<br />

Tool 7: Individual Interview/ Focus Group Guide for Traditional Birth Attendants<br />

1


3. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />

IF YES: please describe <strong>the</strong>ir role.<br />

4. What is <strong>the</strong> best (most effective) way to reach women in this community in order to provide <strong>the</strong>m malaria<br />

prevention and treatment information?<br />

F. Topical Area: Preventive strategies<br />

1. In general, how do women protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant?<br />

(Probe for traditional methods: infusions, teas, smoke, leaves for dousing <strong>the</strong> walls, going to bed earlier; and<br />

modern methods: insecticides, use <strong>of</strong> nets or treated curtains; clo<strong>the</strong>s)<br />

Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman or <strong>the</strong> baby? Yes___No___<br />

IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />

2. Which preventive strategies do you think work best to prevent malaria when someone is pregnant? Please identify<br />

which method you think is most effective to use.<br />

G. Topical Area: Treatment sources<br />

1. What concerns do most women voice regarding malaria treatments during pregnancy?<br />

2. If a pregnant woman experiences a fever or malaria during pregnancy, what recommendations would you make?<br />

H. Topical Area: Acceptance <strong>of</strong> antenatal care<br />

1. When do most pregnant women in this area start to get antenatal care from a traditional birth attendant?<br />

2. How do traditional birth attendants give support and advice to pregnant women?<br />

(Probe: Do <strong>the</strong>y routinely make visits to a woman’s house?)<br />

3. Does <strong>the</strong> distance to <strong>the</strong> health care facility limit <strong>the</strong> number <strong>of</strong> women who can attend antenatal clinics in this<br />

district?<br />

4. What reasons have you heard as to why women in this community might not want to go to <strong>the</strong> health facility for<br />

antenatal care?<br />

(Probes: What types <strong>of</strong> complaints have you heard about <strong>the</strong> health facility?<br />

What have you heard about <strong>the</strong> attitudes <strong>of</strong> health care workers toward women in<br />

<strong>the</strong> clinics?)<br />

5. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />

6. What could be done to improve your services?<br />

7. What is <strong>the</strong> best way to encourage women to obtain antenatal care?<br />

(Probes: Have you seen successful strategies being used to increase <strong>the</strong> number <strong>of</strong> women who attend<br />

antenatal clinics?)<br />

I. Topical Area: Role <strong>of</strong> traditional birth attendants in influencing behaviors<br />

1. What advice do you give to pregnant women in regard to starting antenatal care? (Probe: Do you routinely make<br />

visits to a woman’s house?)<br />

2. Do you routinely refer pregnant women to antenatal care at a health facility? Yes__No__<br />

If not, why not?<br />

Under what circumstances?<br />

Do you give pregnant women cards to refer <strong>the</strong>m?<br />

3. Is <strong>the</strong>re a policy stating that traditional birth attendants should refer all pregnant women to <strong>the</strong> health care<br />

facilities?<br />

4. Do you follow up with women that you have referred to ask if <strong>the</strong>y have actually gone to <strong>the</strong> health facility after you<br />

have referred <strong>the</strong>m?<br />

5. If a pregnant woman comes to you experiencing fever/malaria during her pregnancy, what advice is routinely given<br />

to her?<br />

6. How can health care workers work better with traditional birth attendants?<br />

(Probes: Should health care workers provide any training to traditional<br />

birth attendants?)<br />

7. Do you think your own training is sufficient in <strong>the</strong> area <strong>of</strong> malaria during pregnancy?<br />

BE SURE TO THANK THE PARTICIPANTS FOR THEIR TIME, AND ASK IF THEY HAVE ANY QUESTIONS FOR YOU.<br />

2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 8: Conducting an Antenatal Clinic<br />

Client Exit Interview<br />

An antenatal clinic client exit interview is designed to determine<br />

• Client’s knowledge <strong>of</strong> malaria and experience with malaria prevention<br />

and treatment methods<br />

• Services received that day in <strong>the</strong> antenatal clinic<br />

• Satisfaction with services received<br />

This module contains sample materials for an Antenatal Clinic Client Exit Interview. <strong>The</strong>se materials can<br />

and should be adapted to suit local needs, including translating <strong>the</strong> information sheet into <strong>the</strong> pregnant<br />

woman’s primary language. General guidance for conducting assessment tools survey and managing data<br />

can be found in Chapters 3-4.<br />

A. Sample Sizes<br />

B. Study Site<br />

C. Eligibility Criteria<br />

D. Information Sheet<br />

E. Data Analysis<br />

Contents<br />

Module 8: Conducting an Antenatal Clinic<br />

31


A. Sample Sizes<br />

Note that <strong>the</strong> clients participating in <strong>the</strong> client exit interviews should not be <strong>the</strong> same clients<br />

that participate in <strong>the</strong> antenatal clinic survey. Approximately 15 women per site should be<br />

selected.<br />

B. Study Site<br />

<strong>The</strong> survey should be conducted at antenatal clinics. In countries with clinics that have<br />

specific antenatal care days, it would be most appropriate to conduct this survey on those<br />

days.<br />

C. Eligibility Criteria<br />

Women who participate in <strong>the</strong> Antenatal Clinic Client Exit Interview should be as<br />

representative as possible <strong>of</strong> all women attending <strong>the</strong> antenatal clinic. <strong>The</strong> eligibility<br />

criteria are <strong>the</strong> same as those for <strong>the</strong> antenatal clinic and delivery unit surveys. However,<br />

if women have participated in <strong>the</strong> antenatal clinic survey, <strong>the</strong>y should be excluded from<br />

participating in <strong>the</strong> exit interview.<br />

Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements :<br />

Gestation: Women who have experienced “quickening” (i.e., <strong>the</strong> recognition <strong>of</strong> fetal<br />

movement) are eligible.<br />

Gravidity: All gravidities. Although primigravidae and secundigravidae are <strong>the</strong> groups<br />

typically most affected by malaria in high transmission areas, women <strong>of</strong> all gravidities should<br />

be eligible so that <strong>the</strong> local situation can be confirmed.<br />

Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />

most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />

and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> age <strong>of</strong><br />

<strong>the</strong> youngest participants may well be less than <strong>the</strong> age <strong>of</strong> majority and should be consistent<br />

with any country policy or norm regarding this type <strong>of</strong> survey.<br />

Women are not eligible for <strong>the</strong> client exit interview if <strong>the</strong>y have participated in <strong>the</strong><br />

Antenatal Clinic Survey.<br />

D. Information Sheet<br />

<strong>The</strong> following information sheet should be given to each potential survey participant.<br />

If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong> information<br />

should be read aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong><br />

information sheet to take home.<br />

Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or if she has low literacy<br />

skills, read this information aloud to her. Give each potential survey participant a copy <strong>of</strong> this<br />

information sheet to take home.<br />

2<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Introduction<br />

<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />

[assessment area] have malaria and to find out <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong> malaria<br />

on pregnant women and <strong>the</strong>ir babies. We plan to assess this problem in about _____ women in<br />

antenatal clinics in <strong>the</strong> [assessment area].<br />

Purpose <strong>of</strong> <strong>the</strong> Survey<br />

In this survey, we’d like to find out more about <strong>the</strong> services you received today in <strong>the</strong> antenatal<br />

clinic and how satisfied you are with <strong>the</strong> services you received.<br />

This will help us better plan programs to decrease malaria in pregnant women.<br />

Procedures<br />

If you agree to participate in this survey, we will ask you some questions about yourself and<br />

your antenatal care visit. We will not be telling anyone about your individual answers to <strong>the</strong><br />

questions, and we will keep all assessment information about you safe and secure. You also do<br />

not need to answer any questions on <strong>the</strong> survey forms that you do not want to. <strong>The</strong> survey will<br />

take about “x” minutes.<br />

If you do not wish to participate in this survey, it will not affect <strong>the</strong> care given to you by <strong>the</strong><br />

clinic. If you have questions later, please feel free to ask. You can ask me today or if you have<br />

questions later, you can ask _________________ (responsible assessment team member).<br />

Thank you very much for your time. Would you like to participate?<br />

Remind participant to keep this information sheet in case <strong>the</strong>re are questions later on.<br />

E. Data Analysis<br />

Antenatal Clinic Client Exit Interview results can be summarized as tables or graphs.<br />

Outcome variables include <strong>the</strong> following:<br />

Percentage <strong>of</strong> pregnant women satisfied with <strong>the</strong> services <strong>the</strong>y received<br />

Percentage <strong>of</strong> women who use antimalarial drugs for treatment and prevention <strong>of</strong> malaria<br />

Percentage <strong>of</strong> women who use ITNs<br />

Module 8: Conducting an Antenatal Clinic<br />

3


4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Woman’s full name:<br />

ID #_____A________<br />

TOOL 8: CLIENT EXIT INTERVIEW<br />

Today’s date: _____/_____/_____<br />

Day Month Year<br />

ID number: ___ _A__ -- ___ ___ ___<br />

Digit 1 = facility number Digit 2 = A (for Antenatal Clinic)<br />

Digits 3, 4 & 5 = woman’s consecutive number<br />

SCREENING INFORMATION:<br />

Interviewer number _______<br />

1. Age (years):: [ ]<br />

(If <strong>the</strong> mo<strong>the</strong>r does not know her age, <strong>the</strong>n estimate her age using <strong>the</strong> categories below)<br />

less than 15 years [ ] 30-34 years [ ]<br />

15-19 years [ ] 35-39 years [ ]<br />

20-24 years [ ] 40-44 years [ ]<br />

25-29 years [ ] more than 44 years [ ]<br />

If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time, and DO<br />

NOT enroll her<br />

in this survey.<br />

2. Did you receive antenatal care services today? [ ]<br />

YES = 1<br />

NO = 2 (skip to end <strong>of</strong> interview)<br />

UNKNOWN = 9<br />

If <strong>the</strong> woman did not receive antenatal care services, thank her for her time, and DO<br />

NOT enroll her in this survey.<br />

3. Have you felt <strong>the</strong> baby move inside you yet? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

If <strong>the</strong> woman has not experienced quickening, thank her for her time, and<br />

DO NOT enroll her in this survey.<br />

4. What village/town do you live in? _______________________________________________________________<br />

Interviewer: skip <strong>the</strong> next question; to be coded later so that it is done uniformly.<br />

5. Is this a rural or urban area? [ ]<br />

Urban = 1<br />

Rural = 2<br />

Periurban = 3<br />

Unknown = 9<br />

6. What language do you usually speak with family members at home? [ ]<br />

Language a = 1<br />

Language b = 2<br />

Language c = 3<br />

O<strong>the</strong>r = 8 (specify) ______________________________________<br />

<br />

Tool 8: Conducting an Antenatal Clinic 1


EDUCATION<br />

7. What is <strong>the</strong> highest level <strong>of</strong> school you attended? [ ]<br />

Primary = 1<br />

Secondary = 2<br />

Higher = 3<br />

Never attended = 4<br />

Unknown = 9<br />

8. Can you read? [ ]<br />

YES = 1 NO = 2<br />

SOCIOECONOMIC INDICATORS<br />

9. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />

corrugated iron = 1<br />

cement or concrete = 2<br />

wood and mud = 3<br />

thatch or grass = 4<br />

reed or bamboo = 5<br />

plastic sheet = 6<br />

mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />

o<strong>the</strong>r = 8 (specify) __________________________________<br />

10. What kind <strong>of</strong> floor does your house have? [ ]<br />

earth or sand = 1<br />

dung = 2<br />

wood planks = 3<br />

reed or bamboo = 4<br />

vinyl tiles or carpet = 5<br />

cement = 6<br />

cement tiles or brick = 7<br />

o<strong>the</strong>r = 8 (specify) ___________________________________<br />

11. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />

job a = 1<br />

job b = 2<br />

job c = 3<br />

job d = 4<br />

12. What is <strong>the</strong> monthly household income for your family? [ ]<br />

income bracket a = 1<br />

income bracket b= 2<br />

income bracket c=3<br />

(FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE)<br />

13. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound:<br />

YES = 1 NO = 2<br />

Own a bicycle/scooter/moped? [ ]<br />

Own a radio? [ ]<br />

Own a TV? [ ]<br />

Own <strong>the</strong> house you are living in? [ ]<br />

Own crop land? [ ]<br />

Grow cash crops? [ ]<br />

2<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


MARITAL STATUS<br />

14. Are you married? [ ]<br />

yes, married or living with a man = 1<br />

was married or living with a man, but separated or divorced = 2<br />

widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 3<br />

never married or lived with a man = 4<br />

ANTENATAL CARE<br />

Pregnancy and Antenatal Care<br />

15. How many times have you been pregnant in your life (including this one)?[ ]<br />

16. How many months pregnant are you now? [ ] (Months)<br />

Antenatal Care Received<br />

Interviewer please read to respondent: Now I am going to ask you about your visit today.<br />

17. Were you asked how you are feeling? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

18. Was <strong>the</strong> place (abdomen) where <strong>the</strong> baby is growing (fundal height) measured? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

19. Did someone listen to your baby’s heart? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

20. Was your blood pressure taken? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

21. Did someone check your urine? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

22. Did you receive counseling or health education? [ ]<br />

YES = 1<br />

NO = 2 (skip to question 23)<br />

UNKNOWN = 9 (skip to question 23)<br />

22a. If YES, what topics did <strong>the</strong> service provider discuss?<br />

______________________________________________________________<br />

______________________________________________________________<br />

______________________________________________________________<br />

Tool 8: Client Exit Interview<br />

3


23. Did someone help you make up or review your special birth plan that tells where you’ll be giving birth,<br />

who will be <strong>the</strong>re, and what you’ll need at <strong>the</strong> birth for yourself and <strong>the</strong> baby? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

24. Were you given an insecticide-treated bednet? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

24a. Is today <strong>the</strong> first time you are attending <strong>the</strong> clinic for antenatal care during this pregnancy? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

25. Were you given or prescribed any tablets or drugs? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

Medications/Tablets<br />

Instructions to interviewer: Mark down each kind <strong>of</strong> tablet provided to <strong>the</strong> client<br />

26. Please show me <strong>the</strong> medication/tablets you received today. [ ] [ ] [ ] [ ]<br />

Combined iron and folate = 1<br />

Fansidar = 2<br />

Chloroquine = 3<br />

Hookworm medications = 4<br />

STI medications = 5<br />

O<strong>the</strong>r = 9 (specify) ________________________________________________<br />

27. What is <strong>the</strong> purpose <strong>of</strong> each <strong>of</strong> <strong>the</strong> medications/ tablets that you received<br />

today? [ ] [ ] [ ] [ ]<br />

(Mark all that apply)<br />

Prevent anemia = 1<br />

Prevent malaria = 2<br />

Treat malaria = 3<br />

Prevent congenital malformations = 4<br />

Treat worms = 5<br />

Treat STIs = 6<br />

Did not receive any = 7<br />

O<strong>the</strong>r = 9 (specify) _____________________________________________<br />

Unknown = 9<br />

4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


28. Did you receive any medications/tablets during your last antenatal care visit? [ ]<br />

Yes = 1<br />

No = 2 (skip to question 29)<br />

First antenatal care visit = 3 (skip to question 29)<br />

Unknown/can’t remember = 9 (skip to question 29)<br />

28a. If YES, did you take all <strong>the</strong> tablets you received during your last antenatal<br />

care visit? [ ]<br />

YES = 1<br />

NO = 2<br />

Don’t know/can’t remember = 9<br />

CLIENT SATISFACTION<br />

Interviewer please read to respondent: Now I am going to ask you a few questions about <strong>the</strong> services that you<br />

received today at <strong>the</strong> clinic.<br />

29. About how long did you wait between <strong>the</strong> time you first arrived at <strong>the</strong> clinic and <strong>the</strong> time you received antenatal<br />

services? [ ]<br />

Less than 15 minutes = 1<br />

16-30 minutes = 2<br />

31-45 minutes = 3<br />

46-60 minutes = 4<br />

more than 60 minutes = 5<br />

Unknown = 9<br />

30. Do you feel that your waiting time was reasonable or too long? [ ]<br />

No waiting time = 1<br />

Reasonable/short = 2<br />

Too long = 3<br />

Unknown = 9<br />

31. Did you have enough privacy during your consultation? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

32. Did you feel comfortable to ask <strong>the</strong> provider questions during your visit today? [ ]<br />

YES = 1<br />

NO =2<br />

UNKNOWN = 9<br />

33. Did <strong>the</strong> provider answer all <strong>of</strong> your questions today? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

Tool 8: Client Exit Interview<br />

5


34. Do you feel <strong>the</strong> information you shared about yourself with <strong>the</strong> provider will be kept confidential? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

35. During your visit today, how were you treated by <strong>the</strong> service provider(s)? [ ]<br />

Very well = 1<br />

Well = 2<br />

Badly = 3<br />

Very badly = 4<br />

O<strong>the</strong>r = 9 (specify) ___________________________________________<br />

Unknown = 9<br />

36. How satisfied are you, overall, with <strong>the</strong> services that you received today? [ ]<br />

Very satisfied = 1<br />

Somewhat satisfied = 2<br />

Not very satisfied = 3<br />

Completed unsatisfied = 4<br />

Unknown = 9<br />

37. Do you plan to come to ano<strong>the</strong>r visit at this clinic? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

38. Would you encourage a friend or relative <strong>of</strong> yours to come to this facility for antenatal care services? [ ]<br />

YES = 1<br />

NO = 2<br />

UNKNOWN = 9<br />

Thank respondent for her time.<br />

INTERVIEWER COMMENTS:<br />

(Please note any additional observations in <strong>the</strong> space below):<br />

6<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 9: Conducting Interviews and Focus<br />

Groups with Recently or Currently Pregnant Women<br />

Individual interviews or focus groups with recently/currently pregnant women are<br />

designed to determine<br />

• How pregnant women understand <strong>the</strong> problem <strong>of</strong> malaria in pregnancy<br />

• What types <strong>of</strong> preventive and treatment measures are currently being recommended and used<br />

• Factors that motivate or inhibit women from using antenatal care<br />

• Best methods for promoting health education messages to pregnant women<br />

• Acceptance and usage <strong>of</strong> antimalarials during pregnancy.<br />

This module contains sample materials relevant to conducting a focus group or an individual interview. <strong>The</strong>se<br />

materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong> <strong>the</strong> local situation.<br />

A. Focus Group/Interview Timetable<br />

Contents<br />

B. Focus Group or Individual Interview or Both?<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

D. Eligibility Criteria<br />

E. Venues and Equipment<br />

F. <strong>Assessment</strong> Team Members<br />

G. <strong>Assessment</strong> Team Training<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

I. Information Sheet<br />

J. Debriefing<br />

K. Focus Group/Interview Analysis<br />

Please see Resource 2, which includes a Sample Interviewer Training Manual and a Resource List.<br />

Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />

1


A. Focus Group/Interview Timetable<br />

To prepare for focus groups or individual interviews, it is important to alert health facilities<br />

and community leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong><br />

facilities so that potential participants know that this activity will be occurring and that <strong>the</strong>y<br />

will be asked to participate. In addition, advance notice is needed so that community and/<br />

or facility focus groups can be established and that arrangements can be made for interview<br />

venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />

After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />

<strong>the</strong> focus groups/interviews can begin.<br />

B. Focus Group or Individual Interview or Both?<br />

It may not always be possible to conduct both focus groups and individual interviews and<br />

thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />

chosen based on <strong>the</strong> local situation.<br />

• Individual interviews are a better choice when individual variability within communities is<br />

<strong>of</strong> interest.<br />

• Focus group interviews elicit community norms.<br />

• Focus group interviews might help stimulate thinking and expose conflicting feelings–<strong>the</strong>y<br />

can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />

• Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which <strong>the</strong>y<br />

might individually be unaware or not <strong>of</strong>ten think about.<br />

• Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />

individual opinions or emotions.<br />

• Focus group interviews are better for a small number <strong>of</strong> issues.<br />

• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />

• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />

vehicles), and money—are limited.<br />

C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />

At least one focus group with 5 to 15 participants for each facility. Four to five individual<br />

interviews per facility.<br />

D. Eligibility Criteria<br />

<strong>The</strong> only criterion is that <strong>the</strong> women who are in <strong>the</strong> focus group or who are participating in <strong>the</strong><br />

interview should ei<strong>the</strong>r be pregnant or have been recently pregnant (within <strong>the</strong> last 2 years).<br />

E. Venues and Equipment<br />

<strong>The</strong> focus group will ideally be held in a quiet space in a health facility or within a village.<br />

Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a<br />

tape recorder if <strong>the</strong> decision to use one has been made.<br />

Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator and<br />

<strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong> interested<br />

people, ask that a member <strong>of</strong> <strong>the</strong> health-care facility or a community member politely<br />

dismiss <strong>the</strong> crowd, with a brief explanation <strong>of</strong> what is occurring.<br />

Individual interviews can also be conducted at health facilities. Homes in villages near <strong>the</strong><br />

health facilities can also serve as interview sites.<br />

62<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />

have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />

that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session,<br />

even if a tape recorder is used.<br />

F. <strong>Assessment</strong> Team Members<br />

For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders<br />

are used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong><br />

summary <strong>of</strong> findings.<br />

An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />

interviews.<br />

G. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal<br />

Clinic and Delivery Unit Surveys.<br />

Training can include <strong>the</strong> following subjects:<br />

• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />

• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />

epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />

related to malaria)<br />

• differences between qualitative and quantitative studies<br />

• interviewing techniques<br />

• data recording techniques<br />

• differences between individual and focus group interviews<br />

For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />

can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />

to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />

sessions.<br />

To assist in building capacity in qualitative research methodologies, all team members<br />

can be given information on qualitative assessments and methodology, as well as written<br />

handouts on interviewing techniques.<br />

<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are<br />

linguistically consistent. In addition, using <strong>the</strong> team members as community experts, each<br />

interview guide should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong><br />

this district, and minor modifications in <strong>the</strong> interview guides can be made.<br />

H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide.<br />

<strong>The</strong> guide will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder<br />

with <strong>the</strong> questions that will be discussed.<br />

<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />

It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />

<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See J below, Debriefing.<br />

Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r<br />

it is used for a focus group or an individual interview.<br />

Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />

13


I. Information Sheet<br />

<strong>The</strong> following information sheet should be given to each potential interview participant.<br />

If <strong>the</strong> person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to<br />

her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />

Notes to interviewer:<br />

• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />

that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />

participant.<br />

• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />

different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />

scared, try to clarify <strong>the</strong>ir concerns.<br />

• If participant refuses to participate, please remember that this was an INVITATION to<br />

participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />

• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />

keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />

Introduction<br />

<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />

pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />

malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women seek<br />

health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria when<br />

<strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and o<strong>the</strong>rs<br />

will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />

Purpose<br />

What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />

are pregnant will help us plan programs to decrease malaria in pregnant women.<br />

Procedures<br />

Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />

be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />

and do about malaria, and about where you get help and information about malaria. You also<br />

do not need to answer any questions that we ask that you do not want to. If you agree to<br />

participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />

can withdraw at any time. We will not be asking for any blood or urine samples.<br />

Benefits<br />

Although what we learn might not help you directly, it will help us know how best to prevent<br />

malaria in pregnant women in this district.<br />

Risks or discomforts<br />

We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />

Would you like to participate?<br />

Thank you very much for your time.<br />

Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />

4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


J. Debriefing<br />

Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />

focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />

hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />

<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />

Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />

data (qualitative methods are iterative, thus, you can change questions as needed as you<br />

conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />

sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />

show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />

if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />

<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />

collected that day), identifies what is common, what is different, and mutually agrees on what<br />

local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />

local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />

tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />

clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />

During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />

each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />

local language), as well as <strong>the</strong> agreed-upon translations.<br />

During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />

<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />

and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />

understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />

<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />

during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />

order to obtain <strong>the</strong> needed information.<br />

K. Focus Group/Interview Analysis<br />

Recording and analyzing information for a focus group is somewhat different from recording<br />

and analyzing information for an individual interview.<br />

For focus groups:<br />

• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />

details afterwards.<br />

• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />

participants felt <strong>the</strong> same way is.<br />

• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />

different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />

• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by <strong>the</strong>ir<br />

job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />

When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />

local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />

primary language used in <strong>the</strong> rapid assessment, if different.<br />

Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />

5


6<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


TOOL 9: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />

PREGNANT WOMEN AND RECENTLY PREGNANT WOMEN<br />

This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />

Interview information<br />

Region___________________________<br />

Name <strong>of</strong> facility/facility area___________________________<br />

Date: ____/____/____<br />

Month Day Year<br />

Time______________________________________<br />

Interviewer_________________________________<br />

Recorder___________________________________<br />

INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />

participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />

A. Demographics:<br />

For each <strong>of</strong> <strong>the</strong> participants, record <strong>the</strong> following information:<br />

Age<br />

Marital status<br />

Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />

Total number <strong>of</strong> pregnancies, including this one<br />

Date <strong>of</strong> last delivery<br />

Ethnic group<br />

Religion<br />

B. Topical Area: Preventive strategies<br />

1. In general, how do people protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probes: types<br />

<strong>of</strong> traditional remedies...infusions, teas, smoke, leaves for dousing <strong>the</strong> walls; use <strong>of</strong> nets or treated curtains; going to<br />

bed earlier; clo<strong>the</strong>s)<br />

Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman? YES/NO<br />

IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />

2. What do you personally do to protect yourself against malaria when you are pregnant? (Probes: Would you be<br />

willing to try anything else? For example, would you be willing to take <strong>the</strong> drug Fansidar to guard against malaria?)<br />

3. Which things do you think work best to prevent malaria when someone is pregnant? [Can rank items]<br />

4. Do you routinely use a mosquito net? YES/NO<br />

IF YES: is it treated with an insecticide? YES/NO<br />

How many persons live in your house? ________ How many sleep under a net?__________<br />

If you have only one net, who sleeps under it? (Who made that decision?)<br />

5. What effect does malaria have on you when you are pregnant? (Probes: how does malaria affect <strong>the</strong> baby?<br />

What happens to you?)<br />

6. Do you take medicine at <strong>the</strong> antenatal clinic to help prevent malaria?<br />

<br />

Tool 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />

1


C. Topical Area: Treatment sources<br />

1. Where do you go for antenatal care?<br />

2. In this area, where is <strong>the</strong> best place to go for antenatal care? Why?<br />

3. If you got sick with malaria when you were pregnant, what would you do?<br />

4. Have you ever taken <strong>the</strong> drug (insert <strong>the</strong> name <strong>of</strong> <strong>the</strong> recommended treatment drug) when you were pregnant?<br />

YES/NO<br />

IF YES: did you have any problems taking <strong>the</strong> drug? YES/NO<br />

5. Did <strong>the</strong> malaria go away/Did you feel better? YES/NO<br />

6. Have you ever taken <strong>the</strong> drug Fansidar when you were pregnant? YES/NO<br />

If YES: Was it given to you to prevent malaria? YES/NO<br />

IF YES: Did you have any problems taking <strong>the</strong> drug? YES/NO<br />

7. Did <strong>the</strong> malaria go away/Did you feel better? YES/NO<br />

8. What types <strong>of</strong> things have people recommended that you should do to treat malaria in pregnancy?<br />

9. Of <strong>the</strong>se, are <strong>the</strong>re any that you will not or can not do? WHY? (Probes: it is unsafe for you? Is it unsafe for <strong>the</strong> baby?<br />

Is it too expensive? Do you understand why <strong>the</strong>y are suggesting it?)<br />

D. Topical Area: Acceptance <strong>of</strong> antenatal care<br />

1. How far do you live from <strong>the</strong> clinic/hospital (probe: Where could you receive care for <strong>the</strong> pregnancy)?<br />

2. When you come for a visit, how do you get to <strong>the</strong> health care facility? (Probe: Is <strong>the</strong>re transport available? What do<br />

you do in emergency situations? How many hours must you travel for care?)<br />

3. Have you been referred to a higher level health facility for care during your pregnancy? YES/NO<br />

IF YES, did you follow-up and go to <strong>the</strong> clinic? YES/NO<br />

4. When do most pregnant women in this area start to get antenatal care from a clinic?<br />

IF SHE ANSWERS “IN SECOND or THIRD TRIMESTER”: Why do women wait until <strong>the</strong>n<br />

to get care?<br />

5. When did you first get care?<br />

IF ANSWERS “IN SECOND OR THIRD TRIMESTER”: Why did you wait until <strong>the</strong>n to get care?<br />

6. What is <strong>the</strong> cost <strong>of</strong> basic antenatal care in this community? [ ]<br />

Is that too expensive? YES/NO (Probes: How do you get <strong>the</strong> money to pay for it?<br />

Are <strong>the</strong>re times in <strong>the</strong> year that you can not come because you don’t have enough money? Does someone help you<br />

pay for it? IF YES: who? Do you ever barter goods for service?)<br />

7. When you come for care, are you satisfied with <strong>the</strong> services? (Probes: Are you treated well, do you receive any<br />

education while here? IF YES: from whom? Do you feel comfortable in asking questions?)<br />

What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health care center?<br />

2<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


E. Topical Area: Acceptability <strong>of</strong> treatments for malaria during pregnancy<br />

1. Do you routinely go to <strong>the</strong> clinic/hospital for antenatal care? YES/NO<br />

If YES: Do you go during pregnancy because you have an appointment or because you think you need to go?<br />

IF YES to QE1: Do <strong>the</strong>y give you any medicine to prevent malaria in pregnancy? YES/NO<br />

IF YES: What do <strong>the</strong>y give you?<br />

Did anyone talk to you about <strong>the</strong> drug? What things did <strong>the</strong>y tell you? (Probes: When and how <strong>of</strong>ten should you take<br />

<strong>the</strong> drug? What side effects should you look for? When should you return to <strong>the</strong> clinic?}<br />

Are you currently using it?<br />

IF YES: how <strong>of</strong>ten?<br />

2. Are <strong>the</strong>re o<strong>the</strong>r treatments to use against malaria that can be used when you are pregnant? (Probes: Have you<br />

taken chloroquine, Fansidar, or o<strong>the</strong>r pills? How <strong>of</strong>ten? Are <strong>the</strong>re traditional medicines that can be used?)<br />

3. Can you please tell me all <strong>the</strong> traditional medicines, home remedies, or treatments that you know <strong>of</strong> that can be<br />

used to treat malaria in a pregnant woman?<br />

OF THIS LIST: which ones work best?<br />

4. Can you tell me about traditional taboos related to pregnancy and malaria in this area?<br />

F. Topical Area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />

1. If you had a problem with <strong>the</strong> pregnancy, or got sick while pregnant, to whom would you ask advice?<br />

2. Who provides <strong>the</strong> best information about how to manage malaria when you are pregnant?<br />

What information have you been given about malaria from that person?<br />

3. What kind <strong>of</strong> roles do husbands in families play in deciding whe<strong>the</strong>r a woman should seek antenatal care or advice<br />

from lay midwives? (Probes: Do husbands play an active role in assisting pregnant women, or is this normally done<br />

by women in <strong>the</strong> household? Do you normally go to your mo<strong>the</strong>r or mo<strong>the</strong>r-in-law for advice? Do husbands ever go<br />

to clinic with you when you are pregnant?)<br />

Do husbands also play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />

4. If <strong>the</strong>re was a new treatment for malaria during pregnancy, how would you hear about it? (Probes: How do you hear<br />

about important news in your village? Is <strong>the</strong>re one person to whom everyone goes to ask advice, such as a village<br />

headman?)<br />

G. Topical Area: Drug-purchasing behaviors<br />

1. If you get sick when you are pregnant, where do you get medicine? (Probes: do you take bottles to <strong>the</strong> clinic with<br />

you and get drugs from <strong>the</strong> dispensary? Do you buy drugs from <strong>the</strong> regular market or o<strong>the</strong>r types <strong>of</strong> shops? Mobile<br />

drug vendors? If so, where? Do traditional healers in this area give out western medicines?)<br />

FOR EACH SOURCE OF MEDICINE MENTIONED ABOVE, ASK THE FOLLOWING QUESTION:<br />

2a. Do/does __________ <strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />

If YES: Is it helpful?<br />

2b. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />

If YES: Is it helpful?<br />

Tool 9: Individual Interview/ Focus Group Guide for Pregnant and Recently Pregnant Women<br />

3


2c. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />

If YES: Is it helpful?<br />

2d. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />

If YES: Is it helpful?<br />

3. Once you feel better, do you ever save <strong>the</strong> remaining pills to take <strong>the</strong> next time you are have malaria? YES/NO<br />

4. Where is <strong>the</strong> BEST place to get drugs to treat malaria when you are pregnant? WHY?<br />

5. What drugs would you take for malaria when you are pregnant?<br />

6. Who do you trust most in giving advice about drugs when you are pregnant?<br />

H. Topical Area: Role <strong>of</strong> traditional birth attendants and health care workers in<br />

influencing behaviors<br />

1. How do traditional birth attendants and health care workers give support and advice to pregnant women?<br />

2. Do traditional birth attendants and health care workers in this community recommend that pregnant women<br />

attend antenatal clinics or do <strong>the</strong>y leave that decision to individual women?<br />

3. Is it better to see a traditional birth attendant or go to a health center for antenatal care? Why?<br />

THANK RESPONDENT FOR HER TIME, AND ASK HER IF THERE ARE ANY QUESTIONS.<br />

PLEASE NOTE ANY ADDITIONAL OBSERVATIONS IN THE SPACE BELOW.<br />

4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Module 10: Conducting Interviews with<br />

Key Informants<br />

Individual interviews with key informants are designed to determine<br />

• How pregnant women understand <strong>the</strong> problem <strong>of</strong> malaria in pregnancy<br />

• What types <strong>of</strong> preventive and treatment measures are currently being recommended and used<br />

• Factors that motivate or inhibit women from using antenatal care<br />

• Best methods for promoting health education messages to pregnant women<br />

This module contains sample materials relevant to conducting an individual interview.<br />

<strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong> <strong>the</strong> local situation.<br />

A. Focus Group/Interview Timetable<br />

B. Number <strong>of</strong> Individual Interviews<br />

C. Eligibility Criteria<br />

D. Venues and Equipment<br />

E. <strong>Assessment</strong> Team Members<br />

F. <strong>Assessment</strong> Team Training<br />

Contents<br />

G. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />

H. Information Sheet<br />

I. Debriefing<br />

J. Focus Group/Interview Analysis<br />

See Resource 2, which includes a Sample Interviewer Training Manual and a<br />

Resource List.<br />

Module 10: Conducting Interviews with Key Informants<br />

1


A. Interview Timetable<br />

To prepare for individual interviews, it is important to alert health facilities and community<br />

leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong> facilities so<br />

that potential participants know that this activity will be occurring and that <strong>the</strong>y will be asked<br />

to participate. In addition, advance notice is needed so that arrangements can be made for<br />

interview venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />

After planning for <strong>the</strong> interviews, selecting sites, and training interviewers, <strong>the</strong> interviews can<br />

begin.<br />

B. Number <strong>of</strong> Individual Interviews<br />

Individual interviews with two to four key informants per site. Individual interviews are<br />

strongly preferred to focus groups.<br />

C. Eligibility Criteria<br />

Key informants can include esteemed members <strong>of</strong> <strong>the</strong> community (“opinion leaders”), elders,<br />

someone who is trusted for advice and o<strong>the</strong>rs. Key informants can be identified by asking<br />

o<strong>the</strong>r assessment participants and health facility team members to identify community<br />

members from whom women sought advice concerning pregnancy. Names <strong>of</strong> key informants<br />

usually emerge consistently as people start to identify a few people known to have knowledge/<br />

expertise in this area. A leader <strong>of</strong> a local women’s group, for example, might be named as a key<br />

informant.<br />

D. Venues and Equipment<br />

Individual interviews can be conducted at health facilities or homes in villages near <strong>the</strong> health<br />

facilities.<br />

<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />

have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual).<br />

E. <strong>Assessment</strong> Team Members<br />

An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />

interviews.<br />

F. <strong>Assessment</strong> Team Training<br />

<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal Clinic<br />

and Delivery Unit Surveys.<br />

Training can include <strong>the</strong> following subjects:<br />

• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />

• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />

epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />

related to malaria)<br />

• differences between qualitative and quantitative studies<br />

• interviewing techniques<br />

• data recording techniques<br />

• differences between individual and focus group interviews<br />

42<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />

can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />

to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />

sessions.<br />

To assist in building capacity in qualitative research methodologies, all team members can be<br />

given information on qualitative assessments and methodology, as well as written handouts on<br />

interviewing techniques.<br />

<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />

consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />

should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />

minor modifications in <strong>the</strong> interview guides can be made.<br />

G. Notes Regarding <strong>the</strong> Interview Guide<br />

<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />

It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />

<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See I below, Debriefing.<br />

H. Information Sheet<br />

<strong>The</strong> following information sheet should be given to each potential interview participant. If <strong>the</strong><br />

person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to her. All<br />

potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />

Notes to interviewer:<br />

• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />

that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />

participant.<br />

• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />

different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />

scared, try to clarify <strong>the</strong>ir concerns.<br />

• If participant refuses to participate, please remember that this was an INVITATION to<br />

participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />

• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />

keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />

Module 10: Conducting Interviews with Key Informants<br />

3


Introduction<br />

<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />

pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />

malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women seek<br />

health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria when<br />

<strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and o<strong>the</strong>rs<br />

will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />

Purpose<br />

What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />

are pregnant will help us plan programs to decrease malaria in pregnant women.<br />

Procedures<br />

Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />

be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />

and do about malaria, and about where you get help and information about malaria. You also<br />

do not need to answer any questions that we ask that you do not want to. If you agree to<br />

participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />

can withdraw at any time. We will not be asking for any blood or urine samples.<br />

Benefits<br />

Although what we learn might not help you directly, it will help us know how best to prevent<br />

malaria in pregnant women in this district.<br />

Risks or discomforts<br />

We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />

Would you like to participate?<br />

Thank you very much for your time.<br />

Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />

4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


I. Debriefing<br />

Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />

focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />

hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />

<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />

Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />

data (qualitative methods are iterative, thus, you can change questions as needed as you<br />

conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />

sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />

show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />

if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />

<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />

collected that day), identifies what is common, what is different, and mutually agrees on what<br />

local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />

local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />

tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />

clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />

During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />

each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />

local language), as well as <strong>the</strong> agreed-upon translations.<br />

During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />

<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />

and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />

understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />

<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />

during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />

order to obtain <strong>the</strong> needed information.<br />

J. Interview Analysis<br />

Recording and analyzing information for a focus group is somewhat different from recording<br />

and analyzing information for an individual interview.<br />

When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />

local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />

primary language used in <strong>the</strong> rapid assessment, if different.<br />

Module 10: Conducting Interviews with Key Informants<br />

5


6<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


TOOL 10: INDIVIDUAL INTERVIEW GUIDE<br />

FOR KEY INFORMANTS<br />

Region___________________________<br />

Name <strong>of</strong> facility/facility area___________________________<br />

Date: ____/____/____<br />

Month Day Year<br />

Time______________________________________<br />

Interviewer_________________________________<br />

Recorder___________________________________<br />

INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />

participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> information, as applicable<br />

A. Demographics<br />

Age:<br />

Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />

Ethnic group:<br />

Pr<strong>of</strong>ession or position in <strong>the</strong> community:<br />

B. Topical area: Prevailing health problems and malaria in pregnancy<br />

1. What are <strong>the</strong> 3 most common health problems among pregnant women in this area?<br />

List <strong>the</strong>m in order <strong>of</strong> how common <strong>the</strong>y are.<br />

2. Which <strong>of</strong> <strong>the</strong>se 3 problems is <strong>the</strong> most severe?<br />

<br />

3. (Ask if malaria is not mentioned in Question 1) Is malaria a serious or common health problem among pregnant<br />

women in this community?<br />

C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />

1. What are <strong>the</strong> 3 most common illnesses in pregnancy that cause fever in this area?<br />

(Be sure to note local terms.)<br />

2. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria?<br />

3. Are <strong>the</strong>se signs and symptoms different for pregnant women? If so, how?<br />

Tool 10: Conducting Interviews with Key Informants<br />

1


D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />

1. What are <strong>the</strong> causes <strong>of</strong> malaria?<br />

2. Are <strong>the</strong> causes different for pregnant women than for o<strong>the</strong>r people?<br />

3. Are pregnant women more susceptible to malaria? If so, why? At what months <strong>of</strong> gestation?<br />

4. Do pregnant women with malaria get more severely ill than o<strong>the</strong>r people?<br />

5. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />

E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />

1. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />

If YES: Please describe <strong>the</strong>ir role.<br />

2. If <strong>the</strong>re were a new treatment for malaria during pregnancy, what would be <strong>the</strong> best way to get that information to<br />

pregnant women?<br />

(Probes: How do you hear about important news in your village? Is <strong>the</strong>re one person to whom everyone goes to ask<br />

advice, such as a village headman?)<br />

3. In <strong>the</strong> community, who provides <strong>the</strong> best information about how to treat malaria when someone is pregnant?<br />

F. Topical area: Preventive strategies<br />

1. In general, how do women protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probe<br />

for traditional methods: infusions, teas, smoke, leaves for dousing <strong>the</strong> walls, going to bed earlier; and modern<br />

methods: insecticides, use <strong>of</strong> nets or treated curtains; clo<strong>the</strong>s)<br />

Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman?<br />

IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />

2. Which things do you think work best to prevent malaria when someone is pregnant?<br />

(Can rank items from most effective at top to least effective at bottom.)<br />

3. Do most pregnant women routinely use a mosquito net?<br />

4. Who in <strong>the</strong> family makes <strong>the</strong> decision about who sleeps under <strong>the</strong> net?<br />

G. Topical area: Treatment strategies<br />

1. What are available sources <strong>of</strong> care for fever or malaria during pregnancy in this area?<br />

2. What types <strong>of</strong> things do people (anybody) recommend that women should do to treat malaria in pregnancy?<br />

Of <strong>the</strong>se, what is <strong>the</strong> most effective strategy, in your opinion?<br />

3. Can you please tell me all <strong>the</strong> traditional medicines or treatments that can be used to treat malaria in a pregnant<br />

woman?<br />

(Be sure to note local names.)<br />

OF THIS LIST: Which ones work best?<br />

Which ones are used most <strong>of</strong>ten in this community?<br />

4. Can you tell me about traditional taboos for pregnant women? (examples: foods, medicines, or plants that should<br />

be avoided) Can you list <strong>the</strong> taboos?<br />

Are <strong>the</strong>re any specific taboos related to malaria?<br />

Do most pregnant women in this community listen to <strong>the</strong>se taboos?<br />

2<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


H. Topical Area: Acceptance <strong>of</strong> antenatal care from health facilities and traditional<br />

birth attendants<br />

1. Are <strong>the</strong>re traditional birth attendants in this community? Are <strong>the</strong>re o<strong>the</strong>r community-based workers that give care<br />

to pregnant women?<br />

IF YES: what are <strong>the</strong>y called and how do <strong>the</strong>ir roles differ from traditional birth attendants? (Note to interviewer:<br />

Add <strong>the</strong> name for <strong>the</strong> site-specific community-based worker in <strong>the</strong> questions where community-based worker is<br />

mentioned.)<br />

2. If yes, how do <strong>the</strong> traditional birth attendants or o<strong>the</strong>r community-based workers give support and advice to<br />

pregnant women?<br />

(Probe: do <strong>the</strong>y routinely make visits to a woman’s house?)<br />

3. Do traditional birth attendants and o<strong>the</strong>r community-based workers in this community advise that pregnant<br />

women attend antenatal clinics? (Note any differences between traditional birth attendants and community-based<br />

workers.)<br />

4. Where do most women in this community go for antenatal care?<br />

5. At how many months’ gestation do most pregnant women in this area start to get<br />

antenatal care:<br />

from a traditional birth attendant or o<strong>the</strong>r community-based worker?<br />

from a health facility?<br />

why at this gestational age?<br />

6. What are <strong>the</strong> reasons why women go to antenatal care?<br />

7. What is <strong>the</strong> cost <strong>of</strong> basic antenatal care in <strong>the</strong> health facility?<br />

Is that cost acceptable?<br />

8. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> traditional birth attendants? Of <strong>the</strong> o<strong>the</strong>r community-based<br />

workers?<br />

9. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />

10. What roles do husbands in families play in deciding whe<strong>the</strong>r a woman should seek antenatal care or advice?<br />

(Probes: do husbands play an active role in assisting pregnant women? Do husbands<br />

ever go to clinic with pregnant women?)<br />

11. How could services for pregnant women regarding <strong>the</strong> prevention and treatment <strong>of</strong> malaria be improved?<br />

12. What is <strong>the</strong> best way to encourage women to receive antenatal care?<br />

I. Topical Area: Drug purchasing behaviors<br />

1. Where do pregnant women obtain antimalarials? Which is <strong>the</strong> best place to buy<br />

<strong>the</strong>se medicines?<br />

BE SURE TO THANK THE PERSON FOR HIS OR HER TIME, AND ASK IF HE OR SHE HAS ANY QUESTIONS FOR YOU.<br />

Tool 10: Individual Interview Guide for Key Informants<br />

3


24<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Resource 1: Articles<br />

Relevant Articles : <strong>Malaria</strong> in Pregnancy<br />

<strong>The</strong> <strong>Malaria</strong> in Pregnancy Consortium maintains a <strong>Malaria</strong> in Pregnancy (MiP) Library, a bibliographic database <strong>of</strong><br />

published and unpublished literature relating to malaria in pregnancy, including a trial registry <strong>of</strong> planned and ongoing<br />

trials, for use by scientists, policy makers, funding agencies, industry and o<strong>the</strong>r interested parties, at<br />

http://www.mip-consortium.org/resource_centre/index.htm. Many <strong>of</strong> <strong>the</strong> articles listed below are in this database.<br />

Ashwood-Smith, H., Y. Coombes, et al. (2002). "Availability and use <strong>of</strong> sulphadoxine-pyrimethamine (SP) in pregnancy<br />

in Blantyre District: A Safe Mo<strong>the</strong>rhood and Blantyre Integrated <strong>Malaria</strong> Initiative (BIMI) Joint Survey." Malawi Medical<br />

Journal 14(1): 8-11.<br />

Ayisi, J., A. van Eijk, et al. (2004). "Maternal malaria and perinatal HIV transmission, western Kenya." Emerging<br />

Infectious Diseases 10(4): 643-652.<br />

Brabin, B. (1991). "An assessment <strong>of</strong> low birthweight risk in primiparae as an indicator <strong>of</strong> malaria control in<br />

pregnancy." International Journal <strong>of</strong> Epidemiology 20(1): 276-83.<br />

Brabin, B. J., S. O. Agbaje, et al. (1999). "A birthweight nomogram for Africa, as a malaria-control indicator." Annals <strong>of</strong><br />

Tropical Medicine & Parasitology 93 Suppl 1: S43-57.<br />

Brabin, B. J., M. Hakimi, et al. (2001). "An analysis <strong>of</strong> anemia and pregnancy-related maternal mortality." Journal <strong>of</strong><br />

Nutrition 131(2S-2): 604S-614S; discussion 614S-615S.<br />

Briggs, G. G., R. K. Freeman, et al. (1998). Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk.<br />

Baltimore, Williams & Wilkins.<br />

Browne, E. N., G. H. Maude, et al. (2001). "<strong>The</strong> impact <strong>of</strong> insecticide-treated bednets on malaria and anaemia in<br />

pregnancy in Kassena-Nankana district, Ghana: a randomized controlled trial." Tropical Medicine & International<br />

Health 6(9): 667-76.<br />

Crawley, J., J. Hill, et al. (2007). "From evidence to action? Challenges to policy change and programme delivery for<br />

malaria in pregnancy." Lancet Infectious Diseases 7(2): 145-55.<br />

D'Alessandro, U. (1999). "A rational approach to malaria control in pregnancy in sub-Saharan Africa: <strong>the</strong> need for a<br />

link between scientific research and public-health interventions." Annals <strong>of</strong> Tropical Medicine & Parasitology 93<br />

Suppl 1: S75-7.<br />

D'Alessandro, U., P. Langerock, et al. (1996). "<strong>The</strong> impact <strong>of</strong> a national impregnated bed net programme on <strong>the</strong><br />

outcome <strong>of</strong> pregnancy in primigravidae in <strong>The</strong> Gambia." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine &<br />

Hygiene 90(5): 487-92.<br />

Desai, M., F. O. ter Kuile, et al. (2007). "Epidemiology and burden <strong>of</strong> malaria in pregnancy." Lancet Infectious Diseases<br />

7(2): 93-104.<br />

Dolan, G., F. O. ter Kuile, et al. (1993). "Bed nets for <strong>the</strong> prevention <strong>of</strong> malaria and anaemia in pregnancy." Transactions<br />

<strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 87(6): 620-6.<br />

Goodman, C. A., P. G. Coleman, et al. (2001). "<strong>The</strong> cost-effectiveness <strong>of</strong> antenatal malaria prevention in sub-Saharan<br />

Africa." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(1-2 Suppl): 45-56.<br />

Greenwood, B., P. Alonso, et al. (2007). "<strong>Malaria</strong> in pregnancy: priorities for research." Lancet Infectious Diseases<br />

7(2): 169-74.<br />

Resources<br />

1


Guyatt, H. L., M. H. Gotink, et al. (2002). "Free bednets to pregnant women through antenatal<br />

clinics in Kenya: a cheap, simple and equitable approach to delivery." Tropical Medicine and<br />

International Health 7(5): 409-20.<br />

Guyatt, H. L. and R. W. Snow (2001). "<strong>The</strong> epidemiology and burden <strong>of</strong> Plasmodium falciparumrelated<br />

anemia among pregnant women in sub-Saharan Africa." American Journal <strong>of</strong> Tropical<br />

Medicine & Hygiene 64(1-2 Suppl): 36-44.<br />

Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M et al. (2003).<br />

"Community-wide effects <strong>of</strong> permethrin-treated bed nets on child mortality and malaria<br />

morbidity in western Kenya." American Journal <strong>of</strong> Tropical Medicine & Hygiene; 68 (4<br />

Suppl);121-7.<br />

Hawley WA, ter Kuile FO, Steketee RW, Nahlen BL, Terlouw DJ, Gimnig JE et al. (2003).<br />

Implications <strong>of</strong> <strong>the</strong> Western Kenya permethrin-treated bed net study for policy, program<br />

implementation, and future research. American Journal <strong>of</strong> Tropical Medicine & Hygiene;<br />

68 (4 Suppl): 168-73.<br />

Inion, I., F. Mwanyumba, et al. (2003). "Placental malaria and perinatal transmission <strong>of</strong> human<br />

immunodeficiency virus type 1." Journal <strong>of</strong> Infectious Diseases 188(11): 1675-8.<br />

Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS,<br />

Maiga B, Mungai M, Parise ME, Doumbo O. (2005). "Comparison <strong>of</strong> intermittent preventive<br />

treatment with chemoprophylaxis for <strong>the</strong> prevention <strong>of</strong> malaria during pregnancy in Mali."<br />

Journal <strong>of</strong> Infectious Diseases 1;191(1):109-16.<br />

Ladner, J., V. Leroy, et al. (2002). "HIV infection, malaria, and pregnancy: a prospective cohort<br />

study in Kigali, Rwanda." American Journal <strong>of</strong> Tropical Medicine & Hygiene 66(1): 56-60.<br />

Le Hesran, J. Y., M. Cot, et al. (1997). "Maternal placental infection with Plasmodium falciparum<br />

and malaria morbidity during <strong>the</strong> first 2 years <strong>of</strong> life." American Journal <strong>of</strong> Epidemiology<br />

146(10): 826-31.<br />

Leke, R. F., R. R. Djokam, et al. (1999). "Detection <strong>of</strong> <strong>the</strong> Plasmodium falciparum antigen<br />

histidine-rich protein 2 in blood <strong>of</strong> pregnant women: implications for diagnosing placental<br />

malaria." Journal <strong>of</strong> Clinical Microbiology 37(9): 2992-6.<br />

Luxemburger, C., R. McGready, et al. (2001). "Effects <strong>of</strong> malaria during pregnancy on infant<br />

mortality in an area <strong>of</strong> low malaria transmission." American Journal <strong>of</strong> Epidemiology 154(5):<br />

459-65.<br />

Luxemburger, C., F. Ricci, et al. (1997). "<strong>The</strong> epidemiology <strong>of</strong> severe malaria in an area <strong>of</strong> low<br />

transmission in Thailand." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene<br />

91(3): 256-62.<br />

Marchesini, P. and K. Crawley (2004). Reducing <strong>the</strong> burden <strong>of</strong> malaria in pregnancy. Geneva,<br />

Roll Back <strong>Malaria</strong>, World Health Organization.<br />

McCormick, M. C. (1985). "<strong>The</strong> contribution <strong>of</strong> low birth weight to infant mortality and<br />

childhood morbidity." New England Journal <strong>of</strong> Medicine 312(2): 82-90.<br />

McGready, R. (2002). <strong>The</strong> use <strong>of</strong> artemisinin derivatives in pregnancy: <strong>the</strong> experience on <strong>the</strong><br />

Thai-Burma border. PREMA-EU. 1: 6-11.<br />

McGready, R., K. A. Hamilton, et al. (2001). "Safety <strong>of</strong> <strong>the</strong> insect repellent N,N-diethyl-Mtoluamide<br />

(DEET) in pregnancy." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />

65(4): 285-9.<br />

2<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


McGready, R., J. A. Simpson, et al. (2001). "A double-blind randomized <strong>the</strong>rapeutic trial <strong>of</strong> insect repellents for <strong>the</strong><br />

prevention <strong>of</strong> malaria in pregnancy." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 95(2): 137-8.<br />

Menendez, C. (2003). Anaemia in pregnancy in developing areas: its causes and consequencies. <strong>Malaria</strong> and Anemia in<br />

Pregnancy, Amsterdam, PREMA-EU.<br />

Menendez, C. (1999). "Priority areas for current research on malaria during pregnancy." Annals <strong>of</strong> Tropical Medicine<br />

& Parasitology 93 Suppl 1: S71-4.<br />

Menendez, C., U. D'Alessandro, et al. (2007). "Reducing <strong>the</strong> burden <strong>of</strong> malaria in pregnancy by preventive strategies."<br />

Lancet Infectious Diseases 7(2): 126-35.<br />

Menendez, C., A. F. Fleming, et al. (2000). "<strong>Malaria</strong>-related anaemia." Parasitology Today 16(11): 469-76.<br />

Menendez, C., J. Ordi, et al. (2000). "<strong>The</strong> impact <strong>of</strong> placental malaria on gestational age and birth weight." Journal <strong>of</strong><br />

Infectious Diseases 181(5): 1740-5.<br />

Msyamboza, K., E. Senga, et al. (2007). "Estimation <strong>of</strong> effectiveness <strong>of</strong> interventions for malaria control in pregnancy<br />

using <strong>the</strong> screening method." International Journal <strong>of</strong> Epidemiology.<br />

Mutabingwa, T. K. (2002). Antimalarial Intermittent Treatment during Pregnancy in Africa. PREMA-EU Newsletter.<br />

Liverpool. 1: 4-6.<br />

Mwapasa, V., S. J. Rogerson, et al. (2004). "<strong>The</strong> effect <strong>of</strong> Plasmodium falciparum malaria on peripheral and placental<br />

HIV-1 RNA concentrations in pregnant Malawian women." Aids 18(7): 1051-1059.<br />

Nahlen, B. L. (2000). "Rolling back malaria in pregnancy. [letter; comment]." New England Journal <strong>of</strong> Medicine<br />

343(9): 651-2.<br />

Newman, R. D., A. Hailemariam, et al. (2003). "<strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy in Areas <strong>of</strong> Stable and Unstable<br />

Transmission in Ethiopia during a Nonepidemic Year." Journal <strong>of</strong> Infectious Diseases 187(11): 1765-72.<br />

Newman, R. D., M. E. Parise, et al. (2003). "Safety, efficacy and determinants <strong>of</strong> effectiveness <strong>of</strong> antimalarial drugs<br />

during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa."<br />

Tropical Medicine and International Health 8(6): 488-506.<br />

Nosten, F., R. McGready, et al. (2007). "Case management <strong>of</strong> malaria in pregnancy." Lancet Infectious Diseases<br />

7(2): 118-25.<br />

Nosten, F., R. McGready, et al. (1999). "Effects <strong>of</strong> Plasmodium vivax malaria in pregnancy." Lancet 354(9178): 546-9.<br />

Nosten, F., F. ter Kuile, et al. (1991). "<strong>Malaria</strong> during pregnancy in an area <strong>of</strong> unstable endemicity." Transactions <strong>of</strong> <strong>the</strong><br />

Royal Society <strong>of</strong> Tropical Medicine & Hygiene 85(4): 424-9.<br />

Ouma, P., M. E. Parise, et al. (2006). "A Randomized Controlled Trial <strong>of</strong> Folate Supplementation When Treating <strong>Malaria</strong><br />

in Pregnancy with Sulfadoxine-Pyrimethamine." PLoS Clin Trials 1(6): e28.<br />

Parise, M. E., J. G. Ayisi, et al. (1998). "Efficacy <strong>of</strong> sulfadoxine-pyrimethamine for prevention <strong>of</strong> placental malaria in an<br />

area <strong>of</strong> Kenya with a high prevalence <strong>of</strong> malaria and human immunodeficiency virus infection." American Journal <strong>of</strong><br />

Tropical Medicine & Hygiene 59(5): 813-22.<br />

Parise, M. E., L. S. Lewis, et al. (2003). "A rapid assessment approach for public health decision-making related to <strong>the</strong><br />

prevention <strong>of</strong> malaria during pregnancy." Bulletin <strong>of</strong> <strong>the</strong> World Health Organization 81(5): 316-23.<br />

Phillips-Howard, P. A. (1999). "Epidemiological and control issues related to malaria in pregnancy." Annals <strong>of</strong> Tropical<br />

Medicine & Parasitology 93 Suppl 1: S11-7.<br />

Rogerson, S. J., L. Hviid, et al. (2007). "<strong>Malaria</strong> in pregnancy: pathogenesis and immunity." Lancet Infectious Diseases<br />

7(2): 105-17.<br />

Resources<br />

3


Rogerson, S. J., E. Chaluluka, et al. (2000). "Intermittent sulfadoxine-pyrimethamine in<br />

pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99."<br />

Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 94(5): 549-53.<br />

Saute, F., C. Menendez, et al. (2002). "<strong>Malaria</strong> in pregnancy in rural Mozambique: <strong>the</strong> role <strong>of</strong><br />

parity, submicroscopic and multiple Plasmodium falciparum infections." Tropical Medicine and<br />

International Health 7(1): 19-28.<br />

Schultz, L. J., R. W. Steketee, et al. (1994). "<strong>The</strong> efficacy <strong>of</strong> antimalarial regimens containing<br />

sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental<br />

Plasmodium falciparum infection among pregnant women in Malawi." American Journal <strong>of</strong><br />

Tropical Medicine & Hygiene 51(5): 515-22.<br />

Schultz, L. J., R. W. Steketee, et al. (1995). <strong>Malaria</strong> prevention during pregnancy: an antenatal<br />

intervention strategy whose time has come. <strong>The</strong> female client and <strong>the</strong> health-care provider. J. H.<br />

Roberts and C. Vlass<strong>of</strong>f. Ottawa, International Development Research Centre: 113-128.<br />

Schultz LJ, Steketee RW, Chitsulo L, Macheso A, Kazembe P, Wirima JJ. (1996). "Evaluation <strong>of</strong><br />

maternal practices, efficacy, and cost-effectiveness <strong>of</strong> alternative antimalaria regimens for use<br />

in pregnancy:chloroquine and sulfadoxine-pyrimethamine." American Journal <strong>of</strong> Tropical<br />

Medicine and Hygiene 55(1 Suppl): 87-94.<br />

Shulman, C. E. (1999). "<strong>Malaria</strong> in pregnancy: its relevance to safe-mo<strong>the</strong>rhood programmes."<br />

Annals <strong>of</strong> Tropical Medicine & Parasitology 93 Suppl 1: S59-66.<br />

Shulman, C. E. and E. K. Dorman (2003). "Importance and prevention <strong>of</strong> malaria in pregnancy."<br />

Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 97(1): 30-5.<br />

Shulman, C. E., E. K. Dorman, et al. (2002). "<strong>Malaria</strong> as a cause <strong>of</strong> severe anaemia in pregnancy."<br />

Lancet 360(9331): 494.<br />

Shulman, C. E., E. K. Dorman, et al. (1999). "Intermittent sulphadoxine-pyrimethamine to<br />

prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled<br />

trial." Lancet 353(9153): 632-6.<br />

Shulman, C. E., E. K. Dorman, et al. (1998). "A community randomized controlled trial <strong>of</strong><br />

insecticide-treated bednets for <strong>the</strong> prevention <strong>of</strong> malaria and anaemia among primigravid<br />

women on <strong>the</strong> Kenyan coast." Tropical Medicine & International Health 3(3): 197-204.<br />

Singh, N., R. K. Mehra, et al. (2001). "<strong>Malaria</strong> during pregnancy and infancy, in an area <strong>of</strong> intense<br />

malaria transmission in central India." Annals <strong>of</strong> Tropical Medicine & Parasitology 95(1): 19-29.<br />

Singh, N., A. Saxena, et al. (1998). "Studies on malaria during pregnancy in a tribal area <strong>of</strong><br />

central India (Madhya Pradesh)." Sou<strong>the</strong>ast Asian Journal <strong>of</strong> Tropical Medicine & Public Health<br />

29(1): 10-7.<br />

Singh, N., M. M. Shukla, et al. (1999). "Epidemiology <strong>of</strong> malaria in pregnancy in central India."<br />

Bulletin <strong>of</strong> <strong>the</strong> World Health Organization 77(7): 567-72.<br />

Sirima, S. B., R. Sawadogo, et al. (2003). "Failure <strong>of</strong> a Chloroquine Chemoprophylaxis Program<br />

to Adequately Prevent <strong>Malaria</strong> during Pregnancy in Koupela District, Burkina Faso." Clinical<br />

Infectious Diseases 36(11): 1374-82.<br />

Steketee RW, Nahlen BL, Parise ME, Menendez C (2001). <strong>The</strong> burden <strong>of</strong> malaria during<br />

pregnancy in malaria-endemic areas. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 64 (1-2<br />

Suppl): 28-35.<br />

Steketee, R. W., B. L. Nahlen, et al. (2001). "<strong>The</strong> burden <strong>of</strong> malaria in pregnancy in malariaendemic<br />

areas." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(1-2 Suppl): 28-35.<br />

4<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Steketee RW, Wirima JJ, Campbell CC (1996). Developing effective strategies for malaria prevention programs for<br />

pregnant African women. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 55(1 Suppl): 95-100.<br />

Steketee RW, Wirima JJ, Slutsker L, Heymann DL, Breman JG (1996). <strong>The</strong> problem <strong>of</strong> malaria and malaria control in<br />

pregnancy in sub-Saharan Africa. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 55 (1 Suppl): 2-7.<br />

Steketee, R. W., J. J. Wirima, et al. (1996). "Impairment <strong>of</strong> a pregnant woman's acquired ability to limit Plasmodium<br />

falciparum by infection with human immunodeficiency virus type-1." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />

55(1 Suppl): 42-9.<br />

ter Kuile, F. O., A. M. van Eijk, et al. (2007). "Effect <strong>of</strong> sulfadoxine-pyrimethamine resistance on <strong>the</strong> efficacy <strong>of</strong><br />

intermittent preventive <strong>the</strong>rapy for malaria control during pregnancy: a systematic review." Jama 297(23): 2603-16.<br />

ter Kuile, F. O., D. J. Terlouw, et al. (2003). "Reduction <strong>of</strong> malaria during pregnancy by permethrin-treated bed nets in an<br />

area <strong>of</strong> intense perennial malaria transmission in western Kenya." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />

68(4 Suppl): 50-60.<br />

van Eijk, A. (2004). "Effectiveness <strong>of</strong> intermittent preventive treatment with sulfadoxine-pyrimethamine for control<br />

<strong>of</strong> malaria in pregnancy in western Kenya: a hospital-based study." Tropical Medicine & International Health 9(3):<br />

351-360.<br />

van Eijk, A. M., J. G. Ayisi, et al. (2003). "HIV increases <strong>the</strong> risk <strong>of</strong> malaria in women <strong>of</strong> all gravidities in Kisumu, Kenya."<br />

Aids 17(4): 595-603.<br />

Verhoeff, F. H., B. J. Brabin, et al. (1998). "An evaluation <strong>of</strong> <strong>the</strong> effects <strong>of</strong> intermittent sulfadoxine-pyrimethamine<br />

treatment in pregnancy on parasite clearance and risk <strong>of</strong> low birthweight in rural Malawi." Annals <strong>of</strong> Tropical Medicine<br />

& Parasitology 92(2): 141-50.<br />

Verhoeff, F. H., P. Milligan, et al. (1997). "Gestational age assessment by nurses in a developing country using <strong>the</strong><br />

Ballard method, external criteria only." Annals <strong>of</strong> Tropical Paediatrics 17(4): 333-42.<br />

Ward, S. A., E. J. Sevene, et al. (2007). "Antimalarial drugs and pregnancy: safety, pharmacokinetics, and<br />

pharmacovigilance." Lancet Infectious Diseases 7(2): 136-44.<br />

Williams HA and Jones COH (2004). Review. A critical review <strong>of</strong> behavioral issues related to malaria control in sub-<br />

Saharan Africa: what contributions have social scientists made? Social Sciences and Medicine; 59: 501-523.<br />

Wolfe, E. B., M. E. Parise, et al. (2001). "Cost-effectiveness <strong>of</strong> sulfadoxine-pyrimethamine for <strong>the</strong> prevention <strong>of</strong> malariaassociated<br />

low birth weight." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(3-4): 178-86.<br />

World Health Organization (2003). <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> safety <strong>of</strong> artemisinin compounds in pregnancy: Report <strong>of</strong> two<br />

informal consultations convened by WHO in 2002. Geneva, World Health Organization.<br />

World Health Organization (2000). "Severe falciparum malaria. World Health Organization, Communicable Diseases<br />

Cluster." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 94 Suppl 1: S1-90.<br />

World Health Organization and UNICEF (year). Antenatal Care in Developing Countries: Promises, achievements and<br />

missed opportunities. 1-32. (http://www.childinfo.org/eddb/antenatal/antenatal_full.pdf<br />

Resources<br />

5


6<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Resource 2: Resources for <strong>the</strong><br />

Qualitative <strong>Assessment</strong><br />

Sample Interviewer Training Manual<br />

List <strong>of</strong> Resources<br />

Sample Interviewer Training Manual<br />

II. Overview<br />

A. Introduction<br />

B. Health impacts caused by malaria<br />

II. Qualitative research components<br />

A. Differences between qualitative and quantitative research<br />

III. Qualitative research methods<br />

I. OVERVIEW:<br />

A. Introduction:<br />

We are here to help learn about [insert statement to describe purpose <strong>of</strong> study]. For example<br />

for a study about pregnant women and malaria: We are here to find out how women in <strong>the</strong><br />

XXX District [insert name <strong>of</strong> specific district] deal with malaria when <strong>the</strong>y are pregnant. We<br />

are trying to find out what women know about malaria and <strong>the</strong> risks that are associated with<br />

<strong>the</strong> illness when you are pregnant, what care women get when <strong>the</strong>y are pregnant, things that<br />

women in this area do to try to prevent malaria, and what <strong>the</strong>y think about <strong>the</strong> various places<br />

that <strong>the</strong>y can go in order to obtain care during <strong>the</strong>ir pregnancy. We want to understand also<br />

how women get support during <strong>the</strong>ir pregnancy and where <strong>the</strong>y get advice regarding what to<br />

do if <strong>the</strong>y get sick while being pregnant.<br />

In addition to talking to women who are currently pregnant or who were recently pregnant<br />

(defined as having delivered in <strong>the</strong> past two years), we will be talking to some health care<br />

workers, and lay midwives and traditional birth attendants (TBAs).<br />

This project is part <strong>of</strong> a bigger study that will look at (insert statement). It will first try to<br />

determine <strong>the</strong> extent <strong>of</strong> <strong>the</strong> problem in this area, looking at levels <strong>of</strong> parasitemia (how many<br />

parasites that cause malaria are in a person’s blood), levels <strong>of</strong> anemia, degree <strong>of</strong> placental<br />

parasitemia, and how many babies with low-birth weight are being born (a complication <strong>of</strong><br />

having malaria during pregnancy). All <strong>the</strong> information ga<strong>the</strong>red in <strong>the</strong> different parts <strong>of</strong> <strong>the</strong><br />

study will help us (insert statement). [insert names <strong>of</strong> assessment team members] Dr. XX will<br />

be leading <strong>the</strong> one part <strong>of</strong> <strong>the</strong> study and Dr. XX will be doing <strong>the</strong> qualitative part—<strong>the</strong> aspect <strong>of</strong><br />

<strong>the</strong> study for which you were hired.<br />

Resources<br />

7


B. Health Impacts Caused by <strong>Malaria</strong>:<br />

<strong>Malaria</strong>: Why is malaria important? <strong>Malaria</strong> is a very serious illness, particularly in sub-<br />

Saharan Africa. Each year between 300 and 500 million people in <strong>the</strong> world develop malaria<br />

and 1.5 to 2.7 million people die each year from malaria. Young children (those under 5<br />

years) who have not yet developed immunity (limited protection) against <strong>the</strong> illness are most<br />

vulnerable to <strong>the</strong> effects <strong>of</strong> malaria. Pregnant women, especially during <strong>the</strong>ir first pregnancy,<br />

are also at risk.<br />

<strong>Malaria</strong> is caused by a parasite carried by a female Anopheles mosquito. She bites a person<br />

to take a blood meal and injects parasites. <strong>The</strong>y take several weeks to develop and eventually<br />

attack <strong>the</strong> red blood cells in your body. <strong>The</strong> red blood cells carry oxygen, which is essential for<br />

your body to work. Destroying <strong>the</strong> red blood cells causes anemia, which is why people with<br />

malaria <strong>of</strong>ten feel very tired. In order for <strong>the</strong> infection to spread, ano<strong>the</strong>r female Anopheles<br />

mosquito must bite a person who is infected with malaria and <strong>the</strong> cycle starts again. If <strong>the</strong><br />

parasites go to <strong>the</strong> brain, it is called “cerebral malaria,” and it is a grave sign. This is <strong>of</strong>ten when<br />

people develop convulsions (seizures, or “fitting”) and need to be treated with quinine.<br />

<strong>The</strong>re are four types <strong>of</strong> malaria: Plasmodium vivax, Plasmodium ovale, Plasmodium malariae,<br />

and Plasmodium falciparum. Of <strong>the</strong> four types, P. falciparum is <strong>the</strong> only one that can<br />

potentially be fatal. P. ovale and P. vivax are <strong>the</strong> two relapsing forms, which means that <strong>the</strong><br />

illness can re-appear months to years later.<br />

Usually, malaria in Africa is diagnosed by clinical symptoms. [Note: this may not be pertinent<br />

depending in which area <strong>the</strong> study will occur.] When someone complains <strong>of</strong> fever, <strong>the</strong>y are<br />

treated for malaria. However, <strong>the</strong> only way to really know if someone has <strong>the</strong> parasite that<br />

causes malaria is to examine <strong>the</strong>ir blood under <strong>the</strong> microscope. We take a small sample <strong>of</strong><br />

blood from a finger stick and put it on a glass slide. <strong>The</strong> laboratory technologists can <strong>the</strong>n<br />

“read” <strong>the</strong> smear and tell us if <strong>the</strong> person has malaria or not. However, as many places in<br />

Africa do not have laboratory facilities, standard treatment is to assume someone has malaria<br />

if <strong>the</strong>y have fever or history <strong>of</strong> fever. Since malaria can kill quickly, <strong>the</strong> practice is to over-treat<br />

for malaria so that we don’t miss someone who may die if not treated.<br />

We can determine <strong>the</strong> type <strong>of</strong> malaria by looking at a blood smear under <strong>the</strong> microscope. We<br />

can also determine how severe <strong>the</strong> infection is by <strong>the</strong> number <strong>of</strong> parasites that we can count.<br />

Probably all <strong>of</strong> you in this room have experienced malaria as an illness. Symptoms include<br />

fever, chills, headache, vomiting, diarrhea and feeling bad. Problems related to malaria <strong>of</strong>ten<br />

are related to late diagnosis or inadequate or inappropriate treatment. Part <strong>of</strong> our job now is<br />

to try to figure out <strong>the</strong> best ways to insure that pregnant women in XX [insert name <strong>of</strong> district]<br />

District use preventive measures to guard against malaria. In addition, we need to help <strong>the</strong>m<br />

learn how to get prompt and effective treatment when <strong>the</strong>y develop malaria.<br />

<strong>Malaria</strong> and Pregnancy: <strong>Malaria</strong> causes serious complications in pregnancy that can affect not<br />

only <strong>the</strong> pregnant woman, but can also hurt <strong>the</strong> baby. Chloroquine (CQ) used to be <strong>the</strong> main<br />

drug that was used to treat malaria, but CQ is no longer working well in most parts <strong>of</strong> sub-<br />

Saharan Africa. <strong>Malaria</strong> can cause severe anemia, which means that you have fewer red blood<br />

cells to carry oxygen, which is needed for our body to work each day. <strong>Malaria</strong> can cause early<br />

labor, which means<br />

that <strong>the</strong> baby does not have sufficient time to develop fully, or it can cause higher rates <strong>of</strong><br />

miscarriage (losing <strong>the</strong> pregnancy). <strong>Malaria</strong> infections during pregnancy can also cause lowbirth<br />

weight babies and babies that are born “stillborn” (dead at birth).<br />

Antenatal care is an accepted means <strong>of</strong> finding complications in pregnancy and can help us<br />

teach women what to expect from malaria in pregnancy, and how to prevent it. We now know<br />

that if pregnant women use intermittent preventive treatment (IPTp) with an effective drug,<br />

Fansidar (called SP), during <strong>the</strong>ir second and third trimesters, we can reduce<br />

8<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


<strong>the</strong> problems caused by malaria. Part <strong>of</strong> this research will look at how we can best get women to accept using IPTp<br />

during pregnancy.<br />

Local Beliefs about <strong>Malaria</strong>: Many people think that malaria is caused by different things. For example, some people<br />

believe that you get malaria from sleeping beside someone who is infected. O<strong>the</strong>rs believe that eating unripe sugar<br />

cane or getting soaked from <strong>the</strong> rains causes <strong>the</strong> illness, or that malaria occurs after a long trip. Some people believe<br />

that malaria comes with “fitting.” O<strong>the</strong>rs believe that malaria is caused by witchcraft. Have any <strong>of</strong> you heard <strong>of</strong> o<strong>the</strong>r<br />

causes <strong>of</strong> malaria?<br />

Why do people believe <strong>the</strong>se things? Do any <strong>of</strong> <strong>the</strong>se explanations make sense when we know that malaria is caused by<br />

parasites carried by a female mosquito? How do people make up <strong>the</strong>se explanations?<br />

If you think about what people are telling you, you will start to see and understand that people’s beliefs <strong>of</strong>ten merge<br />

with scientific understandings. People base <strong>the</strong>ir beliefs on years <strong>of</strong> experience, watching <strong>the</strong> environment and how<br />

things happen. People look for sameness, for patterns in explanations, and <strong>the</strong>ir thinking reflects what has happened to<br />

<strong>the</strong>m personally, as well as what <strong>the</strong>y see in <strong>the</strong>ir communities. Most behavior has purpose and <strong>the</strong> purpose is derived<br />

from a meaning system. People actively make choices in <strong>the</strong>ir environments based on <strong>the</strong>se meanings.<br />

Let’s look at some <strong>of</strong> <strong>the</strong>se explanations:<br />

“Eating unripe fruit”—Mosquitoes are most plentiful when <strong>the</strong> outside conditions are warm and wet. At <strong>the</strong> end <strong>of</strong> <strong>the</strong><br />

rains come <strong>the</strong> harvest - this coincides with transmission season for malaria.<br />

“Sleeping with someone” —is <strong>of</strong>ten because a mosquito can bite two people in one night (<strong>the</strong> mosquitoes that carry<br />

malaria bite between dusk and dawn).<br />

“At <strong>the</strong> end <strong>of</strong> a long trip” —<strong>of</strong>ten traveling involves being outside at night, which is when <strong>the</strong>se mosquitoes bite.<br />

“Getting wet and rain soaked” —coincides with transmission season, <strong>the</strong> rainy time <strong>of</strong> <strong>the</strong> year.<br />

“Sleeping outside” —again, this increases your chance <strong>of</strong> being bitten.<br />

During this research, we will be looking at some <strong>of</strong> <strong>the</strong> beliefs that pregnant women have in regard to causes <strong>of</strong><br />

malaria and how to best prevent it. It will be important to understand <strong>the</strong> complexities <strong>of</strong> how people create <strong>the</strong>se<br />

explanations.<br />

Patterns <strong>of</strong> Treatment: For example, if you ask what do pregnant women do when <strong>the</strong>y have a fever or think <strong>the</strong>y have<br />

malaria, <strong>the</strong>y may come up with several different patterns <strong>of</strong> behavior:<br />

Day #1, 1st Day <strong>of</strong> Illness: go to a shop and buy medicines to take at home<br />

Day #2 <strong>of</strong> Illness: rest and see if <strong>the</strong> medicines are working<br />

Day #3 <strong>of</strong> Illness: seek advice from someone <strong>the</strong>y respect<br />

Day #4 <strong>of</strong> Illness: go to <strong>the</strong> health care facility.<br />

We need to ask how/why/when people make <strong>the</strong>se decisions and what are <strong>the</strong> factors that influence such decisions.<br />

For example, <strong>the</strong> first decision to go to a shop may be based on <strong>the</strong> perceived cause <strong>of</strong> <strong>the</strong> illness. If <strong>the</strong> person thinks it<br />

is due to “malaria,” <strong>the</strong>n seeking out shop medicines may be <strong>the</strong> accepted practices <strong>of</strong> that community. If <strong>the</strong> illness was<br />

perceived to be caused by something spiritual (e.g., personal transgressions), <strong>the</strong> person may instead go to a traditional<br />

healer on Day #1.<br />

Resources<br />

9


O<strong>the</strong>r factors that might influence how people make treatment decisions may include:<br />

• co-sharing cost <strong>of</strong> medications or treatments at health care facilities<br />

• perceived seriousness <strong>of</strong> illness<br />

• timing <strong>of</strong> illness (If illness starts during <strong>the</strong> day, <strong>the</strong> person may first go to a drug vendor<br />

or shop keeper. However, if illness starts at night, treatment options are more limited<br />

and <strong>the</strong>y may chose to wait until morning before seeking care. At this point, <strong>the</strong> person is<br />

much sicker and may go straight to <strong>the</strong> hospital or health care facility)<br />

• geographical distance to care (e.g., a shop keeper may be much closer than a health<br />

care facility)<br />

• availability <strong>of</strong> credit schemes for payment at a shop<br />

• advice from someone who is respected.<br />

Using <strong>the</strong>se examples, it becomes clearer how complicated <strong>the</strong> process is to understand how<br />

people think about things or make decisions about <strong>the</strong>ir behavior.<br />

Proposed Activities: We hope to do <strong>the</strong> activities in XX different sites [insert number <strong>of</strong> sites]<br />

throughout <strong>the</strong> district. We will be in health care facilities, as well as in individual homes or<br />

maybe a common ga<strong>the</strong>ring area. Each site should take about (insert estimate). We will start<br />

with “pilot” testing our activities prior to formally conducting <strong>the</strong> research, which means that<br />

we will practice our interviews with people who are not part <strong>of</strong> <strong>the</strong> study team. Piloting <strong>the</strong><br />

interview guides helps us to see what might need to be changed and we can change things<br />

before we start <strong>the</strong> assessment.<br />

1. Individual Interviews: <strong>The</strong>se will be done with currently or recently pregnant women, and<br />

health-care workers. In each site, we will aim to interview 4-5 pregnant or recently pregnant<br />

women, but we will need to see how much time this takes. In addition, we will be working with<br />

“key informants,” people in <strong>the</strong> area who have a particularly strong knowledge about what<br />

happens to pregnant women in this area. <strong>The</strong>se key informants will be identified by village<br />

leaders, community health care workers, community members or health care facility workers.<br />

Usually we will try to interview 2-4 key informants per facility area. We will also interview<br />

facility-based health care workers, interviewing from 1-10 per facility, depending on <strong>the</strong><br />

numbers employed in that facility.<br />

2. Focus Group Interviews: <strong>The</strong>se will be done with currently or recently pregnant women,<br />

as well as lay midwives and TBAs. For each focus group, we hope to have 5 -15 pregnant or<br />

recently pregnant participants and 5 -15 lay midwives and TBAs. We may also do health care<br />

worker interviews.<br />

II. Qualitative Research Components:<br />

A. Differences between Qualitative and Quantitative Research:<br />

We will be doing what is called “qualitative” research. It differs from quantitative research,<br />

which deals primarily with studying things that can be easily counted. Qualitative research<br />

focuses on what people think about things, what makes sense to <strong>the</strong>m (individually and from<br />

a community perspective), how <strong>the</strong>y describe things and <strong>the</strong> meaning <strong>of</strong> those things, to<br />

mention a few areas. In addition, qualitative research can be used to understand how much<br />

someone knows about something, such as what causes malaria or what are common childhood<br />

10<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


febrile illnesses. Ano<strong>the</strong>r area that we look at involves describing how people do things—what are common patterns <strong>of</strong><br />

behaviors, such as what parents actually do when <strong>the</strong>ir child has a fever, or what nurses say to patients when <strong>the</strong>y see<br />

<strong>the</strong>m at a health care facility.<br />

A key element in qualitative research is to remain “value-free” while listening to <strong>the</strong> information provided by <strong>the</strong><br />

participants. At <strong>the</strong> end <strong>of</strong> <strong>the</strong> assessment, it is also important to provide feedback about what was learned. Providing<br />

feedback acknowledges <strong>the</strong> participants’ contributions and may encourage participants to assist in future projects.<br />

While “quantitative” research strives to understand exactly how many people say something or how <strong>of</strong>ten an event<br />

happens, <strong>the</strong> same type <strong>of</strong> counting can be used with qualitative research. Qualitative research can be quantified,<br />

meaning that we can attach numbers to some <strong>of</strong> <strong>the</strong> information that we ga<strong>the</strong>r. For example, <strong>the</strong>re are times when we<br />

can count how many persons interviewed said that <strong>the</strong>y always first go to a traditional healer when <strong>the</strong>y are sick. We<br />

might also be able to count how many different illnesses are named when we ask participants (people who are being<br />

interviewed for <strong>the</strong> study) to tell us illnesses that cause fever in children or pregnant women.<br />

However, <strong>the</strong>re are o<strong>the</strong>r times when we listen to general <strong>the</strong>mes in conversations and want to summarize <strong>the</strong> thoughts<br />

without counting <strong>the</strong>m. For example, if we were to ask about something like “hope,” it would be very difficult to put a<br />

number on how much hope someone has.<br />

Certain activities that we will be doing, like focus groups, will be directed towards listening to understand general<br />

things people are telling us. O<strong>the</strong>r activities, such as individual or personal interviews, will allow us to count how<br />

many people do something. Both quantitative and qualitative research is important as <strong>the</strong>y give us different types <strong>of</strong><br />

information. Nei<strong>the</strong>r is better than <strong>the</strong> o<strong>the</strong>r, <strong>the</strong>y just are different. It is important to know what types <strong>of</strong> information<br />

you need, and that will guide you in <strong>the</strong> type <strong>of</strong> research to do.<br />

Summary <strong>of</strong> Differences Between Qualitative and Quantitative Research Methods<br />

QUALITATIVE<br />

Tries to understand meaning—to make<br />

sense <strong>of</strong> things that are observed in <strong>the</strong> “real<br />

world.”<br />

Looks at perceptions, knowledge, beliefs,<br />

ways <strong>of</strong> thinking, levels <strong>of</strong> understandings<br />

(meaning systems, ways <strong>of</strong> acting) behaviors,<br />

norms <strong>of</strong> behaviors<br />

Examples: research examining local terms for<br />

fever illnesses in children, or research asking<br />

about how people treat malaria.<br />

Researcher very involved with interviewing<br />

research participants. Often, community is<br />

very involved in process—both with data<br />

collection (finding out <strong>the</strong> information) and<br />

analysis (making sense <strong>of</strong> <strong>the</strong> information).<br />

More open to interpretation.<br />

Uses open or semi-structured questions<br />

(asking people to tell you about something).<br />

Depending on <strong>the</strong> question, you can use<br />

quantitative measures to analyze at times.<br />

QUANTITATIVE<br />

Primarily focuses on quantifying or using<br />

objective measurements.<br />

Uses research methods that allow <strong>the</strong><br />

variable (what you are studying) to be<br />

counted in some manner. For example,<br />

laboratory-controlled experiments, research<br />

on behaviors that can be observed (such as<br />

drug efficacy testing), or surveys to find out<br />

amounts <strong>of</strong> things.<br />

Examples: surveillance data that tell us <strong>the</strong><br />

number <strong>of</strong> people diagnosed with malaria<br />

at <strong>the</strong> health care facilities, <strong>the</strong> number <strong>of</strong><br />

stillborn babies born to pregnant women<br />

with malaria, or <strong>the</strong> number <strong>of</strong> children that<br />

get fever a few days after stopping malaria<br />

treatments.<br />

Researcher may or may not be involved much<br />

in process <strong>of</strong> data collection. Community<br />

rarely involved.<br />

Seeks to define outcomes in numbers.<br />

Generally has close-ended (“yes/no”) type<br />

questions, or asking for a count <strong>of</strong> something<br />

and <strong>of</strong>ten has pre-determined categories <strong>of</strong><br />

answers.<br />

Qualitative techniques are used in <strong>the</strong> writing<br />

<strong>of</strong> <strong>the</strong> research results.<br />

Resources<br />

11


III. Qualitative Research Methods:<br />

Often people confuse research methodologies. For example, people talk about surveys and<br />

interviews as if <strong>the</strong>y are <strong>the</strong> same thing. I will first show you how <strong>the</strong>y differ, and <strong>the</strong>n we will<br />

talk more in detail about interviewing. A survey may be done without personal contact, or<br />

with limited interaction with <strong>the</strong> research team.<br />

SURVEY<br />

(CAN BE EITHER QUALITATIVE OR<br />

QUANTITATIVE)<br />

1. Structured 1. Unstructured<br />

2. How many? (counting) 2. Why?<br />

3. Surveyor is expert: uses pre-determined<br />

responses<br />

INTERVIEW<br />

(QUALITATIVE)<br />

3. Community is expert: uses open-ended<br />

questions<br />

4. Quicker to administer 4. Slower to administer<br />

5. Done with limited involvement <strong>of</strong> research 5. Research team members are part <strong>of</strong><br />

<strong>the</strong> process<br />

6. Example: knowledge, attitudes, and<br />

practices (KAP) survey<br />

6. Example: determining what malaria<br />

treatments are.<br />

Interviews:<br />

In a situation where you have some knowledge about something (e.g., malaria) but want to<br />

learn more (e.g., information related to pregnancy women and malaria), we usually use <strong>the</strong><br />

technique <strong>of</strong> interviewing with “semi-structured” questions. For example, we start with a<br />

base <strong>of</strong> information about a topic, such as malaria. We know how malaria is caused and what<br />

happens when a pregnant woman gets malaria during her pregnancy, but we don’t know<br />

what women in this area do to prevent malaria. We also don’t know <strong>the</strong> best way to give <strong>the</strong>m<br />

information. So, we need to ask <strong>the</strong>m what <strong>the</strong>y do to prevent malaria and we need to ask <strong>the</strong><br />

women to identify <strong>the</strong> best people for <strong>of</strong>fering information.<br />

Our questions are “structured” or guided by <strong>the</strong> information that we know, as well as by what<br />

we need to know. “Semi” means that although we direct or focus <strong>the</strong> questions, we allow<br />

participants to <strong>of</strong>fer more information than we requested—in essence, we are asking <strong>the</strong>m<br />

to tell us stories and to share <strong>the</strong>ir knowledge and <strong>the</strong>ir viewpoints with us. Building on what<br />

information you know is important when time and money are issues, such as when you are<br />

doing a rapid community assessment (e.g., what we will be doing). We have limited time to<br />

find out a lot <strong>of</strong> information, and so we must focus on several specific areas and build on what<br />

we already know.<br />

Ano<strong>the</strong>r way to interview is to do what is called an “open” interview. Generally that happens<br />

when you know almost nothing about a topic or when you want to just find out what happens<br />

in a new area. For example, if someone comes to XX District [insert name <strong>of</strong> district] from a<br />

European country, <strong>the</strong>y may need to do open interviews to learn <strong>the</strong> rules about courtship<br />

and marriage, or to learn what to do if someone gets sick in <strong>the</strong> village. Sometimes an open<br />

interview has one or two main questions and participants can freely talk for hours. Once <strong>the</strong><br />

participants talk, new questions are formed and <strong>the</strong>y may differ interview by interview, even<br />

though <strong>the</strong> interviews may all happen in <strong>the</strong> same village. During this research, we will be<br />

using <strong>the</strong> semi-structured approach, ra<strong>the</strong>r than <strong>the</strong> open approach.<br />

12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


1. Individual Interviews: This type <strong>of</strong> interview is done with a single person being interviewed by an interviewer. We are<br />

looking for <strong>the</strong> individual perspective, as compared to a group or community perspective. Often, <strong>the</strong>y can take a long<br />

time to complete (more than one hour) but you obtain very specific information. <strong>The</strong>se interviews usually yield a lot <strong>of</strong><br />

information. You need someone to interview, an interviewer, and sometimes you may need an additional person to help<br />

record <strong>the</strong> responses. You might want to use a tape recorder to record <strong>the</strong> information.<br />

2. Focus Group Interviews: <strong>The</strong>se are done in a group, usually composed <strong>of</strong> 5-15 people. <strong>The</strong> purpose <strong>of</strong> this type <strong>of</strong><br />

interview is to obtain <strong>the</strong> “normative” view <strong>of</strong> <strong>the</strong> community—what people generally think or what behaviors are<br />

considered acceptable, i.e., <strong>the</strong> norms <strong>of</strong> <strong>the</strong> community. For example, <strong>the</strong> normative view in an area may be that a<br />

person should only marry someone from his or her own specific sub-tribe or clan, and that is what most people do.<br />

However, some individual behaviors may differ from that as people do marry outside <strong>the</strong>ir clans or sub-tribes.<br />

For focus groups, you need a “facilitator” (someone who will direct <strong>the</strong> questions <strong>of</strong> <strong>the</strong> group, and guide its<br />

interactions), people to participate, and a “recorder,” who is someone who will write down what is happening in <strong>the</strong><br />

group. As with an individual interview, sometimes, audio tape players are used to also record <strong>the</strong> responses.<br />

<strong>The</strong> advantages <strong>of</strong> this type <strong>of</strong> interview are that you can explore a wide range <strong>of</strong> topics and <strong>the</strong>n narrow down <strong>the</strong><br />

topics. Ideas can be explored freely and many people can <strong>of</strong>fer <strong>the</strong>ir perspectives. Often when one person talks, it<br />

will stimulate <strong>the</strong> memory or thoughts <strong>of</strong> someone else in <strong>the</strong> group, and serves to move <strong>the</strong> discussion along. As<br />

participants raise new issues, you can go from topic to topic. It will also give you a sense <strong>of</strong> how well <strong>the</strong> community<br />

or group works toge<strong>the</strong>r, or whe<strong>the</strong>r <strong>the</strong> group/community is splintered in <strong>the</strong>ir thoughts. Focus group data can be<br />

“triangulated” with data collected from individual interviews to see if <strong>the</strong>re are similarities (thus streng<strong>the</strong>ning <strong>the</strong><br />

overall results), or it will show you that <strong>the</strong>re are big differences within <strong>the</strong> community. “Triangulation” is a research<br />

term used to describe using several different research methods to ask <strong>the</strong> same questions).<br />

Disadvantages to this method are that unless <strong>the</strong> facilitator and recorder are very good, <strong>the</strong>re may be problems using<br />

this method. <strong>The</strong> expectation for a focus group is that everyone should participate. <strong>The</strong> facilitator needs to be able to<br />

limit people who talk too much and monopolize <strong>the</strong> conversations, and also to be able to encourage shy, quiet people.<br />

<strong>The</strong> recorder must be able to listen for <strong>the</strong>mes and fill in <strong>the</strong> details later. He/she needs to be able to record <strong>the</strong><br />

dynamics <strong>of</strong> <strong>the</strong> group (for example, <strong>the</strong> group got very argumentative over a certain question) and needs to be able<br />

to focus when several people are talking at one time. Ano<strong>the</strong>r disadvantage, particularly when you hold focus groups<br />

outside, such as in a village, is that <strong>the</strong>ir size may grow quickly and soon be too big as many people are interested and<br />

want to be part <strong>of</strong> this activity. When <strong>the</strong> group becomes larger than 15 people, it becomes too difficult to manage <strong>the</strong><br />

group, to make sure everyone is participating, and to record. Lastly, it may be time-consuming and difficult to convene<br />

such a group.<br />

Recording <strong>the</strong> focus group is a bit different than recording an individual interview as <strong>the</strong> recorder must be able to<br />

record general <strong>the</strong>mes. Counting responses is not important, but identifying <strong>the</strong>mes and noting that most or many <strong>of</strong><br />

<strong>the</strong> participants felt <strong>the</strong> same way about issues is important. It is important to note if someone is very different from<br />

<strong>the</strong> group with <strong>the</strong>ir behaviors or thoughts. We call this type <strong>of</strong> person an “outlier” and we need to understand this<br />

dynamic <strong>of</strong> <strong>the</strong> group when we analyze <strong>the</strong> data. Names are never used in <strong>the</strong> recording, although you might identify a<br />

speaker by <strong>the</strong>ir job description, should you know it. For example, “<strong>the</strong> nurses in <strong>the</strong> group felt...”<br />

Resources<br />

13


Conducting an Interview:<br />

1) Components <strong>of</strong> interview:<br />

a) <strong>The</strong> person being interviewed: “interviewee,” (assessment or research participant)<br />

b) <strong>The</strong> person who does <strong>the</strong> interview: “interviewer” (staff)<br />

c) Subject matter:<br />

i) Coherent list <strong>of</strong> questions around <strong>the</strong>me<br />

ii) 1 - 2 broad questions that allow a person to talk freely<br />

iii) Historical perspective: “tell me what used to be done for malaria control”<br />

d) Venue (where to hold interview):<br />

i) Use a quiet space that is free <strong>of</strong> distractions<br />

ii) Ensure that it is as private as possible<br />

e) Equipment:<br />

i) Chairs for participants, interviewer and recorders<br />

ii) Copies <strong>of</strong> interview field guide<br />

iii) Writing materials (paper, pencils/pens with extra supplies as needed)<br />

iv) Optional: tape recorders (not recommended)<br />

2) Process <strong>of</strong> <strong>the</strong> interview:<br />

a) Introduction <strong>of</strong> study team<br />

b) Explain purpose <strong>of</strong> interview<br />

c) Types <strong>of</strong> information to be obtained<br />

d) Benefit to participant or to greater good<br />

e) Obtain informed consent (this depends on what is required in a particular country)<br />

f) Conduct interview<br />

g) Conclude, check for missing data and thank participant:<br />

i) Acknowledge that you understand that <strong>the</strong> participant came voluntarily and<br />

committed a length <strong>of</strong> time<br />

to be with you<br />

ii) Show respect for what <strong>the</strong>y have told you<br />

iii) Reassure <strong>the</strong>m that <strong>the</strong>y have given you valuable information<br />

14<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


3) Characteristics that improve interviewing skills:<br />

a) Values:<br />

i) Patience<br />

ii) Good sense <strong>of</strong> humor<br />

iii) Flexibility<br />

iv) Tolerance<br />

b) Ability to recognize <strong>the</strong> need to change interviewing style:<br />

i) May need to speed up or slow down<br />

ii) May require a different way <strong>of</strong> phrasing a question:<br />

(1) Use <strong>of</strong> paraphrasing, which is re-phrasing what you think <strong>the</strong> participant said (e.g.., “I understand that<br />

you just said that you think most women use antenatal care in this area—have I understood correctly<br />

what you meant?”)<br />

(2) Use <strong>of</strong> “third party” technique (e.g., “Someone told me that <strong>the</strong>y think… [insert a statement that you<br />

want <strong>the</strong> participant to respond to]. Do you agree with that?”]<br />

(3) Use <strong>of</strong> reflexive questioning, which is changing <strong>the</strong> responses into question format (e.g., Do I<br />

understand that you think XX drug is <strong>the</strong> best to use for malaria?)<br />

(4) Clarifying when something <strong>the</strong> participant said does not make sense to you (e.g., “I am sorry, I do not<br />

understand what you mean. Could you please help me by giving me an example <strong>of</strong> what you mean?”)<br />

iii) May need to direct participants back to <strong>the</strong> question if <strong>the</strong>ir response focuses on o<strong>the</strong>r issues<br />

c) Interviewer behaviors that encourage participants:<br />

i) Knowing <strong>the</strong> interview guide questions very well:<br />

(1) Practicing <strong>the</strong> questions many times before you start <strong>the</strong> assessment or study<br />

(2) Use <strong>the</strong> guide to only glance at <strong>the</strong> questions, ra<strong>the</strong>r than reading it<br />

(3) Recognizing if <strong>the</strong> participant has already given you information that would answer a later question (if<br />

you know <strong>the</strong> guide well enough, you will know where participants’ answers belong)<br />

ii) Demonstrating relaxed body language, leaning slightly forward in <strong>the</strong> direction <strong>of</strong> <strong>the</strong> participant, not<br />

appearing restless<br />

iii) Making direct eye contact with participant, nodding head or showing ano<strong>the</strong>r physical sign that you are<br />

hearing what <strong>the</strong> participant is saying (NOTE: this does not signify that you necessarily agree with <strong>the</strong><br />

participant, only that you are paying attention to what <strong>the</strong>y are saying)<br />

iv) Not interrupting <strong>the</strong> participant until he or she is finished<br />

v) Using encouraging language: e.g., “That is really interesting, no one ever told me that before.”<br />

Resources<br />

15


d) Demonstrating good “listening” skills:<br />

i) Be attentive while you write<br />

ii) Write quickly and use abbreviations that are known to you<br />

iii) Ask participant to slow down if needed<br />

iv) Record major <strong>the</strong>mes and fill in gaps later<br />

v) Write legibly:<br />

(1) Remember that sometimes o<strong>the</strong>r people must do <strong>the</strong> transcribing and analysis.<br />

Your data must be able to be read by <strong>the</strong>m or else it is considered “lost” data.<br />

vi) Make sure you do a thorough check <strong>of</strong> <strong>the</strong> data at <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview:<br />

(1) Ensure that all questions have been answered BEFORE <strong>the</strong> participant leaves.<br />

If something is missing, ask <strong>the</strong> question.<br />

(2) Correct any abbreviations used and fill in gaps to make <strong>the</strong> data<br />

understandable to o<strong>the</strong>rs<br />

(3) Spell correctly<br />

(4) If including a quote given in a local language, write <strong>the</strong> quote exactly as given<br />

in <strong>the</strong> local language and include a translation. You can discuss <strong>the</strong> translation<br />

in debriefing sessions.<br />

4) Solutions to common problems during interviewing:<br />

a) Interviewer can not understand <strong>the</strong> words being used:<br />

i) Ask participant to slow down, ask for clarity, ask for a spelling <strong>of</strong> <strong>the</strong> word<br />

b) Interviewer can not understand <strong>the</strong> concepts or ideas expressed by participant:<br />

i) Ask for examples<br />

c) Answers given are too long or complicated:<br />

i) Re-phrase what you think you heard and ask participant if you have missed anything<br />

BEFORE going on<br />

to next question<br />

16<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


d) Environment is noisy and you cannot hear what is being said:<br />

i) Stop interview and see if you can change venue or position <strong>of</strong> where you are seated to<br />

maximize your hearing<br />

e) Participant seems uncomfortable with a question or topic:<br />

i) Acknowledge to participant that you understand it is a difficult or sensitive topic<br />

ii) Identify <strong>the</strong> benefit for <strong>the</strong> participant (e.g., “I understand that it is difficult to discuss your child’s serious<br />

illness. You might feel better if you are able to talk about your feelings. As well, your experience might assist<br />

o<strong>the</strong>r parents in this situation as we can learn from your experience.”)<br />

iii) Move to ano<strong>the</strong>r question if participant is too uncomfortable<br />

iv) Make notation in interview guide why question was not answered<br />

List <strong>of</strong> Resources<br />

Green, J. Qualitative Methods for Health Research. Thousand Oaks: Sage Publications, 2004.<br />

Johns Hopkins University. January 2000. Qualitative research for improved health programs: A Guide to Manuals for<br />

Qualitative and Participatory Research on Child Health, Nutrition, and Reproductive Health. (a review <strong>of</strong> manuals on<br />

rapid assessment procedures (RAP)http://sara.aed.org/publications/cross_cutting/qualitative/qualitative.pdf<br />

Patton, MQ. How to use Qualitative Methods in Evaluation. Thousand Oaks: Sage Publications, 1987.<br />

Resources<br />

17


18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Resource 3: Resources for Training Sessions<br />

(PowerPoint presentations)<br />

Overview <strong>of</strong> rapid assessment: <strong>Rapid</strong> assessments:<br />

general issues<br />

Overview <strong>of</strong> modules: 1 & 2; 3, 4, 5 & 8; 6, 7, 9 & 10<br />

Epidemiology <strong>of</strong> malaria: Epidemiology and control <strong>of</strong><br />

malaria in pregnancy<br />

Clinical and laboratory methods: <strong>Assessment</strong> <strong>of</strong> gestational age, Body<br />

measurements, Laboratory methods<br />

O<strong>the</strong>r assessment topics: Data management and sample size calculation<br />

<strong>The</strong> Presentations are available only on <strong>the</strong> CD-ROM.<br />

Note: A CD-ROM will be enclosed that contains all <strong>the</strong> items listed.<br />

<strong>The</strong> entire package will be available electronically on<br />

CDC's <strong>Malaria</strong> Web site: www.cdc.gov/malaria.<br />

Resources<br />

19


20 18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Resource 4: S<strong>of</strong>tware and Planning Tools<br />

(Costing Tool included in review package)<br />

Costing Tool<br />

Epi Info (for information and to download go to www.cdc.gov/epiinfo/)<br />

Note: A CD-ROM will be enclosed that contains all <strong>the</strong> items listed.<br />

<strong>The</strong> entire package will be available electronically on<br />

CDC's <strong>Malaria</strong> Web site: www.cdc.gov/malaria.<br />

Resources<br />

21


Costing Tool for <strong>Rapid</strong> <strong>Assessment</strong><br />

Adapted from UNICEF’s Multiple Indicator Cluster Survey End<br />

Decade <strong>Assessment</strong>, as accessed at http://www.childinfo.org/MICS2/<br />

finman/M2finM.htm, March 1, 2005.<br />

Table 1<br />

<strong>Assessment</strong> Budget Items and Estimates for a <strong>Rapid</strong> <strong>Assessment</strong><br />

Using Both Quantitative and Qualitative Components<br />

Budget item<br />

Basis for calculation<br />

Personnel (salaries plus indirect costs) Quantitative Component<br />

Quantitative assessment coordinator<br />

Data management coordinator<br />

Site supervisors<br />

Laboratory supervisor<br />

Interviewers<br />

Laboratorians<br />

Data entry clerks<br />

Computer programmers<br />

Drivers<br />

Qualitative Component<br />

Qualtitative assessment coordinator<br />

Interviewers<br />

Drivers<br />

Transportation<br />

Vehicle rental<br />

Public transportation allowance (urban areas)<br />

Fuel<br />

Contingency costs (repairs, ferries, etc.)<br />

Consumables<br />

Stationery (paper, pencils, pens, etc.)<br />

Identification cards<br />

Envelopes for filing<br />

Computing supplies<br />

(paper, diskettes, ribbons, cartridges)<br />

Lab supplies<br />

(microscope, RDTs, hemocues, etc.)<br />

O<strong>the</strong>r costs<br />

Questionnaire and form printing<br />

Photocopies <strong>of</strong> maps, listings and<br />

instruction manuals<br />

Anthropometric equipment<br />

(weighing scales, height/length boards, etc.)<br />

Communications (phone, fax, postage, etc.)<br />

Report writing and printing<br />

Training<br />

Hospital costs<br />

1 coordinator x 24 weeks<br />

1 coordinator x 12 weeks?<br />

4 supervisors x 8 - 9 weeks<br />

1 supervisor x 8-9 weeks<br />

8 interviewers x 8 - 9 weeks<br />

4 laboratorians x 8-9 weeks<br />

2 clerks x 5 weeks<br />

1 programmer x 8 weeks?<br />

4 drivers x 8 - 9 weeks<br />

1 coordinator x 24 weeks<br />

6 - 8 interviewers x 8 - 9 weeks<br />

1 driver x 8 - 9 weeks<br />

5 cars x 8 -9 weeks<br />

variable<br />

provision for 5 cars x 8 - 9 weeks<br />

variable<br />

variable<br />

variable<br />

120 envelopes<br />

variable<br />

variable<br />

variable<br />

variable<br />

variable<br />

variable<br />

variable<br />

variable<br />

variable<br />

22<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Table 2<br />

Costing Framework: Items Included in Cost and Activity Categories<br />

Personnel (salaries)<br />

Cost categories<br />

<strong>Assessment</strong> coordinator (Quantitative,<br />

qualitative)<br />

Data management coordinator<br />

Site supervisors<br />

Laboratory supervisor<br />

Interviewers<br />

Laboratorians<br />

Drivers<br />

Data entry clerks<br />

Computer programmers<br />

Drivers<br />

Transportation<br />

Vehicle rental<br />

Public transportation allowance<br />

Fuel<br />

Maintenance costs<br />

Consumables<br />

Stationery<br />

(papers, pencils, pens, etc.)<br />

Identification cards<br />

Envelopes for filing<br />

Computing supplies<br />

(paper, diskettes, ribbons,<br />

cartridges)<br />

Lab supplies<br />

(microscopes, RDTs, hemocues, etc.)<br />

Equipment<br />

Anthropometric equipment (weighing<br />

scales, height/length boards, etc.)<br />

O<strong>the</strong>r costs<br />

Printing (questionnaire, etc.)<br />

Photocopies <strong>of</strong> maps, listings,<br />

instruction manuals<br />

Equipment maintenance<br />

Communications (phone, fax, postage,<br />

etc.)<br />

Report writing and printing<br />

Training<br />

Hospital costs<br />

Activity categories<br />

Preparation/sensitization<br />

Adaptation <strong>of</strong> questionnaire<br />

Translation and back-translation<br />

Pre-testing <strong>of</strong> questionnaire<br />

Survey design and sample calculation<br />

Planning<br />

Sample calculation<br />

Training<br />

Preparation <strong>of</strong> training materials<br />

Translation into training language<br />

Implementation <strong>of</strong> training,<br />

including piloting<br />

<strong>Assessment</strong> implementation<br />

Implementation<br />

Monitoring and supervision<br />

Data retrieval<br />

Data input<br />

Data entry<br />

Error checking<br />

Data processing and analysis<br />

Data processing<br />

Data cleaning<br />

Tables <strong>of</strong> analysis<br />

Report writing<br />

Dissemination and fur<strong>the</strong>r analysis<br />

Report printing<br />

Distribution<br />

Feedback meetings, if needed<br />

Fur<strong>the</strong>r analysis, if needed<br />

Resources<br />

23


Table 3<br />

Costing Framework<br />

COST<br />

CATEGORIES<br />

TOTAL<br />

COSTS<br />

ACTIVITY CATEGORIES<br />

Preparation/<br />

sensitization<br />

Pilot<br />

study<br />

Survey<br />

adaptation<br />

and<br />

calculation<br />

<strong>of</strong> sample<br />

size<br />

Training<br />

<strong>Assessment</strong><br />

implementation<br />

Data<br />

input<br />

Data<br />

processing<br />

and<br />

analysis<br />

Report<br />

writing<br />

Dissemination<br />

and fur<strong>the</strong>r<br />

analysis<br />

Personnel<br />

Transportation<br />

Consumables<br />

Equipment<br />

O<strong>the</strong>r costs<br />

TOTAL COSTS<br />

Any<br />

participating<br />

agencies or<br />

institutions<br />

(names)<br />

Supplementary details<br />

1. Sample size: ________<br />

2. Number <strong>of</strong> interviewers/laboratorians/supervisors<br />

Interviewers: ______ Laboratorians: ______ Supervisors: ______<br />

3. Duration <strong>of</strong> training for assessment team (number <strong>of</strong> days): ________<br />

4. Duration <strong>of</strong> assessment (number <strong>of</strong> days): ________<br />

24<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy


Resources 25


26<br />

<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!